ZIMBABWEAN

GOVERNMENT GAZETTE
Published by Authority

Vol. XC, No. 69 14th DECEMBER, 2012 Price US$2,00

General Notice 592 of 2012.

MEDICINES AND ALLIED SUBSTANCES CONTROL ACT [CHAPTER 15:03\

Approval of Registration of Human Medicines

IT is hereby notified, in terms of section 24( 1 )(b) of the Medicines and Allied Substances Control Act [Chapter 15:03], that the Medicines
Control Authority has approved the registration of the medicines specified in the Schedule.

G. N. MAHLANGU,
14-12-2012. Director-General.
Sc h e d u l e

F ile N o . A ppI N o . A p p ro v ed n a m e T V ad e S tre n g th F o rm . A p p lic a n t

4 2 2 5 0 0 F 6 8 2 H E P A T IT IS B S U R F A C E A N T IG E N S H A N V A C -B 2 0 M C O P E R M L U Q U ID S S H A N T H A B IO T E C H N IC S ( P V T ) L T D

4 2 2 6 0 0 0 G 4 1 A T E N O L O L N O V A T E N -5 0 5 0 M G T A B L E T S .C O A T E D A JA N T A P H A R M A L IM IT E D

4 2 2 7 0 0 G 1 2 J N E V IR A P IN E N E V IR A P IN E 2 0 0 M O T A B L E T S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

4 2 3 0 0 0 F 9 3 7 T H IO P E N T O N E S O D IU M IN T R A M E D T H IO P E N T O N E S O D IU M 0 .5 G /2 0 M L P O W D E R S F O R IN J E C T IO N IN T R A M E D (P T Y ) L T D , K O R S T E N ,P E ,S A

4 2 3 3 0 0 0 G 8 8 S IB U T R A M IN E H C L M O N O H Y D R A T E S IB U T R IM -JO lO M G C A P S U L E S G L E N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 4 O O G II8 E S O M E P R A Z O L E M A G N E S IU M T O IH Y D R A T E E S O Z -2 0 2 0 M G . T A B L E T S .C O A T E D G L E N M A R K P H A R M A C E U T IC A L S L T D , IN D IA

4 2 3 5 0 0 G II7 E S O M A P R A Z O L E M A G N E S IU M T R H Y D R A T E E S O Z -4 0 4 0 M G T A B L E T S . C O A T E D G l^ N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 6 0 0 0 G 8 5 G L IM E P IR ID E G L IM U L IN -2 2 M G T A B L E T S G L E N M A R K P H A R M A C E U T IC A L S L T D , IN D IA

4 2 3 7 (K )0 G 7 8 A D A P A L E N E D E R IV A A Q U E O U S G E L 0 .1 % W W G E L S G L E N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 9 0 0 G I2 2 N O R G E S T R E L & E T H IN Y L E S T R A D IO L L U S IA -F 0 .3 /0 .0 3 M G T A B L E F S . C O A T E D F A M Y C A R E L T D

4241 0 0 F 8 3 6 A L B E N D A Z O L E N E M O Z O L E 1 0 0 M O /5 M L S U S P E N S IO N S , O R A L IP C A L A B O R A T O R IE S L T D . IN D IA

4 2 4 2 Z 0 0 2 9 6 M A IN T E L Y T E M A IN T E L Y T E 2 .0 5 /I .8 6 /0 J I G , IN T R A V E N O U S S O L U T IO N S D A T L A B S P V T L T D . B U L A W A Y O .Z I M B A B W E

4 2 4 3 G 0 F 8 I9 C IP R O F L O X A C IN H Y D R O C H L O R ID E C lP R O X lN -5 0 0 5 0 0 M G T A B L E T S .C O A T E D U M E D iC A , M U M B A I, IN D IA

4 2 4 4 0 0 F 5 3 2 C E F T R IA X O N E C E F T R IA X O N E lO O M G /V lA L P O W D E R S F O R IN JE C H O N M IC R O L A B S L T D , B A N G A L O R E . IN D IA

4 2 4 5 0 0 F 3 7 I C IP R O F L O X A C IN H Y D R O C H L O R ID E M IC R O F L O X -5 0 0 5 0 0 M G /T A B L E T T A B L E T S M IC R O L A B S L T D . B A N G A L O R E , IN D IA

I 4 2 4 6

4 2 4 9
0 0 F 6 4 8

0 0 F 8 6 5
O M E P R A Z O L E

I R O N ( lll)H Y D R O X I D E

P O L Y M A L T O S E C O M P L E X
O M IC A P

O R O F E R
2 0 M G

5 0 M G
C A P S U L E S

S Y R U P S
M IC R O L A B S L T D , B A N G A L O R E , IN D IA

E M C U R E P H A R M A C E U T IC A L S L T D

4 2 5 0 0 0 F 6 2 4 C E T IR IZ IN E H Y D R O C H L O R ID E A L L E R C E T lO M G T A B L E T S , C O A T E D M IC R O L A B S L T D , B A N G A L O R E .I N D I A

4251 0 0 0 G 4 7 L A M IV U D IN E & S T A V U D IN E C O V IR O L S -3 0 1 5 0 /3 0 M G T A B L E T S R A N B A X V L A B S L T D , G U R G A O N , IN D IA

4 2 5 3 0 0 0 G 1 9 IB U P R O F E N IB U P R O F E N 2 0 0 M G T A B L E T S .C O A T E D F D C L I M I T E D . J O G E S H W A R I .IN D I A

4 2 5 4 0 0 0 G 2 0 IB U P R O F E N IB U P R O F E N 4 0 0 M G T A B L E T S .C O A T E D F D C L IM IT E D , JO G E S H W A R I. IN D IA

4 2 5 6 0 0 F 9 8 0 A T O R V A S T A T IN C A L C IU M L IP IT A S 2 0 2 0 M G T A B L E T S .C O A T E D IN T A S P H A R M A C E U T IC A L S L IM IT E D

4 2 5 7 O O F 769 L p S A R T A N P O T A S S IU M P R E S A R T A N -2 5 2 5 M G ' T A B L E T S IP C A L A B O R A T O R IE S L T D . IN D IA

4 2 5 8 0 0 F 77 O L O S A R T A N P O T A S S IU M P R E S A R T A N -5 0 5 0 M G T A B L E T S IP C A L A B O R A T O R IE S L T D , IN D IA

4 2 5 9 O O O O G 2 L A M IV U D IN E 3 T C 3 0 0 M C 3 0 0 M G T A B L E T S .C O A T E D G L A X O -W E L L C O M E Z IM B A B W E P V T

L T D . H A R A R E

4261 0 0 0 1 8 1 S T A V U D IN E S T A V U D IN E 3 0 M G 3 0 M G C A P S U L E S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

4 2 6 2 0 0 G 1 3 5 ro V ID O N E -IO D IN E P O V IC ID E 0 .1 G O IN T M E N T S P L U S F IV E P H A R M A C E U T IC A L S P V T

L T D , B U L A W A Y O

4 2 6 3 0 0 F 7 0 2 H Y O S C IN E C H L O R ID E , H Y O S C IN E C H L O R ID E lO M G T A B L E T S m o r n in o s id e ph a r m l t d .u k
4 2 6 5 0 0 G I4 8 G E L A T IN S U C C IN Y L G E L O F U S IN E 4 % 4 % IN F U S IO N S B . B R A U N M E L S U N G E N A G

(C O N C E N T R A T E D S O L U T IO N )

4 2 6 6 O O O G 58 A D R E N A L IN E A C ID T A R T R A T E A D R E N A U N E -F R E S E N iU S 1 .8 M G /1 0 0 0 M L S IN F U S IO N S INTRAMED (PTY) LTD, KORSTEN. PE,SA

4 2 6 8 0O F 887 C L O T R IM A Z O L E C A N D ID V -1 5 0 0 M G T A B L E T S GLENMARK PHARMACEUTICALS LTD. INDIA
4271 0 0 0 0 G 5 L IS IN O P R IL • ’
T O R R E N T -L IS IN O P R IL -5 5 M G T A B L E T S I . .TORRENT PHARMACEUTICALS INDIA
4 2 7 2 0O O O G 6 L IS IN O P R IL T O R R E N T -U S IN O P R IH O ]0 M G T A B L E T S TORRENT PHARMACEUTICALS INDIA
4 2 7 3 0 0 F 9 0 8 T R IF L U O P E R A Z IN E H Y D R O C H L O R ID E T R IF L U O P E R A Z IN E 5 T A B L E T S 5 M G T A B L E T S , C O A T E D REMEDICA LTD CYPRUS
4 2 7 4 O O G 107 P R E D N IS O N E P A N A F C O R T 5 M O T A B L E T S ADCOCK INGRAM LIMITED
4 2 7 7 0 0 0 0 8 0 N O R F L O X A C IN N O R F L O X A C IN 4 0 0 M G T A B L E T S .C O A T E D VARICHEM PHARMACEUTICALS (PVT) LTD, HRE
4 2 7 8 0 0 F 8 4 2 S A L B U T A M O L S A L B U T A M O L 4 M O T A B L E T S FLAMINGO PHARM CHEMBUR, MUMBAI. INDIA
4 2 7 9 O O O G 93 N A L ID IX IC A C ID N A L ID IX IC A Q D 5 0 0 M G T A B L E T S f ix : LIMITED, JOGESHWARI.INDIA
4 2 8 0 0 0 F 7 4 9 B E N Z Y L P E N IC IL L IN S O D IU M B E N Z Y L P E N IC IIU N S O D IU M 5 M U POWDERS FOR INJECTION UMEDICA. MUMBAI, INDIA
4281 0 0 G 2 0 1 K E T A M IN E H Y D R O C H L O R ID E K E T A M I N E - F R E S E N I U S 5 0 M O /M L 5 0 M G /M L IN JE C T IO N S IN T R A M E D (P T Y ) L T D . K O R S T E N , P E , S A

4 2 8 2 0 0 G 1 I4 A M O X Y C IL L IN T R IH Y D R A T E & P O T A S S IU M 8 7 5 /I2 5 M G T A B L E T S .C O A T E D R A N B A X Y L A B S L T D .
E N H A N C IN

C L A V U L A N A T E G U R G A O N . IN D IA

4 2 8 3 0 0 O G 2 6 A M O X Y C IL L IN T R IH Y D R A T E A M O X Y C IL L IN 1 2 5 M G /5 M L S U S P E N S IO N S , O R A L M IS S IO N P H A R M A A /S . D E N M A R K

4 2 8 4 . 0 0 0 1 9 2 IS O P H A N E IN S U L IN T O O IU /M L IN JE C T IO N S M ./ . B IO P H A R M A (P V T ) L T D
IN S U L ID D N

4 2 8 5 0 0 C 2 O 9 M E T H Y L D O P A 2 5 0 M G T A B L E T S .C O A T E D T A N T U R E IN V E S T M E N T S
D O P A T A B M 2 5 0 •

4 2 8 6 0 0 G I7 8 E R Y T H R O M Y C IN S T E A R A T E 2 5 0 M G T A B L E T S .C O A T E D IN D O C O R E M E D IE S L T D . , •
IN D O -2 5 0

4 2 8 9 O O G 146 P R O P O F O L lO M O /M L IN JE C T IO N S
P R O P O F O L * U P U R O I% B .B R A U N M E L S U N G E N A O

4 2 9 0 0 0 0 0 7 9 L A M IV U D IN E 150M O . '’ T A B L E T S .C O A T E D
L A M IV U D IN E V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D , H R E
'9 7 0 Zim b a b w e a n Go v e r n m e n t Ga z e t t e ,, 14t h De c e m b e r , 2012

F ile N o . A p p I N o .. A p p ro v e d n a m e T V ad e n a m e S tren g d i F o rm A p p lic a n t

4292 0O F609 , C E F T R I A X O N E S O D IU M C E F T R IA X O N E S O D I U M 250M O m AL P O W D E R S F O R IN JE C T IO N C A P S P V T L T D , H A R A R E , Z IM B A B W E

♦ 293 00PS39 C L O X A C IL L IN S O D IU M C L O X A C IL L IN S O D IU M 5W M G P O W D E R S F O R I N I E C T IO N F L A M I N G O P B A R M C H E M B U R ,M U M B A I , I N D I A

4294 00G 193 I N S U L IN Z I N C .I N S U L ID D L l O O I U /M L . I N A C T IO N S M . J . B IO P H A R M A (P V T ) L T D

4295 0 0 Q I9 4 S O L U B L E IN S U U N ( H U M A N I N S U L IN ) ' I N S U L ID D -R ■ lO O IU /M L IN JE C T IO N S M . J . B T O P H A R M (P V T ) L T D
4296' 000G 89 G U A IP H B N E S I N E X P E L IN C T 2 0 0 M G /1 0 M L SYRUPS A D C O C K IN G R A M U M IT E D

4297 00F874 D O M P E R ID O N E DOM STAL I M Q /M L S U S P E N S IO N S TO R R ENT EXPO RTS LTD

4298 0O G 14O . L O R A T ID IN B L O R A T IN T O M G /T A B L E T TA B LETS C IP L A L T D , M U M B A I, IN D IA

4301 00F912 F L U T IC A S O N E D IP R O P IO N A T B F L O M IS T 50M C G SPRAYS, N A SA L C IP L A L T D , M U M B A I, IN D IA

4302 O O F909 B E C L O M B T H A S O N E D I P R O P IO N A T E BECLA TEA Q UA N ASE 5 0 M C G /S P R A Y S P R A Y S ,N A S A L C I P L A L T D , M U M B A I , I N D IA

M ONOHYDRATE

4303 00F685 D IC L O F E N A C V r v IA N -2 5 25M G TABLETS, CO ATED P H A R M A C E U T IC A L & C H E M I C A L D I S T .

HARARE
4305 000G 6O S O D C L M A G C L J > 0 T A S C L ,D E X T R O S E IN T R A M E D P O S T S U R G IC A L IN F U S IO N S I N T R A M E D X P T Y ) L T D , K O R S IE N , P E . S A

ANHYDROUS S O L U T IO N
4306 O OO G59 ; S O D C L J > O T A S C L 3 0 D L A C T A T E ,C A L C C L . IN T R A M E D R IN G E R L A C T A T E IN F U S IO N S IN T R A M E D (P T Y ) L T D , K O R S T E N , P E . S A
4307 0 0 G I8 0 C H L O R P H E N IR A M IN E M A L E A T E ' A LLERGEX 4M G TA B LETS A D C O C K I N G R A M L I M IT E D
4308 00O G 31 G L IB E N C L A M I D E * G L I B E N C L A M ID E 5M G TA B LETS M I S S IO N P H A R M A A /S , D E N M A R K

4309 000G 37 C A R B A M A Z E P IN E C A R B A M A Z E P IN E 2 « )M G TA B LETS M IS S IO N P H A R M A A /S , D E N M A R K

4312 0 0 G 2 I8 L A M IV U D IN E 3 T A V U D IN E & N E V IR A P IN E T R I O M U N E -3 0 I 5 0 /3 0 /a X )M G TA B LETS C I P L A L T D , M U M B A I , I N D IA
4314 00F323 C A P T O P R IL C A PO R EX 2 5 M G /T A B L E T TABLETS . C A P S P V T U T D . H A R A R E . Z IM B A B W E

4317 00G 21! A M O X l .a L L I N T R IH Y D .+ P O T A S S IU M C L A V M Y C L A V -3 7 5 , TAB LETS, C O A TED U N IC H E M L A B O R A T O R IE S L IM IT E D

4318 O O G212 S E C N ID A Z O L E TA GERA FO RTE IG TA BLETS, C O A TED U N IC H E M L A B O R A T O R IE S U M IT E D
4319 000G 12 , DOXYCYCUNEBP , A LLD O X , lO O M G CA PSU LES P H A R M A C E im C A L & C H E M IC A L D IS T .

HARARE
4323 00G 286 C E L E C O X IB C E L I B lO O M G lO O M G CAPSULES U N IC H E M L A B O R A T O R IE S U M IT E D
4324 00G 287 C E L E C O X IB C E L IB 2 0 0 M G 200M G CAPSULES U N IC H E M L A B O R A T O R IE S U M IT E D
4326 00G 147 L ID O C A IN E H Y D R O C H L O R ID E L I D O C A IN B B B R A U N 1 ® lO M G /M L I N J E C T IO N S B .B R A U N M E L S U N G E N A G

4328 000367 N Y S T A T IN - N Y S T A T I N P E S S A R Y lO O O O O O lU . l O O O O O O IU P E S S A R IE S S M P H A R M A C E U T IC A L S
4329 000142 ' K ETOK O NA ZO LE Z lN p R A L 2 % V //V /1 0 Q M L SHAM POOS a P L A L T D , M U M B A I. IN D IA
4332 Z00313 . M A N N lT O L 5 % F O R IR R IG A T IO N M A N N IT O L 5 % F O R I R R IG A T IO N 5% I R R IG A T I O N S D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E
4333 ’ 00F847 A TENO LO L
H IP R E S 50M O TAB LETS • C I P L A L T D . M U M B A I , I N D IA

I
4334 000G82 Z ID O V U D IN E Z ID O V U D I N E 300M G TA BLETS, CO A TED , V A R IC H E M P H A R M A C E U T I C A L S ( P V T ) L T D , H R E
4335 00G 457 C H L O R P R O M A Z IN E H Y D R O C H L O R ID E C H I- O R P R O M A Z IN E H C U F R E S E N T U S 5 0 M G /2 M L IN JE C T IO N S B O D E N E { P T Y )U rD

4336 00G 458 P R O M E T H A Z IN E H Y D R O C H L O R ID E P R O M E T H A Z IN E H C L -H IE S E N I U S U S 2 5 M G /M L IN JE C T IO N S B O D E N E (P T Y ) L T D

4338 00G 150 A M O X laL U N T R IH Y D R A T E & C L A V U L A N A T E C LAV AM 625 TABLETS, CO A TED A LKEM LA BS LTD -

P O T A S S IU M

4339 00P838 G U A IP H E N K IN G U A IP H E N E S IN B E T A M IN T 1 (» M G /5 M L SYRUPS Z I M B A B W E P H A R M A C E U T IC A L S

4340 00G 280 A C Y C L O V IR A D C O -A C Y C L O V IR T O P IC A L C R E A M 2 5 0 M G /5 G CREAM S A D C O C K IN G R A M U M IT E D

4342 00G 422 E N () X A P A R I N C LEX A N E 20 2 0 M G A )Z M L IN J E C T IO N S ■ A V E N T IS P H A R M A ( P T Y ) L T D

4343 00G 423 E N O X A P A R IN C LEXA NE60 6 0 M G « > .6 M L I N J E C T IO N S A V E N T IS I ^ A R M A (P T Y ) L T D

4344 00G 424 E N O X A P A R I N S O D IU M C L EX A N E 80 80M G IN JE C T IO N S A V E N T IS P H A R M A (P T Y ) L T D

4345 00F913 FLUCO NA ZO LE F O R C A N -5 0 50M G C A PSU LES C I P L A L T D . M U M B A I , I N D IA

4347 00F898 C A N D E S < \K T A N C I L E X E T IL ATACAND 8M G TABLETS IN D U S T R IA L C H E M IC A L IM P O R T E R S , H A R A R E

4348 00F899 C A N D E S A R T A N a tE X E T IL ATACAND I6 M G TAB LETS . IN D U S T R IA L C H E M IC A L IM P O R T E R S , H A R A R E

4349 00F824 E S O M E P R A Z O L E M A G N E S I U M T R IH Y D R A T E N B X IU M 20M G TA BLETS, CO A TED IN D U S T R IA L C H E M IC A L IM P O R T E R S , H A R A R E

4350 00F825 E S O M E P R A Z O L E M A G N E S I U M T R IH Y D R A T E N E X IU M 40M O TA B LETS, CO ATED IN D U S T R IA L C H E M IC A L IM P O R T E R S , H A R A R E

4353 000302 SALBUTAM OL A SM ED SY RUP 2 M G /5 M L SYRUPS . P L U S F IV E P H A R M A C E U T IC A L S P V T

LTD. BULAW AYO

4354 00G 290 C L O T R IM A Z O L E U S P C A N D ID D U S T IN G P O W D E R 1% - POW DERS G L E N M A R K P H A R M A C E U T I C A L S L T D . I N D IA

4356 00G 388 P IR O X IC A M F L A M A C A P .y O lO M G C A PSU LES G R A N IT E S ID E C H E M I C A L S ( P V T ) L T D , H A R A R E
4357 ■ 000389 P I R O X IC A M F L A M A C A P -2 0 20M G G R A N IT E S ID E C H E M I C A L S ( P V T ) L T D , H A R A R E
C A PSU LES
4362 00F995 C L O X A C IL L I N S O D IU M IC L O X 250M G C A PSU LES I P C A L A B O R A T O R IE S L T D , I N D IA
4363 00G 365 S U L P H A M E T H O X A Z O L E + T R IM E T H O P R IM S U L P H A M E T H
2 000X+ A
4 02M
OLGB
/ 5&
M L S U S P E N S IO N S , O R A L S M P H A R M A C E U T IC A L S

T R I M E T H O P R IM

4364 , 000397 A LBEN DA ZO LE ABZ 400M G TAB LETS IN D O C O R E M H 5 IE S L T D

4366 00G 317 U D O C A I N E H Y D R O C H L O R ID E L IG N O X 2 % 2 % W /V IN JE C T IO N S IN D O C O R E M E D IE S L T D

4370 0O F7O 4 FL U O R O U R A at F IV O F L U 5 0 M G /M L IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D
4371 0O F7O 5 M ETHO TREX ATE ‘Z E X A T E 2 5 M G /M L IN J E C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D
4372 000G 94 C L O B E T A S O L P R O P IO N A T E G L E V A T E O .0 5 % 0B 5% CREAM S G L E N M A R K P H A R M A C E U T I C A L S L T D , I N D IA
4373 00G 281 B E T /V M E T H A S O N E A D C O -B E T A M E T H A S O N E C R E A M 6 M G /5 G CREAM S A D C O C K I N G R A M L IM IT E D

4376 O O G284 A TO RV A STA H N T G -T O R 1 0 lO M G TA BLETS, C O A TED U N IC H E M L A B O R /O O R IE S U M IT E D

4377 00G 285 A T O R V A S T A T IN T G -T O R 2 0 20M G TA B LETS, CO ATED U N IC H E M L A B O R A T O R IE S U M IT E D

4378 00G 32I : A M L O D I P IN E B E S IL A T E A M L O C O R -1 0 lO M G TAB LETS T O R R E N T P H A R M A C E U T IC A L S I N D I A

4379 O O Q322 A M L O D IP I N E B K IL A T E A M L O C O R -5 5M G TAB LETS T O R R E N T P H A R M A C E U T IC A L S IN D IA

4380 O OO F55 a M B n D IN E 2 ( K ) M G T A B L E T S U L C E R IN E 2 0 0 2 (K )M G TABLETS P L U S F I V E P H A R M A C E U T IC A L S P V T L T D .

4381 0Q 0F56 C I M E T ID I N E 4 0 0 M G T A B L E T S U L C E R IN 4 0 0 4 (» M G TAB LETS

BU LA W A YO

P L U S F I V E P H A R M A C E U T IC A L S P V T L T D ,
i
BULAW AYO . •

4383 00G 272 A C n fC L O V IR V IR A M E D 5 % T O P I C A L C R E A M 5% CREAM S P L U S R V E P H A R M A C E U T IC A L S P V T L T D ,

BULAW AYO
4384 O O E 4 7 I. P H Y T O M E N A D IO N E K O N A K IO N M I X E D M I C E L L E 2 M G /0 1 M L S O L U T IO N S H O F F M A N L A R O C H E S W IT Z E R L A N D
4385 000113 S IL D E N A R L C IT R A T E CA N O VA TA BLETS 50M G TAB LETS. CO A TED R A N B A X Y L A B S L T D , G U R G A O N , IN D IA

4386 00G 3n S IL D E N A F IL C T T R A T E CANOVA lO O M G TA B LETS. CO ATED R A N B A X Y L A B S L T D . G U R G A O N , IN D IA

4387 000166 ' D IS O D IU M H Y D R O G E N C T T R A T E C IT A L U 7 Q /5 M L SYRUPS IN D O C O R E M E D IE S L T D

4388 000158, . F L U (X ) N A Z O L E . F L U M Y C -5 0 50M O C A PSU LES I P C A L A B O R A T O R IE S L T D .I N D IA

4390 00G 16O FLUCONAZOLE F L U M Y C -2 0 0 200M G C A PSU LES I P C A L A B O R A T O R I E S L T D .I N D IA

4391 00F811 C IP R O F L O X A C IN H Y D R O C H L O R ID E C IP L O X 0 .3 % W /V D R O P S .E Y E C I P L A L T D . M U M B A I , I N D IA

4392 00F736 O L A N Z A P IN E ZYPREXA lO M G P E R V IA L P O W D E R S F O R I N J E C T IO N L IL L Y E U (S A ) (F T Y ) U M IT E D

4393 00G 275 N E V IR A P IN E N E V IR A P IN E 200M G TAB LETS C A P S P V T L T D , H A R A R E , Z IM B A B W E

4394 00G 199 H E P A T I T I S - B ( rD N A K P A U J lA T R IC ) S I I H E P A T I T IS - B ( r D N A ) ( P A E D I A T R I C ) 1 DOSE V A C C IN E S S E R U M I N S T O F IN D IA L T D . P U N E .

I N D IA
4395 00G 200 H E P A T m S - B ( rD N A ) ( P A H lIA T R I C ) S E R U M I N S T O F IN D IA L T D , P U N E ,
S I I H E P A T lT IS - B ( r D N A ) ( P A E D I A T R IQ . 10 D O SE V A C C IN E S

IN D IA
4397 O O G 3 I8 PARACETAM OL PARACETAM OL 500M O TAB LETS IN D O C O R E M E D IE S L T D

4398 0 0 G I6 ! C IP R O F L O X A aN H Y D R O C H L O R ID E P R O C lP -5 0 0 5 (X )M G TA B LETS, CO ATED I P C A L A B O R A T O R IE S L T D . I N D IA

4400 00G 24! E N A L A P R IL M A L E A T E R E N N IM E D 10 lO M G TAB LETS P L U S F IV E P H A R M A C E U T IC A L S P V T L T D .

BULAW AYO

4401 00G 242 E N A L A P R IL M A L E A T E , R E N N IM E D 2 0 20M G TAB LETS P L U S F IV E P H A R M A C E U T IC A L S P V T L T D ,

BULAW AYO
4402 0 0 G I6 9 B C G B P ( F R E E Z E D R IE D ) S I I B C G V A C C IN E B P ( F R E E Z E D R I E D ) 0 B 5 M U V IA L V A C C IN E S S E R U M I N S T O F IN D IA L T D . P U N E ,

IN D IA
4403 ■ 0 0 G I7 0 B C G B P ( F R E E Z E D R IE D ) S I I B C G V A C C IN E B P ( F R E E Z E D R I E D ) O .IM L A /I A L V A C C IN E S S E R U M I N S T O F IN D IA L tD . P U N E ,

IN D IA
4404 000277 L A M IV U D IN E L A M IV U D IN E I5 0 M G ' TA B LETS, CO ATED C A P S P V T L T D , H A R A R E , Z IM B A B W E

4405 00G 247 F R U S E M ID E - D IU R E N

't a b l e t s P L U S F IV E P H A R M A C E U T IC A L S P V T L T D ,
40M Q

BULAW AYO

4406 000273 ECONAZOLE F U N G IS T O P T O P I C A L 1% CREAM S, P L U S F IV E P H A R M A C E U T IC A L S P V T L T D ,

BULAW AYO

4407 000246 E F A V IR E N Z ’ A V IR A N Z 600M G TA B LETS, CO ATED R A N B A X Y L A B S L T D . G U R G A O N , IN D IA

4408 0 0 G I8 5 ‘ C H L O R P H E N I R A M IN E C H L O R P H E N IR A M IN E 4M G TAB LETS SK AG EEXPO R TS

4409 000188 P Y R I D O X IN E H Y D R O C H L O R I D E P Y R ID O X IN E H Y D R O C H L O R ID E 25M G TAB LETS S K A G E EX PO R TS

4410 00G 410 S A L B U T A M O L S U L P H A IB ’ A S T H A L IN R E S P I R A T O R S O L U T I O N 5M G S O L U T IO N S C I P L A L T D , M U M B A I , I N D IA

 Zimb a b w e a n Go v e r n m e n t Ga 2e t t e , 14t h De c e m b e r , 2 0 1 2 971

F ile N o . A i^ )l N o . A p p ro v e d n a m e IV ad e n a m e S tren g th F o rm A p p lica n t

. 44H 00G 248 A C Y C L O V IR V IR A M E D 200M G TAB LETS P L U S F IV E P H A R M A C E U T IC A L S P V T L T D ,

BULAW AYO
4412 00G 263 C A P T O P R IL C A IP O L E X 25M G TAB LETS P L U S F IV E P H A W » 4A C E U T IC A L S P V T L T D .

BULAW AYO
4414 000570 R I F A M P IC I N .IS O N IA Z ID R I F A M P I C IN , I S O N IA Z I D I5 0 M G /7 5 M G TA B LETS, C O ATED M E D IV IS IO N W H O L E S A L E R S
4418 00G 182 FER R OU S SU LPH ATE FERROU S SULPHATE 60M O T A B L E T S ,C O A T E D SK A G E EXPORTS
4419 700909 G E E ’S L IN C T U S G E E ’S L IN C T U S L IN C T U S E S G ED DES LTD H AR A R E
4420 00G 449 A M O X I C IL L I N T R IH Y D R A T E A N D M Y C L A V -6 2 5 5 0 0 /1 2 5 M G TA BLETS. C O A TED U N I C H E M L A B O R A T O R IE S U M I T E D
C L A V U L A N A T E P O T A S S IU M

4421 00G 484 F R U S E M ID E F U R O S E M I D E -F R E S E N IU S 2 0 M G /2 M L IN JE C T IO N S B O D E N E (P T Y ) L T D ’

4422 00G 568 PARACETAM OL PARACETAM OL . 500M G . TA B LETS M E D I V I S IO N W H O L E S A L E R S

4423 00G 294 D IC Y C L O M IN E H Y D R O C H L O R ID E C Y C L O P A M S U S P E N S IO N 1 0 & 4 0 M G /5 M L S U S P E N S IO N S I N D O C O R E M E D IE S L T D
& S IM E T H IC O M E

4424 00G 278 C L O T R IM A Z O L E A D C O -C L O T R IM A Z O L E V A G I N A L , 5 0 M G /5 G CREAM S A D C O C K IN G R A M U M IT E D

CREAM
4425 00G 279 C L O T R IM A Z O L E A D C O -C L O T R lM A Z C H £ T O P lC A L 5 0 M G /5 G CREAM S A D C O C K I N G R A M L I M IT E D

CREAM
4426 O OG S48 A LB END A ZO LE W O R M ED I O O M G /5 M L S U S P E N S IO N S P L U S F IV E P H A R M A C E U T IC A L S P V T L T D .

BULAW AYO

4427 00C 251 M E T F O R M IN M E T F O R M IN 500M G TA B LETS, C O A TED a P L A L T D , M U M B A I . I N D IA

4430 00F560 T IM O L O L M A L E A T E O C U L A N E Y E D R O P S 0 ,2 5 % 0 .2 5 % W / V DROPS. EYE BA L PHARM A LTD

4431 00F561 T IM O L O L M A L E A T E O C U L A N E Y E D R O P S 0 .5 % 0 .5 % W /V DROPS. EYE BAL PHARM A LTD
4433 O OG 477 P E T H I D I N E H Y D R O C H L O R ID E P E T H I D I N E H C I- R IE S E N I U S 1 0 0 M G /2 M L , IN JE C T IO N S B O D E N E (P T Y ) L T D
4434 00G 476 M O R P H IN E S U L P H A T E M O R P H I N E S U L P H A T E -F R E S E N I U S 1 5 M G /M L I N J E C T IO N S B O D E N E (P T Y ) L T D
4435 00G 474 F E N T A N Y L C IT R A T E F E N T A N Y L -F R E S E N IU S 1 0 0 M C G /2 M L I N J E C T IO N S B O D E N E (P T Y ) L T D
4436 00G 480 A T R O P IN E S U L P H A T E A T R O P IN E S U L P H A T E -F R E S H S IU S 0 .6 M G / M L IN JE C T IO N S B O D E N E (P T Y ) L T D
4437 00G 475 D EX TR O SE D E X T R O S E -F R E S E N IU S 5 0 % 50% I N J E C T IO N S B O D E N E (P T Y ) L T D '
4438 00G 483 M E T R O N ID A Z O L E IN T R A M E D T R IC H A Z O L E IN F U S IO N 5 0 0 M G /1 0 0 M L IN F U S IO N S B O D E N E (P T Y ) L T D
4439 00G 566 A C Y C L O V IR D I S P E R S I B L E H E R PE X 800D T 800M G TA B LETS T O R R E N T P H A R M A C E U T IC A L S I N D IA

4440 00G 567 T E T R A C Y C L IN E H Y D R O C H U JR ID E T E T R A C Y C L IN E H Y D R O C H L O R ID E l O M G /G O IN T M E N T S . E Y E G A L E N T I C P H A R M A ( IN D IA ) ( P V T ) L T D

O P T H A L M IC O IN T M E N T
4441 00G 445 D E X T R O M E T H O R P H A N H Y D R O B R O M ID E D IL IN C T D R Y C O U G H S Y R U P I5 M G /5 M L SYRUPS A D C O C K I N G R A M U M IT E D
4442 00F972 T A D A L A F IL C l A L IS 20M G T A B L ET S. C O A TED L I L L Y E L I ( S A ) ( P T Y ) U M IT E D

4443 000235 S T A V U D IN E , L A M I V U D I N E & N E V I R A P I N E S T A L A N E V -3 0 3 0 /1 5 0 /2 0 0 M G TA B LETS. C O A TED V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

4444 00G 436 N E V IR A P IN E . N E V IR A P IN E ^ 200M O TA B LETS S T R ID E S A R C O L A B L I M IT E D

4445 00G 468 S T A V U D IN E & L A M I V U D I N E & N E V I R A P I N E S T A V U D IN E & L A M IV U D IN B A 30+150+200M O TA B LETS S T R ID E S A R C O L A B U M IT E D

N E V IR A P IN E
4446 00G 353 C E T i R J Z I N E H Y D R O C H L O R ID E A D C O - C E T I R 1 Z IN E lO M O TA B LETS, C O A TED A D C O C K I N G R A M U M IT E D
4447 00G 496 M E T R O N ID A Z O L E M E T R O N ID A Z O L E l .V . I N F U S I O N 5 0 /1 0 0 0 M L I N F U S IO N S M A R C K P A R E N T E R A L S (IN D IA ) L T D 3
4448 O 0G 495 C IP R O F L O X A C IN L A (T T A T E C I P R O F L O X A C IN L A C T A T E 0 .2 % W /V IN F U S IO N S M A R C K P A R E N T E R A L S (IN D IA ) L T D 3

4450 OOOOG3 L O S A R T A N P O T A S S IU M T O Z A A R -5 0 50M G TA B LETS, C O A TED T O R R E N T P H A R M A C E U T IC A L S I N D IA

4452 00G 699 N O R G E S T R E L A N D E T H IN Y L E S T R A D IO L C O N T R O L P IL L 0 3 & 0 .0 3 M G TA B LETS ' FA M Y C A R E LTD

4453 00G 700 N O RG ESTR EL S E C U R E P IL L 0 .0 7 5 M G TA B LETS FA M Y C A R E LTD
4454 00G 528 T A M S U L O C IN H Y D R O C H O R ID E E X T E N D E D CONTIFLOOD 0 .4 M G C A PSU LES R A N B A X Y L A B S L T D . G U R G A O N , IN D IA

R ELEA SE
4455 00G 438 L A M IV U D IN E L A M I V U D IN E 150M G TA B LETS, C O A TED S T R ID E S A R C O L A B L I M I T E D

4457 00G 547 S T A V U D IN E + L A M I V U D I N E S T A V U D I N E 3 0 M G + L A M I V U D IN E 1 5 0 M G 3 0 /1 5 0 M G TA B LETS S T R ID E S A R C O L A B U M IT E D

4460 000230 L A M O T R I G IN E L A M I T O R -2 5 25M G TA B LETS T O R R E N T P H A R M A C E U T IC A L S I N D I A

4461 00G 23I L A M O T R I G IN E L A M I T O R -5 0 50M G TAB LETS T O R R E N T P H A R M A C E U T IC A L S I N D I A

4462 00F858 C L A V U L A N A T E P O T . & A M O X IQ L L IN E N H A N C IN 1 .2 O / 2 0 M L IN JE C T IO N S R A N B A X Y L A B S L T D , G U R G A O N JN D IA

4463 O OO G25 L A M IV U D IN E , N E V IR A P IN E St S T A V U D IN E T R IV IR O -L N S 3 0 I5 0 /2 0 0 /3 0 0 M O TA B LETS R A N B A X Y L A B S L T D . O U R O A O N JN D IA

4465 000464 L A M IV U D IN E + Z ID O V U D IN E + N E V IR A P IN E V A R IC O M B 150+300+200M O' TA B LETS. C O A TED V A R I C H E M P H A R M A C E U T I C A L S (P V T ) L T D ,H R E

4466 00G 491 C A R B O P LA T 1N 450M G KEM OCARB 450M G IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4467 00G 490 C A R B O P L A T IN 1 5 0 M G KEM OCARB 150M G IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4468 0O G 513 V I N O R E L B IN E V IN E L B IN E lO M O /M L IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4469 00G 489 V IN O R E L B IN E I N J E C T I O N V IN E L B IN E lO M G /M L I N J E C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4470 O O G487 P A C L I T A X E L F O R I N J E C T IO N C O N C E N T R A T E IN T A X E L 3 0 M G 6 M G /M L I N J E C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4471 00G 488 P A C L IT A X E L 1 0 0 M G /1 7 M L I N T A X E L lO O M G 6M G I N J E C T IO N S F R E S E N IU S K A B I O N C O L O G Y IT D

4472 O O G515 IR IN O T E C A N H Y D R O C H L O R ID E I R IN O T E L 4 0 M G 4 0 M G /2 M L • I N J K T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4473 0 0 G 5 i6 IR iN O T E C A N H Y D R O C H L O R ID E I R IN O T E L I0 0 M G /5 M L I N J K T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4477 00G 229 L E F L U N O M ID E L E F R A -2 0 20M G .T A B L E TS T O R R E N T P H A R M A C E U T I C A L S I N D IA

4481 00G 706 G L IM E P I R ID E A Z U L l X -4 4M G TA B LETS T O R R E N T P H A R M A C E U T I C A L S I N D IA

4482 00G 707 G L IM E P I R ID E A Z U L IX -2 2M G TA B LETS T O R R E N T P H A R M A C E U T IC A L S I N D IA

4483 00G 563 B E N Z A T H I N E P E N IC I L L IN B E N Z A T H IN E P E N I C IL U N 2 .4 M E G A l U I N J E C T IO N S m is s io n ph a r m a a /s

4484 000554 P A R A C E T A M O L + C A F F E IN E + D O X Y L A M IN E . A D C O -D O L 4 5 0 / 4 5 / 5 /1 0 M O TA B LETS A D C O C K I N G R A M U M IT E D

S U C C .+ C O D E I N E P H O S P H
4485 000276 Z ID O V U D IN E Z ID O V U D IN E 300M G TA B LETS. C O A TED C A P S P V T L T D . H A R A R E . Z IM B A B W E

.4 4 8 6 000G 14 A LB END A ZO LE ANTHEL 400M O TAB LETS P H A R M A C E U T IC A L * C H E M I C A L D I S T . H A R A R E

4489 00G 635 L A M IV U D I N E + Z I D O V U D IN E A N D E F A V IR E N Z A V O C O M B - E C O M P L IA N C E P A C K 1 5 0 /3 0 M G + 6 0 0 M G C O M B IP A C K R A N B A X Y L A B S L T D . G U R G A O N , I N D IA

4493 O O G282 E F A V IR E N Z A V IR A N Z 2 0 0 M O 200M G C A PSU L ES . R A N B A X Y L A B S L T D .G U R G A O N .I N D I A

4494 00G 632 A M L O D I P IN E B E S I L A T E AM LOVAS lO M G TA B LETS - R A N B A X Y L A B S L T D .G U R G A O N J N D I A

4495 00G 572. R IF A M P IC IN /IS O N IA Z ID R I F A M P I C IN & I S O N IA Z I D D I S P K t S IB L E 6 0 M G / 3 0 M G TAB LETS M A C L E O D S P H A R M A C E U T IC A L S L I M I T E D

4498 00G 543 L A M I V U D IN E A S P E N L A M IV U D IN E S Y R U P l O M G /M L S O L U T IO N S PH A R M A C AR ELTD

4500 O O G536 L A M I V U D I N E + Z I D O V U D IN E A N D N E V I R A P I N E A S P E N L A M Z ID A N D N E V IR A P IN E 1 5 0 /3 0 0 M G + 2 0 0 M G C O M B IP A C K PH A R M A C AR ELTD

4501 O O F 7 I1 K ETOC O N A ZOLE AZOPLUS I O O M G /5 M L S U S P E N S IO N S , O R A L P L U S F I V E P H A R M A C E U T IC A L S P V T L T D ,

BULAW AYO

4503 00G 442 L A M IV U D IN E A N D S T A V U D IN E L A M I V IR - S 3 0 3 0 /1 5 0 M G TA B LETS C IP L A L T D , M U M B A I, IN D IA

4507 00G 426 R A B IE S V A C C IN E U S P S IIR A B IV A X 2 . 5 1 .U / M L VACCTNES S E R U M I N S T O F I N D IA L T D . P U N E . I N D IA

4508 00G 647 D I P T H E R IA + T E T A N U S + P E R T U S I S + D I P T H E R IA + T E T A N U S + P E R T U S 1 S + V A C C IN E S S E R U M I N S T O F I N D I A L T D .P U N E .I N D I A

H E P A T IT I S f i V A C C I N E A D S H E P A T I T IS B .
4509 00G 764 M IC O N A Z O L E M IC O N A Z O L E O R A L G E L 20M G G ELS C A P S P V T L T D , H A R A R E . Z IM B A B W E

4510 00G 226 R A M I P R IL T O P R I L -2 .5 23M 0 • C A PSU LES T O RR E N T EX PO R TS LTD

4511 000227 R A M I P R IL T O P R IL -5 5M G C A PSU LES T O R R E N T P H A R M A C E U T IC A L S I N D IA

4513 0 0 G 5 I7 T O PO T EC A N T O P O T E L 2 .5 - 2 5 M G /2 5 M L IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4514 000518 T O PO T EC A N TOPO TEL4 4 M G /4 M L IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D

4515 00F733 D IP H E N H Y D R A M IN E , P A R A C E T A M O L . B E N Y L IN F O U R F L U 2 5 /1 0 0 0 /4 5 M G L IQ U I D S JO H N S O N & JO H N S O N (P V T ) L T D , S O U T H

P S E U D O E P H E D R IN E A F R IC A

4516 O O G676 C E F T R IA X O N E U S P C E F T R I A X O N E F O R I N J E C T IO N U S P IG P O W D E R S F O R IN JE C T IO N K A R N A T A K A A N T I B IO T I C S &

P H A R M A C E U T IC A L S L T D

4519 O O G573 R I F A M P IC I N / IS O N I A Z I D / P Y R A Z I N A M I D E R I F A M P I C IN / I S O N I A Z I D / 6 0 /3 0 /1 5 0 M G S O L U T IO N S - T A B L E T S M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D

D IS P E R S IB L E T A B L E T S P Y R A Z IN A M I D E
4520 O O G744 R I F A M P l C IN + i S O N I A Z I D + P Y R A Z I N A M l D E R I F A M P I C IN + IS O N I A Z I D + I5 0 /7 5 /4 0 0 /2 7 5 M G TA B LETS. C O ATED M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D

+ETHAM BUTOL HCL P Y R A Z IN A M ID E + E T H A M B U T O L

4521 000746 E T H A M B U T O L H C L + I S O N IA Z I D 4 0 0 /1 5 0 M O TA B LETS, C O A TED M A C L E O D S P H A R M A C E U T I C A L S L I M IT E D
EGONEX^
4522 00G 745 R I F A M P I C IN + I S O N I A Z I D R I F A M P I C IN A N D I S O N I A 2 3 D 250nSM G T A B L E T S .C O A T E D M A C L E O D S P H A R M A C E U T IC A L S U M I T E D

4523 00G 749 E T H I O N A M ID E E T H IO N A M ID E 250M G T A B L E T S . (3 3 A T E D M A C L E O D S P H A R M A C E U T I C A L S L I M IT E D

4524 O O G79I L O S A R T A N P O T A S S IU M 25M G TA B LETS U N IC H E M L A B O R A T O R IE S L IM IT E D

L O SA R * - 25
4525 000792 L O S A R T A N P O T A S IU M T A B L E T S L O S A R * -5 0 • 50M G T A B L E T S .C O A T E D U N I C H E M L A B O R A T O R I E S L I M IT E D

4526 00G 348 S IL D E N A F IL C IT R A T E lO O M G T A B L E T S .C O A T E D A JA N T A P H A R M A L IM IT E D

K A M A G R A -1 0 0
4527 O O G349 S IL D E N A F IL C IT R A T E K A M A O R A -5 0 50M G T A B L E T S .C O A T E D A J A N T A P H A R M A U M IT E D

4528 00G 788 A M L O D I P IN E B E S I L A T E T A B L E T S 5M G , TA B LETS U N IC H E M L A B O R A T O R IE S L IM IT E D

C O R V A D l L -5
4529 0 0 G 3 I0 S O D I U M C H L O R ID E , P O T A S S I U M C H L O R I D E , O R A L R E H Y D R A T IO N S A L T 2 .6 / 1 5 / 2 . 9 / 1 3 5 G PO W DERS SO LU B LE F D C L I M I T E D , J O G E S H W A R I, I N D I A

S O D IU M C I T E R A T E & G L U C O S E P O W D E R
 972 Zimb a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

F ile N o . A fip IN o . A ^ ro v c d n am e T rad e n am e S tren g th Form A p p U am t

4530 M G 179 T E T A N U S T O X O ID A D S O R B ED A D S O R B E D T E T A N U S V A C C IN E 2 0 L f/M L . V A C C IN E S B IO V A C Z IM B A B W E P V T L T D , H A R A R E

4531 000196 . SALBUTAM OL A S T H A L IN R E S P U L E S 2 .5 M O /2 iM L S O L U T IO N S a P L A L T D , M U M B A I, IN D IA
4532 00G 71S L O P IN A V IR /R IT O N A V IR A L U V IA 2 0 0 M G /5 0 M Q TABLETS, COATED A B B O T T L A B S S A (P T Y ) L T D
4533 ' 00F563 D IC L O F E N A C S O D IU M D ICL O F EN A C 50M G /T A B L JE T TABLETS P H A R M A C E U T IC A L & C H E M IC A L D IS T .
H A RA RE,
4534 00G 841 L A M IV U D IN E /Z ID O V U D IN E T A B L E T S I^ 3 0 0 M G Z O V IL A M 150/300M G TABLETS M Y L A N L A B O R A T O R IE S L T D .
4535 00G 842 A B A C A V IR S U L F A T E 30C fM G T A B L E T S ABAM AT TABLETS 300M G TABLETS, COATED M Y L A N L A B O R A T O R IE S L T D ,
4536 000846 T E N O F O V IR D IS O PR O X JL FU M A R A T E R IC O V IR 300M G . TABLETS. COATED M Y L A N L A B O R A T O R IE S L T D .
TA B LETS 300M G
4537 000677 C L O X A C IL L IN S O D IU M B P . C L O X A C IL L IN S O D IU M F O R 500M G P O W D ER S F O R IN JE C T IO N K A R N A T A K A A N T IB IO T IC S &
IN JE C T IO N B P P H A R M A C E U T IC A L S L T D
4540 000740 H Y D R O C O R T IS O N E S O D IU M S U C C IN A T E P R IM A C O R T -IO O lO O M G P O W D ER S F O R IN JE C T IO N M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4541 000681 B L E O M Y C IN B E M O C IN 15 U N IT S 15IU P O W D ER S F O R IN JE C T IO N F R E S E N IU S K A B I O N C O L O G Y L T D
4542 (» G 6 4 0, D (X :E T A X E L C O N C E N T R A T E DAXOTEL 4 0 M C /M L IN JE C T IO N S F R E SE N IU S K A B I O N C O L O G Y L T D
4543 00F558 M E T R O N ID A Z O L E M ET R O N ID A Z O L E 0 ,5 ,% W A ' IN JE C T IO N S BA L PH A RM A LTD
4544 00F559 G E N T A M IC IN G E N T A M IC IN 0 .3 7flW A ? D R O PS , E Y E BA L PHARM A LTD
4545 Q 0G 691 DOCETAXEL DAXOTEL 8 0 M G /2 M L IN JE C T IO N S F R K E N IU S O N C O L O G Y L T D
4546 00G 383 E F A V IR E N Z E F A V IR 600M G TABLETS, COATED C IP L A L T D , M U M B A I, IN D IA
4548 00G 748 C Y C L O S E R IN E C Y C L O S E R IN E ' 250M G C A P SU L E S • M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4549 00G 790 C E T IR IZ IN E H Y D R O C H L O R ID E T A B L E TS ZY N CET ■ lO M G TABLETS, COATED U N IC H E M L A B O R A T O R IE S L IM IT E D
4550 00G 683 S T R E F T O M Y aN S U L P H A T E S T R E P T O M Y O N S U LP H A T E F O R IG P O W D ER S F O R IN JE C T IO N K A R N A T A K A A N T IB IO T IC S &
IN JE C T IO N IG P H A R M A C E U T IC A L S L T D
. 4553 00G 772 SA LBU TA M O L SULPHATE A S T H A L IN IN H A L E R (C F C F R EE ) lO O M C G . IN H A LA T IO N S C IP L A L IM IT E D
4554 00G 581 C O T R IM O X A Z O L E O R A L S U S P E N SIO N C IP LIN S U S P E N S IO N 4 0 /2 00 M G S U S P E N SIO N S , O R A L a P L A L T D . M U M B A I, IN D IA
4555 <^353 • P A R A C ET A M O L A PIM O L -5 00 50Q M Q TA BLETS A JA N T A P H A R M A L IM IT E D
4556 00G 658 T E N O F O V IR D IS O P R O X IL F U M A R A T E + TRUVADA 3 0 0 /2 0 0 M G TABLETS. COATED PH A RM A CA RE LTD
E M T R IC IT A B IN E
4557 000833 E F A V IR E N Z T A B L E T S EFAM AT 600M O T A B L E T S , C O A TE D M Y L A N L A B O R A T O R IE S L T D .
4558 00G 855 N E V IR A P IN E T A B L E T S - N E V IM A T 200M G TABLETS M Y L A N L A B O R A T O R IE S L T D .
4559 00G 854 Z3D O V U D 1N ETA BLETS ' Z ID O M A T 300M G TABLETS M Y L A N L A B O R A T O R IE S L T D .
4562 00G 877 S T R E P T O M Y C IN S U LP H A T E IN JE C T IO N STREPTOM Y O N SU LPH A TE 5G IN JE C T IO N S M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4563 00G 653 T E N O F O V IR D IS O PR O X IL F U M A R A T E V IR E A D 300M G TABLETS, COATED PHARM ACARE LTD
4564 00G 350 C IP R O F L O X A C IN H Y D R O C H L O R ID E T Y F L O X -2 5 0 250M G T A B L E T S , C O A TE D A JA N T A P H A R M A L IM IT E D
4565 00G 35I C IP R O F L O X A C IN U S P T Y F L O X -5 0 0 500M G TABLETS, COATED A JA N T A P H A R M A L IM IT E D
4566 O O G 843 L O P IN A V IR /R IT O N A V IR 2 0 0 /50 M G T A B L E T S ALLTERA 2 0 0 /5 0 M G T A B L E T S , C O A TE D M Y L A N L A B O R A T O R IE S L T D ,
4567 Q 0G 57I R IF A M P IC IN + IS O N IA Z ID + E T H A M B U T O L R 1F A M P IC IN + IS O N IA Z 1D + I5 0 /7 5 /2 7 3 M O TABLETS. COATED M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
ETHAM BUTO L
4568 00G 292 A M O X IC IL L IN KAMOX 1 2 5 M G /5M L P O W D E R S F O R S U S PE N S IO N F L A M IN G O P H A R M C H E M B U R , M U M B A I. IN D IA
4569 000719 S IL D E N A F IL ' S E R E G R A -5Q 50M G TABLETS. COATED B A L P H A R M A , H O S U R , B A N G A L O R E . IN D IA
4570 00G 908 A B A C A V IR S U LP H A T E 6 0 M O T A B L E T ^ ABAMAT PED 60M G T A B L E T S , C O A TE D M Y L A N L A B O R A T O R IE S L T D ,
4571 0 0 G 2 I7 N E V IR A P IN E N E V IM U N E 5 0 M G /5 M L S U S P E N S IO N S , O R A L a P L A L T D . M U M B A I, IN D IA
4572 00G 530 E F A V IR E N Z EFCURE 600M G T A B L E T S , C O A TE D E M C U R E P H A R M A C E U T IC A L S L T D .
4573 00G 739 K A N A M Y C IN S U L P H A T E K A N A M A C -1 0 0 0 lO O O M G P O W D ER S F O R IN JE C T IO N M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4574 00G 754 A R T T E M E T H E R A N D L U M E FA N T R IN E LUM AKTEM 2 0 /12 0 M O TABLETS a P L A L T D . M U M B A I, IN D IA
4575 0 0 G 9 I9 L A M IV U D IN E Z ID O V U D IN E V A R IV A R P A E D IA T R IC 3 0 /6 0 M O TABLETS, COATED V A R IC H E M P H A R M A C E U T IC A L S (P V R L T D .H R E
4576 00G 716 C E F PO D O X IM E P R O X E T IL C EP O D E M ' lO O M G T A B L E T S . C O A TE D R A N B A X Y L A B S L T D , G U R G A O N .IN D IA
4577 0 IK J7 I7 C E IT O D O X IM E P R O X E IT L ' C E PO D E M 2 0 0 200M G T A B L E T S , C O A T ED R A N B A X Y L A B S L T D . G U R G A O N , IN D IA
4578 00G 657 L A M IV U D IN E A D C O -L A M IV U D IN E 150M G T A B L E T S , C O A T ED A D C O C K IN G R A M L IM IT E D
4579 00G 742 IS O N IA Z ID IS O N IA Z ID 300M G ' TABLETS M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4580 00G 74I IS O N IA Z ID IS O N IA Z ID lO O M O T A B LE T S M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4581 00G 64I O X A L IP L A T IN • O X IT A N 50 50M G IN JE C T IO N S F R E S E N IU S K A B I O N C O LO G Y L T D
4582 00G 690 O X A L IP L A T IN lO O M G IN JE C T IO N O X IT A N lO O M G lO O M G IN JE C T IO N S F R E S E N IU S K A B I O N C O L O G Y L T D
4583 00F840 K A N A M Y C IN A C ID S U L P H A T E KANAMAF lO O O M O P O W D E R S F O R IN JE C T IO N F L A M IN G O P H A R M C H E M B U R , M U M B A M N D lA
4584 ' 00O 4D 1 LEV ONO RGEST REL PREGNON 0 .7 5 M G T A B L E T S , C O A T ED FA M Y CA RE LTD
4585, 00G 656 Z ID O V U D IN E A D C O -Z ID O V U D IN E 300M G T A B L E T S, C O A T ED A D C O C K IN G R A M L IM IT E D
4586 (K )G 751 E F A V IR E N Z A D C O -E F A V IR E N Z 600M G T A B L E T S , C O A T ED A D C O C K IN G R A M L IM IT E D
4587 00G 755 A T A Z A N A V IR S U LP H A T E A T A Z O R -100 lO O M G C A P SU L E S E M C U R E P H A R M A C E U T IC A L S L T D .
4588 00G 756 A T A Z A N A V IR S U L P H A T E A T A Z O R -150 150M G C A P SU L E S E M C U R E P H A R M A C E U T IC A L S L T D .
4589 00G 757 A T A Z A N A V IR S U LP H A T E A T A Z O R -20O 200M G C A P SU L E S E M C U R E P H A R M A C E U T IC A L S L T D .
4590 00G 644 O R A L P O L IO V A C C IN E B IO F A R M A O R A L P O L IO V A C C IN E O .IM L V A C C IN E S B IO V A C Z IM B A B W E (P V T ) L T D
4591 00G 924 ' B IC A L U T A M ID E B Y PR O 50M G T A B L E T S , C O A T ED F R E S E N IU S K A B I O N C O L O G Y L T D
4597 0 0 F I55 B E N Z O Y L P E R O X ID E C L E A R A S IL B E N Z O Y L P A C N E A N D 5% CREA M S P R O C T E R G A M B L E S A .S A
P IM P L E T R E A T M E N T
4600 O O F490 E T O P O S ID E E P O S IN . 2 0 M O /M L IN F U SIO N S P H A R M A C H E M IE (P T Y )L T D C E N T U R IO N , R S A
4601 W IP 809 A C IC L O V IR A C IC L O V IR 3% W A V CREAMS C IP L A L T D . M U M B A I. IN D IA
4602 00F878 KETOCON AZO LE DEZOR . 2 % W /W CREAMS H O E P H A R M A C E U T IC A L S S D N B H D
4603 . 00G 669 A Z IT H R O M Y C IN S U S TA IN E D R E L E A S E ZM AX 2M G P O W D E R S F O R S U S P E N S IO N P H Z E R S P E C IA L IT IE S L T D
4604 O O G 674 L A T A N O PR O S T A N D T IM O L O L X A L A C O M E Y E D R O PS 50M C G DROPS. EYE P n Z E R S P E C IA L IT IE S L T D
4605 00G 964 H E A M O P H IL U S IN F L U E N Z A E T Y P E S H E A M O PH IL U S IN F L U E N Z A E T Y P E 1 0 /1 9-3 3 u G IN JE C T IO N S S E R U M IN ST O F IN D IA L T D . P U N E , IN D IA
C O N JU G A T E V A C C IN E B C O N JU G A T E V A C C IN E
4607 000G 75 , D IP T H ,T E T A N U S ,P E R T U S .D N A H E P A T , t r it a n r ix -h b +h ib e r ix c o m b o pa c k V A C C IN E S G L A X O -W E L L C O M E Z IM B A B W E P V T
H A E M .IN F L B LTD , HARARE
4608 00G 560 L IG N O C A IN E H Y D R O C H L O R ID E L IG N O C A IN E -H C L -FR E S E N iU S 2% IN JE C TIO N S ' B O D E N E (P T Y ) L T D
4609 0Q G 559 G E N T A M Y C IN S U L P H A F E G E N T A M Y C IN -F R E S E N IU S 2 0 M G /2 M L . IN JE C T IO N S B O D E N E (P T Y )L T D
4610 00G 478 , G E N T A M Y C IN S U L P H A T E G E N T A M Y CT N -F R E S E N iU S 8 0 M G /2 M L ; IN JE C TIO N S B O D E N E (P T Y ) L T D
461L 00G 283 A B A C A V IR S U L P H A T E ABAC 300 M G T A B L E T S . C O A TE D R A N B A X Y L A B S L T D , G U R G A O N ,IN D IA
4612. 00G 289 S A L B U L T A M O L P R E SS U R ISE D IN H A L A T IO N S A L V EN T IN H A L E R lO O M G /A C T U A T lO N A E R O S O L IN H A L A T IO N S M /S M E D IS PR A Y L A B O R A T O R IE S P V T L T D
4613 000320 R A B E P R A 2 0L E V ELO Z20 20M C T A B L E T S , C O A T ED T O R R E N T P H A R M A C E U T IC A L S IN D IA
4614 00G 492 C O N JU G A T E D O E S T R O G E N T A B L E T S E S T R IN 0 .6 2 5 M G T A B L E T S , C O A TE D C IP L A L T D . M U M B A I, IN D IA
4615 000514 C Y T A R A B IN E B P C Y T A R IN E iO O M G IN JE C TIO N S ra E S E N IU S K A B I O N C O L O G Y L T D
4617 00G 360 R IF A M P IC IN + IS O N IA Z ID R IM A C T A Z ID 1.50/75 T A B L E T S . C O A TE D S A N D C « (IN D IA ) L T D , IN D IA
4618 0Q G 91I L O P IN A V IR /R ITO N A V IR 1 0 0 M G /2 5 M G T A B L E T S A L L T E R A -1 2 5 100M G /Z 5M G TABLETS, COATED M Y L A N L A B O R A T O R IE S L T D
4619 00G 409 L A M IV U D IN E / Z ID O V U D IN E / N E V IR A P IN E D U O V IR -N 1 5 0 /3 0 0 /2 00 M G T A B L E T S, C O A TE D a P L A L T D .M U M B A I, IN D IA
4620 Q 0G 14S O X Y T O C IN O X Y T O C IN IN JE C TIO N S U M E D IC A , M U M B A I. IN D IA
lO lU /M L
4621 00G 190 KETOCON AZO LE K E T A R IN 200 F L A M IN G O P H A R M C H E M B U R ,M U M B A U N D IA .
■ 200M G . T A B LE T S
4622 00G 384 M IS O PR O S T O L M IS O PR O S T -2 00 200M C G T A B LE T S C IP L A L T D , M U M B A I, IN D IA
4623 - O O G 399,, A T E N O L O L + C H L O R T H A L ID O N E T E N O R IC -5 0 50M G TABLETS. COATED IP C A L A B O R A T O R IE S L T D , IN D IA
462 4 00G 446 C L A R IT H R O M Y C IN KLABAX 1 2 5 M G /5 M L S U SP E N SIO N S R A N B A X Y L A B S L T D . G U R G A O N . IN D IA
4626 000762 L A M IV U D IN E /Z ID O V U D IN E W IT H N E V IR A P IN E C O -P A C K E D L A M IV U D IN E & 1 5 0 /3 0 0 /2 00 M G T A B L E T S. C O A T ED S T R ID E S A R C O L A B L IM IT E D
Z ID O V U D IN E W IT H N E V IR A PIN E
4627/ 0 0 G 9 I3 L O P IN A V IR /R IT O N A V IR A L U V IA 100/25 T A B LE T S A B B C rr L A B O R A T O R IE S S .A , (P T Y ) L T D
462 8 00G 852 L A M IV U D IN E /N E V IR A P IN E /S T A V U D IN E TR ESLA M 30 1 5 0 /2 0 0 /3 0 T A B L E T S, C O A T E D M Y L A N L A B O R A T O R IE S L T D .
T A B LE T S 1 5 0 /2 0 0/3 0 M O
462 9 O 0G 91O L A M IV U D IN E 3 0 M G /Z ID O V U D IN E Z O V IL A M P E D 30M G /6G M G TABLETS M Y L A N L A B O R A T O R IE S L T D ..
60M G TA BLETS
4630 00G 869 . B EC LO M ETH A SO N E 200 B E C L A T E 200 2 0 0 M C G /D O SE IN H A L A T IO N S C IP L A L T D . M U M B A I. IN D IA
4631 Q Q G 868 B E C L O M E T H A S O N E 50 B E C LA T E 50 5 0 M C G /D O S E IN H A L A T IO N S C IP L A L T D , M U M B A I, IN D IA ^
4632 00G 497 S O D IU M C H L O R ID E B . P. S O D IU M C H L O R ID E I.V . IN F U S IO N B .P . 9 G /1 0 0 0 M L { 0 5 % ) IN F U S IO N S M A R C K P A R E N T E R A L S (IN D IA ) L T D 3
4633 000391 P A R A C E T A M O L + D O X V L A M IN E S U C C IN A TE ■ DOXSYN 4 5 0 /5 /3 0 /1 0 M G TABLETS M ULLER & P H IP PS , H A R A R E ,2 3 M B A B W E
+ C A F F E IN E + C O D E IN B
4634 000967 C E F U R O X IM E S O D IU M O R A T IL 7 5 0 750 M G IN JE C T IO N S ■ M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
4635 00G 736 S IL V E R S U L P H A D IA Z IN E S IL V E R S U L P H A D IA Z IN E 1% W /W CREAM S S K A G E E X P O R T S , IN D IA
4636 O O G 743 P Y R A Z IN A M JD E P Y R A Z IN A M ID E 400M O T A B LE T S M A C L E O D S P H A R M A C E U T IC A L S U M IT E D
 Zimb a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012 9 7 3

F ile N o . A i^ l N o . A p p ro v ed n a m e T V ade n am e S tre n ^ h F o rm A p p H c m it

4637 0 0 G 7 7 7 A M P IC IL L IN S O D IU M A M P IC IL L IN -F R E S E N IU S 500M G P O W D E R S F O R IN JE C T IO N B O D E N E (P T Y ) L T D

4638 0 0 G 9 4 2 T IM O L O L 5 % M /V O C C U M O L 5 M G /M L D R O P S , E Y E M A R K P A R E N T E R A L S L T D

4639 O O G 943 T IM O L O L M A L E A T E O C C U M O L 0 .2 5 M G M L D R O P S , E Y E M A R K P A R E N T E R A L S L T D

4640 0 0 G 5 9 I T E R B IN A F IN E H Y D R O C H L O R ID E T E R B IH N 250M G . T A B L E T S C IP L A L T D , M U M B A I, IN D IA

• 4641 0 0 G 85 6 S T A V U D IN E S IA V M A T 30 M G C A P S U L E S M Y L A N L A B O R A T O R IE S L T D ,

4642 O O G 73S P Y R A Z IN A M ID E M A C R O Z ID E 5 0 0 5 0 0 M O T A B L E T S M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D

4643 0 0 G 4 9 3 G L U C O S E IV IN F U S IO N G L U C O S E IV IN F U S IO N B P • s o g /l ; IN F U S IO N S M A R C K P A R E N T E R A L S (IN D IA ) L T D 3

4644 0 0 G 6 7 2 S IL D E N A F IL S E R E G R A -1 0 0 lO O M G T A B L E T S . C O A T E D B A L P H A R M A , H O S U R , B A N G A L O R E . IN D IA

4645 0O G 807 D O X Y C Y C L IN E H Y C L A T E D O X Y C Y C L IN E lO O M O T A B L E T S . C O A T E D M A C L E O D S P H A R M A C E U T IC A L S L I M I T E D

4646 0 0 G 8 0 2 P A R A C E T A M O L P A R A C E T A M O L B P 500M G T A B L E T S M A C L E O D S P H A R M A C E U T IC A L S U M I T E D

4647 0 0 0 6 7 0 A Z IT H R O M Y C IN Z IT H R O M A X IV 500M G IN F U S IO N S P F IZ E R S P E C IA L IT IE S L T D

4648 0 0 G 9 5 8 A M O X IC IL L IN M E D O M O X 500 M O C A P S U L E S M E D O P H A R M IN D IA

4649 0 0 0 8 8 2 T E N O F O V IR D IS O P R O X IL F U M A R A T F ./ T E N O F O V IR D IS O P R O X IL F U M A R A T E / 3 0 0 M G /6 0 0 M G /2 0 0 M G T A B L E T S M Y L A N L A B O R A T O R IE S L T D ,

E F A V IR E N Z /E M T R IC IT A B IN E 3 0 0 /6 0 0 /2 0 0 E F A V IR E N Z /E M T R IC IT A B IN E

4650 000776 DEXTROSE 507<j IN T R A M E D D E X T R O S E 50% IN F U S IO N S B O D E N E (P T Y ) L T D

4651 00G 781 S O D IU M B IC A R B O N A T E IN T R A M E D S O D IU M B IC A R B O N A T E S -S ^ -c M /V IN JE C T IO N S B O D E N E (P T Y ) L T D

I N J E C T IO N

4 6 5 2 0 0 G 6 7 5 C H L O R A M P H E N I C O L S O D IU M S U C C IN A T E C H L O R A M P H E N IC O L S O D IU M IG P O W D E R S F O R IN J E C T IO N K A R N A T A K A A N T IB IO T IC S &

S U C C IN A T E P H A R M A C E U T IC A L S L T D

4653 O O G 853 T E N O F O V IR D IS O P R O X IL F U M E R A T E R IC O V IR -L 3 0 0 /3 0 0 M G T A B L E T S M Y L A N L A B O R A T O R IE S L T D .

& L A M IV U D IN E

4654 0 0 0 H 5 2 P H Y T O M E N A D IO N E K O N A K IO N IN JE C T IO N lO M G /M L - IN JE C T IO N S H O F F M A N L A R O C H E S W IT Z E R L A N D

4655 O O G 6 I2 D I C L O F E N A C S O D IU M D IC L O F E N A C S O D IU M 2 5 M G /M L IN JE C T IO N S M E D IV IS IO N W H O L E S A L E R S

4656 0 0 G 4 7 9 • N E O S T IG M IN E M E T H Y L S U L P H A T E N E O S T IG M IN E M E T H Y L S U L P H A T E - 2 .5 M G /M L IN JE C T IO N S B O D E N E (P T Y ) L T D

F R E S E N IU S

4657 O O G 482 N E O S T IG M IN E M E T H Y L S U L P H A T E N E O S T IG M IN E M E T H Y L S U L P H A T E - 0 .5 M O /M L IN J E C T IO N S B O D E N E (P T Y ) L T D

F R E S E N IU S

4 6 5 8 0 0 0 2 4 5 H E P A R IN S O D IU M H E P A R IN S O D IU M -F R E S E N IU S 5 0 0 0 IU /M L IN J E C T IO N S . IN T R A M E D ( P T Y ) L T D . K O R S T E N .P E . S A

5 0 0 0 1 U /M L

4659 00G 651 M E T H Y L E R G O M E T R IN E M A L E A T E M E T H Y L E R G O M E T R IN E M A L E A T E 0 .2 M G /M L IN JE C T IO N S ID A F O U N D A T IO N , T H E N E T H E R L A N D S

4 6 6 0 0 0 G 7 7 9 B E N Z Y L P E N IC IL L IN B E N Z Y L P E N IC IL U N -F R E S E N IU S 5 M U 5M U P O W D E R S F O R IN J E C T IO N B O D E N E (P T Y ) L T D

4661 0 0 G 4 9 4 S O D IU M L A C T A T E C O M P O U N D C O M P O U N D S O D IU M L A C T A T E IV 0 .3 2 /0 .6 /0 .0 4 % IN F U S IO N S M A R C K P A R E N T E R A L S (IN D IA ) L T D 3

IN F U S IO N B P

4 6 6 2 O O G 459 P O L Y V IN Y L A L C O H O L A Q U A T E A R S L U B R IC A T IN G E Y E D R O P S 14M G D R O P S , E Y E C I P L A L T D . M U M B A I, IN D IA

4 6 6 3 0 0 G 6 8 4 V IN C R IS T IN E S U L P H A T E C Y T O C R IS T IN A Q U E O U S IM G ■ IN JE C T IO N S C IP L A L T D . M U M B A I, IN D IA

4 6 6 4 O O G 685 B L E O M Y C IN S U L P H A T E B L E O C IP is lU /V IA L P O W D E R S F O R IN JE C T IO N C I P L A L T D . M U M B A I, IN D IA

4665 0 0 G 9 5 6 L O P IN A V IR A N D R IT O N A V IR O R A L S O L U T IO N L O P IN A V I R A N D R IT O N A V IR O R A L 8 0 /2 0 M G /M L S O L U T IO N S C I P L A L T D . M U M B A I, IN D IA

S O L U T IO N

4 6 6 6 0 0 0 1 0 9 C E F T R IA X O N E U S P U T R IX O N E -5 0 0 500M O P O W D E R S F O R IN J E C T IO N U M E D IC A , M U M B A I. IN D IA

4667 0 0 G 8 3 0 P N E U M O C O C C A L C O N JU G A T E V A C C IN E P R E V E N A R 2 , 2 / 4 .4 / 2 . 2 /U O iN J E c r r iO N S W Y E T H S A (P T Y ) L T D R S A

4668 0 0 G 9 8 0 E N O X A P A R IN S O D IU M L O M O H -4 0 40M G IN JE C T IO N S E M C U R E P H A R M A C E U T IC A L S L T D .

4669 0 0 G 8 I8 L A M lV U D lN E /S T A V U D IN E ff^ E V IR A P IN E L A M IV U D IN E I5 0 M O , S T A V U D IN E . 1 5 0 /3 0 /2 0 0 M G T A B L E T S M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D

1 5 0 /3 0 /2 0 0 M G 3 0 M G , N E V IR A P IN E 2 0 0 M G T A B L E T S

4 6 7 0 0 0 G 7 4 7 E T H A M B U T O L E T H A M B U T O L 4 0 0 M G T A B L E T S , C O A T E D M A C L E O D S P H A R M A C E U T IC A L S U M I T E D

4671 0 0 0 0 H 2 IS O F L U R A N E U S P L IQ U ID IS O F L U R A N E I0 0 % W /V IN H A L A T IO N S P IR A M A L H E A L T H C A R E L IM IT E D ,

4 6 7 2 O O O O H l IS O F L U R A N E IS O F L U R A N E I0 0 % W /V IN H A L A T IO N S P IR A M A L H E A L T H C A R E L IM IT E D .

4 6 7 3 (W G 6 3 8 T E R B IN A F IN E H Y D R O C H L O R ID E t e Rb if in 1% W /W , C R E A M S C I P L A L T D . M U M B A I, IN D IA

4 6 7 4 M O H U R IT O N A V IR R IN A V O 1 .0 0 M G T A B L E T S M Y L A N L A B O R A T O R IE S L T D ,

4675 0O G 857 T E N O F O V IR D IS O P R IX IL F U M A R A T E / R IC O V IR -E M 3 0 0 /2 0 0 M G T A B L E T S , C O A T E D M Y L A N L A B O R A T O R IE S L T D ,

E M T R I C IT A B I N E

4 6 7 6 O O O O H 4 D ID A N O S IN E D E L A Y E D N IS A N O D ID 400M G • C A P S U L E ,S L O W R E L E A S E M Y L A N L A B O R A T O R IE S L T D ,

4 6 7 7 0 0 0 8 4 7 L A M IV U D IN E /S T A V U D IN E D 1L A S T A V 30 1 .5 0 /3 0 M G T A B L E T S M Y L A N L A B O R A T O R IE S L T D .

4 6 7 8 0 0 G 8 5 8 L A M IV U D IN E ,N E V IR A P I N E A N O Z ID O V U D IN E T R E Z A V I5 0 /2 0 0 /3 0 0 M G T A B L E T S M Y L A N L A B O R A T O R IE S L T D .

4 6 7 9 0 0 G 6 0 9 IB U P R O F E N IB U P R O F E N 400M G T A B L E T S M E D IV IS IO N W H O L E S A L E R S

4 6 8 0 0 0 G 6 1 0 G E N T A M IC IN G E N T A M IC IN 80 M G IN JE C T IO N S M E D IV IS I O N W H O L E S A L E R S

4681 00G 621 C H L O R P H E N IR A M IN E M A L E A T E A L L E R G E X 2 M G /5 M L E L IX IR S D A H .A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

4 6 8 2 00G 471 O N D A N S E T R O N U S P E M IS T O P 2 M G /M L A M P O U L E S C L A R IS L IF E S C IE N C E S L T D

4 6 8 3 0 0 G 3 3 4 C A R B A M A Z E P IN E T A B L E T S C A R B A M E Z A P IN E 200M G T A B L E T S S T R ID E S A R C O L A B L IM IT E D

4 6 8 4 00G 951 E F A V IR E N Z E F A V IR -2 0 0 200 M G C A P S U L E S C IP L A L IM IT E D

4685 0 0 G 72 0 A T O R V A S T A T IN L IP O F IX -2 0 20M G T A B L E T S . C O A T E D B A L P H A R M A . H O S U R . B A N G A L O R E . IN D IA

4 6 8 6 0 0 G 9 9 2 IR O N S U C R O S E IN J E C T IO N E N C IF E R tO O M G - IN J E C T IO N S E M C U R E P H A R M A C E U T IC A L S L T D .

4687 0 0 G 9 9 8 E F A V IR E N Z E F A V IR E N Z T A B L E T S 600M G T A B L E T S M A C L E O D S P H A R M A C E U T IC A L S L IM I T E D

4 6 8 8 0 0 G 5 8 8 L E V O F L O X A C IN L E V O F L O X 250 250M G T A B L E T S , C O A T E D C I P I.A L T D . M U M B A I, IN D IA

4 6 8 9 0 0 G .5 9 0 L E V O F L O X T A B L E T S, L E V O n -O X -5 0 0 . 500 M G • T A B L E T S . C O A T E D C IP U A L T D , M U M B A I. IN D IA

4 6 9 0 0 0 G 9 6 3 D I P T H E R IA .T E T A N U S .P E R T U S S I S .H E P A T I T I S D I P rH E R IA .T B T A N U S , P E R T U S S IS , IN J E C T IO N S S E R U M IN S T O F IN D IA L T D , P U N E . IN D IA

B & H A E M O P H IL U S IN F U E N Z A B V A C C IN E H E P A T IT IS B & H A E M O P H IL U S V A C

4691 0 0 G 98 4 L O P IN A V IR & R IT O N A V IR L O P IM U N E 200/ 50M G T A B L E T S , C O A T E D C I K .A L T D , M U M B A I. IN D IA

4 6 9 2 0 0 G 8 6 5 F L U T IC A S O N E P R O P IO N A T E IN H A L E R F L O H A L E -5 0 125 M C G A E R O S O L IN H A L A T IO N S C IP L A L T D , M U M B A M N D IA

4 6 9 2 0 0 G 86 6 n .U T I C A S O N E P R O P R iO N A T E F L O H A L E 125 125 M C G A E R O S O L IN H A L A T IO N S Q P L A L T D , M U M B A I, IN D IA

4 6 9 4 O O O O H 3 S E V O F L U R A N E U S P S E V O F L U R A N E U S P 25 0 M L 100% ’ IN H A L A T IO N S P IR A M A L C R IT IC A L C A R E . IN C

4 6 9 5 0 0 G 88 5 N E V IR A P IN E N E V IT E R O 2 0 0 M G T A B L E T S H B T E R O D R U G S L T D

4 6 9 6 0 0 G 5 1 2 N Y S T A T IN N Y S T A T IN V A G IN A L T A B L E T S lO O O O O IU P E S S A R IE S C IP L A L T D . M U M B A I. IN D IA

4 6 9 7 0 0 G 94 6 A B A C A V IR S U L P H A T E A B A C A V IR S U L P H A T E 300M C T A B L E T S . C O A T E D C IP L A L T D . M U M B A I. IN D IA

4 6 9 8 0 0 G 9 5 3 A B A C A V IR S U L F A T E O R A L S O L U T IO N A B A C A V IR S U L F A T E O R A L S O L U T IO N 2 0 M G /M L S O L U T IO N S C IP L A L T D , M U M B A I. IN D IA

4 6 9 9 0 0 0 7 0 3 O X Y T O C IN O X Y T O C IN lO lU /M L IN J E C T IO N S I D A F O U N D A T IO N .T H E N E T H E R L A N D S

4 7 0 0 0 0 G 4 8 J D O B U T A M IN E H Y D R O C H L O R ID E D O B U T A M IN E -F R E S E N IU S 2 5 0 M G /2 0 M L IN JE C T IO N S B O D E N E (P T Y ) L T D

4701 O O G 753 M E T F O R M IN H Y D R O C H L O R I D E M O D IF IE D R A N O P H A O E O D lO O O M O T A B L E T S R A N B A X Y L A B S L T D , G U R G A O N ,I N D I A

R E L E A S E

. 4 7 0 2 0 0 G 68 0 C L O X A C IL L IN S O D IU M B P . C L O X A a iX IN S O D IU M F O R IN J E C T IO N 1G P O W D E R S F O R IN J E C T IO N K A R N A T A K A A N T IB IO T IC S &

P H A R M A C E U T IC A L S L T D

4 7 0 3 0 0 G 7 2 9 M E L D O L T A B L E T S T A B L E T S M E U X JM E P H A R M A C E U T IC A L S L T D
P A R A C E T A M O L 500M O

4 7 0 4 0 0 G 3 8 5 T A B L E T S C IP L A U T D . M U M B A M N D IA
A M L O D IP IN E B E S Y L A T E A M L O P R E S -5 5M G

4 7 0 5 0 0 G 9 1 2 T R E Z A V F E D , T A B L E T S M Y L A N L A B O R A T O R IE S L T D .
L A M I V U D IN E / N E V I R A P I N E /Z I D O V U D I N E 3 0 /5 0 /6 0 M O

4 7 0 6 0 0 G 5 4 9 T A B L E T S U M E D IC A , M U M B A I, IN D IA
P R A Z IQ U A N T E L U S P P R A Z IQ U A N T E L U S P 600M G

4 7 0 7 0 0 G 4 3 9 T A B L E T S . C O A T E D A V E N T IS P H A R M A (P T Y ) L T D
R IF A M P IC IN + IS O N IA Z ID R IF IN A H -3 0 0 3 0 0 /1 5 0 M G

4 7 0 8 00O H 97 g u a if e n e s in V A R IC O U G H S O M G /5 M L S Y R U P S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D .

H R E

4 7 0 9 0 0 0 8 8 7 L A M I V U D IN E 1 5 0 M G /S T A V U D IN E 3 0 M G / 1 5 0 /3 0 /2 0 0 M G T A B L E T S H E T E R O D R U G S L T D
N E V IL A S T -3 0

N E V IR A P IN E 2 0 0 M O

4 7 1 0 0 0 G 9 9 7 L E V O F L O X A C IN 500M G T A B L E T S . C O A T E D M A C L E O D S P H A R M A C E U T IC A L S L IM IT E D
L E V O M A C
4 7 1 0 O O O H 43 A M L O D IP IN E B E S Y L A T E T A B L E T S P H A R M A C IA S O U T H A F R IC A P T Y L T D
L O M A N O R 5 M G

4711 0Q G 569 R IF A M P IC IN /IS O N IA Z ID /P Y R A Z IN A M ID E / 1 5 0 /7 5 /4 0 0 /2 7 5 M G T A B L E T S , C O A T E D M ro iV lS lO N W H O L E S A L E R S

R IF A M P ia N + IS O N IA Z ID +

E T H A M B U T O L P Y R A Z IN A M ID E + E T H A M B U T O L

4 7 1 2 0 0 G 36 4 F L U P H E N A Z IN E D E C A N O A T E IN JE C T IO N S S M -P H A R M A C E U T IC A L S
S H R IZ IN E IN J E C T IO N 2 5 M G /M L 2 5 M G /M L

4713 0 0 0 H 4 6 Q U IN A P R IL H Y D R O C H L O R ID E A N D T A B L E T S , C O A T E D P H A R M A C IA S O U T H A F R IC A P T Y L T D
A C C U M A X C O 1 0 /1 2 .5 M G

H Y D R O C H L O R O T H IA H D E

4 7 1 4 Q 0G 558 U A M IV U D IN E + N E V IR A P IN E + Z ID O V U D IN E T A B L E T S , C O A T E D R A N B A X Y L A B S L T D , G U R G A O N ,I N D I A
A V O C O M B 'N 1 5 0 /2 0 0 /3 0 0 M G

4 7 1 5 -O O O H 4 5 Q U IN A P R IL / H Y D R O C H L O R O T H IA Z ID E T A B L E T S . C O A T E D P H A R M A C IA S O U T H A F R IC A P T Y L T D
A C C U M A X -C O 2 0 /1 2 ,5 M G

4 7 1 7 O O O H 42 A M L O D IP IN E B E S Y L A T E T A B L E T S P H A R M A C IA S O U T H A F R IC A P T Y L T D
L O M A N O R lO M O

4718 0 0 0 8 7 8 ' O X A L IP L A T IN IN J E C T IO N S V E N U S R E M E D IE S L T D . B H A T O U K A L A N ,
O X O L 2 M G

B A D D I

4719 0 (k 3 6 0 5 Q U IN IN E H Y D R O C H L O R ID E ID A F O U N D A T IO N . T H E N E T H E R L A N D S
Q U IN IN E H Y D R O C H L O R ID E , 3 0 0 M G /M L IN JE C T IO N S

4720 Q 00H 48 Q U IN A P R IL H C L T A B L E T S ,C O A T E D P H /^ IM A C IA S O U T H A F R IC A P T Y L T D
A C C U M A X lO M G
974 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

F ile N o . A p p I N o .. A p p ro v ed n a m e T rad e n a m e S tr e n g th F o rm A p p lic a n t

4721 (K X )H 4 9 Q U IN A P R IL ACCUM AX 20M G TAB LETS, C O A TED P H A R M A O A S O U T H A F R IC A P T Y L T D

4722 (K X )H 9 0 A T O R V A T A T IN C A L C IU M A SPA V O R 10 10 M G TAB LETS. C O A TED P H A R M A Q A S O U T H A F R IC A P T Y L T D

4723 000H 89 A S P A R V A S T A T IN C A U C IU M A SPAV O R 20 20 M G T A B L E TS, C O ATED P H A R M A C I A S O U T H A F R IC A P T Y L T D

4724 < X K )H 9 1 A T O R V A S T A T IN C A L Q U M A SPA VO R 40 40 M G TAB LETS, C O A T Eb P H A R M A C IA S O U T H A F R IC A P T Y L T D

4725 00G 837 P A C L IT A X E L PAXOL 1 0 0 M G /1 6 .7 M L I N J E C T IO N S V H « J S R E M E D IE S L T D , B H A T O L I K A L A N , B A D D I

4730 (K K 3 4 S 5 H U M A N R O T A V IR U S L IV E A T T E N U A T E D R O T A R IX I0 ^ C C D 5 0 P E R M L V A C C IN E S G L A X O S M IT H K L IN E S A (P T Y ) L T D

R 1X 4414

4732 00G 879 P A C L IT A X E L U S P PAXOL 3 0 M G /5 M L I N J E C T IO N S V E N U S R E M E D IE S L T D , B H A T O L I K A L A N , B A D D I

4733 O K}H 68 L A M I V U D IN E N E V I R A P I N E Z ID O V U D IN E Z IL A N E V I 0 0 /2 (X )/3 0 0 M G TA B LETS V A R I C H E M P H A R M A C E U T IC A L S ( P V T ) L T D , H R E

4734 < X K )H 5 0 ETH A M B UTOL ETH AM B U TO L lO O M G TAB LETS, C O ATED M A C L E O D S P H A R M A C E U T IC A L S L I M IT E D

4735 00G 463 L A M I V U D I N E + 2 iD O V U D I N F > N E V lR A P lN E Z iD O L A M - N 1 5 0 ^ /2 0 0 M G TAB LETS, C O ATED H B T ER O D R U G S LTD

4738 (K )Q 4 6 2 H Y DR O XY ETH Y LSTA R CH VOLUVEN 60G I N F U S IO N S F R E S E N I U S K A B I S O U T H A F R IC A ( fT Y ) L T D

4739 0X 3979 H U M A N P A P I L L O M A V IR U S V A C C I N E T Y P E S C E R V A R IX 20M C G ^M C G I N J E C T IO N S G L A X O S M IT H K L IN E S A (P T Y ) L T D

1 6 7 18 R E C O M B IN A N T A S 0 4
4746 ( K )0 H 7 8 V A L A C IC L O V I R TA BLETS V A L O V IR 500 M O TA BLETS H E T B R O I» U G S L T O

General Notice 593 of 2012.

MEDICINES AND ALLIED SUBSTANCES CONTROL ACT [CHAPTER 15:03]

Approval of Registration of Veterinary Medicines

IT is hereby notified, in terms of section 24( 1 )(b) of the Medicines and Allied Substances Control Act [Chapter 75:03], that the Medicines
Control Authority has approved the registration of the medicines specified in the Schedule.

G.N.MAHLANGU,
14-12-2012. . Director-General.
Sc h e d u l e

F ile N o . A p p lN o . A p p ro v ed n a m e lY a d c n a m e S tr e n g th F o rm A p p lic a n t

9631 V 00733 D IM IN A Z E N E D IA C E T U R A T E D IM IN A Z E N E 445M Q GRANULES C O O P E R Z IM B A B W E L T D

9632 V 00745 A M IT R A Z E C P U L V E X T R IA T I X D O G D IP 12J% U Q U ID S C O O P E R Z IM B A B W E L T D
9633 V 00738 D E L T A M E T H R IN C O O P E R S T IC K G R E A S E 0 .1 % M /M D IP S C O O P E R Z IM B A B W E L T D
( IM P R O V E D F O R M U L A )

9636 V 00746 L IV E A T T E N U A T E D S A L M O N E L L A A V IP R O S A L M O N E L L A V A C E V A C C IN E S I M M U N O V E T S E R V IC E S P T Y ( L tD )

E N T E R r r iD lS
9640 (W V 7 5 3 A M I T R i\Z T IC K B U S T E R E C 1 2 .5 % U Q U ID S C H E M P L £ X i\N lM A L & P U B L I C H E A L T H
9642 V 00758 IO D IN E ' D A IR I T E A T D I P 13% L I Q U ID S Z IM B A B W E P H O S P H A T E I N D U S T R I E S L T D
9644 V 00744 ' O X Y T E T O A C Y C U N E H Y D R O C H L O R ID E T E R R A N O X T O P IC A L O IN T M E N T O IN T M E N T S G R A N T T E S I D E C H E M IC A L S ( P V T ) L T D ,
HARARE

9645 V 00754 P A S T E U R E U - A M U L T O C I D A T Y P E S 1 ,3 ,4 & 3 X 4 A V IP R O I 0 8 F C 4 G O L D V A C C IN E S L O H M iA N N A N IM A L H E A L T H S A . ( P V T ) L T D

9646 V 00755 N E W C A S T L E D IS E A S E V IR U S L A S O T A I N A C T /V A C N D -I B I V A C C IN E S L O H M A N N A N IM A L H E A L T H S A . ( P V T ) L T D
( K I L L E D ) I N F E C T IO U S B R O N C H I T IS M A S S
T Y P E P G S T R A IN ( K I L L E D )

9647 V 00756 S A L M O N E L L A E N T E R i n D IS S T R A IN S P T 8 , A V IP R O 1 0 9 S E 4 4 % W /W V A C C IN E S L O H M A N N A N IM A L H E A L T H S A , ( P V T ) L T D
P T 1 4 B & P T 2 3 (B A C T E R IN )

9650 V 00802 A M tT R A Z I2 .5 % T IC K B U S T E R D O G D IP • 1 2 .5 % m /v D IP S C H E M P L E X A N IM A L & P U B L IC H E A L T H

9651 V 00762 M Y C O P L A S M A G A L L IS E P T I C U M S T R A I N S 6 A V IP R O 1 0 4 M O 1 0 .9 E I D J 0 V A C C IN E S L O H M A N N A N IM A L H E A L T H G E R M A N Y
9652 V (X )8 0 6 R A B IE S K IL L E D V I R U S V A C C I N E D EFENSO R 3 V A C C IN E S P F IZ E R L A B O R A T O R IE S (P V T ) L T D
9653 V 00792 M A R E K S D IS E A S E V IR U S S T R A I N A V IP R O M D R I S P E N S R L V A C C IN E S L O H M A N N A N IM A L H E A L T H S A . ( W T ) L T D

R I S P E N S C V I9 8 8
9654 V 0079I I N F E C T IO U S L A R Y N G O T R A C H E IT IS T A D I L T ( A V I P R O I L T ) V A (X IN E V A C C IN E S L O H M A N N A N IM A L H E A L T H S A , ( P V T ) L T D
V A C C IN E S T R A IN C O N N E C T I C U T
9655 , V 00796 O X Y T E T R A C Y C L IN E H Y D R O C H L O R ID E 2 0 % C E N C Y C L IN E 20% P O W D E R S F O R S U S P E N S IO N C ENTAU R C O NSU LTA NTS
9656 V 00799 S U L P H -A D IM I D IN E S O D IU M C E N T A D IM I D I N E 1 6 % M /V L I Q U ID S ( X IO P E R Z I M B A B W E L T D
9657 V 00801 A L P H A C Y P E R M E T H R I N /P I P E R O N Y L C ENA LPH A POU R ON 2 2 5 / 3 ,0 % D IP S C E N T A U R C O N SU L TA N TS
B U T O X ID E

9658 V 00807 O X Y T E T R A C Y C L IN E T E T N IL 10% IN JE C T IO N S N A N J I N G B E N S T E N M E D IC .4 L A P P A R A T U S

CO. LTD
9659 V (K )8 1 1 A M P R O L IU M V ETPR O 20% PO W D ER S SO LUB LE C H E M P l£ X A J4 IM A L & P U B L IC H E A L T H
9660 V 0 0 8 I0 O X Y T E T R A C Y C L IN E OTC • 20% POW DERS C H E M P L E X / m i M A L & P U B L IC H E A L T H
9661 V 0 0 8 I2 I N F E C T IO U S B U R S A L D I S E A S E L I V E A V IP R O IB D X T R E M E V A C C IN E S L O H M A N N A N IM A L H E A L T H S A , ( P V J ) L T D
V I R U S V A C C IN E
9662 V 00786 IN F E C T IO U S B R O N C H IT IS & N E W C A S T L E A V I P R O N D - IB L A S O T A V A C C IN E V A C C IN E S L O H M A N N A N IM A L H E A L T H S A , ( P V T ) L T D
D IS E A S E V IR A L V A C C I N E
9663 V 00505 N E W C A S T L E D IS E A S E V A C C I N E V I N E L A N D N E W C A S T L E D IS E A S E V A C C IN E S I M M U N O V E T S E R V IC E S P T Y ( L T D )
V A C C IN E
9664 V 0 0 8I3 A L B E N D A Z O L E O R A L S U S P E N S IO N BENVET i0 % W /V ■ S U S P E N S IO N S , O R A L C H E M P L E X A N 1 I4 A L & PUBUC H EA LTH
9665 V 00763 I B D /N C D A B K I L L E D V IR A L V A C C I N E A V I P R O 3 0 1 N D -I B - I B D E M U L S IO N S L O H M A N N A N IM A L H E A L T H S A ,'( P V T ) L T D
9666 V 00764 N E W C A S T L E . I N F E C T IO U S B R O N C H IT I S A V I P R O 2 0 1 N D - IB E M U L S IO N S - L O H M A N N A N IM A L H E A L T H S A , ( P V D L T D
K IL L E D V I R U S V A C C IN E
9667 V 00765 I B D /N C D /I B /R E O V I R U S V A C C I N E AVIPRO 401 ND-TB-IBD-REO E M U L S IO N S L O H M A N N A N IM A L H E A L T H S A . ( P V T ) L T D
9668 V 00819 . ENHOXAQN ENROCIP 10% W/V ORAL SOLUTION 1 0 0 M G /M L S O L U T IO N S V E T E R IN A R Y D I S T R IB U T O R S
9669 V 00816 I V E R M E C T IN BREMAMECTIN lO M G /M L I N J E C T IO N S BREM ER PHARM A GM BH
9670 VOO^ IR O N D E X T R A N IRON DEXTRt VN • 200M G IN JE C T IO N S N i\N J I N G B 0 4 S T E N M E D I C A L A P P A R A T U S
C X 3 .L T D
9671 V (»8 1 7 B U R S A L D I S E A S E -N E W C A S T L E D IS E A S - A V IP R O 4 4 ! N D - I B - B T O - R E O IN JE C n O N S I M M U N O V E T S E R V IC E S P T Y ( L T D )
B R O N C H IT I S
9672 V (» 8 2 0 C A L C IU M F O S F O M Y C IN A N D F O S B A C P U IS T 2 0 % /5 % P O W D E R S F O R S U S P E N S IO N B ^ O N A F R IC A . S O U T H A F R IC A

T Y L O S IN T A T R A T E
9673 V 00822 T Y L O S IN S O L U B L E P O W D E R T Y L O C IP ^ % P O W D E R 20% PO W D E R S F O R SU SPE N SK X 4 V C T E R IN A R Y D IS T R IB U T O R S

General Notice 594 of 2012.

MEDICINES AND ALLIED SUBSTANCES CONTROL ACT [CHAPTER 15:03]

Cancellation of Certificates of Registration of Veterinary Medicines

IT is hereby notified, in terms of section 24(1 )(b) of the Medicines and Allied Substances Control Act \Ch<XDter 15*031 that the Medicines
Control Authority has approved the registration of the medicines specified in the Schedule.

G.N. MAHLANGU,
14-12-2012 Director-General.
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012 975

Sc h e d u l e

F ile N o . A ppI N o. A p pro v ed n a m e T V ade nam e S tre n g th Fonn A p p lita iU

9 (W l V 00014 PY R A NTEL PA M OA TE NEM EX H POW DERS S K F A N IM A L H E A L T H

9004 V O O O ll B E N Z A T H IN E C L O X A C I L U N O R B E N IN D R Y C O W 500M G IN T R A M A M M A R Y S K F A N iM A L H E A L T H

P R E P A R A T IO N

9006 V 00013 A M P I C IL L I N A N D C L O X A C I L U N P E N D IC L O X IN T R A M A M M A R Y S K F A N IM A L H E A L T H

P R E P A R A T IO N

9013 V 00035 LECTA D E PO W DERS SO LU BLE S K F A N IM A L H E A L T H

9043 V 00050 O X Y T E T R A C Y C U N E H Y D R O C H L O R ID E H l-T E T M F 7 .3 % L IQ U ID S ! M I L B O R R O W A N I M A L H E A L T H Z I M ( P V l ') L T D

9044 V 00086 VANGUARD DAZP+CPV . V A C C IN E S S K F A N IM A L H E A L T H

9046 V 00099 V A N G U A R D D A 2PL+C PV ; V A C C IN E S S K F A N IM A L H E A L T H

9056 V 0 O IO 7 S A L IN O M Y C IN C O X lS T A C P R E M J X 6 % 6 0 G /K G PO W D ER S S K F A N IM A L H E A L T H ^

9061 V 00U 4 S E R U M G O N A D O T R O P H IN F O L L IG O N , P O W D E R S F O R I N J E C T IO N Z IM V E T P V T L T D , Z IM B A B W E

9064 V 00118 R A B I E S V A C C IN E RABDOM UN V A C C IN E S C O O P E R Z IM B A B W E L T D

9076 V 00124 C Y H A L O T H R IN L IB R E K T O 5% D IP S S C H E R IN G P T Y L T D , M ID R A N D , S A

9077 V 00105 D O D E C Y L B E N Z E N E S U L P H O N IC A C I D CH EM SPEC 2% D IP S C E R N O L C H E M I C A L S Z IM B A B W E P V T LTD

9091 ZV0160 P R C iC A lN E P E N lC lL U N A N D D IS P O L A C R X 4 * B IN T R A M A M M A R Y C O O P E R Z iM B A B W E L T D

D IH Y D R O S T R E P T O M Y C IN S U L P H P R E P A R A T IO N

9092 ZV0009 S U L P H A D O X IM E A N D T R I M E T H O P R I M B O R G A L 7J% 7 .5 % IN JE C T IO N S I N T E R V E T S .A , ( P T Y ) L T D

9093 ZV0073 S U L P H A D O X I N E A N D T R I M E T H O P R IN B O R G A L24% 24% IN JE C T IO N S I N T E R V E T S .A . ( P T Y ) L T D

9109 ZV0264 O X Y T E T R A C Y C L IN E H Y D R O C H L O R I D E T E R R A M Y C I N B L U E F O R M A S T IT IS 4 S 0 M G /T U B E IN T R A M A M M A R Y S K F A N IM A L H E A L T H

P R E P A R A T IO N

9115 ZV0042 FU RA LTA D ON E FURASOL , , PO W DERS SO LU BLE S K F A N IM A L H E A L T H

9117 V 00203 PREGUARD 9 V A C C IN E S S K F A N IM A L H E A L T H

9123 ZV0258 ' ,
TERR A V 7T POW DERS SO LUBLE S K F A N IM A L H E A L T H

9147 V 00223 H E P T A V A C -P H E P T A V A C -P P L U S V A C C IN E S IN T T O V E T SA. ( P T Y ) LTD

9174 Z y 0 I0 4 IS O P Y R IN E & P H E N Y L B U T A Z O N E ' • TOM ANOL . 2 4 G / I 2 .1 3 G IN JE C T IO N S C O O P E R Z IM B A B W E L T D

9188 V 00228 L A S A L O C ID S O D IU M B O VA TEC 1 7 2 .5 G POW DERS RO CH E PRO D UCTS PTY LTD RSA

9195 ZV0060 M E T A M I Z O L S O D I U M ( D IP Y R O N E ) V ETALGTN 5 0 0 M G /M L IN JE C T IO N S I N T E R V C T S A . ( I’T Y ) L T D

9199 ZV0269 PY R AN TEL PA M OA TE N EM EX : 4 M G /G PO W D ER S S K F A N IM A L H E A L T H

9202 V 00225 F E N T H IO N ■ S F L E A S Y S T E M IC F O R C A T S 10% S O L U T IO N S B A Y E R Z IM B A B W E (P V T ) L T D

9203 V 00226 F E N T H IO N F L E A S Y S T E M IC F O R S M A L L D O G S 20% S O L U T IO N S B A Y E R Z IM B A B W E (P V T ) L T D

9204 V 00227 F E N T H IO N F L E A S Y S T E M IC T O R L A R G E I X )G S ‘ 20% S O L U T IO N S B A Y E R Z IM B A B W E (P V T ) L T D

9219 ZV0070 B E S E R E L IN RECEPTAL 0 .0 0 4 M G /M L I N J E C T IO N S I N T E R V E T S .A .(P T Y ) L T D

9220 ZV0158 L E V A M I S O L E H Y D R O C H L O R ID E T R A M IS O L L O V O L 7 .5 % S O L U T IO N S S C H E R IN G -P L O U G H (P T Y ) L T D

9228 ZV0108 F E R R IC H Y D R O X ID E A N D D E X T R A N M Y O FER 100 IN JE C T IO N S IN T E R V E T S A . (P T Y ) L T D ,

9236 V 00006 P R O C A IN E P E N I C IL U N & D IS P O L A C D R Y C O W CREAM S C O O P E R Z IM B A B W E L T D

D IH Y D R O S T R E P T O M Y C IN S U L P H A T E

M 40 V 00245 PROPOXUR B A YO PET D O G C O LLAR 9 .4 % C O LLAR S B A Y E R Z IM B A B W E ( P V D L T D

9241 V 00243 , PROPOXUR B A YO PET C O LLA R FO R CA TS A N D 9 .4 % CO LLARS B A Y E R Z IM B A B W E ( P V T ) L T D

SM ALL DOGS

9243 V 00241 F L U M E T H R IN B A Y O P E T T IC K R IN S E 2% E M U L S IO N S B A Y E R .Z I M B A B W E ( P V T ) L T D

9250 V 00249 P R O P O X U R 1% B A Y O P E T T IC K A N D F L E A P O W D E R 1% POW DERS B A Y E R Z IM B A B W E (P V T ) L T D

9257 Z V 0329 P R A Z IQ U A N T E L D R O N C IT 50M O TAB LETS B A Y E R Z IM B A B W E ( P V T ) L T D

9272 V 00302 F E B A N T E L J 'Y R A N T E L E M B O A T E , D R ON TA L TAB LETS B A Y E R Z IM B A B W E ( P V T ) L T D

P R A Z IQ U A N T E L

9297 ZV0320 N lC m S A M ID E L IN T E X M 20% . S U S P E N S IO N S B A Y E R Z IM B A B W E ( P V T ) L T D

9299 V 00317 S U L P H A Q U I N O X A L I N E S O D IU M A N D T R IQ U IN GRANULES C O O P E R Z IM B A B W E L T D

93«) V 00330 A LBEND AZOLE A L B E N D A V E T J0% 10% S U S P E N S I O N S .O R A L D I V A S A - F A R M A V I C S A S P A IN

9333 V 00375 F L U M E T H R IN B A Y T IC O L A E R O S O L 0 2 % 0 .2 % M /M A ER O SO LS B A Y E R Z IM B A B W E ( P V T ) L T D

9335 V 00366 E N R O F L O X A C IN B A Y T R IL T A B L E T S 50M G TAB LETS B A Y E R Z IM B A B W E ( P V T ) L T D

•9 3 4 3 ZV0057 T E T A N U S T O X O ID E Q U IL iS T E T A N U S V A C C IN E IN JE C T IO N S I N T E R V E T S .A .(P T Y ) L T D

9 3 7 2 .- ^ V 00424 C O C C I D I O S I S V A C C IN E P A R A C O X V A C C IN E V A C C IN E S C O O P E R Z IM B A B W E L T D

9374 , V 00407 C O C aS T O P 2 000 C O C C IS T O P 2 0 0 0 POW DERS Z IM V E T P V T L T D , Z IM B A B W E

9375 ■ V 00411 C L O X A C IL L IN B E N Z A T H I N E CHANAM ASTDC 5 0 0 M G P E R 3 G IN IN T R A M A M M A R Y C H A N E L L E P H A R M M A N U F L T D IR E L A N D

P R E P A R A T IO N
9384 V 00428 O T IC U R E O T IC U R E O IL Y S U S P E N S IO N S Z IM V E T P V T L T D . Z IM B A B W E

9401 V 00436 N O R G E S T O M E T O E S T R A D IO U CRESTAR TR A NSD ER M AL SY STEM Z I M V E T P V T L T D . Z IM B A B W E

9402 V 00345 N E W C A S T L E D IS E A S E L IV E V A C C IN E N E W C A S T L E D IS E A S E L I V E V A C C IN E • V A C C IN E S D E H T E Q ( P T Y )L T D

9416 V 00470 A M P I C IL L I N C L O X A C I L U N S O D IU M C H A NA M A STLC IN T R A M A M M A R Y C H A N K I -E P H A R M M A N U F L T D I R E L A N D

P R E P A R A T IO N
. 9420 V 00427 F L U M E T H R IN . C Y F L U T H R IN E C T O L IN B . S U S P E N S IO N S B A Y E R Z IM B A B W E (P V T ) L T D

9430 V 00341 N E W C A S T L E A N D B R O N C H IT I S D I S E A S E V I -S O - H O L V A C C IN E S D E H T E Q ( P T Y )L T D

V A C C IN E

9438 V 00489 C H O R I O N IC G O N A D C ^ O P H I N C H O R U LO N P O W D H IS F O R I N J E C T IO N Z I M V F T P V T L T D . Z I M B A B ^ f t’E

9440 V 00485 C A N IN E P A R B O V IR U S V A C C IN E N O B I V A C P a rv o G V A C C IN E S Z I M V E T P V T L T D . Z IM B A B W E

9442 V 00492 N A N D R O LO N E LA UR EA TE LAURABOUN I N J E C T IO N S Z I M V E T P V T L T D , Z IM B A B W E

9443 V 00342 B U R S A L D IS E A S E V A C Q N E L IV E V IB U R S A G . V A C C IN E S D E H T E Q (P T Y )L T ‘D

9«1 V 0Q 473 S A U N O M Y C IN SACOX PO W D ER S SO LUB LE I N T E R V E T S .A . ( P T Y ) L T D

9453 V 00490 TESTO STERO NE D UR A TESTO N I N J E C T IO N S Z I M V E T P V T L T D . Z IM B A B W E

9454 V 00432 D EX A M ETHA SO NE D EX AD RESO N 2 M G /M L . IN JE C T IO N S Z I M V E T P V T L T D , Z IM B A B W E

9455 V 00504 A V I A N R E O V IR U S V A C C I N E V IN E L A N D A V IA N R E O V IR U S V A C C IN E S ' D E H T E Q (P T Y ) L T D

V A C C IN E (K IL L E D )

9467 V 00346 N E W C A S T L E /B R O N C H in S IN A C T IV A T E D N E W C A S T L E /B R O N C H IT IS V A C C IN E S D E H T E Q (P T Y ) L T D

. V I R U S V A C C IN E I N A C T I V A T E D V IR U S V A C C IN E

9468 V 00550 FARROW SURE FA R RO W SU R E V A C C IN E S S K F A N IM A L H E A L T H

9469 V 00552 M Y C O P L A S M A P N E U M O N IA E V A C C IN E R E S P IS U R E V A C C IN E S S K F A N IM A L H E A L T H

9471 V 0050I B U R S A L D I S E A S E V A C C IN E V I B U R S A C E (U V E ) V A C C IN E S D E H T E Q (P T Y ) L T D

9472 V 00506 T E N O S Y N O V IT I S V A C a N E L IV E C H IC K S Y N O V A C ( L IV E ) V A C C IN E S D E H T E Q (P T Y ) L T D

9480 V 00499 P R A Z IQ U A N T E L . - CESTOCUR 25% S U S P E N S IO N S . O R A L B A Y E R Z IM B A B W E (P V T ) L T D

9482 V 00460 - P E R M E T H R I N .C H L O R P Y R T F O S PU LV EX PO URO N D IP S C O O P E R Z IM B A B W E L T D

9487 V 00583 O X Y T E T R A C Y C L IN E H Y D R O C H L O R I D E DUOCYCUNE 1 0 % W /W I N J E C T IO N S U N IV E T I R E L A N D

9488 V 00584 O X Y T E T R A C Y C U N E H Y D R O C H L O R ID E D U O C Y C L IN E 2 0 2 0 % W /W IN JE C n O N S U N IV E T I R E L A N D
9493 V 00606 R P E R A Z IN E A D IP A T E , P IP E R IP R A 25% PO W DERS SO LU BLE G R A N iT E S lD E C H E M IC A L S (P V T ) L T D ,

HARARE
9500 ZV0209 T IC K G R E A S E C O O P E R T IC K G R E A S E O IN T M E N T S C O O P E R Z IM B A B W E L T D

9504 V 00343 B U R S A L . N E W C A S T L E -B R O N C H IT IS B U R S A L D IS E A S E ^ ^ E W C A S T L E - D E H T E Q (P T Y ) L T D
V A C C IN E S

B R O N C H I T I S D IS E A S E V A C C IN E
9505 V 00578 O X Y T E T R A C Y C L IN E H Y D R O C H L O R I D E T E N A L IN E 2 0 % L A C E V A S A N T E A N IM A L E
2 0 % W /V IN JE C m O H S
9506 V 00579 O X Y T E T R A C Y C L IN E H Y D R O C H L O R I D E TEN A L1N E10% C E V A S A N T E A N IM A L E
1 0 % W /V I N J E C T IO N S -
9507 V 00503 VI M ARK VI M ARK . D E H T E Q (P T Y ) L T D
V A C C IN E S
9509 V 00600 M A R E K S D IS E A S E V A C C IN E V IN E L A N D S M A R E K D IS E A S E V A C C I N E D E H T E Q (P T Y ) L T D
V A C C IN E S
9510 V 00565 M O X ID E C T IN
C Y D E C T IN 1% IN JE C T IO N S P F IZ E R L A B S P T Y L T D R S A
9513 V 0060I VANGUARD PUPPY VANGUARD PLUS 5 S K F A N IM A L H E A L T H
V A C C IN E S
9518 V 00538 V ED A PR O FEN
Q U D R IS O L 5 M G /M L G ELS Z IM V E T P V T L T D , Z IM B A B W E
9520 V 00611 C A N IN E C O R O N A V A C C IN E Z IM V E T P V T L T D , Z IM B A B W E
NOBI VAC CORONA V A C C IN E S .
9525 ZV0221 C H L O R P Y R IF O S
P U L V E X D O G D IP 15% L IQ U I D S C O O P E R Z IM B A B W E L T D
9526 V 00645 B U R S A L D I S E A S E -N E W C A S T L E -B R O N C H IT IS V IN E L A N D B U R S A L D IS E A S E -
E M U L S IO N S D E H T E Q (P T Y ) L T D

N E W C A S T L E - B R O N C H I T I S V A C C IN E
9535 V 00617 X Y L A Z IN E
C H A N A Z IN E 2% IN JE C T IO N S C H A N E L L E P H A R M M A N U F L T D IR E L A N D
9536 V 00616 X Y L A Z IN E C H A N A Z IN E C H A N E U E P H A R M M A N U F L T D IR E L A N D '
IQ % I N J E C T IO N S ■
9538' V 00632 A M IT R A Z b o v it r a z -s 125 % W A ^ : L IQ U I D S B A Y E R Z IM B A B W E ( P V T ) L T D
 976 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2

F ile N o . A ppI N o. A p p ro v e d n a m e IV a d e n a m e S t r e n g th F o rm A p p lica n t '

9539 V 00633 A M IT R A Z B O V IT R A Z -D 1 2 .5 L IQ U IE « B A Y E R Z IM B A B W E (P V T ) L T D
9542 • V 00652, A M IT R A Z A G R IT R A Z D IP . 12^5% U Q U ID S B A Y E R Z IM B A B W E (P V T ) L T D
9543 V O 0653 : A M IT R A Z A O R IT R A Z S P R A Y 1 2 .5 % ■ -■ L IQ U ID S B A Y E R Z IM B A B W E (P V T ) L T D
9544 V 0 0 6 I4 S E M D U R A M Y C IN A V IA X 5 % ■ 5% PO W D ERS S K F A N IM A L H E A L T H
9545 V 00650 D E L T A M E T H R I N .T A R A C I D S A ) L O P H O N Y P U L V E X F L Y R E P E L L E N T A N D W O U N D D R E S S IN G U Q U ID S . C O O P E R Z IM B A B W E L T D
9548 V 00649 S A L IN O M Y C IN S O D IU M K O K C lS A N V
1 2 % M /M GRANULES K R K A , S L O V E N IA
9549 ZV 0224 CARBARYL P U L V E X D IE IT O X D O G S H A M P O O POW DERS C O O P E R Z IM B A B W E L T D
9551 V 0 0 6 I3 F A I W iO W S U R E V A C C IN E S S K F A N IM A L H E A L T H
9561 V 00654 FEN BEN D A ZO LE ZEROFEN 22%}Am GRANULES CH AN ELLE PHARM M A N U F LTD
IR E L A N D
9565 V 00644 S E L A M E C T IN R E V O L U T IO N F O R D O G S 1 2 0 M G /M L LOZENGES S K F A N IM A L H E A L T H
, 9570 V 00663 P Y R E T H R IN E X T R A C T C (X > P E R S P O U L T R Y D U S T 0 .2 5 % POW DERS C O O P E R Z IM B A B W E L T D
9 .5 7 2 V 00660 T R IC L A B E N D A Z O L E T R IB E X 5 % . 5% M A 7 ■ S U S P E N S IO N S . O R A L A O R IC U R A P V T L T D
9573 • V 00661 T R IC L A B E N D A Z O IX T R IB E X 1 0 % 1 0 % M /V S U S P E N S I O N S .O R A L A G R IC U R A P V T L T D
9582 V 0069I C Y P E R M E T H R IN C A P S S E N T I N H .T I C K D R E S S I N G 0 .2 5 % W / W O IN T M E N T S A G R IC U R A P V T L T D
‘ 9583 V 00690 C Y P E R M E T H R IN V E T C O S E N T I N E L T I C K D R E S S IN G 0 .2 5 % W / W O IN T M E N T S A G R IC U R A P V T L T D
9584 V 00625 OXFENOAZOLE O X F E N -C 9 ,0 6 % W / V S U S P H ^ S I O N S .O R A L B A Y E R Z IM B A B W E (P V T ) L T D
9588 V 00678 P O L Y H E X A N ID E C X X )P E R S A M E T H Y S T T E A T D IP 5% M A / S O L U T IO N S C O O P E R Z IM B A B W E L T D
9589 V 00679 C H L O R H E X I D I N E G L U C .& B K 'G A L K O N I U M C X X )P E R S R U B Y T E A T D IP S O L U T IO N S C O O P E R Z IM B A B W E L T D
9593 . V 00657 N IT R O S C A N A T E TR O SCA N 500 500M G TABLETS. COATED C H A N E L L E P H A R M M A N U F L T D IR E L A N D
9594 V 00658 N IT R O S C A N A T E . T R O S C A N IO O lO O M G TA B LET S. CO A TED C H A N E L L E P H A R M M A N U F L T D IR E L A N D
9600 : V 00707 A M P IC IL U N S O D & C L O X A C IL U N S O D . N E O M A S T IK IA -L A C IN T R A M A M M A R Y G R A N IT E S ID E C H E M IC A L S (P V T ) L T D . H A R A R E
P R E P A R A T IO N
9608 V 00684 A M O X Y C IL L I N C L A V .& P R B D N . CLAVALOX IN T R A M A M M A R Y S K F A N IM A L H E A L T H
P R E P A R A T IO N
• 9614 V0070I MORAXELLA BOVIS b 'a CTERIN P IU G U A R D P IN K E Y E -1 V A C C IN E S C O O P E R Z IM B A B W E L T D
9617 V 00724 O X Y T E T R A C Y C U N E H Y D R O C H L O R ID E C O O P E R M Y C IN S O L U B L E P O W D E R 2 0 % M /M P O W E R S F O R S U S P E N S IO N C O O P E R Z IM B A B W E L T D
9625 V 00702 O X Y T E T R A C Y C U N E H Y D R O C H L O R ID E O X IP R A -1 0 lO O M G /M L S O L U T IO N S G R A N I T E S I D E C H E M IC A L S ( P V T ) L T D . H A R A R E
9626 V 00703 O X Y T B T R A C Y C L IN E H Y D R O C H L O R ID E O X I P R A -2 0 L A 2 0 0 M G /M L S O L U T IO N S G R A N IT E S ID E C H E M IC A L S (P V T ) L T D . H A R A R E
9627 • V 00734 A M IT R A Z E C T R IA T IX S T O C K S P R A Y 1 2 .5 % M /V D IP S CO O PER aM B A BW E LTD
. . 9628 - V 00735 A M IT R A Z . V ETRA ZSTCX K SPRAY 1 2 5 G /L D IP S C O O P E R Z IM B A B W E L T D
9630 . V 00737 A M IT R A Z V E T R A Z C A T T L E D IP 1 2 5 % M /V D IP S C O O P E R Z IM B A B W E L T D
9634 V 0074I IV E R M E C T IN

I
N E O M E C (V e terin a ry ) 1 % W /V IN JE C T IO N S IN T A S P H A R M A C E U T IC A L S L IM IT E D
9635 V 00742 M E L O X IC A M M E U 3 X IC A M (V e te rin a ry ) 5 M G /M L IN JE C T IO N S I N T A S P H A R M A C E U T IC A L S L I M I T E D
. 9637 V 00743 E N R O F L O X A C IN Q U IN IN T A S . lO O M G /M L IN JE C T IO N S I N T A S P H A R M A C E U T IC A L S L I M I T E D
9638 V 00749 C H L O R P Y R IF O S 4 -D IC H L O R V O S + O U R O F IN O W O U N D S re A Y A ERO SO LS O U R O F IN O Z IM B A B W E (P V T ) L T D
G E N T IA N V IO L E T
, 9641 , V 00740 O X Y T B T R A C Y C L IN E IN T A M Y C IN -L A 2 0 0 M G /M L IN JE C T IO N S I N T A S P H A R M A C E U T IC A L S L I M I T E D
9641 . 00V 740 O X Y T E T R A C Y C U N E D IH Y D R A T E IN T A M Y C IN L A 200M G S O L U T IO N S I N T A S P H A R M A C E U T IC A L S U M I T E D
9643 V 00757 P R O C A IN E B E N Z Y L f E N I C I L L I N U N I C I L L IN 3 0 0 M G /M L IN JE C T IO N S U N IV E T IR E L A N D
9644 00V 744 O X Y T E T R A C Y C U N E H Y D R O C H L O R IC ® T E R R A N O X T O P IC A L O IN T M E N T 3 0 /I0 M G O IN T M E N T S G R A N IT E S ID E C H E M IC A L S (P V T ) L T D , H A R A R E
9648 ■ V 00706 C L O X A C IL L IN B E N Z A T H IN E + N E O M A S T I P R A -S E C IN T R A M A M M A R Y G R A N IT E S ID E C H E M IC A I> S (P V T ) L T D .
S U L P H A D IM ID IN E + T R IM E T H O P R IM P R E P A R A T IO N HARARE

General Notice 595 of 2012.

MEDICINES AND ALLIED SUBSTANCES CONTROL ACT {CHAPTER 15:03]

Cancellation of Certificates of Registration of Human Medicines

IT is hereby notified, in terms of section 24(l)(b) of the Medicines and Allied Substances Control Act [Chapter 75.-05], that the Medicines
Control Authority has approved the registration of the medicines specified in the Schedule.
G. N. MAHLANGU,
1 4 -1 2 -2 0 1 2 . Director-General.
Sc h e d u l e

F i le N o . A ppl N o. A p p ro v e d n a m e IV a d e n a m e S tre n g th F o rm A ppH caht

0001 000013 M E T H Y L P R E D IN I S O L O N E S O L U -M E D R O L 4 0 M G /2 M L IN JE C T IO N S N .V . U P J O H N - P H A R M A C I A & U P J O H N ,

B E L G IU M
0002 000014 M E T H Y L P R E D N IS O U 3 N E S O L U -M E D R O L 1 2 5 M G /2 M L IN JE C n O N S N .V . U P J O H N - P H A R M A C I A & U P J O H N ,
B E L G IU M
0012 000010 L0R A 2EPA M A T IV A N T A B L E T I .0 M G TA BLETS W Y E T H S A (P T Y ) L T D R S A r1
0014 000012 . L0R A 2EPA M A T IV A N T A B L E T 2 .5 M G TABLETS W Y E T H S A (P T Y ) L T D R S A
0020 , 000019 M O T IV A L - I O lO .O M G TA BLETS B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
0023 000023 C A L C IU M P A N T O T H E N A T E C A L C IU M P A N T O T H E N A T E 59M G TABLETS Q V P H A R M A C I E S .Z I M B A B W E
0025 000034 C L I N D A M Y C IN H Y D R O C H L O R I D E D A L A C IN C 150M G CAPSULES N .V . U P J O H N - P H A R M A C I A & U P J O H N .
B E L G IU M
0028 000028 T IL ID IN E H Y D R O C H L O R ID E V A LO R O N C A PSU LES 50M G CAPSULES P F IZ E R L A B S P T Y L T D R S A
0034 000031 M E A SL E S, M U M PS & R U B ELLA M - M - R 1 1 V A C C IN E V A C C IN E S M SD PTY LTD RSA
0059 000082 N Y S T A T IN M Y C O S T A T IN lO O O O O U N I T S /M L S U S P E N S IO N S ; O R A L B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
0065 000098 S A L B U T / J v lO L S U L T O A T E V E N T O L IN R E S P IR A T O R S O L U T IG N 0 .6 % S O L U T IO N S G L A X O -W E L L C O M E Z IM B A B W E P V T L T D .

HARARE
. 0067 000501 - P R O C A IN E P E N IC IL U N G P E N A C IL -P -3 0 3 M G I N J E C T IO N S G U L P D R U G C O . H A R A R E . Z IM B A B W E
0075 000579 P O L IO V IR U S (L IV E A T T E N U A T E D ) P O U O V IR U S V A C C IN E I 4 O O (W 0 T C ID 5 O I N J E C T IO N S S K B P T Y L T D S U N N 1 N G H IL L .S A
0076 000547 K L O R E F -P K L O R E F -P TA BLETS. EFFERV ESCEN T A B B O T L A B O R A T O R I E S S .A .( P T Y ) L T D
; 0128 000509 G U A IP H E N E S IN C H A M B E R L A IN ’S P E P P F J IM I N T . 5 0 M G /S M L SYRUPS W A R N E R - L A M B E R T S .A .(P T Y ) L T D R S A

COUGH REM EDY

0134 O O O A 48 V E R A P A M IL IS O P T IN A M P O U L E 5 M O /7 M L AM TOULES A B B O T L A B O R A T O R IE S S A . (P T Y ) L T D
0135 O O O A 47 V E R A P A M IL H Y D R tX H L O R lD E IS O P T IN D R A G E E 40M G DRAGEES A B B O T L A B O R A T O R I E S S .A . ( P T Y ) L T D
0188 O O A 116 C A R B 1D O PA & LEV O D O PA S IN E M E T T A B L E T TABLETS M SD PTY LTD RSA
2 5 M G /2 5 0 M G
0196 00A 126 T H IA M IN E + P Y R ID O X IN E + N E U R O B IO N A M P O U L E IN JE C T IO N S M ERCK FTY LTD

C Y A N ( X :O B A L A M I N
0197 O O A 125. T H I A M I N E + P R I D O X I N E + C Y A N O C O B A L A M IN N E U R O B IO N TABLETS, COATED M ERCK PTY LTD
0252 000089 G L IB E N C L A M ID E EUGLU CON TA BLETS RO CH E PRO DU CTS PTY LTD RSA
5M O
0258 O O A 297. T A M O X IF E N NOLVADEX lO M O TABLETS, COATED
0274 ' 00A 342 . ' B O O T S H E A L T H C A R E ( S O U T H A F R IC A ) ( P T Y )
S T R E P S IL S W IT H H O N E Y A N D L E M O N LO ZEN G ES
LTD
0277 00A 252 ly iE R A S Y N G K . GELS A D C O C K IN G R A M L IM IT E D . S A

0289 00A 259 T H IA M P H E N IC O L U R F A M Y C IN C A P S U L E S CAPSULES D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

250M O
0291 00A 346 D O T H IE P IN H Y D R O C H L O R ID E P R O T H IA D E N C A P S U L E S CAPSULES A B B C f T L A B O R A T O R I E S S .A .( F T Y ) L T D
25M G
0296 00A 294 CAPSULES RO CH E PRO DU CTS PTY LTD RSA
M A D O PA R 250M G C A PSU LE S
0304 O O A 133 M ETHYLDOPA A U X 3M ET250 T A B L E T S. C O A TED M SD PTY LTD RSA
250M O
0341 O 0A 337 A L U M IN H Y D R O X /M A G C A R B O N A T E TABLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
R U B R A G E L M IN T S
A N D D IA T O M IT E
0359 00A 285 D E X A M E T H A S O N B S O D IU M P H O S P H A T E D R O PS, EY E C A P S P V T L T D . H A R A R E , Z IM B A B W E
D E X O N E E Y E /E A R D R O P S 0 .1 %
0360 00A 17I O IN T M E N T S G RO U P LA BS SA PTY LTD RSA
E S K A M E L A C N E A N D P IM P L E
O IN T M E N T
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2 977

F ile N o . A ppl N o. A p p ro v e d n a m e . IV a d c n a m e S tie n g th F o rm A p p lic a n t

0365 0 0 A I3 9 G IL L L IQ U ID S O A P SOAPS DATLABS PVT LTD , BULAW AYO.

Z IM B A B W E

0366 0 0 A I9 1 KENACOM B CREAM CREA M S B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D

0367 00A 192 K E N A C O M B O IN T M E N T O IN T M E N T S B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D

0368 O O A 193 . T R IA M C IN O IO N E K E N A L O G IN O R A B A S E 0 .1 % GELS B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D

0424 O O A 363 S O T A L O L H Y D R O C H L O R ID E S O T A C X )R 80M G TABLETS B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D

0441 000908 M A G N E S IU M H Y D R O X ID E P H IP P S M IL K O P M A G N E S IA 3U M G TABLETS A D C O C K IN G R A M S S A (P T Y ) L T D

0442 0 ( M 9 iO - M IL L Y P A R S U S P E N S IO N S A D C O C K IN G R A M S S A (P T Y ) L T D

0447 00A 42I NORDETTE TA B LET S,CO A TED W Y E T H S A (P T Y )L T D RSA

0452 000907 M A G N E S IU M H Y D R O X ID E P H IP P S M IL K O F M A G N E S IA 95% S U S P E N S IO N S A D tO C K IN G R A M S S A (P T Y ) L T D

0474 O O A 317 D IM E T A P P E L IX IR E L IX IR S W Y E T H S A (P T Y ) L T D RSA

0494 00A 350 F R U S E M ID E L A S IX T A B L E T S 40M G TABLETS A V E N T IS P H A R M A (P T Y ) L T D

0495 O O A 655 F R U S E M ID E L A S IX A M P O U L E S 2 0 M G /A M P O U L E AM POULES A V E I ^ I S P H A R M A .{ P T Y ) L T D

0496 O O A 781 PROPRANOLOL IN D E R A L lO M G TA B LET S. CO A TED A S T R A Z E N E C A L IM IT E D

0497 O 0A 782 PROPRANOLOL IN D E R A L 40M G T A B L E T S ,C C ) A T E D

0504 000290 G R IP P O N C A P S U L E C A PSU LES D A B P H A R M A C E U T IC A L S P V T L T D . H A R A R E

0515 00A 850 D IN O P R O S T P R O S T IN F 2 A L P H A IN JE C T IO N 5 M G /M L IN JE C T IO N S N .V . U P J O H N -P H A R M A C 1 A & U P J O H N . B E L G I U M

0516 O O A 865 A S P IR IN P IN K A S P IR IN 300M G TABLETS P H A R M A N O V A (P V T ) L T D . H A R A R E

0574 00A 846 T R A N E X A M IC A C ID C Y C L O K A P R O N IN JE C T IO N O .I G /M L IN JE C T IO N S D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

0591 00A 875 V IC K S V A P O U R U B N V IC K S V A P O R U B N O IN T M E N T S PROCTER AND G A M BLE

0603 0 (K )9 0 5 D R E W S L IV E R S A L T . PO W D ERS,EFFERVESCENT A D C O C K IN G R A M S S A (P T Y ) L T D

0609 O 0A 536 C H L O R O Q U IN E P H O S P H A T E NOROLOL 250M O TA BLETS,CO A TED A D C C K T K IN G R A M S S A (P T Y ) L T D

0639 (W A 3 8 4 FENTANYL S U B L IM A Z E Oj OSMG/ML IN JE C T IO N S JO H N SO N & JO H N SO N P V T L T D H A R A R E

0647 (« A 4 2 2 IR O N F E R R IM E D IN JE C T IO N 5 0 M G /M L IN JE C T IO N S C A P S P V T L T D . H A R A R E . Z IM B A B W E

0667 00A 434 M A G N E S IU M H Y D R O X ID E P H IP P S M IL K O F M A G N E S IA 2AG POW DERS A D C O C K IN G R A M S S A (P T Y ) L T D

.0 6 7 8 O O O B 21 G L U C X 3 P E C T S U S P E N S IO N S U S P E N S IO N S . O R A L G U L F D R U G C O . H A R A R E .Z I M B A B W E •

0698 00A 656 P H E N IR A M IN E M A L E A T E A V IL R E T A R D 75M G TAB LETS,COATED A V E N T IS C R O P S C IE N C E Z IM B A B W E -

0701 00A 298 C E T Y L P Y R ID 1 N IU M C H L O R ID E C E P A C O L A N T IB A C T E R IA L 0 J)5 % M O U TH W A SH ES A D C O C K IN G R A M L IM IT E D , S A

M OUTHW ASH

0707 00A 510 N E T H A P R IN D O S P A N TA BLETS A D C X 5 C K IN G R A M L IM IT E D , S A

0708 0 3 A 8 I2 N E T H A P R IN E X P E C T O R A N T SY R U PS A D C X X :K I N G R A M L I M I T E D , S A

0727 000422 A S C O R B IC A a O REDOXON IG T A B L E T S .E F F E R V E S C E N T R O C H E PRO D U CTS PTY LTD RSA

0751 0000B 6 S IL V E R S U L P H A D I A Z IN E F L A M A Z IN E C R E A M 1% CREAM S S M IT H & N E P H E W L T D . R S A

0755 O O O B 95 D IS O P Y R A M ID E R Y TH M O D A N C A PSU LES lO O M O C A PSU LES A V E N T IS P H A R M A (P T Y ) L T D

0776 00A 853 M ED RO X Y PR O G ESTER O N E A CETA TE .PROVERA 5M G TABLETS N .V . U P J O H N - P H A R M A C I A & U P J O H N ,B E L G I U M

0777 00A 498 D IM E T A P P E X T E N T A B S T A B L E T S .C O A T E D W Y E T H S A (P T Y ) L T D RSA

0782 0 0 A 1 I8 O X Y M E T A Z O L IN E H Y D R O C H L O R ID E lU A D I N 0 .0 5 % D R O P S Oj 05% S O L U T IO N S M ERCK PTY LTD

0783 0 0 A II9 O X Y M E T A Z O L IN E H Y D R O C H im iD E IL IA D IN N A S A L S P R A Y ,^ 0 X 3 5 % SPRAY S, NASAL M ERCK PTY LTD

0785 00A 143 P Y R IT IN O L H Y D E O C H L O R ID E EN C EPH A 80L TA BLET lO O M G T A B L E T S ,C » A T E D M ERCK PTY LTD

0801 O O A 135 A M IT R IP T Y U N E H Y D R O C H L O R ID E TR Y PTA N O L25 . 25M G T A B L E T S .C O A T E D M SD PTY LTD RSA

0805 00A 117 O X Y M E T A Z O L IN E H Y D R O C H L O R ID E I L I A D I N 0 .0 2 5 % D R O P S O X )2 5 % S O L U T IO N S M ERCK PTY LTD

0806 00A 965 G L IB E N C L A M ID E D A O N IL 5M G TABLETS A V E N T IS P H A R M A (P T Y ) L T D

. 0813 000963 TABLETS /W H IT E H A L L IN T E R N A T IO N A L IN C .

A N A D IN
0818 O O B182 H IS T A L Y N E X P E C T O R A N T SY R U PS C A P S P V T L T D , H A R A R E .Z I M B A B W E

0830 00A 991 C E P A G A IN E S O L U T IO N S O L U T IO N S A D C O C K I N G R A M L I M I T E D .S A

0831 O 0A 309 D O CD O L TA BLETS TA BLETS A D C O C K I N G R A M L I M I T E D .S A

0840 000210 S E L E N IU M S U L P H ID E S E L S U N S U S P E N S IO N 225% S U S P E N S IO N S A B B O T T L A B S S A (P T Y ) L T D

0842 00A 810 S T R E P S IL S O R IG IN A L LOZENGES B O O T S H E A L T H C A R E (S O U T H A F R IC A ) (P T Y )

LTD

0847 00A 924 M E T H Y L P R E D N IS O L O N E M EDROL TABLET 4M G TABLETS N .V . U P /O H N - P H A R M A C f A & U P J O H N , B E L G I U M

0862 O O A 423 D O X O R U B ia N H Y D R O C H L O R ID E A D R IB L A S T IN A lO M G /V IA L P O W D E R S F O R IN J E C T IO N P H A R M A C IA S A P T Y L T D , C R A IG H A L L . S A

0863 0 0 A .5 0 0 A U R A L O IC IN A U R A L O IC IN DROPS,EAR RO CH E PRO D U CTS PTY LTD RSA

0911 O O B 3 I3 P H E N O B A R B IT O N E P H E N O B A R B IT O N E 6 0 M G T A B L E S 60M G TA BLETS P K A R M A N O V A (P V T ) L T D . H A R A R E

0918 00A 654 P O L Y M Y X IN B & N E O M Y C IN S U L P H A T E O T O S P O R IN DROPS,EAR G L A X O -W E L L C O M E Z IM B A B W E P V T L T D .

HARA RE

0926 00B 328 N IF E D IP IN E A D A LA TCA PSU LES lO M G C A PSU LES B A Y E R (P T Y ) L T D S A

(» 4 6 00B 340 P IR A C E T A M N O O T R O P IL T A B L E T S 800M G T A B L E T S .C O A T E D U CB SA PTY LTD

0954 O O A 598 S U L P H A C E T A M ID E S U L P H A C E T A M ID E E Y E O IN T M E N T 10% O IN T M E N T S , E Y E D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E

0964 00B 364 R 5 L IC A C ID F O L IC A a D T A B L E T S 5M G TA BLETS D A T L A B S P V T .L T D , B U L A W A Y O . Z I M B A B W E

0978 O O B368 ATENOLOL T E N O R M IN lO O M G T A B L E T S .C O A T E D IN D U S T R IA L C H E M IC A L IM P O R T E R S . H A R A R E

0981 O O B 358 M ESNA M IS T A B R O N 600M G AM POULES U CB SA PTY LTD

0990 00B 382 R E S E R P IN E R E S E R P IN E T A B L E T S 0 .2 5 M G TA BLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E

0992 00B 384 C A L C IU M G L U C O N A T E C A L aU M G L U C O N A T E T A B LE T S 500M G TABLETS D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E

1008 00B 132 D IA Z E P A M NOTENSETABLETS 2M G TA B LETS. D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

1009 O O B I3 3 D IA Z E P A M N O TEN SE TA BLETS 5M G TABLETS D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E

1010 00B 134 D IA Z E P A M N O TEN SETA BLETS lO M O TA BLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E

I 1012

1059
- (M 0 B 9 7

O O B391
F R U S E M ID E A Q U A S IN T A B L E T S

L IN C T IF E D E X P E C T O R A N T P A E D IA T R IC
20M G TABLETS

SY R U PS
D A T L A B S P V T L T D , B U L A W A Y O . Z IM B A B W E

G L A X O -W E L L C O M E Z IM B A B W E P V T L T D .

HARA RE

1093 00A 767 TABLETS A D C O C K IN G R A M S S A (P T Y ) L T D

FRAM O L
1137 00B 440 TABLETS B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
P R O T E N S IN -M

1179 0 0 A 3 I8 A L L O P U R IN O L . - 3 C X )M G TA BLETS G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
Z Y L O P R lM -3 0 0
HARARE

1182 000619 SY R U PS A D C O C K IN G R A M L IM IT E D , S A
P R O PA JN
1194 00B 477 GRANULES M A D A U S P H A R M A C E U T IC A L S (P T Y ) L T D
A G IO L A X
1201 O O A 366 TA BLETS S E A R L E D IV IS IO N O F M O N S A N T O S .A ( P T Y ) L T D
L O M O T IL
SA

1205 0G B 292 8 0 M 0 /5 M L SY R U PS A D C O C K IN G R A M S S A (P T Y ) L T D
C H L O R O Q U IN & P H O S P H A T E NOROLOL
1242 00B 421 5M G TA BLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
N IT R A Z E P A M NOCTENE
1243 00B 426 TA BLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
P Y R IM E T H A M IN E A N D D A P S O N E T A B L E T S P Y R IM E T H A M IN E A N D D A P S O N E T A B L E S
1245 00B 360 O IN T M E N T S D A T L A B S P V T L T D , B U L A W A Y O . Z IM B A B W E
T E T R A C Y C U N E O IN T M E N T T E T R A C Y C L IN E O IN T M E N T 3%
1253 0B 314A TA BLETS N .V . U P J O H N - P H A R M A a A & U P J O H N , B E L G I U M
T R IA Z O L A M H A L C IO N 0 .2 5 M G
1254 O 0 B 3 I4 O JM G TA BLETS U P JO H N P V T L T D IS A N D O R S A
T R IA Z O L A M H A L C IO N
1256 O O O C 64 GELS M A D A U S P H A R M A C E U T IC A L S (P T Y ) L T D
R E P A R IL O E L
1261 O O O C63, T IM O L O L M A L , A M IL O R ID E & TA BLETS . M SD PTY LTD RSA
M ODUCREN '

H Y D R O C H L O R O T H IA Z ID E
1263 0B 473A S U P P O S IT O R IE S A V E N T IS C R O P S C IE N C E Z IM B A B W E
M E T R O N ID A Z O L E FLAGYL IG
1267 O O B268 T E T R A C Y C L IN E H Y D R O C H L O R ID E , C A PSU LES D A T L A B S P V T L T D .B U L A W A Y O .Z I M B A -
T E T R A C Y C L IN E H Y D R O C H L O R ID E 250M G
BW E

1278 000C 91 M ESNA 5 G /1 0 0 M L SPRAY S. NASAL U C BSA PTY U D

M IS T A B R O N
1280 <K »C 88 T IM O L O L M A L E A T E DROPS. EYE M SD PTY LTD RSA
T IM O P T O L . 0 .5 %
1290 00S430 C E T R IM ID E L O T IO N S R ECK m & COLM AN HARARE
V A L D E R M A A N T IS E P T IC L O T IO N 0 .7 %
1291 00B 429 CREAM S R E C K IT T &COLM AN HARARE
VALDERM A
1301 000B 34 ' A M P IC IL U N 1 2 5 M G /5 M L GRANULES C A P S P V T L T D .H A R A R E ,Z I M B A B W E
F A M ia i L lN
1302 O O O B 35 A M P IC IL L IN 2 5 0 M G /5 M L GRANULES C A P S P V T L T D , H A R A R E ; Z IM B A B W E
F A M IC IL L IN
1303* O O O B 38 A M P IC IL U N P O W D E R S F O R IN JE C T IO N C A P S P V T L T D , H A R A R E , Z IM B A B W E
250M O '
F A M IC IL L IN
1304 O O O B 39 A M P IC IL L IN 500M G P O W D E R S F O R IN JE C n O N C A P S P V T L T D . H A R A R E .Z IM B A B W E
F A M IC IL L IN
1306 000B 41 A M P IC IL U N 250M G C A PSU LES C A P S P V T L T D . H A R A R E , Z IM B A B W E
F A M IC IL L IN
1307 0 0 0 B 4 2 ^ V M P )C IL U N ' C A P S P V T L T D . H A R A R E , Z IM B A B W E
500M G .C A P S U L E S
F A M ia i L I N
1311 00B 453 F L U R B IP R O F E N T A B L E T S .C O A T E D A B B O T L A B O R A T O R IE S S .A . ( P T Y ) L T D
FROBEN 50M G
1313 000C 8I CLOBAZAM TA BLETS S A N O F I-S Y N T H E L A B O (P T Y ) L T D
URBANYL lO M O
1316 000C 73 A M P IC IL L IN 500M G P O W D E R S F O R IN JE C T IO N P H A R M A C A R E L IM IT E D , S A
P E T E R C IL L IN
1347 00C 140 S O D IU M V A L P R O A T E TABLETS P H IL L IP L E E P V T L T D . H A R A R E , Z IM B A B W E
E P IU M 200M G : ;
 978 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2

F ile N o . A ppI N o. A p p ro v e d n a m e IV a d e n a m e S tre n g th F o rm A p p lic an t

1349 (X 3C I4 6 P S E U D O E P H E D R IN E H Y D R O C H L O R ID E SU DA FED 60M G TABLETS G L A X O -W E L L C O M E 3 M B A B W E P V T L T D ,

HARARE
1350 0 0 C I4 5 P S E U IX ) E P H E D R 1 N E H Y D R O C H L O R I D E S U D A ra D P A E D IA T R IC 3 0 M G /5 M L SYRUPS G L A X O - W E IX C O M E H M B A B W E P V T L T D .

HARARE
1362 (W 0 C 8 2 P O V ID O N E IO D IN E C H E M S E R V E C H E M - O - D IN E 9 .3 % S O L U T IO N S C E R N O L C H E M IC A L S Z I M B A B W E P V T L T D
1363 O O C 216 S P A S M O -U R O E N IN D RA GEES M A D A U S P H A R M A C E U T IC A L S ( P T Y ) L T D
1373 O OQ 563 D E X T R O P R O P O X Y P H E N E .C A F F E I N E A S P I R I N D 0L0X EN E C 065 CA PSU LES L IL L Y E L I (S A ) (P T Y ) L T D
1374 (W 0 5 6 2 D EXTRO PRO PO XY PH EN E DOLOXENE 65M G CAPSULES L IL L Y E L I (S A ) (P T Y ) L T D
1377 00C 281 A M I L O R I D E & H Y D R O C H L O R O T H IA Z ID E M O DU R EnC TABLETS • M SD PTY LTD R SA
1379 0 0 )4 6 5 A S P IR IN & C O D E IN E C O D IS TAB LETS R E C K IT T & C O L M A N H A R A R E
1387 00B 504 M E T H Y L B E N Z E T H O N IU M C H L O R ID E J O H N S O N 'S A N n S E P T I C P O W D E R PO W D ERS JO H N S O N & JO H N S O N P V T L T D H A R A R E
1396 (K 3 B I8 8 TETRA CY CU N E C A P C Y C L IN E 2S0M G CA PSULES C A P S P V T L T D , H A R A R E , Z IM B A B W E
1398 (K )6 2 0 A C A T H IN E H Y D R O C H L O R ID E N O BESEN O. I 50M G C A PSU LE5LO W R ELEA SE A D C O C K I N G R A M L I M IT E D . S A
1425 0 ( X )C 8 6 G E N T A M IC I N S U L P H A T E SEPTOPAL 7 .5 M G /B E A D IM P L A N T S M ERCK PTY LTD
1444 00C 273 SENNA SENOKOT • TA B LETS R E C K IT T & C O L M A N H A R A R E
1490 0 O )C ^ P R O P A F E N O N E H Y D R O C H L O R ID E RYTM ONORM 150M G TA BLETS. C O A TED A B B O T L A B O R A T O R IE S S j\. (P T Y ) L T D
1491 • 1^C 2J P R O P A F E N O N E H Y D R O C H L O R ID E
RYTM ONORM 300M G T ^L E T S , CO ATED A B B O T L A B O R A T O R I E S S .A .< P T Y ) L T D
1492 W 0C 22 W I O P A F E N O N E H Y D R O C H L O R ID E RYTM ONORM 7 0 M G /2 0 M L IN JE C T IO N S A B B O T L A B O R A T O R IE S SJi. ( P T Y ) LTD
1502 00C 274 BENZBROM ARONE. M IN U R IC lO O M G TA BLETS R E C K I T T & C C M .M A N H A R A R E
1503 < K )C 2 7 5 G A V IS C O N G A V IS C O N TABLETS R E C K IT T & C O L M A N H A R A R E
1517 0 ( K )C 3 8 T H m P H Y L U N E & E T H Y L E N E D I A M IN E E U P H Y IX IN R E T A R D 281 H OM O TA B LETS. C O A TED H O E C H S T Z IM B A B W E C O P V T L T D
1526 00C 264 S E N E O A J P E C A C L I Q E X T R A C T & L IQ U O R IC E C H A M B E R L A IN ’ S C O U G H M I X T U R E M IX T U R E S W A R N E R -L A M B E R T S .A .(P T Y ) L T D R S A
1538 O O C 263 S L O A N ’S H E A T R U B CREAM S W A R N E R - L A M B E R T S . A .( P T Y ) L T D R S A
1546 O O C 377 A M O X Y C I L L IN S O D IU M A M O a L L IN 500M G P O W D E R S F O R IN JE C T IO N C A P S P V T L T D . H A R A R E , Z IM B A B W E
1547 00C 378 A M O X Y C I L L IN S O D I U M A M O C IL L IN 250M G P O W D E R S F O R IN JE C T IO N C A P S P V T L T D , H A R A R E . Z IM B A B W E
1561 O O B 281 I S O N IA Z I D A N D T H I A C E T A Z O N E H T3 TABLETS , D A T L A B S P V T L T D .B U L A W A Y O . Z I M B A B W E
1562 O O B 282 IS O N IA Z ID A N D T H IA C E T A Z O N E H TI TABLETS D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
.1 5 6 8 00C 175 V IC K S C O U G H S Y R U P V IC K S C O U G H S Y R U P SYRUPS PR O C TER G A M B L E S A .S A
1588 0 0 C I9 5 T E T R A H Y D R O Z O L IN E IN S T O L 0 .0 5 % DROPS,EYE A D C O C K IN G R A M S S A (P T Y ) L T D
1593 O O C 365 T R IN O R D 1 0 L 2 1 TAB LETS. CO ATED W Y E T H S A (P T Y ) L T D RSA
1594 ( X )C 6 3 3 T R IN O R D IO L 2 8 TA BLETS. C O A TED W Y E T H S A (P T Y ) L T D R S A

i
1605 00C 563 C Y T A R A B IN E CY TO SAR lO O M G P O W D E R S F O R I N J E C T IO N N .V . U P J O H N - P H A R M A a A & U P J O H N .B E L G I U M
1607 00C 242 E N O A C T IV E F R U I T S A L T ( L E M O N F L A V O U R ) SA LT. EFFER V ESC ENT G ROU P LABS SA PTY LTD RSA
1623 00B 422 C H L O R O Q U IN E C H L O R C iQ U lN 4 0 M G /M L I N J E C T IO N S D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E
1624 00B 270 C H L O R A M P H E N IC O L C H L O R A M P H E N IC O L 250M G OVULES D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E
1626 00B 271 C H L O R A M P H E N IC O L P A L M IT A T E C H L O R A M P H E N IC O L P A L M IT A T E 1 2 5 M G /5 M L S U S P E N S IO N S D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E
1645 (» C 5 9 1 LEV ON ORG ESTREL M IC R O V A L 0 .0 3 M G TA B LETS, CO ATED W Y E T H S A (F T Y ) L T D RSA
1651 00C 581 R IF A M P IC IN R I F A D IN 1 0 0 M G /5 M L SYRUPS D O W C H E M I C A L A F R IC A P T Y L T D R A N D B U R G
1653 000638 C O M B IV I T E SYRUPS P H A R M A C A R E L IM IT E D . S A
1654 (X 1 0 6 3 9 C O M B IV I T E T A B L E T S .C O A T E D P H A R M A C A R E L I M I T E D .S A
1698 00C 617 A C Y C L O V IR Z O V IR A X 3% O IN T M E N T S , E Y E G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,

HARARE
1706 00C 722 N IM O R A Z O L E N A X O O IN 500M G TABLETS P H A R M A C IA S A P T Y L T D . C R A I G H A L L , S A
1718 00C 720 T H IO P E N T O N E S O D IU M T H IO P E N T A L 0 ,5 0 P O W D E R S F O R I N J E C T IO N B I O C H E M IE , T Y R O L . A U S T R IA
1732 O O C 678 A M O X Y C I U .I N A N D C L A V U L A N IC A C ID A U G M E N T IN 375M G TA BLETS. C O A TED S M I T H K L IN E B E E C H A M P H A R M P T Y L T D . S A
1739 (M C 7 4 9 N O R E T H IS T C R O N E M IC R O N O R 035M O TABLETS JO H N S O N & JO H N S O N P V T L T D H A R A R E
1740 00C 735 C IS P L A T IN P L A T A M IN E lO M G P O W D E R S F O R IN JE C T IO N P H A R M A C IA S A P T Y L T D , C R A IG H A L L , S A
1745 O O C 725 S U L F A D O X I N E A N D P Y R IM E T H A M I N E F A N S ID A R TABLETS R O C HE PRO DU CTS PTY LTD RSA
1761 (X 1 C 7 7 5 O R A L R E H Y D R A T IO N S A L T S PO W DERS SO LU BLE D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E
1768 «>C 70S M E A S L E S V A C C IN E ROUVAX 1000 TC I D 50 P O W D E R S F O R I N J E C T IO N A V E N T IS C R O P S Q E N C E Z IM B A B W E
1770 O O C 826 N O R G E S T R E L & E T H IN Y L N E S T R A D IO L L O F E M IN A L TA BLETS p n Z E R L A B O R A T O R IE S (P V T ) L T D
1790 (X )C 5 0 7 CEFAM ANDOLE M A ND OK EF IG P O W D E R S F O R IN JE C T IO N L IL L Y E L I ( S A ) (P T Y ) L T D
1799 ( K )C 7 7 9 G E N T A M IC I N A N D B E T A M E T H A S O N E G A R A S O N EE Y E JE A R D R O P S DROPS,EYE G EDD ES LTD H ARA RE
E Y E /E A R D R O P S

1800 0Q C 7^ G E N T A M IC I N A N D B E T A M E T H A S O N E G A R A S O N E O P T H A L M IC O IN T M E N T O IN T M E N T S , E Y E G EDD ES LTD . H ARA RE

O P H T H O IN T

1805 W )C 7 9 4 T IO C O N A Z O L E TROSYD DERM AL CREAM 1% CREAM S P H A R M A C E U T I C A L & C H E M I C A L D IS T ,

HARARE
1815 0O C 708 I N A C T I V A T E D R A B IE S V A C C I N E M E R IE U X I N A C T IV A T E D 2 .5 IU /D O S E V A C C IN E S A V E N T IS C R O P S C I E N C E Z IM B A B W E

R A B IE S V A C C IN E
1828 00C 796 T IO C O N A Z O L E G Y N O -T R O S Y D V A G IN A L C R E A M 2% CREAM S P H A R M A C E U T IC A L & C H E M IC A L D IS T , H A R A R E
1 8 .3 4 O O C 906 E P I R U B IO N H Y D R O C H L O R ID E F A R M O R U B I C IN lO M O P O W D E R S F O R I N J E C T IO N P H A R M A C IA S A P T Y L T D . C R A IG H A L L . S A
1840 (M C 9 2 5 S P IR O N O L A C T O N E A LDA CTO N E lO O M G S E A R L E D IV IS I O N O F M O N S A N T O S .A ( P T Y ) L T D
TABLETS

SA ■
,1 8 4 1 W X :6 7 2 W A T E R F O R IN JE C T IO N W A T E R F O R IN JE C T IO N S 5 M L O R IQ M L L IQ U I D S D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E
1850

1851
(X 3 C 82 9

O O C 853
C E F T R IA X O N E

C E F T R IA X O N E ;
R O C E P H IN

R O C ^ H IN
250M G

500M O
P O W D E R S F O R I N J E C T IO N

P O W D E R S F O R I N J E C T IO N
R O C HE PRO D UCTS PTY LTD RSA

R O C HE PRO D UCTS PTY LTD RSA

(<
1852 O O C 854 C E F T R IA X O N E R O C E P H IN IG P O W D E R S F O R I N J E C T IO N RO CHE PRO D UCTS PTY LTD RSA
1867 ( X )C T 6 4 M E T F O R M IN M E T F O R M IN . 500M G TA B LETS. CO ATED N ORTON H EA LTHCA RE LTD UK
1871 0 )C 9 9 9 H Y D R O C H L O R O T H I A Z ID E A N D A M IL O R I D E C O -A M IL O Z ID E TABLETS N ORTON H EA LTHCA RE LTD U K
1877 T H K M U D A Z IN E T H IO R ID A Z IN E TA B LETS. CO ATED N ORTON H EA LTHCA RE LTD U K
25M G
1879 O O C 967 T H IO R ID A Z IN E T H IO R I D A Z IN E , lO O M G T A B L E T S ,C O A T E D N OR TON H EALTH C A R E LTD U K
1888 (X )C 4 3 6 H O N E Y B E E (A P 1 5 M IL L IF E R A ) A LBA Y H ON EY B EE V ENO M 500M C G IN JE C n O N S M E D I C H A L L E N G E (P T Y ) L T D
1889 0 ( K )D 5 2 A M O X V a L L JN A N D C L A V U L A N IC A C ID A U G M E N T IN S Y R U P 1 5 6 2 5 M G /5 M L PO W D ER S S M IT H K L IN E B E E C H A M P H A R M P T Y L T D , S A
1893 ( K )C 5 8 8 E P H E D R IN E H Y D R O C H L O R ID E E P H E D R IN E H Y D R O C H L O R ID E 60M G TABLETS P H A R M A N O V A (P V T ) L T D , H A R A R E
1903 00C 94I T R IN O V U M JO H N S O N & JO H N S O N P V T L T D H A R A R E
TABLETS
1925 O O C 486 C E P H A L O T H IN S O D IU M K B F L IN N E U T R A L P O W D E R S F O R I N J E C T IO N P H A R M A C A R E L I M I T E D .S A
10
1935 00D 14O D R E W S L IV E R S A L T O R A N G E F L A V O U R P O W D E R S ,E F F E R V E S C E N T A D C O C K IN G R A M S S A (P T Y ) L T D
1948 O O C 977 , A D REN A UN E A D R E N A L IN I N J E C T IO N S D A T L A B S P V T L T D . B U L A W A Y O .Z I M B A B W E
1 :1 0 0 0
1960 00C 938 I S O T R E T I N O IN RO ACCU TA NE R O C HE PRO DU CTS PTY LTD RSA
20M G CAPSULES
1965 00D J38 G L I P IZ ID E M IN ID IA B P H A R M A C IA S A P T Y L T D . C R A I G H A L L , S A
5M G TA BLETS
1976 0 (K 3 D 3 3 M A N N I T O L & S O R B IT O L O S M O F U N D IN 20% IN T R A V E N O U S S O L U T IO N S B .B R A U N M E L S U N G E N A G
1981 O O D I6 1 B IO -S Y N T H E T IC H U M A N IN S U L IN Z IN C M O N O T A R D H M (G E ) N O V O -N O R D IS K (P T Y )
lO O lU /M L I N J E C T IO N S
S U S P E N S IO N LTD SA
1983 O QD 163 S K d I- S Y N T K E T IC H U M A N IN S U L IN Z IN C U L T R A T A R D H M (G E ) I N J E C T IO N S N O V O -N O R D IS K (P T Y ) L T D S A
lO O IU /M L
S U S P E N S I O N (C R Y S

1997 «>D 186 A M O X Y C IL U N A N D C L A V U L A N IC A C ID A U G M E N T IN P O W D E R S F O R I N J E C T IO N S H R E Y A L IF E S C I E N C E S P V T L T D

600M G
1998 0 O D I8 7 . A M O X Y C I L L IN A N D C L A V U L A N IC A C ID A U G M H ^ T IN P O W D E R S F O R IN JE C T IO N S M IT H K L IN E B ^ H A M P H A R M P T Y L T D . S A
12G
1999 0B 187A B E N Z Y L P E N IC I L L I N S O D I U M B E N Z Y L P E N IC I L L IN S O D I U M P O W D E R S F O R I N J E C T IO N C A P S P V T L T D , H A R A R E , Z IM B A B W E
IM E O A ■
2001 O TD 144 A TEN O LO L
T E N O R M IN ' TA B LETS, CO ATED IN D U S T R IA L C H E M IC A L IM P O R T E R S , H A R A R E
50M G
2014 ( X )D 1 8 3 H A L O P E R iD O L D A T L A B S P V T L I D , B U L A W A Y O , Z IM B A B W E
H A L O P E R ID O L - 2M G TAB LETS
2026 M C 4U A T E N O L O L A N D C H L O R T H A L ID O N E ‘ T E N O R E T IC T A B l^ T S , C O A T E D
2028 0 O D I9 1 PARACETAM OL A D C O C K IN G R A M S S A (P T Y ) L T D
C H IL D R E N ’S P A N A D O L 80M O TABLETS.
2036 O O D154 M IT O X A N T R O N E W Y E T H S A (P T Y ) L T D R S A
N O VA N TRO NE 2 M G /M L I N J E C T IO N S
2042 00D 237 G E N T A M I C IN S U L P H A T E ^ 8 0 M G /2 M L
FERM ENTM YQN IN JE C T IO N S P H A R M A C A R E U M IT E D . S A
2049 OODl94 P Y R IM E T H A M IN E A N D S U L F A D O X IN E F A N S ID A R H O F F M A N L A R O C H E S W IT Z E R L A N D
I N J E C T IO N S
2059 000695 V I T A M IN S C O M P L E X D A T L A B S P V T L T D , B U L A W A Y O .Z IM B A B W E
V IT A M IN B C O M P L E X I N J E C T IO N S
2061 • M B 195 B E N Z A T H I N E . P R O C A IN E & B E N Z Y L P E N IC I U 4 N U L T R A C I L L IN C A P S P V T L T D . H A R A R E .Z IM B A B W E
1 .2 M E G A P O W D E R S F O R I N J E C T IO N
2072 0Q C 975 T R IM E T H O P R IN D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
U T I P R IM lO O M O TAB LETS
2073 • 00D 192 T R IM E T H O P R IN D A T L A B S P V T L T D .B U L A W A Y O .Z I M B A B W E
U T IP R I M 300M G TAB LETS
2084 00D 213 IN D A P A M ID E TA B LETS. C O A TED L E S L A B S S E R V I E R . 6 P L A C E D E S P L E IA D E S ,
N A T R IU X 2 .5 M G
924S5C
2104 0 0 )4 7 8 TABLETS, EFFERVESCENT C A P S P V T L T D J I A R A R E .Z IM B A B W E
M E D O X C A L a C O R B IN
 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012 979

F ile N o . A ppl N o. A p p ro v e d n a m e T ra d e n am e S tre n g th F o rm A p p l ic a n t

2115 O O D 204 G L IC L A Z ID E D IA M IC R O N 80M G TA BLETS L E S L A B S S E R V IE R . 6 P L A C E D B S P L E I A D E S ,

92415C

2117 O O D 220 PA RA CETAM O L PANADO JUNIOR STRENGTH I6 0 M G TABLETS A D C O C K IN G R A M S S A (P T Y ) L T D

2120 O O D 135 T E T R A C Y C L IN E H Y D R O C H L O R ID E TETRACYCLINE HYDROCHLORIDE 500M G CA PSULES D A T L A B S P V T L T D , B U L A W A Y O . Z IM B A B W E

2130 00C 335 A S P IR IN • DISPRIN e x t r a STRENGTH 500M G TABLETS R K ;K IT T & C O L M A N H A R A R E

2131 O O D 241 SA LBUTA M OL SALBUTAMOL lO O M C G /P U F F . A E R O S O L IN H A L A T I O N S N ORTO N H EA LTHCA RE LTD U K

2151 O O C 321 P E T H ID IN E H Y D R O C H L O R ID E P E T H I D IN E H Y D R O C H L O R I D E I O Q M O /2 M L IN JE C T IO N S D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E

2159 00D 198 R IF A M P IC IN H E L M R IF A M P IN I5 0 M G CA PSULES H a ,M P H A R M A C E U T IC A L S G M B H G E R M A N Y

;2 1 6 6 00D 246 F L U M A Z E N IL A N EX A TE I M O /I O M L IN JE C T IO N S H O F F M A N L A R O C H E S W IT Z E R L A N D

2167 00D 262 A D S O R B E D D I P T H E R IA A N D T E T A N U S IN JE C T IO N S A V E N T IS C R O P S C I E N C E H M B A B W E

V A C C I N E P A S T E U R D .T . V A C C IN E

2169 000D 44 S O D IU M B I C A R B O N A T E I N J E C T I O N 4 .2 % S O D IU M B IC A R B O N A T E 4 .2 % IN T R A V E N O U S S O L U T IO N S B .B R A U N M E L S U N G E N A G

IN J E C T IO N 4 .2 %

2176 00D 286 B C G V A C C IN E P A S T E U R B C G V A C C IN E IN JE C T IO N S A V E N T IS C R O P S C IE N C E Z IM B A B W E

(IN T R A D E R M A L )

2179 00D 242 FLUCO N AZO LE D IF L U C A N 50M O CA PSULES P H A R M A C E U T IC A L & C H E M IC A L D IS T ,

H A RARE

2180 00D 243 FLU CO N AZO LE D IF L U C A N I5 0 M G CA PSULES P H A R M A C E U T IC A L & C H E M IC A L D fS T ,

H A RARE

2194 O OD 27I P IR O X IC A M FELDEN E 0 ,5 % G ELS P H A R M A C E U T IC A L & C H E M IC A L D IS T ,

H ARA RE

2201 00D 263 D J ’.T , V A C C I N E D X P. IN JE C T IO N S A V E N T IS C R O P S C I E N C E Z IM B A B W E

2202 00D 285 P U R I H E D A N T I- R A B IE S S E R U M P A S T E U R A N T I -R A B I E S S E R U M lO O O fU IN JE C T IO N S A V E N T IS C R O P S O E N C E Z IM B A B W E

2209 00D 337 B E N Z Y L P E N I C IL L IN S O D iU N B U F F E R E D B E N Z Y L P E N IC I L L IN S O D IU M 1 M EGA P O W D E R S F O R IN J E C T IO N C A P S P V T L T D , H A R A R E , Z IM B A B W E

BU FFERED

2210 O O D 338 B E N Z Y L P E N C IL L I N S O D IU M B U F F E R E D B E N Z Y L P E N I C IL L I N S O D I U M 5 M EGA P O V iD E R S F O R IN JE C T IO N C A P S P V T L T D , H A R A R E , Z IM B A B W E

BU FFERED

2211 O O D 316 EXTRACT BERMUDA GRASS & PERENNIAL RYE ALLPYRAL SPECIAL ORJ^S IN JE C T IO N S M E D I C H A L L E N G E (P T Y ) L T D

2214 00D 319 EXTRACT HOUSE DUST A L L P Y R A L P U R E M IT E IN JE C T IO N S M E D I C H A L L E N G E (P T Y ) L T D

2216 00D 284 POLYVALENT ANTI-SNAKE VENOM SERUM P A S T E U R IP S E R A F R IC A IN JE C T IO N S A V E N T IS C R O P S C I E N C E Z IM B A B W E

2240 00D 358 HALOFANTRINE HYDROCHLORIDE H ALFA N 250M G TABLETS G L A X O S M IT H K L I N E P L C

I 2259
2260
2264
00D 354

00D 360

O O D 351
FAMOTIDINE
VINCRISTINE
NORH.OXACIN
P E P C ID

O N C O V IN

N O R O X IN
40M G

IM G

400M G
TA BLETS,C O A TED

IN JE C T IO N S

TA BLETS. C O ATED
M S D N J .U S A

L IL L Y E L I (S A ) (P T Y ) L T D

M SD PTY LTD RSA

2265 00D 361 ENALA'p RIL MALEATE R H ^IT E C 5M G TABLETS M SD PTY LTD RSA

2266 00D 362 ENALAPRIL MALEATE . . R E N IT E C 20M G TABLETS M SD FFY LTD RSA

2275 00D 391 I N D O M E T H A C IN IN D O M B T H A C IN 50M G CA PSULES D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

2282 00D 429 CA M PH OR CREAM IN G R A M S C A M P H O R C R E A M N O R M A L CREA M S D A T L A B S P V T L T D , B U L A W A Y O . Z IM B A B W E

2283 O O D 430 CA M PH OR CREA M IN G R A M S C A M P H O R C R E A M H E R B A L CREAM S D A T L A B S P V T L T D , B U L A W A Y O ,Z I M B A B W E

2284 00D 165 SA LBUTA M OL SA LBU TA M OL 2M G TA BLETS D A T L A B S P V T L T D , B U L A W A Y O .Z I M B A B W E

2290 O O D 439 T O L B U T A M ID E T O L B U T A M ID E 500M G TABLETS D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

2293 O O D 328 O F L O X A C IN T A R I V ID 200M O T A B L E T S .C O A T E D A V E N T IS C R O P S O E N C E Z I M B A B W E

2302 O O D 393 IT R A C O N A Z O L E SK 3R A N O X lO O M G C A PSU LK JO H N S O N & JO H N S O N P V T L TD H A R A R E

2308 O O D 449 FLU CO N AZO LE D IF L U C A N 200M G CA PSULES PH ZER .H ARA RE

2310 00D 447 FLU CO N AZO LE D IF L U C A N 2 M G /M L IN T R A V E N O U S S O L U T IO N S P H A R M A C E U T IC A L & C H E M I C A L D IS T , H A R A R E

2323 00D 336 N I F E D I P IN E N IF E D IP IN E lO M G CA PSU LES N O R T O N H E A L T H C A R E L I M IT E D , U K

2327 . 00C 344 M Y COTA M Y CO TA PO W DERS R E C K irr CO LM A N RSA

2328 00C 343 M Y COTA M Y CO TA CREA M S R E C K IT T & C O L M A N R S A

2329 O O C 345 M Y COTA M Y CO TA A ERO SO LS ‘ . R E C K IT T & C O L M A N R S A

2331 00D 399 T H R IF L U O P E R A Z IN E A P O -T R IF L U O P E R A Z IN E IM G T A B L E T S .C O A T E D A P O T E X IN C . C A N A D A

2333 00D 486 R A N IT ID IN E A P O - R A N IT 1 D 1 N E 150M G T A B L E T S .C O A T E D A T O T E X IN C . C A N A D A

2333 0000F7 R A N IT ID I N E 1 5 0 M G T A B L E T S A P O - R A N IT ID IN E 1 5 0 M G I5 0 M G T A B L E T S .C O A T E D A P O T E X IN C . C A N A D A

2334 00D 485 N IF E D I P IN E A P O -N IF E D IP IN E lO M G CA PSULES A P O T E X IN C . C A N A D A

2335 00D 369 C A R B A M A Z E P IN E A P O -C A R B A M A Z E P IN E 200M G TABLETS A P O T E X IN C . C A N A D A

2341 00C W 5 P O T A S S IU M C H L O R ID E P O T A S S IU M C H L O R ID E J0% INJECTIONS D A T L A B S P V T L T D . B U L A W A Y O , Z IM B A B W E

2343 O O D 334 F L U C L O X A C IL L IN F L U C L O X A C IL L IN 250M O CA PSULES N O RTO N H EA LTHCA RE LTD U K

2345 O O D 335 M E F E N A M IC A C ID M E F E N A M IC A C ID 250M G CA PSU LES N O RTO N H EA LTHCA RE LTD U K

2346 00D 396 G L I B E N C L A M ID E A P O -G L Y B U R ID E 5 M G 5M G TABLETS A P O T E X IN C . C A N A D A

2349 00D 483 N A PROX EN A P O -N A P R O X E N 2 5 0 M O 250M G TABLETS A P O T E X IN C . C A N A D A

2350 00D 484 N APRO XEN A K l- N A P R O X E N 5 0 0 M G 500M G TA BLETS A K JT E X IN C . C A N A D A

2351 00C 696 I S O N IA Z I D I S O N IA Z ID lO O M G TA BLETS P H A R M A N O V A (P V T ) L T D , H A R A R E

2354 00D 478 S T R O N G C A L C IF E R O L S T R O N G C A L C IF E R O L 5 0 0 0 0 IU T A B L E T S .C O A T E D P H A R M A C A R E L I M IT E D , S A

2356 00D 332 A M I T R I P T Y L IN E A M JT R IP T Y U N E 25M O T A B L E T S .C O A T E D N O RTO N H N LO ND O N

2376 00D 512 FLEM EX 2 5 0 M G /5 M L SY RUPS W A R N E R - L A M B E R T S . A .( P T Y ) L T D R S A

C A R B O C IS T E I N E

T A B L E T S .C O A T E D L E S L A B S S E R V IE R , 6 P L A C E D E S P L E IA D E S .

I
2377 O O D 517 T E R T A T O L O L H Y D R O C H L O R ID E A RTCX 5M G

9 2 4 I5 C

2378 00D 488 P R O S T IN E 2 3M G TA BLES ^ N .V .U P JO H N -P H A R M A C 1 A & U P J O H N , B E L G IU M

D IN O P R O S T O N E

2386 00D 532 BA CTRO BAN N ASA L 2 % O IN T M E N T S S M I T H K L IN E B E E C H A M P H A R M P T Y L T D , S A

M U P IR O C IN N A S A L

2398 O O D 583 P R O P R A N O L O L H Y D R O C H L O R ID E lO M G TA BLETS D A T L A B S P V T L T D , B U L A W A Y O .Z I M B A B W E

P R O P R A N O L O L H Y D R O C H L O R ID E

2404 . 00D 564 B E N Z H E X O L (T R IH E X Y P H E N ID Y L ) 5M G TABLETS W A L L A C E L A B O R A T O R IE S P V T L T D .

B E N Z H E X O L ( T R IH E X Y P H E N I D Y L )
Z IM B A B W E

2414 O 0D 560 200M G T A B L E S .C O A T E D B C X Y T S H E A L T H C A R E (S O U T H A F R IC A ) (P T Y )

IB U P R O F E N N URO FEN
LTD

2418 0 .0 7 5 M G TA BLETS P F IZ E R L A B O R A T O R IE S (P V T ) L T D
00C 899 N ORG ESTREL O VRETTE

2419 00D 575 IN JE C T IO N S C IL A G G m b H IN T E R N A T IO N A L

R E C O M B I N A N T H U M A N E R Y T H R O P O I E T IN EPREX 2 0 0 0 IU /M L

2420 00D 595 IN JE C T IO N S C IL A G G m b H IN T E R N A T IO N A L

R E C O M B I N A N T H U M A N E R Y T H R O P O IE T I N EPREX 4 0 0 0 U /M L

2433 00D 489 S O L U T IO N S H A E M O T E C H P V T L T D . H A R A R E . Z IM B A B W E

C H L O R H E X ID IN E D IG L U C O N A T E 5 % C H L O R H E X I D IN E D I G L U C O N A T E 5 % 5%

2446 00D 609 TA BLES A P O T E X IN C . C A N A D A

C A P T O P R IL A P O -C A P T O 25M G

2447 00D 612 C A PSU LES A T O T E X IN C . C A N A D A

C L O X A C IL L IN S O D IU M A P O -C L O X I 250M G

2453 00D 620 50M G TABLETS A P O T E X IN C . C A N A D A

A TEN O LO L A P O -A T E N O L
2454 00D 62I lO O M G TA BLETS A W Y T E X IN C . C A N A D A
A TEN O LO L A P O -A T E N O L
A P O T E X IN C . C A N A D A
2456 O O D 616 m e t (x :l o pr a m id e A P O -M E T O C L O P lO M G T A B I-E T S

2459 00D 606 SIMUASTATIN ZOCO R ,

io m g ' TA BLETS M SD PTY LTD RSA

2464 Z00012 L IQ U ID S A D C O C K IN G R A M S S A (P T Y ) L T D
P H IP P S G R IP E W A T E R
2469 Z00014 IN JE C T IO N S C A P S P V T L T D , H A R A R E . Z IM B A B W E
C H L O R O Q U IN E P H O S P H A T E M A L A Q U IN 40M G B A S& M L

2474 00D 641 O T A B L E T S .C O A T E D A K Y T E X IN C . C A N A D A

A M IT R IP T Y L IN E A P O -A M IT R IP T Y U N E 25M G

2475 - 00B 454 T A B L E T S .C O A T E D A B B O T L A B O R A T O R IE S (P T Y ) L T D

F L U R G IP R O F E N FRO BEN lO O M G

2476 00D 607 N O R F L O X A C IN E 3 M G /M L D ROPS, EYE M SD N J. U SA

C H IB R O X I N E
2478 00D 653 G E L A T IN P L A S M A E X P A N D E R W IT H I N T R A V E N O U S S O L U T IO N S B .B R A U N M E L S U N G E N A G
C E L A F U N D IN 3%

ELECTROLYTES
2481 00D 664 C O N J U G A T E D O E S T R O G E N S W rm N O R G E S T R E L P R E M P A K -C T A B L E T S .C O A T E D W Y E T H S A (P T Y ) L T D RSA

2482 O O D 665 C O N JU G A T E D O E S T R O G E N S W IT H T A B L E T S .C O A T E D W Y E T H S A (P T Y ) L T D RSA

P R E M P A K -C

N O R E T H IS T E R O N E

2484 00D 647 V IT A M I N S A N D M I N E R A L S T A B L E T S .C O A T E D S C A N P H A R M A /S D E N M A R K

PREG NA TA L
2491 0O D 704 Q U IN A P R IL T A B L E T S .C O A T E D PR ZER LAB S PTY LTD RSA
A C C U P R IL lO M G
2493 00D 706 SA LM ETER OL H YD RO XY NA PH TH OA TE 2 5 M C G /A C T U A T IO N M E T E R E D D O S E IN H A L E R C L A X O -W E L L C O M E Z IM B A B W E P V T L T D .
S E R E V E N T 1 2 0 A C T U A T IO N
H A RARE

2496 00D 432 S E R T R A L IN E TA BLETS P F IZ E R , H A R A R E

ZOLOFT 50M O

2501 ■ Z 00669 S U X A M E T H O N IU M C H L O R ID E IN JE C T IO N S G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
S C O L IN E 5 0 M C /M L
H ARA RE

2502 O O D 490 C H L O R H E X I D IN E D IQ L U C O N A T E S O L U T IO N S H A E M O T E C H P V T L T D , H A R A R E . Z IM B A B W E
C H L O R H E X ID I N E D IG L U C O N A T E 20%
2514 00D 638 C L O X A C IL L I N S O D IU M P O W D E R S F O R IN JE C T IO N H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y
H H JM C L O X A C IL L IN 500M G

2515 00D 627 C A L C IU M C H L O R ID E IN JE C T IO N S P H A R M A C A R E L IM I T E D , S A

C A L C IU M C H L O R ID E 10%
 980 Zimb a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2

F ile No. A ppI N o. A p p ro v e d n a m e T ra d e n a m e S tren g th F o rm A p p ik an t

2518 OOOOD3 IB U P R O F E N IB U P R O F E N 400M C TA B LETS. C O A TED NORTON HEALTHCARE LTD UK

2519 OOOODi IB U P R O F E N IB U P R O F E N 200M O T A B L E T S, C O A TE D NORTON HEALTHCARE LTD UK
2538 00D 655 O N D A N S E T R O N H Y D R O C H L OZ
ROIDFE
RAN 2 M G /M L IN JE C T IO N S G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
HARARE
2539 00D 656 . O N D A N S E T R O N H Y D R O C H L O R ID E ZOFRAN 4M G TA B LETS. C O A TED G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
H A RA RE
2540 00D 657 O N D A N S E T R O N H Y D R O C H L O R ID E ZOFRAN 8M O TA B LETS, C O A TED G L A X O -W E L L C O M E Z IM B A B W E P V T L T D . -
HARARE
2542 00D 768 C E T IR IZ IN E H Y D R O C H L O R ID E ZY RTEC lO M G TA B LETS, C O A TED UGB SA PTY LTD
2549 00D 602 C L O X A C IL L IN H E L M C L O X A C IL L IN 250M G C A PSU L E S H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y ..
2554 Z00215 PRO CTO SED Y L PR O C T O SE D Y L S U P P O S IT O R IE S A V E N T IS C R O P S a E N C E Z IM B A B W E
2555 Z00214 PRO CTO SED Y L PR O C T O SE D Y L O IN T M E N T S A V E N T IS P H A R M A (P T Y ) L T D
2564 00C 694 A C Y C L O V IR , Z O V IR A X 2 5 0 M G /V IA L P O W D E R S F O R IN JE C T IO N G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
HARARE
2565 00D 755 F L U T IC A S O N E P R O P IO N A T E F L IX O N A S E 0 .0 5 % SPRAYS, N A SA L G L A X O -W E L L C O M E 2 1 M B A B W E P V T L T D ,
HARARE
2574 00D 642 C L O X A C IL L IN S O D IU M A P O -C L O X l 1 2 5 M G /5 M L P O W D E R S F O R S U S P E N S IO N A P O T E X IN C . C A N A D A
2575 00D 780 O M EPRA ZO LE IX )SE C 20M G C A PSU L E S A S T R A Z E N E C A L IM IT E D
2578 - O O D 698 ATENOLOL T C N B L O K A -H K ) lO Q M G T A B L E T S, C O A T E D - P H A R M A C A R E L IM IT E D . S A
2589 00D 765 R A N IT ID IN E ZA N TA C I5 0 M G TA BLETS. EFFERV ESCEN T G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
HARARE
2605 00D 798 M E T F O R M IN ' M E T F O R M IN -^ 500M G TA B LETS, C O A TED ALPHARM A
2606 O O O D 13 A M IL O R ID E A N D H Y D R O C H IO R O T H IA Z ID E A M IL O R E T IC TABLETS P H A R M A C A R E U M IT E D , S A
2611 00D 635 E R G O M E T R IN E IN T R A M E D E R G O M E T R IN E 0 .5 M G /M L IN JE C T IO N S P H A R M A C A R E L IM IT E D , S A
2616 00D 769 A C ID C O M P O N E N T H A E M O D IA L Y S IS A C ID C O M P O N E N T H A E M O D IA L Y S IS S O L U T IO N S D A T L A B S P V T L T D . B U L A W A Y O . Z IM B A B W E
CONCENTRATE ' C O N CEN TR A TE
2627 Z00052 C E T R IM ID E A N D C H L O R H E X ID IN E H IB IC E T H O S P IT A L C O N C E N T R A T E S O L U T IO N S S S L IN T E R N A T IO N A L P L C
GLU CONA TE
2631 : Z00097 M E T F O R M IN : G L U C O PH A G E 500M G TA B LETS. C O A TED P H IL L IP L E E P V T L T D . H A R A R E . Z IM B A B W E
2633 00D 787* A C R IV A S T IN E •S E M P R E X 8M G C A PSU L E S G L A X O -W E L L C O M E Z IM B A B W E P V T L T D .
H A RA RE
2634 00D 722 N A PRO X EN N A F A S O L -5 0 0 50Q M G TA B LETS P H A R M A C A R E U M IT E D , S A
2635 00D 781 GREAT STUFF . GREATSTUFF U Q U ID S V A L E N T IN E IN T E R N A T IO N A L P V T L T D
2667 Z00310 H A LF CO N CEN TRA TED DARROW S H A LF STREN G TH D A R R O W S 2 .5 % . IN T R A V E N O U S S O L U T IO N S D A T L A B S P V T L T D .B U L A W A Y O .H M B A B W E
S O L U T IO N W IT H D E X T R O S E S O L U T IO N W IT H D E X T R O S E
2675 ^ 00D 84O V E C U R O N IU M B R O M ID E N O RCU RO N 4M G P O W D E R S F O R IN JE C T IO N S A N O R O M N IM E D P T Y L T D R S A
2676 ' 00D 841 V K iU R O N lU M B R O M ID E
N O RCU RO N lO M G . P O W D E R S F O R IN JE C T IO N S A N O R O M N IM E D P T Y L T D R S A
2692 00D 832 L IP ID S O L U T IO N L IP O F U N D IN M C T /L C T 1 0 % 10% IN T R A V E N O U S S O L U T IO N S B .B R A U N M E L S U N G E N A G
2699 Z00107 H Y D R O X Y Z IN E ATERAX 25M G TA B LETS, C O A TED U CB SA PTY LTD
2716 00D 849 ‘ lO H E X O L O M N IP A Q U E N Y C O M E D I8 0 M G /M L IN JE C T IO N S GE HEALTHCARE AS
2717 , 00D 850 lO H E X O L O M N IP A Q U E N Y C O M E D 2 4 0 M G /M L IN JE C T IO N S A M E RSH A M H EA LTH A S
2718 00D 85I . lO H E X O L O M N IP A Q U E N Y C O M E D 3 0 0 M G /M L IN JE C T IO N S G E H EA LTH C AR E A S
2719 00D 852 ROHEXOL O M N IP A Q U E N Y C O M E D .3 5 0 M O /M L , IN JE C T IO N S G E H EA LTH C AR E A S
2732 00D 789 S O M A T R O P IN (R IO -S Y N T H E T IC ) N O R D IT R O P IN 4 IU /M L P O W D E R S F O R IN JE C T IO N N O V O -N O R D IS K (P T Y ) L T D S A
2733 O O C 5 I2 P A N C U R O N IU M B R O M ID E PAVULON 2 M G /M L in j e c t io n 's S A N O R O M N IM E D P lY L T D R S A
2734 Z00450 F L U P H E N A Z IN E D E C A N O A T E M O D EC A TE 2 5 M O A 4L IN JE C T IO N S B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
2743 . O O D 855 A M P IC IL U N A M PEN 250M G C A PSU L E S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D
M S A S A .H R E
2744 00D 856 A M P IC IL L IN AM PEN 500M G C A PSU L E S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D
M S A S A .H R E
2745 O O D 853 P Y R IM E T H A M IN E A N D S U L P H A D O X IN E P Y R A L F IN TABLETS L U P IN L IM IT E D B O M B A Y
2749 00D 757 PARA CETAM OL A IY T A L G IC S U G A R A N D A L C O H O L F R E E I2 0 M G /5 M L S Y R U PS C A P S P V T L T D , H A R A R E , Z IM B A B W E
2753 00D 875 P Y R A Z IN A M ID B P Y R A Z IN A 500M O TA B LES P H A R M A N O V A (P V T ) L T D , H A R A R E
275 5 00D 862 BALLOFEN BACLOFEN lO M G TABLETS N O R TON H EA LTH CA R E LTD U K
2759 00C 998 G L IB E N C L A M ID E G L IB E N C L A M ID E 5MG TABLETS NORTON HEALTHCARE LTD UK
2760 ■ 00D 860 ATENOLOL ATENOLOL 50M G TAB LET S, COATED N O R T O N H E A L T H C A R E U M IT E . U K
2761 00D 86I ATENOLOL ATENOLOL lO O M G TABLETS. COATED n o r t o n h e a l t h c a r e l im it b .u k ,
276 2 00C 419 H Y D R O C H L O R O T H IA Z ID E R ID A Q -2 5 25M G TA B LETS P H A R M A C A R E U M IT E D , S A
276 8 00D 823 E N A L A P R IL A N D H Y D R O C H L O R O T H IA Z ID E C O -R E N IT E C 2 0 /1 2 .5 TABLETS M SD PTY LTD RSA
2782 0O D 89O A M P IC IL U N ' A i^ E N 1 2 5 M G /5 M L GRANULES FOR V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D
S U S P E N S IO N M S A S A .H R E
279 6 00D 898 CTH A M BU TO L ETH A M BU TO L 400M G TABLETS P H > U iM A N O V A (P V T ) L T D , H A R A R E
279 7 00D 864 , S O D IU M V A L P R O A T E S O D IU M V A L P R O A T E 200M G TABLETS. COATED NORTON HEALTHCARE LTD UK
2807 00D 920 B E C L O M E T H A S O N E D IP R O P IO N A T E BECONASE AQUEOUS 0 ,0 5 % SPRAYS, n a s a l G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
H A RA RE
2811 00D 930 ■ H E P A T IT IS A V A C C IN E H A V R IX 720 ELU IN JE C T IO N S S H R E Y A L IF E S C IE N C E S P V T L T D
2822 O O D 95 6 . L E V O D O P A A N D C A R B ID O P A S IN E M E T C R T A B L E T 2 0 0 M O /5 0 M G TABLETS M SD PTY LTD RSA
2836 00D 975 ‘ C A L C IU M G L U C O N A T E GLUCAL 300M G TABLETS P H A R M A C A R E L IM IT E D , S A
2840 00D 95S V A N C O M Y C IN V A N C O C IN C P IG P O W D E R S F O R IN JE C T IO N U L L Y E L I (S A ) (P T Y ) L T D
284 2 00D 926 F IN A S T E R ID E PROSCAR 5 5M G TAB LET S, COATED M SD PTY LTD RSA
284 3 000E44 T H IO R ID A Z IN E A P O -T H IO R ID A Z IN E 25M G T A B L E T S, C O A TE D A P O T E X IN C . C A N A D A
2844 0 0 0 E 4 5 •• T H IO R ID A Z IN E A P O -T H IR ID A 2 IN E lO O M G TABLETS, COATED A P O T E X IN C . C A N A D A
2846 O O D 919 N IT R A Z E P A M S O M N IP A R 5M O TABLETS R O L A B P T Y L T D .S A
2850 Z0059I GERMOL GERM OL S O L U T IO N S C A P S P V T L T D , H A R A R E , Z IM B A B W E
2851 00D 941 IM IP E N E N A N D C IL A S T A T IN T IE N A M 5 0 0 P O W D E R S F O R IN JE C T IO N , 8«D PTY LTD RSA
2857 Z00247 C H L O R O Q U IN E P H O S P H A T E - C H L O R O Q U IN P H O S P H A T E 4 0 M G 8 i^ E /M L IN JE C T IO N S D A T L A B S P V T L T D .B U L A W A Y O ,Z IM B A B W E
2858 Z00300 , SODIUM BICARBONa YE S O D IU M B IC A R B O N A T E 8 ,5 % IN JE C T IO N S D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E
2859 00D 912 FR O TEX P R O T E X C L A S S IC SOAPS C O L G A T E -P A L M O U V E Z IM B A B W E P V T L T D
286 3 O O E119 B E N Z Y L P E N IC IL U N B E N Z Y L P E N IC IL L IN H E L M 3 G (5 M E G A ) P O W D E R S F O R IN JE C T IO N H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y
2882 Z00186 C y C L lZ IN E L A C T A T E V A L O ID 5 0 M G /M L IN JE C T IO N S G L A X O -W E L L C O M E Z IM B A B W E P V T L T D ,
H A RA RE
2886 00D 986 GLUCAGON G LU CA GEN IM G . P O W D E R S F O R IN JE C T IO N N O V O -N O R D IS K (P T Y ) L T D S A
2889 00E234 A T R O P IN E A T R O P IN E •• . 1% O IN T M E N T S ,E Y E A L C O N P H A R M L T D , C H A M , S W IT Z E R L A N D
* 2893 00E124 ATCNOLOL
B E T A C A R D -1 0 0 lO O M O T A B L E T S, C O A T E D TO R R EN T EX PO RTS LTD
2898 Z00007 C A L C IU M C A R B O N A T E CALSUBA lO O O M G PO W D ERS G R O U P LA BS SA PTY LTD RSA
2899 00D 925 S A V L O N A N T IS E P T IC L IQ U ID S A V L O N A N T IS E P T IC L IQ U ID U Q U ID S JO H N S O N &. JO H N S O N P V T L T D H A R A R E
2912 000E51 KETOCONAZOLE TO R R ENT K ETO CO N A ZO LE 200M G TA B LETS TO RRENT EXPORTS LTD
2921 Z00103 H Y D R O X Y Z IN E ATERAX PA REN TERA L 5 0 M G /M L IN JE C T IO N S U CB SA PTY LTD
292 8 000E22 A N T A Z O L IN E & N A P H A Z O L IN E A L B A L O N -A L IQ U IF IL M S C « .U T IO N S A L L E R G A N P H A R M A C E U T IC A L S (P T Y ) L T D S A
2931 O O O E98 C O L G A T E T O T A L F L U O R ID E T O O T O P A S T E (X JIX iA T E T C y rA L F U JO R ID E T O O T H P A S T E PASTES ■ C O L G A T E -P A L M O L IV E Z IM B A B W E P V T
LTD
2932 O O O E90 C A L C IU M C A R B O N A T E T U M S -P E P P E R M IN T F L A V O U R SOOM G TA B LETS G R O U P LA BS SA PTY LTD RSA
2935 0O 0E3O ATENOLOL A TEN O LO L lO O M G TA B LETS, C O A TED C O X P H A R M A C E U T IC A L S U K
' 2938 000E29 A M IL O R iD E A M IL O R ID E 5MG TABLETS C O X P H A R M A C E U T IC A L S U K
2939 00E196 P C ^Y V IN A L C O H O L A N D P O V ID O N E T E A R S P L U S A R T IF IC IA L T E A R S DROPS, EYE A L L E R G A N P H A R M A C E U T IC A L S (P T Y ) L T D S A
2944 00E250 B A C IT R A C IN Z IN C A N D N E O M Y O N B A N E O C IN O IN T M E N T S B IO C H E M IE , T Y R O L , A U S T R IA
29A7 000E18 C E P H A L E X IN C E P H A L E X IN 2 5 0 M G /5 M L G RA N U LES FOR C A P S P V T L T D , H A R A R E , Z IM B A B W E
S U S P E N S IO N
2948 000E21 C E P H A L E X IN C K »H A LEX 1N 1 2 5 M O /5 M L GRANULES FOR C A P S P V T L T D , H A R A R E , Z IM B A B W E
S U S P E N S IO N
2949 O O D 96 9 T R IC L O S A N A N D F L U O R ID E D E N T A L R IN S E PLAX RED S O L U T IO N S C O L G A T E -P A L M O L IV E Z IM B A B W E P V T L T D
2950 O 0 D 9 70 T R IC L O S A N A N D F L U O R ID E D E N T A L R IN S E PLAX G REEN S O L U T IO fJS C O L G A T E -P A L M O L IV E Z IM B A B W E P V T L T D
2960 O O E169 C H L O R H E X ID IN E + S IL V E R S U L P H A D IA Z IN E A RRO W G U A RD BLU B M E D IC A T E D C A T H E T E R A R R O W A F R IC A P T Y L T D , K E L V IN , S A
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2 981

F ile N o . A ppi N o. A p p ro v e d n a m e ly a d e n a m e S tre n g th Fo t jh A p p lic a n t

2963 O O O E24 F L U R B IP R O F E N OCUFEN 0 .0 3 % DROPS,EYE A L L E R G A N P H A R M A C E U T IC A L S (P T Y ) L T D S A

2974 O O E244 S U L P H A D O X IN E W IT H P Y IM E T H A M IN E S U L P H A D O X IN E W IT H TABLETS V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D , H R E

P Y R IM E T H A M IN E

2976 000E66 - M E F E N A M IC A C ID P O N S T A N F O R T E F R .M S E A L S 500M G TA BLETS. COATED W A R N E R - L A M B E R T S ,A . ( P T Y ) LTD RSA

2977 00E23I N A F T ID IN E H Y D R O C H L O R ID E E X O D E R IL !% CREA M S B IO C H E M IE , T Y R O L . A U S T R IA

2978 00E179 P E T H ID IN E H Y D R O C H L O R ID E IN T R A M E D P E T H ID IN E 5 0 M G /M L IN J E C T IO N S P H A R M A C A R E L IM IT E D , S A

H Y D R O C H L O R ID E

2979 00E289 A t. H Y D R O X , M A O . H Y D R O X &M E T H IC O N E G E L U S IL -S TABLETS W A R N E R - L A M B E R T S .A .( P T Y ) L T D R S A

2982 00E225 C L IN D A M Y C IN I S U L P H A T E D A L A C IN 2% CREA M S U P JO H N -P H A R M A C 1 A & U P JO H N , B E L G IU M '

2988 00D 995 M E F L O Q U IN E L A R lA M 250M G TABLETS H O F F M A N L A R O C H E S W IT C E R L A N D

2995 00E123 ATENOLOL B E T A C A R D -5 0 50M G TA BLETS,CO A TED TO RRENT EXTORTS LTD

.2 9 9 8 00D 76O C A L C IU M L A C T A T E & C A L C IU M C A L S U B A JU N IO R POW DERS , G RO U P LA BS SA PTY LTD RSA

G LY C ERO PH O SPH A TE

2999 00D 985 O E S T R A D IO L V A G IF E M 25M CG TA BLETS,CO A TED N O V O -N O R D IS K (P T Y ) L T D S A

3003 Z00049 C H L O R H E X ID IN E G L U C O N A T E H IB IT A N E 5 % C O N C E N T R A T E 5% S O L U T IO N S S S L IN T E R N A T IO N A L P L C

3004 00E282 M E F E N A M IC A C ID PONSTAN 125M G S U P P O S IT O R IE S W A R N E R - L A M B E R T S .A .(P T Y ) L T D R S A

3007 00D 987 O E S T R A D IO L -N O R E T H IS T E R IO N E A C E T A T E T R IS E Q U E N S TA BLETS,CO A TED N O V O '- N O R D I S K ( P T Y ) L T D S A

3008 00D 988 O E S T R A D IO L N O R E T H IS T E R O N E A C E T A T E T R IS E Q U E N S F O R T E TA BLETS,CO A TED N O V O -N O R D IS K (P T Y ) L T D S A

3010 0 0 E I4 I C E P H A L E X IN K EFLEX 125P 1 2 5 M G /5 M L G RA N U LES FOR P H A R M A C A R E L IM IT E D . S A

S U S P E N S IO N

3011 00E142 C E P H A L E X IN K EFLEX 250P 2 5 0 M G /5 M L . G RA N U LES FOR P H A R M A C A R E L IM IT E D , S A

S U S P E N S IO N

3012 00E143 C E P H A L E X IN (M O N O H Y D R A T E ) K EFLEX 250 250M G C A PSU LES P H A R M A C A R E L IM IT E D , S A

3030O O E275 , C IM E T ID IN E T O R R E N T C IM E H D IN E 400M Q „• TABLETS TO RREN TEX PORTS LTD

3041 00E332 C E F A Z O L IN S O D IU M KEFZOL IG P O W D E R S F O R .lN J E C n O N L IL L Y E U (S A ) (P T Y ) L T D

3051 00E333 B IO S Y N T H E H C H U M A N IN S U L IN H U M U L IN L (S U S P E N S IO N ) 1 0 0 lU /M L IN JT O T IO N S U L L Y E U (S A ) (P T Y ) L T D

3054 O O E300 C IN N A R IZ IN E R O L A B C IN N A R IZ IN E 25 M G TABLETS R O L A B P T Y L T D .S A

3056 00E303 V E R A P A M IL V E R A P A M IL 40M G TA BLETS. CO A TED COX AH & Co LTD UK

3057 00E30! H Y D R A L A Z IN E H Y D R A L L A Z IN E 50 M G TA BLETS, CO A TED COX AH & Co LTD UK

3060 . 00E32I B R 0M A 2E PA M R O -B R O M A Z E P A M 3M G TABLETS R O L A B P T Y L T D .S A

3073 O O O E59 E R Y T H R O M Y aN J L O T Y C I N T .S . 1 G /5 0 M L S O L U T IO N S P H A R M A C A R E L IM IT E D . S A

3075 0 0 E 3 I8 M IC O N A Z O L E N IT R A T E A N D B H ^ Y L A C N E -C L E A R CREAM S JO H N S O N & JO H N S O N P V T L T D H A R A R E

P E R O X ID E

3080 000E93 M E A S L E S M U M P S & R U B E L L A V A C C IN E , M O R U PA R P O W D E R S F O R IN JE C T IO N B IO V A C 2 3 M B A B W E P V T L T D , H A R A R E

L IV E A T I'

3087 0 0 E i3 5 E R Y T H R O M Y C IN E T H Y L S U C a N A T E E T R O C IN 2 5 0 M G (5 M L G RA N U LES FOR V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

S U S P E N S IO N

3091 00E37I C IS A P R ID E P R E P U L S ID IM G /M L S U S P E N S IO N S JO H N S O N & JO H N S O N IW T L T D H A R A R E

3093 00E373 C IS A P R ID E P R E P U L S ID lO M G TABLETS JO H N SO N & JO H N S O N P V T L T D H A R A R E

3105 000E67 LEV O N O G ESTR EL NORPLANT 3 6 M G P E R IM P L A N IM P L A N T S L E I R A S O Y .F I N L A N D

3124 000E64 IS P A G H U L A H U S K S FY B O G ELO R A N G E 3 .5 G GRANULES R E C K irr& C O L M A N R S A

3127 00D 984 C IM E T ID IN E C IM E C lD -2 0 0 2 0 0 M G /T A B L E T TA BLETS. CO A TED IN T E R N A T IO N A L P H A R M L T D . IN D IA

3132 0 0 E I3 9 E R T H R O M Y aN ESTO LA TE IL O S O N E 5 0 0 500M G TA BLETS, CO A TED P H A R M A C A R E L IM IT E D . S A

3133 0 0 E I4 0 E R Y T H R O M Y C IN E S T O L A T E IL O S O N E 2 5 0 P 2 5 0 M G /5 M L L IQ U ID S P H A R M A C A R E L IM IT E D , S A

3137 00E447 A L P R O S T A D IL ' C A V E R JE C T 20M C G P O W D E R S F O R IN JE C T IO N U P JO H N -P H A R M A C IA & U P JO H N 3 E L G IU M

3138 00E448 A L P R O S T A D IL C A V E R JE C r lO M C O P O W D E R S F O R IN JE C T IO N U P JO H N -P H A R M A C IA & U P J0 H N 3 E I-G IU M

3147 O O O E83 Q U IN IN E S U L P H A T E L E N N O N -Q U IN IN E S U L P H A T E 300M G TABLETS P H A R M A C A R E L IM IT E D . S A

3149 000E63 M ETA Y LSA U CY LA TE A N D M ENTHOL IC Y H O T O IN T M E N -rS S E A R L E D I V I S I O N O F M O N S A N T O P /L S A N D T O N

SA

3150 O O E IO O D E T T O L A N T IS E P T IC C R E A M D E IT O L A N T IS E P T IC C R E A M CREA M S R E C K IT T & C O L M A N H A R A R E

3151 00E J98 M E P Y R A M IN E M A L E A T E M E P Y R A M IN B M A L E A T E 2% C R F .A M S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D , H R E

3153 0 0 E 3 I5 1 7 B -O E S T R A D IO L EV O R EL50 3 .2 M G /P A T C H T R A N S D O iM A L S Y S T E M JO H N S O N & JO H N S O N P V T L T D H A R A R E

3160 O O O E 3I C H L O R P H E N IR A M IN E C H L O R P H E N IR A M IN E 4M G TABLETS C O X P H A R M A C E U T IC A L S U K

3163 00E656 CEFACLOR LILLY-CEFACLOR BD 187 GRANULES 187MG PER 5ML G RA N U LES FOR L IL L Y E U (S A ) (P T Y ) L T D
FOR's u s pe n s io n S U S P E N S IO N

3164 00E657 CEFA CLO R. UIXY-CEFACLOR BD FORTE 375 3 7 5 M G /5 M L GRANULES FOR L IL L Y E U (S A ) (P T Y ) L T D

S U S P E N S IO N

3170 00E502 S T R E P S IL S E U C A L Y P T U S M E N T H O L S T R E P S IL S E U C A L Y P T U S M E N T H O L LOZENGES B O O T S H E A L T H C A R E (S O U T H A F R IC A ) (P T Y )

LTD

3171 00E5O 3 S T R E P S IL S O R A N G E -C S T R E P S IL S O R A N G E -C LOZENGES B O O T S H E A L T H C A R E (S O U T H A F R IC A ) (F F Y )

LTD

3180 00D 999 D O B U T A M IN E H Y D R O C H L O R ID E D O B U T R E X S O L U T IO N 250M G PER 20M L IN JE C T IO N S L IL L Y E L I (S A ) (P T Y ) L T D

3181 00D 989 O E S T R A D IO L ESTR O FEM 2M O TA BLETS, CO A TED N O V O -N O R D IS K (P T Y ) L T D S A

3182 00D 990 O E S T R A D IO L K TR O FEM FORTE 4M G T A B L E T S ,C O A T E D N O V O -N O R D IS K (P T Y ) L T D S A

3183 00E130 KETOCONAZOLE F U N G IN O C 2% CREA M S TO RRENT EXPORTS LTD

3187 00E406 C E P H A L E X IN O S P E X IN 500M G • TA BLETS. CO A TED B I O C H E M I E .T Y R O L , A U S T R IA

3189 00E66I M ETHYLD OPA HELM M E T H Y L D O P A F .C . 250M G TA BLETS.CO A TED H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y

TA B LETS 250M O

3190 00E165 A M O X Y C IL L IN OSPAM OX 500M O TA BLETS, CO A TED B I O C H E M I E .T Y R O L . A U S T R IA

3191 O O E166 A M O X Y C IL U N OSPAM OX 1 2 5 M G /5 M L G R A N U L E S F O R S U S P E N S IO N B I O C H E M I E .T Y R O L . A U S T R IA

3198 00E17I A M IN O P H Y L L IN E P E T E R P H Y L L IN 2 5 0 M G /1 0 M L IN JE C T IO N S P H A R M A C A R E L IM IT E D , S A

3202 O 0E4O 4 C A L C IU M C A R B O N A T E T U M S -O R A N O E F L A V O U R 500M G TABLETS G RO U P LA BS S A PTY LTD RSA

3204 00E660 CEFACLOR L I U .Y - C E F A C L O R C D 375M G TABLETS L IL L Y E U (S A ) (P T Y ) L T D

3217 00E556 M OM ETASONE E L C X :O M O IN T M E N T 1 M G (1 % ) O IN T M E N T S GEDDES LTD HARARE

3218 00E557 M OM ETASONE E L C O M L O T IO N IM G L O T IO N S GEDDES LTD HARARE

3219 00E558 B E T A M E f f lA S O N E D I P R O P I O N A T E D IP R O S O N E C R E A M 0 .5 M G ( O B 5 % ) - . CREAM S GEDDES LTD HARARE

3220 D IP R O S O N E O IN T M E N T 0 .5 M G O IN T M E N T S GEDDES LTD HARARE

00E559 B E T A M E T H A S O N E D IP R O P IO N A T B
3221 00E555 M O M ETA SO N E ELOCOM CREAM IM G CREAM S GEDDES LTD HARARE

3222 D IP R O S O N E L O T IO N 0 .6 4 M G /O L O T IO N S . GEDDES HARARE

00E56O B E T A M E T H A S O N E D IP R O P IO N A T E
3223 00E56I B E T A M E T H A S O N E D IP R O P IO N A T E , D IP R O S A L IC L O T IO N 0 ,6 4 M G & 2 0 M G L O T IO N S GEDDES LTD HARARE

S A L IC Y L lC A a O
3224 00E562 D IP R O S A L IC O IN T M E N T ’0 .6 4 M O / G O IN T M E N T S GEDDES LTD HARARE
B E T A M E T H A S O N E D IP R O P IO N A T E ,

S A L IC Y L IC A C ID
3236 00E201 C E P H A L E X IN O S P E X IN 1 2 5 M G /S M L G R A N U L E S F O R S U S f f iN S I O N B I O C H E M I E .T Y R O L , A U S T R IA

3237 00E202 C E P H A L E X IN , 250M G CA PSU LES B IO C H E M IE . T Y R O L , A U S T R IA

O S P E X IN
3238 00E203 C E P H A L E X IN O S P E X IN 2 5 0 M O /5 M L G R A N U L E S F O R S U S P E N S IO N B IO C H E M IE . T Y R O L . A U S T R IA

3239 00E370 250M G C A PSU LES TO RREN T EXPORTS LTD

A M O X Y C IL L IN T O R M O X IN - 2 5 0
3240 00E368 A C Y C L O V IR 200M G TABLETS TORRENT EXTORTS LTD
H E R P E X -2 0 0
3241 O O O E I5 H E P A T IT IS B R E C O M B IN A N T V A C C IN E H E B E R B IO V A C H B 1 0 M C G /0 .5 M L IN JE C n O N S H E B E R B IO T E C C U B A

3249 00E336 LEVOFOLINICACID (CALCIUM) iS O V O R IN imOJML IN JE C T IO N S W Y E T H S A (P T Y ) L T D RSA

3251 00E615 S U L P H U R , T R IC L O S A N & B E N T O N IT E C R E A M a E A R A S IL T P IM P L E A N D A C N E CREA M S P R O C T E R A N D G A M B L E C O . A R I Z O N A ,U S A

C :R E A M S K IN T O N E
3252 00E616 S U L P H U R , T R IC L O S A N & B E N T O N IT E C R E A M C L E R A S IL T P IM P L E & A C N E C R E A M CREA M S P R O C T E R A N D G A M B L E C O , A R IZ O N A . U S A

COLOURLESS
3255 O O E74I K A N A M Y C IN A C ID S U L P H A T E H E L M K A N A M Y C IN IG POWDERS FOR INJECTION HELM PHARMACEUTICALS'GMBH GERMANY
3256 0 0 E I6 7 A M O X Y C IL L IN OSPAM OX 250M G . C A PSU LES BIOCHEMIE. TYROL,AUSTRIA
3257 00E592 T H E O P H Y L L IN E A N H Y D R O U S ' E U P H Y L L IN R E T A R D 250M G T A B L E T S .C O A T E D AVENTIS CROP SCIENCE ZIMBABWE
3258 00E456 IN D O M E T H A C IN FLAM ARET 25M G C A PSU LES XIXIA PHARMACEUTICALS PTY l t d ; SA
3259 00E460 A M O X Y C IL U N Z O X IL 2 5 0 250M G C A PSU LES XIXIA PHARMACEUTICALS PTY LTD, SA
3261 00E462 A M O X Y C IL U N Z O X IL S 1 2 5 M G /5 M L POWDERS FOR SUSPENSION XIXIA PHARMACEUTICALS PTY LTD. SA
3262 00E463 A M O X Y C I U .I N Z O X IL S F 2 5 0 M G /5 M L POWDERS FOR SUSPENSION XIXIA PHARMACEUTICALS PTY LTD, SA
3264 00E667 G E N T A M IC IN G E N T A M IC IN “ B IO C H E M IE ” 8 0 M G 80M O IN JE C T IO N S BIOCHEMIE, TYROL. AUSTRIA
AM POULES
 982 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h Eie c e m b e r , 2012

F ile N o . A ppl N o. A p pro v ed n a m e T tad e n am e S tren g th F o rm A p p lica n t

3290 00E178 M O R P H IN E S U L P H A T E M O R P H IN E S U L P H A T E P F IN JE C T IO N I5 M G /M L IN JE C T IO N S P H A R M A C A R E L IM IT E D , S A
3291 00E170 A TR O P IN E S U L P H A T E IN T R A M E D A T R O P IN E S U L P H A T E 0 .6 M O /M L IN JE C T IO N S , P H A R M A C A R E L IM IT ED , S A
3292 00E528 V IT A L V IT A M IN E V IT A L V IT A M IN E 4 0 0 l.U . C A P SU L ES V rrA L P A R M P T Y L T D . S A
3303 ' O O E563 B E TA M ET HA SON E D 1PR OP& D iP R O F O S S T E R IL E A Q U E O U S 6 .4 3 0 M G n .6 3 0 M O IN JE C TIO N S G E D D E S L TD H A R A R E
BETAM ETHA SON E PHOSPH S U S P E N S IO N
3310 00E699 C A R B A M A 2 E P IN E E P IM A Z 200M C T A B LE TS N O R TO N H E A L T H C A R E L T D U K
- 33U 00E900 A L EN D R O N A T E S O D IU M FOSAM AX 1 3 .0 5 M G TA BLETS M SD PT Y L TD R SA
3315 000F88 T R IM ET H O P R IM & S U L P H A M E TH O X A Z O LE PURBAC ADULT T A B LE TS P H A R M A C A R E L IM IT ED , S A
3320 00E181 . N E O S T IG M IN E M E T H Y L S U LP H A T E N E O S T IG M IN E M E T H Y L SU L PH A TE 2SMGIML IN JE C n O N S P H A R M A C A R E L IM IT E D , S A
IN T R A M E D
3321 O O E177 P R O M E T H A Z IN E H Y D R O C H L O R ID E INTRAMED PROMETHAZINE 2 5 M G /M L IN JE C T IO N S , P H A R M A C A R E L IM IT E D . S A
HYDROCHLORIDE INJECTION
3323 0 0 E J8 0 N E O S T IG M IN E M E T H Y L S U LP H A T E n e o s t ig m in e METHYLSULPHATE 23MG/ML IN JE C n O N S P H A R M A C A R E L IM IT ED . S A
INTRAMED
3328 00E199 P R A V A S T A T IN S O D IU M PRAVA lO M G T A B LE T S B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
3329 ' 00E200 P R A V A S T A T IN S O D IU M PRAVA 20M G TA BLETS B R IS T O L -M Y E R S S Q U IB B (F T Y ) L T D
3330 O O E763 E T H A M B U TO L H Y D R O C H L O R ID E H E L M E T H A M 8 U TO L H C L T A B L E T S 400M G T A B LE T S H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y
3342 00E632 PRO PO FOL A B B O T T -P R O P O F O L 19b lO M G P E R M L IN JE C TIO N S A B B O TT L A B S S A (P TY ) L T D
3345 00E774 IN A C T IV A T E D H E PA TITIS A V IR U S H A V R IX 1 4 4 0 V A C C IN E S S K B P T Y L T D S U N N IN G H IL L, S A
3348 0O E647 D IF TE TA L L (A D U L T U S E ) A G R IP P A L S -I IN JE C TIO N S B IO V A C Z IM B A B W E P V T L T D , H A R A R E
3349 O O E771 A M O X Y C IL L IN T R IH Y D R .& P O T A U G M E N T IN S F PO W DERS FO R S M ITH K L IN E B E EC H A M P H A R M P T Y
CLAV ULAN ATE S U S P EN S IO N LTD, SA
3350. 0O E2O 7 A S T E M IZ O L E H IS T E E S E lO M G TA BLETS ' M IC R O L A B S L T D , H O S U R , IN D IA

3352 O O P139 A C Y C LO V IR A C IX 20Q M G TA BLETS R A N B A X Y L A B S L T D ,G U R G A O N ,IN D IA

3360 00E564 C L O T R IM A Z O L E & B E T A M E T H A SO N E L O TR ID E R M C R E A M 1 0 M G /O .6 4 3 M G CREAM S G E D D E S L TD H A R A R E
D IP R O P IO N A T E
3366 00E252 P O V ID O N E IO D IN E N O N -A D H ER E N T IN A D IN E 109b D R ES S IN G S JO H N S O N & JO H N S O N P V T L T D H A R A R E
D R E S S IN G
3367 O OO F 13 R IF A M P IC IN S U S P E N S IO N R C IN S U S P E N S K M I IQ O M G P E R S M L S U S P E N S IO N S L U P IN L IM IT E D B O M B A Y
3368- 0 0 E 99 0 E TH A M B U T O L H Y D R O C H LO R ID E 4 < » M G ETH AM BU TOL 400M G TA BLETS L U P IN U M IT E D B O M B A Y
TA B LETS
3369 O O E991 R IF A M P IC IN 1 5 0 M O C A P S U LE S R C IN 1 5 0 IS O M G C A P S U L ES L U P IN L IM IT E D B O M B A Y
3370 00F216 A D R E N A L IN E A N A -G U A R D 1 M G /M L IN JEC T IO N S M E D ! C H A LL E N G E (F T Y ) L TD
3373 0 0 E 78 2 N O R F L O X A C IN N O R F U 3 X A C IN 4Q Q M G , TA BLETS ■ V A R IC H E M P H A R M A C E U T IC A L S (P V T) L T D ,
HRE
3385 O 0E9O 9 T R IT A N R IX 'H R T R IT A N R IX H B V A C C IN ES S H R E Y A L IF E S C IE N C E S P V T L TD
3389 0 0 E 57 7 L O D O X A M ID E T R O M E T H A M IN E A L O M ID E IM G /M L D ROPS. EYE A L C O N L A B O R A T O R IE S S A PT Y L T D , S A
3390 O O E5 8 7 , H Y P R O M E LL O S E IS O PT O P L A IN 5 M G /M L D ROPS, EYE A L C O N P H A R M L T D ,C H A M , S W IT Z ER L A N D
3392 O O E6 6 8 C H O L IN E S A L IC . & , C E T A L K O N IU M C L B O N J H .A G E L 870M G AM G G E LS R E C K irr & C O L M A N H A R A R E
3401 0 0 E 94 6 S P IR A M Y C IN S Y R U P R O V A M Y C IN E S Y R U P 75000 SYRUPS A V EN T IS C R O P S C IE N C E Z IM B A B W E
3406 00E464 M A G N E S IU M T R IS IL & A L U M IN IU M L A N N IE S 750M G T A B L E TS L A N C A S T E R IN D U ST R IA L P V T L TD
H Y D R O X ID E BULAW AYO
3410 0 0 E 72 6 R IS P E R ID O N E 2 M G R IS P E R D A L 2 M G 2M G T A B L E TS JO H N S O N & JO H N S O N P V T L T D H A R A R E
3411 0 0 E 72 7 R IS P E R ID O N E 3 M G R IS P H ID A L 3 M O 3M G T A B L ET S JO H N S O N & JO H N S O N P V T L TD H A R A R E
3414 O O E7 7 6 .. V IN O R E L B IN E T A R TR A T E N A V E L B IN E lO M G /IM L IN JEC T IO N S T E M A M E D IC A L (P T Y ) L TD ,S A
3419 00F291 R IS P E R ID O N E R IS P E R D A L 0 :2 5 M G /T A B L E r T A B L ET S . C O A T ED JO H N S O N & JO H N S O N P V T L T D H A R A R E
3436 O O E155 P A R A C ET A M L A N D P S E U D O E P H E D R IN E S IN U M A X T A B L ET S JO H N S O N & JO H N S O N P V T L T D H A R A R E
3441 O O E 541 P A R O X E TIN E H C L A R OPA X20 20M G T A BL E TS, C O ATED S M IT H K L IN E B E E C H A M , B E R G V L E I, S A
3453 0 0 E 50 5 P E P P ER M IN T & M E N T H O L C O U G H M E H TH IE S P E P P ER M IN T & SYRUPS D A B P H A R M A C E U T IC A L S P V T L T D , H A R A R E
M IX TU R E M E N TH O L C O UG H SY R U P
3471 O O O F 75 F L U TIC A S O N E P R O P IO N A T E F U X O T ID E 1 2 5 1 2 5 M C G /A C T U A T E , IN H A L A T IO N S G L A X O -W E LL C O M E Z IM B A B W E P V T L T D ,
HARARE
3474 O O E735 M E TH YL DO PA M ETHYLDOPA 2 5 0 M G /T A B L E T T A B L E T S . C O A T ED M O R N IN G S ID E P H A R M L T D , U K
3475 0 O E7 8 0 IR IN O T EC A N H Y D R O C H L O R ID E CAM PTO 2 0 M G /M L IN F U S IO N S A V EN T IS C R O P S C IE N C E Z IM B A B W E
T R IH Y D R A T E
3477 Z 0 0 06 2 B E N ZA L K O N IU M C H L O R ID E S A N IT O L A N T ISE P T IC G E R M IC ID E 5% W A I S O L U T IO N S Z IM B A B W E P H A R M A C E U T IC A L S
3478 O O E409 S IM V A S T A T IN ZOO 3R 20 20M O T A B IE T S , C O A T ED M S D P T Y L TD R S A
3482 , O O E552 L O R A T ID IN E C L A R IT IN E T A B L E TS lO M O T A B L ET S G E D D E S L TD H A R A R E
3486 00E86O A M O X Y C IL L IN T R IH Y D R A T E & M ACROPENS POW DERS FOR X IX IA P H A R M A C E U T IC A L S P T Y L T D , S A
F L U C L O X A C IL L IN S O D . S U S P E N S IO N -
3487 0 0 E 8 6 .3 PA R AC ETA M OL & PH EN YL S IN U S T A T C A P SU L ES X lX lA P H A R M A C E U T IC A L S P T Y L T D . S A
P R O P A N O L A M IN E H C L
3489 00F3O 3 T ET R A C Y C L IN E H Y D R O C H L O R ID E T E T R A C Y C L IN E H Y D R O C H L O R ID E 1 % W A' O IN T M E N T S , E Y E F D C L IM IT E D , A U R A N G A B A D , IN D IA
3492 O O E5 7 9 C H L O R A M P H E N IC O L 5% IS O P T O F E N lC O L S % 4% D R O P S .E Y E A L C O N P H A R M L T D , C H A M , S W IT Z ER L A N D
3493 00F346 P A R A C E TA M O L P A C IM O L 5 0 0 M G /T A B L E T T A B L ET S IP C A L A B O R A T O R IE S L T D , IN D IA
3495 00E797 G E M C ITA B JN E H Y D R O C H L O R ID E G E M ZA R IG 10 P O W D E R S F O R IN JE C T IO N L IL L Y E LI (S A ) (P T Y ) L TD

i
3496 00F152 R A L O X IF ^ E H Y D R O C H LO R ID E . E V IS T A 60M G T A BL E TS, C O A TE D L ILL Y E LI (S A ) (P T Y ) L T D
3498 O O E264 S A L IC Y L IC A C ID JO H N S O N S C L E A N & C L EA R 0 .3 % W A ^ E M U LS IO N S JO H N S O N & JO H N S O N P V T L TD H A R A R E
M O IS T U R IS E R
3499 00E265 S A L IC Y L IC A C ID JO H N S O N S C L E A N & C L E A R S E N S . 0^96 S O L U T IO N S JOHNSON & JOHNSON PVT LTD HARARE
S K IN A S T R IN G E N T
3501 O O E267 S A L IC Y L IC A C ID JO H N S O N S C L E A N & C L EA R 2% S O LU TIO N S JOHNSON & JOHNSON PVT LTD HARARE
A S T R IN G E N T
3502 0 0 E 26 8 T R IC L O S A N JO H N S O N S C L E A N & C L A ER 0 .2 5 9 b L IQ U ID S JOHNSON & j Qh NSON PVT LTD HARARE
F O A M IN G C L EA N S E R
3504 00F348 P R O C A IN E P E N IC IL L IN P R O C A IN E P E N IC ILU N 3 G /V IA L P O W D ER S F O R IN JE C T IO N IP C A L A B O R A T O R IE S LT D . IN D IA
3515 O O E646 T U M S A S S O R T E D F R U IT F L A V O U R S T U M S A S S O R T E D F R U IT F L A V O U R S TA BLETS G R O U P L A B S S A P T Y L TD R S A
3516 O O E 883 F L U N IT R A Z E P A M ROHYPNOL IM G T AB L ET S H O F F M A N L A R O C H E S W IT Z E R L A N D
3519 00E936 S A U C Y C IJC A C ID O X Y N IG H T W A T C H A C N E L O T IO N 2 Q P E R lO O G L O T IO N S G R O U P L A B S S A P T Y L TD R S A
3522 00F3O 4 C H L O R A M P H E N IC O L S O D IU M S U C C IN A T E C H L O R A M P H E N IC O L O P H T H A L M IC I % W /W O IN T M E N T S , E Y E F D C L IM IT E D , JO G E S H W A R I. IN D IA
O IN T M E N T
3523 00F295 A C Y C L O V IR A P O -A C Y C L O V IR 200M G T A B L E TS A P O T E X IN C . C A N A D A
3529 0O F 17O R IT O N A V IR N O R V IR lO O M G CA PSULES A B B O TT L A B S S A (P T Y ) L T D
3534 0 0 E 97 2 D O R Z O L A M ID E H Y D R O C H L O R ID E T R U SO P T2% 2% S O L U T IO N S M S D P T Y L TD R S A
3540 O O E 158 D IC L O F E N A C S O D IU M A P O -D IC L O 25M G T A B L ET S , C O A TE D A P O T E X IN C . C A N A D A
3541 00E729 E S T R O P IPA T E 0 .7 5 M G O R T H O -E S T 0.6 2 5 M G 0 .6 2 5 M G T A BL E TS JO H N S O N & JO H N S O N P V T L T D H A R A R E
3546 O O E 938 B E N Z O Y L P E R O X ID E O X Y -1 0 L O T IO N lO G P E R IO O G L O T IO N S G R O U P L A B S S A P T Y L TD R S A
3554 00E434 E N A L A P R IL R E N IT K 10 lO M G T AB L ET S M S D P T Y L TD R S A
3572 0 0 E 87 0 A C Y C LO V IR H m PEX C R EAM CREAM S TO RRENT EXPO RTS LTD
3574 00F133 C E F T R IA X O N E S O D IU M O FRAM A X 250M G P O W D E R S F O R IN JE C T IO N R A N B A X Y L A B S L T D . G U R G A O N , IN D IA
3575 0 0 F I3 4 C E F TR IA X O N E O raA M A X 10 P O W D E R S F O R IN JE C T IO N R A N B A X Y L A B S L T D , G U R G A O N , IN D IA
3576 00E992 L IV E A TT EN U A TE D V A R IC E L L A V IR U S V A R IL R IX V A C C IN ES S H R EY A L IFE S C IE N C E S P V T L TD
V A C C IN E
3578 O O E176 H E PA R IN S O D IU M IN T R A W aJ H E PA R IN S O D IU M 2 5 0 0 0 L U /M L IN JEC T IO N S P H A R M A C A R E L IM IT E D , S A
3579 00F298 F L U p X E T IN E H Y D R O C H L O R ID E A P O -R -U O X E T IN E 20M C CA PSULES A P O T E X IN C . C A N A D A
3584 00E795 C A LT R AT E D C A LT R AT E D C Y N A M ID P T Y , L T D O F S O U T H A F R IC A
3592 0 0 E 82 8 B E C LO M E T H A S O N E D IP R O P IO N A T E B K L A Z O N E 5 0 IN H A L E R 50M O 3 IN H A L A T IO N S N O R T O N H E A L T H C A R E L TD U K
IN H A L E R 5 0 M C G
3593 O O F 225 B E C L A M E T H A S O N E D IP R O P IO N A T E B E C L A Z C » IE lO O M C G /A C T U A T IO IN H A L A T IO N S N O R T O N H E A L T H C A R E L TD U K
3594 O O F 224 B E C LO M ET HA SON E BECLAZO NE 2 5 0 M C G /A C T U A T IO IN H A L A T IO N S N O R T ON H E A LT H C A R E L T D U K
3598 O O F 138 N O R F L O X A C IN B A C T IN O R 400M G T A B L E T S , C O A T ED R A N B .A X Y L A B S L T D , G U R G A O N , IN D IA
. 3602 0 0 E 52 7 V IT A L V IT A M IN E 1 0 0 0 l.U . V IT A L V IT A M IN E 1 0 0 0 l.U . 1 0 0 0 I.U .E Q U IN CA PSULES V IT A L F A R M P T Y L T D , S A
3603 O O E529 V ITA L G IN S E N G “E ” V IT A L G IN S E N G " E ” 5 5 X )M G V rr.E C A P S U LE S V ITA L F A R M P T Y L T D , S A
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012 983

F ile N o . A ppI N o. A p p ro v ed n am e lY ad e n am e S tren g th F o rm A p plk ant

3604 00E 531 V ITA M IN E N A T R O D A L EV ITA M IN E 500IU CA PSULES V ITA I-F A R M P T Y L T D , S A

3605 00E 535 V IT A L A N T IO X ID A N T V IT A L A N T IOX ID A N T CA PSULES V IT A L F A R M P T Y L TD , S A
3606 00E536 Z IN C G L U C O N A T E V IT A L Z IN C T A B L ET S T A B LE TS V IT A L F A R M P T Y L TD , S A
3607 O O F I35 R A N ITID IN E H IS T A C 150M O - T A B L ET S . C O A TE D R A N B A X Y L A B S L TD . G U R G A O N JN D IA
3610 00E 825 D IL TIA Z EM H Y D R O C H LO R ID E D IL T IA Z EM H Y D R O C H L OR ID E 60M O T A B LE T S . C O AT ED N O R T O N H E A LT H C A R E L IM IT ED . U K
T A B L ET S 6 0 M G T A B LE T S « )M G
3611 Z 00533 C H LO R P R O M A ZIN E H Y D R O C H LO R ID E L A R O A C TIL 25M G T A B LE T S , C O A T E D . A V E N TIS C R O P S C IEN C E Z IM B A B W E
3612 Z 00535 C H LO R P R O M A ZIN E H Y D R O C H LO R ID E L A R G A C TIL lO OM G T A B L ET S , C O AT ED A V EN T IS C R O P S C IE N C E Z IM B A B W E
3614 O OE 896 T R IC H L O R O C A R B A N ILID E P R O T E X S U A V E/O EN TL E 250M G SO APS C O LG A T E-P A L M O L IV E Z IM B A B W E P V T L TD
3615 00F 463 T R IC H L O R O C A R B A N ILID E A N D T R IC LO S A N P R O T E X U LT R A SO APS C O LG A T E -P A LM O L IV E Z IM B A B W E P V T L TD
3616 O O E17 4 F E N T A N Y L C ITR A TE . TANYL . 100M C O /2M L IN JEC T IO N S P H A R M A C A R E L IM ITE D . S A
3618 00F335 R A C E C A D O T R IL H ID R A S E C A D U L T lO O M G /C A P S U L E CA PSULES S M ITH R L IN E B EE C H A M C A P E TO W N S A
3622 O O F237 F L U O X E TIN E H Y D R O C H LO R ID E F L U N lL -2 0 20M O CA PSULES IN TE R N A T IO N A L P H A R M L TD . IN D IA
3627 00F464 T R IC L O C A R B A N P R O T E X B A LA N C E 0,25 % W A V SO APS C O LG A T E -P A LM O L IV E Z IM B A B W E P V T L TD
3638 O OE 937 B E N Z O Y L P E R O X ID E O X Y -5 L O T IO N 5 G P E R lO O G L O T IO N S G R O U P L A B S S A P T Y L TD R S A
3645 O O F I98 A C Y C L O \'IR H ER P E R A X 5 % W /W O IN T M E N TS M IC R O L A B S L TD , B A N G A L O R E. IN D IA
3649 00E 785 A C A R BO SE G L UC O B A Y 100 lO O M G T A B L ET S B A Y E R (P T Y ) L T D S A
3650 00E786 A C A R BO SE G L UC O B A Y 50 50 M G T A B LE TS B A \'E R (m )L T D S A
3660 00F 367 Z A F IR LU K A S T A C C OL A T E 20M G /T A B L E T T A B LE T S , C O AT ED
3661 O OE 898 P E R TU S S iS X U P H TH S U A & TE T A N U S T O X O ID IN F AN R IX (D TP A ) V A C CIN ES S H R EY A L IFE S C IE N C E S P V T L TD
3663 O O F436 Z ID O V U D IN E Z IDO V U D IN E lO O M G /C A P S U L E CA PSULES a P L A L TD , M U M B A I. IN D IA -
3673 O OE 978 C H L O R P R O P A M ID E P R O DIA R E T 250M G /T A B L E T T A B L ET S . C O AT ED m o r n in g s id e ph a r m l t d .u k •
3675 00E982 P R O P R A N O LO L P R O P R AN O L O L 40M G rT A B L ET T A B L ET S M O R N IN G S ID E P H A R M L TD , U K
3676 00E787 N IF ED IP IN E A D A LA T C C 30 30M G T A B LE TS .O O A T ED B A Y E R (m iL T O S A
3677 00E 788 N IF ED IP IN E A D A LA T C C 60 60M O T A B L ET S . C O AT ED B A Y E R (P TY ) L TD S A
3682 000F 25 N O R F L O X A C IN N O R F LO X A C IN 400M G T A B LE TS IN T ER N A TIO N A L P H A R M L TD . IN D IA
3684 00E126 D ILT IA Z EM D lL ZE M -« ) 60M G T A B L ET S , C O A T E D T O R R E N T E X P O R TS L T D
3683 O O F120 A M O X Y C IL LIN T R IM O X 250M G CA PSULES M lO tO L A B S L TD , B A N G A LO R E, IN D IA
3689 00F 119 A M O X Y C llilN T R IM O X 500M G CA PSULES M IC R O L A B S L TD , B A N G A LO R E. IN D IA
3691 00F236 C IP R O F L O X A C IN C lP R O iN T A -250 250M G T A B L ET S , C O A T E D IN T E R NA TIO N A L P H A R M L T D . IN D IA
3692 O O F234 C IS A P R ID E azA lO M O T A B LE TS IN T ER N A TIO N A L P H A R M L TD . IN D IA
3693 00F 235 D O X Y C Y C U N E H Y D R O C H LO R ID E D O X Y T A S 100 lO O M G CA PSULES IN T ER N A TIO N A L P H A R M L TD . IN D IA
3697 00B 455 C O -T R IM O X A ZO LE M E R C K C O -T R IM O X AZ O L E 480M G T A B LE TS X IX IA P H AR M A C E UT IC AL S P T Y L TD .S A
3699 00F214 F L U O X E TIN E F L U O X E TIN E 20M G CA PSULES N O R T O N H EA LT H C A R E LIM IT ED . U K
3704 00^79 IB U P R O FE N IB U P R O F EN 200 M G T A B L ET S . C O A TE D M O R N IN G S ID E P H A R M L T D . U K
3706 00F370 C IP R O F L O X A C IN F L O X -250 250M G /T A B L E T T A B L ET S . C O A T E D M IC R O L A B S L TD , B A N G A LO R E ,IN D IA
3707 00F374 C E F T R IA X O N E C E F TR lA X O N E -250 2 5 0 M G A /IA L P O W D ER S F O R IN JEC T IO N M IC R O L A B S L TD , B A N G A L O R E .IN D IA
3708 O O F215 V E R A P A M IL H Y D R O C H LO R ID E L E R A P A M IL S R 240 240 , T A B L ET S , C O A TE D N O R T O N H E A LT H C A R E L T D U K
3 7 )9 O CHX IFZ C A R B ID O P A lO M G & L E V O D O P A lO O M G A P O -L EV O C A R B JO M O /IOO M G T A B L E TS A PC TT EX IN C . C A N A D A
3720 00FU 5 C A R B ID O P A 2 5 M G A N D LE VO DO PA 2 5 0 M G A P O-L EV O C A R B 25M G /250M G T A B LE T S A P OT E X IN C . C A N A D A
3723 000F17 P A R A C ET A M O L PA RACETAM O L 500M G T A B LE TS C A D iL A P H A R M A C E U T IC A LS L TD , IN D IA
3726 O OE 163 F R U S E M ID E IN T R A M E D F U R O S E M ID E 20M G /2M L IN JE C T IO N S P H A R M A C A R E L 1 \U T ED , S A
3728 O O F309 ETHA M BUTO L ETHA M BUTO L 4 0 0 M G /T A B L F r T A B L ET S . C O A TE D IP C A L A B O R A T O R IES L TD . IN D IA
3737 00E588 T ET R A C A IN E H Y D R O C H LO R ID E 0 3 % T C T R A C A IN E H Y D R O C H L O R ID E 0,5% . 03% DROPS. EYE A LC O N P H A R M L T D . C H A M , S W IT Z E R LA N D
3738 00F366 E C O N A Z O L E N ITR A TE E C O N A Z O L E N ITR A TE 150M G /P ES S A R Y P E S S A R IE S . V A R IC H E M P H A R M A C EU TIC A L S (P V T) L TD ,
HRE
3744 00F435 C H LO R O Q U IN E P H O S P H A T E C H LO R O Q U IN E PHOSPHATE 250M G /TA B LE T T A B L E TS .C C A T ED B A L P H A R M A . H O S U R .B A N G A L O R E,IN D IA
3749 0 0 F I8 3 M E F E N A M tC A C ID M E F EN A M IC A C ID S U S P EN S IO N 50M G /5M L S U S PE N SIO N S M O R N IN G S ID E P H AR M L T D . U K
3755 00F186 P IR O X IC A M P IX IC A M 20 ! 2 0 M G /C A P S U LE CA PSULES M O R N IN G S ID E P H AR M L T D , U K
3764 O O F428 A M O X Y C ILL IN T R IH Y D R A T E B A LM O X 250 D T 250M O /T AB L E T T A B L ET S B A L PH A R M A . H O S U R . B A N G A L O R E , IN D IA
3765 00F427 A M O X Y C ILL IN T R IH Y D R A T E B A LM O X K ID 125M G /T A B LE T T A B L ET S B A L P H A R M A , H O S U R . B A N G A L O R E . IN D IA

3767 0000F9 C H L O R D IA Z E P O X ID E H C L & C L IN ID IU M B R . A P O C H LO R A X CA PSULES A P O T EX IN C . C A N A D A .

3768 000F58 S O D IU M C H LO R ID E S A B A X P O U R S A L IN E 0 .9 % IR R IG A T IO N S D A TL A BS P V T L TD . B U L A W A Y O . Z IM B A B W E

3771 00F205 IN D A P A M ID E D A PAM A X 2.5M G T A B L ET S , C O A T E D W A R NE R -LA M B ER T S .A .(F TY ) L T D R S A

3772 O O F204 O R C IP R E N A L IN E S U L P H A T E A N D FLEM EZE SY RUP L IQ U ID S W A R NE R -LA M B ER T S ,A .(P TY ) L TD R S A

B R O M H E X IN E H C L
3776 00F144 F L U O X E TIN E H Y D R O C H LO R ID E L O R IEN 20M G C A P S U LE S P H A R M A C A R E U M ITE D , S A
3783 O O E827 T A M O X IF E N T A B L E T S B P lO M G T A M O X IFE N T A B LE TS B P lO M G lO M G T A B L ET S . C O A T E D N O R T O N H E A LT H C A R E L IM IT ED . U K

3785 00E875 A L C O P U R IN O L T A B L ET S 300M G A LC O P U R IN O L T A B LE TS 300M G 300M G T A B L ET S C O X P H A R M A C EU TIC A L S U K

3790 00E935 S A L IC Y L IC A C ID A N D T R IC L O S A N O X Y M E D IC A T ED P A D S T R A NS D ER M A L S Y S TE M G R O U P LA B S S A P T Y L TD R S A

3791 00E 96O C H L O R P R O M A ZIN E IN T R A M E D C H LO R P R O M A ZIN E 50M G /2M L IN JE C TIO N S P H A R M A C A R E U M ITE D , S A

IN JE C TIO N 50M G /2M L

3793 00E 5O 6 R A N IT ID IN E ZA NTA C • 50M G /2M L IN JEC T IO N S G L A X O -W E LL C O M E Z IM B A B W E P V T L TD ,
HARARE

3794 00F314 C IS P LA T IN C IS P LA TIN lO M G /lO M L IN JEC T IO N S S E R U M IN S T O F IN D IA L T D, P U N E , IN D IA

3795 00F632 C E T IR I2 1 N E D IH Y D R O C H L O R ID E Z Y R TE C O R A L S O L U TIO N IM G P E R M L S O L U TIO N S UCB SA PTY LTD

3801 O O F499 C O N JU C A T E D O ES T R O G EN . P R E M E LL E5 T A B LE T S , C O A TE D W Y E TH S A (P TY ) L TD R S A

M E D R O X Y P R O G ES T ER O N E A C E T A T
3803 00F508 C A LC IU M C A R B O N A T E C ^A L TR A T EN nN T T S O M G H 'A B L E T T A B LE TS W H IT E H A L L IN T E R NA TIO N A L IN C .

3804 O OO OF3 N IF E D IP IN E P R O LO > «3ED A C T IV E A P O -N IF ED PA lO M G T A B LE TS A P OT E X IN C . C A N A D A

T A B L E TS lO M G
3805 0 0 F I1 6 N IF E D IP IN E 20M G A P O -N IF E D PA 20M G 20M G T A B L ET S A P OT E X IN C , C A N A D A

3806 0 0 D 87 3 F L U C O N A ZO LE D IF LU C A N 50M G /5M L P O W D ER S F O R S U S P E N S IO N P F IZ ER .H A R A R E

3809 O OO FI6 E T H A M B U T O L H Y D R O C H LO R ID E M Y C O B U TO L 400M G T A B L ET S C A D ILA P H A R M A C EU TIC A L S L T D , IN D IA

3812 00F513 V E N L A FA X IN E EFEXOR 3 7 S M G /TA B LE T T A B L ET S W Y ET H S A (P TY ) L TD R S A

3840 00P356 F E L O D IPIN E S M O TT A BL E T T A B LE T S . C O A T E D A S T R A A B .S W E D EN

P L E N D IL
3847 00F445 P O L IO V IR U S U V E A T TE N U A T ED O P V -M E R IEU X V A C CIN ES A V E N TIS C R O P S C IEN C E Z IM B A B W E

3848 00F 331 R U B EL LA V A (X IN E (L IV E A TT EN UA TE D ) R U D IV A X lO O O TC ID ^ P O W D E R S F O R IN JE C TIO N A V E N TIS C R O P S C IEN C E ^ M B A B W E

3855 000F57 W A TE R F O R IR R IG A T IO N S A B A X P O U R W A T ER IR R IG A T IO N S D A T L AB S P V T LT D .B U L A W A Y O .ZIM B A B W E

3863 0O F19O , H E PA T IT IS A A N D H EP A TIT IS B S U S P EN S IO N S S H R EY A L IF E S C IE N C E S P V T L TD

T W JN R IX A D U LT
3864 00F253 H EP A TIT IS A A N D H EP A T IT IS B T W IN R IX JU N IO R S U S P EN S IO N S S H R EY A L IF E S C IE N C E S P V T L T D

3865 0 0 F 3 10 C H LO R O Q U IN E P H O S P H A T E 250M G T A B L ET S IP C A L A B O R A TO R IES L T D. IN D IA

L A R IA G O
3866 00F383 D ID A N O S IN E 25M G /T A B L E T T A B LE TS B R IS T O L -M Y ER S S Q U IB B (P TY ) L T D
V ID E X
3867 00F384. D ID A N O S IN E 50M G /T A B L E T T A B LE TS B R IS T O L -M Y ER S S Q U IB B (P TY ) L TD
V ID E X
3878 O O F402 T O P IR A M A TE 25M G /T A B LE T T A B L E T S, C O A T E D . JO H N S O N & JO H N S O N P V T L TD H A R A R E
T O PA M A X
3879 00F403 T O P IR A M A TE lO O M G T A B L ET T A B L ET S , C O A T E D JO H N S O N & JO H N S O N P V T L T D H A R A R E
TOPAM AX
3880 00F404 B U D ES O N ID E- 2 0 0 M C G /D O S E IN H A L A TIO N S A S TR A P H A R M A 4 P TY ) L T D , S U N N IN C H IL L , S A
P U L M IC O R T
3881 00F179 T A B LE TS W Y ET H -A Y ER S T L A B S P T Y L T D R S A
N O R G ES T R E L A N D E TH IN Y L E S T R A D IO L D U OFEM A N D FER R O US FU M A R ATE
3886 0 0 F 3 J8 0 2 5 % W A^ D ROPS, EYE M SD PTYLTD RSA
T IM O LO L M A L EA T E T IM O L O L-X E
3887 00F319 0 .5 % W A I D ROPS, EYE M S D P T Y L TD R S A
T IM O LO L M A L EA T E T IM O P TO L-X E
3888 00E868 250M G T A B LE TS TORRENT EXPO RTS LTD
C IR P R O F L O X A C IN Q U IN T O R -250
3889 00E867 50G M G T A B LE TS T O R R E N T E X P O R T S L TD
C A P R O F L O X A C IN Q U IN T O R -500
3890 00F645 P E C T IN A N D S O D IU M GELS B R IS TO L -M Y E R S S Q U IB B (P TY ) L T D
G R A N U G EL
C A R B O X Y M E TH Y LC E L LU L O S E
3892 00E857 lO OM G S U P P O S ITO R IES X IX IA P H A R M A C EU TIC A L S P T Y L TD , S A
IN D O M E TH A C IN F L A M A R E T S U P P O S ITO R IES
3893 00E859 CA PSULES X IX IA P H A R M A C E U T IC A LS P T Y L T D , S A
A M O X Y C ILL IN & F L U C LO X A C IL LIN S O D . M A C R O P E N 500
3894 00E968 250M G C A P S U LE S X IX IA P H A R M A C EU TIC A L S P T Y L T D .S A
A M P IC IL LIN T R IH Y D R A T E X IA P E N 250
3895 O OE 969 500M G CA PSULES X IX IA P H A R M A C EU TIC A L S P T Y L T D , S A
A M P IC IL LIN T R IH Y D R A T E X IA P E N 500
3904 00F 661 U 5M O T A B L ET S A V E N T IS C liO P S C IE N C E Z IM B A B W E
R A M IP R IL T R ITA C E
3905 00E989 IS O M G /T A B L ET T A B LE T S , C O A T E D V A R IC H E M P H A R M A C E U TIC A L S (PV T) L TD ,
R A N IT ID IN E H Y D R (X H L O R ID E R A N ITID IN E H Y D R O C H L O R ID E
HRE

3909 00F 141 IB U P R O F E N :a)0M G T A B LE T S , C O A T E D A JA N T A P H A R M A U M IT E D

A P lF E N -200
3911 O O F 546 T A M S U LO S IN H Y D R O C H LO R ID E - 0.4M G CA PSULES P H A R M A P LA N (P TY ) L TD .M ID R A N D 1 6 8 5 .S A
F L O M A X 0 .4 S R
 984 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2

S tr e n g th F o rm A p p lic a n t
F ile N o . A p p iN o . A i^ ro v e d n a m e T V ad e n a m e

IO O M O /5 M L M IX T U R E S P H A R M A C A R E U M IT E D , S A
39J6 O O E832 G U A IP H E N E S IN L E N N O N C O U G H M IX T U R E
120M G CAPSULES R O C H E Z IM B A B W E (P V T ) L T D
3920 0O F5O 3 O R L IS T A T X e J iC A L
SO N A T A 10 lO M O C A PSU L ES W Y E T H S A (P T Y ) L T D R S A
3924 O O F557 Z A L E M .O N
2 5 O M C y i0 M L P O W D E R S F O R IN JE C T IO N L IL L Y E L I ( S A ) ( P T Y ) L IM IT E D
3925 00F65O C E F U R O X IM E S O D I U M L IF U R C M ^
L IF U R O N ' 7 5 0 M G /1 0 M L P O W D E R S F O R IN JE C T IO N L IL L Y E U (S A ) (P T Y ) L IM IT E D
3926 ' 00F65J ' C E F U R O X IM E S O D IU M
40M G CAPSULES B R IS T O L -M Y E R S S Q U IB B (P T Y ) L T D
' 3935 O O F381 S T A V U D IN E Z E R IT
PH Y TO R A L 2% O IN T M E N T S M IC K O L A B S L T D , B A N G A L O R E , IN D IA
3942 00E2O6 K E TO C O NA Z OL E USP
3 0 0 M G /M L IN J E C T IO N S I P C A L A B O R A T O R IE S L T D , IN D IA
3943 00F553 Q U IN IN E D IH Y D R O C H L O R ID E C IN K O N A
l a r ia g o lO O M G /lO M L L IQ U ID S I P C A L A B O R A T O R IE S L T D , IN D IA
3944 00F362 C H L O R O Q U I N E W IO S P H A T E
2 7 S 0 M O /A C T U A T 1 O N IN H A L A T IO N S C I P L A L T D . M U M B A I , IN D IA
3948 O O F438 SA LB U TA M OL SU LPH ATE A S T H A L IN
B E C L A T E -2 0 0 2 0 0 M C G /A C T U A T 1 O IN H A L A T IO N S a P L A L T D , M U M B A I . IN D IA
3949 O O F437 B E C L O M E T H A S O N E D IP R O P IO N A T E
P E N T A C T -H IB V A C C IN E S A V E N T IS P H A R M A S A
3955 00F123 P E N T A C T -H IB
C IP R O F L O X A C IN H Y D R ( X H L O R ID E 250M G T AB L ET S. C O ATED V A R IC H E M P H A R M A C E U T IC A L S ( P V T ) L T D .
3965 00F754 C I P R O F L O X A C IN H Y D R O C H L O R ID E
HRE

IS 0 N IA 2 ID lO O M G TAB LETS U M E D IC A , M U M B A I,I N D IA

3969 00F729 I S p N IA Z I D
L IF U R O M IS G ia S M L ■ P O W D E R S F O R IN JE C T IO N L IL L Y H J (S A ) ( P T Y ) L IM IT E D
3970 . 00F652 C E F U R O X I M E S O D IU M
A P O -D lL T I A Z S R « )M G 60M G C A PSU LES A P O T E X IN C . C A N A D A
3971 00E998 D 1 L T IA 2 S M H Y D R O C H U J R ID E
A P O -D IL T IA Z S R 9 0 M G 90M O C A PSU LES A P O T E X IN C , C A N A D A
3972 00F113 D IL T IA Z E M H Y D R O C H L O R ID E
A P O -D I L T I A Z S R l2 flM G 120M G C A PSU LES A P O T E X IN C , C A N A D A
3973 O O Fl 14 D IL T IA Z E M H Y D R O C H L O R ID E
C I K lO H C C m C DROPS. EAR A L C O N L A B O R A T O R IE S IN C
.3 9 7 8 00F529 C I P R O F L O X A C IN H C L & H Y D R O C O R T IS O N E
TAB LETS V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D .
3982 00F623 F A M O T ID IN E F A M O T ID IN E
HRE

A R IN A T E lO O M G TA B LETS D A re A P H A R M A ,
3983 ■ O O F545 A R T ESU N A TE
H Y D I^ A SOOM G CAPSULES B R IS T O L -M Y E R S S Q U IB B ( P T Y ) L T D
3985 00F389 HYDROXYUREA
H Y T R IN IM G TA B LETS A B B O T T L A B S S A (P T Y ) L T D
3987 O OE489 T E R A Z O S IN
H Y T R IN 2M G . TA B LETS A B B O T T L A B S S A (P T Y ) L T D
3988 00E490 T E R A Z O S IN
H Y T R IN 5M G TA B LETS A B B O T T L A B S S A (P T Y ) L T D
3989 00E491 T E R A Z O S IN ,
H Y T R IN lO M G TA B LETS A B B O T T L A B S S A (P T Y ) L T D
3990 00E492 T E R A Z O S IN
C H L O R O Q U IN E P H O S P H A T E 4 0 M G /M L - IN J E C T IO N S U M E D IC A . M U M B A I . IN D IA
3994 00F747 C H L O R O Q U IN E P H O S P H A T E
R A N B A X Y L A B S L T D ,O U R G A O N .I N D I A
4002 O O F453 O M E P R A Z O L E . T IN ID A Z O L E A N D PYLOBACT
C L A R I T H R O M Y C IN
T A B L E TS. C O ATED M SD PTY LTD R SA
4006 O 0F2O 3 L O S A R T A N P O T A S S IU M A N D C O Z A A R ( X IM P
H Y D R O C H L O R O T H IA Z ID E
50M G T A B L E TS. C O ATED M SD PTY LTD R SA
4007 00E 899 LOSA R TA N C O ZA AR
L O C A IN E A IN JE C n O N S A D C O C K IN G R A M S S A (P T Y ) L T D
' 4023 00F664 U G N O C A IN E H C L & A E « E N A L 1 N E T A R T R A T E
TRAN SDERM AL SYSTEM JO H N S O N & JO H N S O N P V T L T D H A R A R E
4036 O 0F6O 5 O E S T R A D IO L & N O R E T H I S T E R O N E A C B T . EVO R ELSEQ Ul
M IO S T A T S T E R I L E I N T R A O C U L A R 0 J)1 % S O L U T IO N S A L C O N L A B O R A T O R IE S IN C
4039 O O F798 CARBACHOL /
A T E N C H .O L 50M G TA B LETS ■ S C H E IN P H A R M A C E U T IC A L S
4040 O O F 679 A TENO LO L
A TEN OLO L lO O M G T A B L E T .S S C H E IN P H A R M A C E U nC A L S
4041 O 0P680 A TENO LO L
A R TEM ETH ER 8 0 M G /M L IN J E C T IO N S D A FR A PH A R M A
4043 00F544 B ETA A R TEM ETH ER
300M G T A B L E TS. C O ATED T O R R E N T EXPO R TS LTD
4045 O O F 689 R A N IT ID I N E H C L R A N I T lN - 3 0 0
C E N TR U M T A B L E T S .C O A T ^ W H IT E H A L L P R O D U C T S S A P T Y L T D
4052 0 (jF 3 4 9 M U L T IV IT A M IN A N D M IN E R A L S
50M G Z2M L IN J E C T IO N S P H A R M A C H E M IE (P T Y )L T D C E N T U R I O N . R S A
4064 00F489 M E TH O T R EX A T E EM THAXATE
C IP R O F L O X A Q N H Y D R O C H L O R ID E SOOM G T A B L E T S .C O A T E D V A R IC H E M P H A R M A C E U T IC A L S ( P V T ) L T D ,
4065 00F795 C I P R O F L O X A C I N H Y D R O C H L O R ID E
HRE

V A R IV A R 150M G Sc. 300M G CAPSULES V A R IC H E M P H A R M A C E U T IC A L S ( P V T ) L T D .

4078 O O F 849 L A M IV U D IN E & Z I D O V U D I N E
HRE

75M G CREAM S D a > IK ,E .O H G .M U N C H E N .G E R M A N Y

4081 00E840 D IC L O F E N A C S O D IU M 7 5 M O D IC L O -D E N K 7 5
D I C L O -D E N K 2 5 25M G T AB L ET S. C O A TED D EN K. E. O H G. M U NC H EN . G ER M A NY
4082 O OE839 D IC L O F E N A C S O D IU M
200M G TA B LETS D E N K .E . O H O . M U N C H E N ,G E R M A N Y
4083 O OE837 A C Y C L O V IR T A B L E T S 2 0 0 M G A C Y C L O -D E N K 2 0 0
D IF L U C A N 200M G TA BLETS P F I Z E R P IE T M A R IT Z B U R G
4084 00F957 FL UC O NA ZO LE
20M C G PER M L V A CD N ES IN T A S P H A R M A C E U T IC A L S L IM IT E D
4087 00F658 H E P A T IT IS B V A C C IN E (R D N A ) B P I M L R E V A C 'B
1 0 /V IA L P O W D E R S F O R IN J E C H 'IO N M I C R O L A B S L T D , B A N G A L O R E , IN D IA
4088 O OF53I C E F O T A X IM S O D IU M ZO TA X
F R U S E M ID E lO M G /M L IN J E C T IO N S I P C A L A B O R A T O R IE S L T D . I N D I A
4090 O O F997 F R U S E M ID E
2 ® W /W CREAM S H O E P H A R M A C E U T IC A L S S D N B H D
4094 O O F883 F U S ID I C A C I D POBAN
2 % W /V SHAM POOS H O E P H A R M A C E U T IC A L S S D N B H D
4095 00F88I K ETOC O NA ZO LE D E ZO R SH A M PO O
75M O IM P L A N T S L E IR A S O Y . F IN L A N D
4098 . 00F982 LEV ON OR G ESTOEL J A D E U - E S I N E IN S E R T E R
P H E N O X Y M E T H Y L P E N IC I L L I N 250M G TA B LETS H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y
4106 O O F^26 P H E N O X Y M E T H Y L P E N IC I L L IN P O T A S S IU M
S E R O M Y C IN 250M O CAPSULES A SPEN PH A RM ACA RE, RSA
4113 00F755 C Y L O S E R IN E
C E L E BR E X 100 IO O M G A :A re U L E CAPSULES S E A R L E D IV IS IO N O F M O N S A N T O PIL
4114 O 0F54O C E L E C O X IB
SA ND TO N SA

C ELEBR EX 200 2 0 0 M G /C A P S U L E CAPSULES S E A R L E D IV IS IO N O F M O N S A N T O PIL

4115 O O F 54 1 , C E L E C O X IB -
SA ND TO N SA

200M G T A B L E T S .C O A T E D A V E N T IS P H A R M A (P T Y ) L T D
4116 00F859 D O L A S E T R O N M E S IL A T E ZAM ANON
1 0 0 M G /5 M L IN T R A V E N O U S S O L U T I O N S A V E N T IS P H A R M A ( P T Y ) L T D
4117 (K )F 8 6 0 D O L A S E T R O N M E S IL A T E ZAM ANON
50M G T A B L E TS. C O ATED A V E N T IS P H A R M A (P T Y ) L T D
4118 O O 0 G 4O D O L A S E T R O N M E S IL A IT ZAM A NO N 50M G
15M G TA B LETS L IL L Y E L I ( S A ) (P T Y ) L IM IT E D
4121 O O F 719 P IO O L IT A Z O N E H Y D R O C H L O R ID E A c n ro s
30M G TA B LETS L I L L Y E L I ( S A ) ( P T Y ) L IM IT E D
4122 00F720 P IO G U T A Z O N B H Y D R O C H L O R ID E A C T IO S
45M G TA BLETS L I L L Y E L I ( S A ) (P T Y ) L I M IT E D
4 )2 3 O O F721 P K X J L I T A Z Q N E H Y D R O C H L O R ID E A C TO S (
A B B O T T V A N C O M Y C IN 5 0 0 M O 500M O P O W D E R S F O R IN JE C T IO N A B B O T T L A B S S A (P T Y ) L T D
4124 000F34 V AN C O M YO N 500M G
A B B O T T -V A N C O M Y C IN 1 0 IG P O W D E R S F O R IN JE C T IO N A B B O T T L A B S S A (P T Y ) L T D
4125 000F35 V A N C O M Y C IN I G
IS O M G T A B L E TS. C O ATED C I P L A L T D , M U M B A M N D IA
4126 « )F 8 4 5 R A N IT ID I N E H Y D R O C H L O R I D E U L T A C -1 5 0
600M G TAB LETS. C O ATED P F IZ E R L A B S P T Y L T D R S A
4138 00F938 A Z IT H R O M Y C IN D IH Y D R A T E Z IT H R O M A X
SOOM G P O W D E R S F O R iN J E im O N G E P A C H IN T E R N A T IO N A L , I N D I A
4139 00E902 C E F T R IA X O N E S O D I U M G E P A T R IN 5 0 0
250M G P O W D E R S F O R IN JE C T IO N G E P A C H IN T E R N A T IO N A L . IN D IA
4140 00E901 C E F T R IA X O N E S O D IU M G E P A T R IN 2 50
IG P O W D E R S F O R IN JE C T IO N G E P A C H IN T E R N A T IO N A L , I N D I A
4141 00E 831 C E F T R IA X O N E S O D IU M G E P A T R IN 1 0
0 3 G /1 (K )G SOAPS C O L G A T E -P A L M O L IV E Z I M B A B W E P V T L T D
4144 000130 T R IC M U JR O C A R B A M IU D E PR O T EX FR E SH
4 0 0 M G /IO O G SOAPS C O L G A T E -P A L M O L IV E Z IM B A B W E P V T L T D
4145 0 0 G I3 1 T R IC H U O R O C A R B A M IU D E PBOTEX H ERBAL
IN J E C T IO N S R A N B A X Y L A B S L T D .G U R G A O N .I N D I A
4146 G 0F447 M ID A Z O L A M PULSED 5 M G /M L
CREAM S V A R IC H E M P H A R M A C E U T I C A L S (P V T ) L T D ,
4147 O O F715 E C O N A Z O L E N IT R A T E K O N A T O L E N IT R A T E 1 % M /M
HRE
P O W D E R S F O R IN J E C T I O N H E L M P H A R M A C E U T IC A L S G M B H G E R M A N Y
4149 00F867 C H L O R A M P H E N IC O L S O D IU M S U C C IN A T E H E L M C H L O R A M P H E N IC O L IG

I 2 0 M G /5 M L SYRUPS V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D .
4152 000009 PA R A C ETAM O L V A R IP A N
HRE

IN F U S IO N S I P C A L A B O R A T O R IE S L T D , IN D IA
4159 00F991 M E T R O N ID A Z O L E G IA R D Y L 5 M G /M L
TA B LETS T O R R E N T P H A R M A C E U T IC A L S IN D IA
4160 00F78I IR O N & F O U C A C ID FEGEM PLU S50
S 0 M O /5 M L SYRUPS T O R R E N T P H A R M A C E U T IC A L S IN D IA
4161 ■ O O F 792 I R O N H Y D R O X ID E FEGEM SYRUP
TA B LETS I P C A L A B O R A T O R IE S L T D . IN D IA
4162 00F993 P R E D N IS O L O N E P R E D N IS O L O N E 5M O
T A B L E TS. C O ATED R A N B A X Y L A B S L T D . O U R G A O N JN D IA
4166 00P905 O F L O X A C IN Z A N O C IN O D 400M G
I 2 5 M G /5 M L G R A N U L ES FO R V A R IC H E M P H A R M A C E U T IC A L S
, 4167 OOOOGI C E F U R O X IM E A X E T IL C E F U R O X IM E A X E T T L
S U S P E N S IO N (P V T ) L T D . H R E

TA B LETS T O R R E N T P H A R M A C E U T IC A L S IN D IA
4168 O O F793 R O F E C O X IB T O R OX X M T125 1 2 iM G
TA B LETS T O R R E N T P H A R M A C E U T IC A L S IN D IA
4169 O O F794 R O F E C O X IB TO ROX X M T25 25M G
CREAM S H O E P H A R M A C E U T IC A L S S D N B H D
4173 00K 82 C L O T R I M A Z O L E & H Y D R O C O R T IS O N E CANDACORT
IN T R A V E N O U S S O L U T IO N S D A T L A B S P V T L T D , B U L A W A Y O . Z IM B A B W E
4177 200308 PLASM ALYTEB PLASM A LY TE B
CAPSULES R A N B A X Y L A B S L T D . G U R G A O N . IN D IA
4178 00F806 V IT A M IN S , M I N E R A L S & G IN S E N G R E V IT A L G IN S E N G P L U S
I % W /V ^ 0 M L IN T R A V E N O U S S O L U T I O N S C L A R IS U F E S C I E N C E S L T D
4181 000G 5Q PROPOFOL PR 0V 1V B 1%
T AB L ET S, C O ATED G L A X O -W E L L C O M E Z I M B A B W E P V T L T D .
4182 00F600 B U P R O P IO N H Y D R O C H L O R I D E ZYB A N SR 1 5 0 M G /T A B L E T
HARARE

PA STES C O L G A T E - P A L M O L IV E Z I M B A B W E P V T L T D
4189 00G 132 T R IC L O S A N C O L G A T E T R IP P L E A C T O N \3%
TABLETS T A N T U R E IN V E S T M E N T S
4193 O O G116 P A R A C E T A M IX PA 1N 8LO K 500M G
H O E P H A R M A C rE U T IC A L S S D N B H D
C L IN D A M V a N P H O S P H A T E G ELS
4194 00F884 C L IN D A M Y C IN P H O S P H A T E
T AB L ET S. C O ATED A V E N T IS C R O P S C I E N C E Z IM B A B W E
4195 C 0F698 L E F L U N O M ID B A R A V A 10 lO M O
T A B L E TS. C O A T ED A V E N T IS C R O P S C I E N C E Z lM B A B W E
4196 00F699 L E H ,U N O M ID E A R A VA 20 20M O
T A B L E TS. C O ATED A V E N T IS C R O P S C I E N C E Z I M B A B W E
4 )9 7 00F700 L E F L U N O M ID B A R AV A 100 lO O M G
TAB LETS W A R N E R -L A M B E R T S .A .( P T Y ) L T D R S A
G L U C T O M ED 80M G
4201 00F212 C L IC L A Z ID E

k
 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012 985

F l ic N o . A ppl N o. A p p ro v e d n a m e T ra d e n am e S tre n g th • F o rm A p p l ic a n t .

4204 POOOG? C IP R O F L O X A C IN P R O C IP 2 0 0 M G /I0 0 M L IN JE C T IO N S I P C A L A B O R A T O R I E S L T D .I N D J A .

4210 O O F797 F E X O F E N A D IN E H a . A L L E G IX -I2 0 120M G • T A B L E T S .C O A T E D ' IN T A S P H A R M A C E U T IC A L S L lM i r i- D

4211 00F055 F L U O X E T IN E H Y D R O C H L O R ID E FLURAN , 20M G CA PSU LES . R A N B A X Y L A B S L T D , G U R G A O N . IN D IA

■ 4217 O O O G23 PA RA CETA M OLO UA LBP PLAPAR 1 2 0 M G /5 M L • SYRUPS F D C U M IT E O .J O G E S H W A R l, IN D IA

4219 000G 45 D O X Y C Y C L IN E H Y D R O C H L O R I D E B ID O X lO O M G C A PSU LES A J A N T A P H A R M A L I M IT E D

4220 0 L X )G 4 6 •__ M E T R O N I D A Z O L E M E T R 0 S U L E -2 ( K 3 '2 0 0 M G T A B L E T S ,C O A T E D . A J A N T A P H A R M A L I M IT E D t

4221 00F958 ^ I O P IN A V IR & R IT O N A V IR
K ALETRA . CA PSU LES A B B O IT L A B S S A ( P P Y ) L T D

4223 • O O F994 S .A L B U T A M O L S U L P H A T E SA LBU TAM O L SU LPH APE 4M 0 TA BLETS I P C A L A B O R A T O R I E S L T D .I N D I A

4224 Q 0 F 9 '.K ) S U L F A D O X L N E & P Y R I M E H IA M I N E L A R ID O X - . IN JE C T IO N S I P C A L A B O R A IO R IE S L T D . I N D IA

4228 00F077 C E F T R IA X O N E S O D I U M •T O R O C E F -i l O O O M G 'P E R V I A L P O W D E R S F O R I N J E C T IO N T O R R E N T P H A R M z \C E U T iC A L S I N D IA

4229 00F676 S T E R IL E C E F T R IA X O N E S O D . TOROCEF 2 5 0 M G P E R V IA L P O W D E R S F O R IN JE C T IO N ' T O R R E N T P H A R M A C E U T I C A I .S I N D IA

, 4231 O O F837 A RTEM ETH ER l.A R IT H E R 40M G CAPSULES - I P C A L A B O R A T O R 1 F .S L T D , I N D IA

4232 000G42 N IF E D IP IN E N IF C A L -1 0 lO M C T A B L E T S ,C O A T E D A J A N T A P H A R M A L I M IT E D
'4 2 3 8 O O O G18 PA R A C ETA M O L B P 500M G NOU 500M G TA B LETS F D C L IM I T E D .J O G E S H W A R I . I N D IA .

4240 00F852 A LB F2ND A ZO LE N H M A ZOLE 200 ' 200M G - T A B L E T S .C O A T E D I P C A L A B O R A T O R I E S L F D . I N D IA

4247 00F956 . F E L O D I P I . N E & R A M I P R IL T R IA P IN E 5M G 15M G T A B L E T S ,C O A T E D A V tiN T IS P H A R M A I P T Y J L T D

■ 4248 O O F955 R A M IP R I L & F E L O D I P I N E T R IA P IN B M IT E ■ 2 . 5 M G / 2 .5 M G . T A B L E T S ,C O A T E D A V E N T IS P H A R M A ( H Y ) L T D

. 4252_ 000G 48 L A M 1 V U D I N E & S T A V U D IN E C O V IR O - L S 4 0 TA B LETS R A N B A X Y L A B S L T D . G U R G A O N ,I N D I A
4255 ’ F D C L I M I T E D . J O G E S H W A R I , I N D IA
O O O G2J M E T R O N ID A Z O L E O R O G Y L -2 I?0 200M G TA BLETS. C O ATED

4260 •O O G IM ■ S T .A V ijD lN B S T A V U D IN E 4 0 M G 40M G CAPSULES , V A R IC H E M P H A R M A C E U T I C . X L S ( P V T ) L T D .

HRE
4264 \ , C I P L A L T D , M U M B A I . I N D IA
00FS93 C E T I R I Z I N F .H Y D R O C H I.O R ID E , A L E R ID - .5 M G /5 M L SYRUPS
4267 O O F .l f iO B E N Z A T H IN E P E N IC I L L IN ' . ' B E N Z A T H I N E P E N IC I L L IN .■ 2 4 0 m X )0 1 U P O W D E R S F O R IN JE C T IO N I P C A L A B O R A T O R IE S L T D .I N D I A

4270 00FS75 C IP R O F L O X A C IN L A C T A T E Q U IN T O R 2 O O M G /IG 0 M L I N T R A V E N O U S S O L U T IO N S T O RR E N T EX PO R TS LTD

4 2 7 ,3 O OG 138 C IS P L A T IN C Y T O P L A T I N -1 0 A Q U E O U S I0 M C /2 0 M L IN JE C T IO N S C I P I.A L T D , M U M B A I . I N D IA

4276 0 0 G I3 9 C IS P L A H N C Y T O P L A -r iN -5 0 A Q U E O U S • 5 0 M G /5 0 M L - IN JE C T IO N S C I P L A L T D . M U M B A I . I N D IA

4287 00F827 F L U C O N A Z O I . .E SY SC A N 150 150M G C A P S U l . F -S T O R R E N T P H A R M A C E U T IC A L S IN D IA

4 2 .S 8 . 00F828 F l.U C O N A Z O L E ■ SY SC A N 100 lO O M G . CAPSULES T O R R E N T P H A R M A C E U T IC A L S IN D IA

4299 00G 162 C E T IR I Z IN E H Y D R O C H L O R I D E C R T E C -5 5M G TA BLETS. C O ATED I P C A L A B O R .M O R I E S L T D . I N D IA

4300 O OG >63 C E T IR I Z I N E C F T F .C -1 0 lO M G . T A Q l.E T S , C O A T E D I P C A L A B O R A T O R I E S L T D . I N D IA :

.4 3 0 4 • 00F87I PL A SM A LY TE L I N T R A V E N O U S S O L .U T I O N S D A T L A B S P V T L T D , B U L A W A Y O , Z IM B A B W E

4310 00G 237 C i P R O r t- O X A C I N B P C IP R O X 0 .2 % W /V IN JE C T IO N S , C L A R IS L IF E S C I E N C E S .L T D

4311 0 ( )G 2 0 8 G L 1 8 E N C L A M ID C C A R M IZ E 5M G - TA B LETS T A N T U R E IN V E S T M E N T S

4313 0 (» G 2 !9 L A M S V U O I N E / S T A V U D I N E / N E V IR A P I N E ' T R JO M U N E 40 1 5 0 /4 0 /2 0 0 M G TAB LETS C IP L A L T D . M U M B A I. I N D IA .

4 3 I5 ' 00F763 C A R B O P L A T IN - P r 5 R A P I ,A T I N R T U 4 5 0 M G 4 5 0 M G /4 5 M I. IN T R A V E N O U S S O L U T IO N S B R I S T O L - M Y E R S S Q U IB B ( F F Y ) L T D

" 4316 00G 167 G L U C O S E 5 % I V S O L U T IO N S - D E X T R O S E 5 % 1 V S O L U T IO N S 5 % W /V - IN T R A V E N O U S S O L U lIO N S , PHA RM A CO RE PLC

4320 O O G I24 C E F T R IA X O N E S O D IU M C E IT R IA X O N E 2 5 0 M G 2 5 O M C /1 0 M L P O W D E R S F O R IN JE C T IO N O R C H I D .H E A L T H C A R E

4321 00G 125 C E F T R L \X O N E S O D IU M . C E F T R I A X O N E lO O O M C r lO O O M G P O W D E R S P O R IN J E C T I O N O R C H ID H E A L T H C A R E '

4322 00G 123 C E F U R O X IM E . S P I Z E F 7 .5 0 M G 7 5 0 M G /I5 M I . ' P O W D F T 5 S F O R I N J E C T IO N O R C H ID H E A L T H C A R E

4325 O O F91I V I N B L A S T I N E S U I .P H A T E C Y T O B L A S T IN A Q U E O U S lO M G lO M L , IN JE C T IO N S C I P L A L T D , M U M B A I , I N D IA
4327 00G 363 A M O X Y C I L L IN T R IH Y D R A T E SYM OXYL 250M G CAPSULES S M P H A R M A C E U T IC A L S

4 .1 3 0 O O F829 FLUCONAZOLE S Y S C .A N • 2 t) 0 M G /I 0 f )M L IN JE C T IO N S T O R R E N T P H A R M A C E U T IC A L S I N D IA

4331 . O 0F904 IN D IN A V IR A V IR O D I N 400M G • CA PSU LES R A N B A X Y L A B S L T D , G U R G A O N . I N D IA

433 7 00F949 G E N T A M V C IN .T E T R Y Z O U N E . C O L IR C U S I O E N T A D E X A DROPS, EAR A LCO N CU SI

D EX AM ETHA SO NE

4341 00G 395 D I C Y C L O M IN E B P CY CLO 20 ' 20M G T A B L E FS I N D O C O R E M E D I F .S L T D

' 4546 . •0 0 F 8 9 7 C A N D E S A R T A N C T L E X E T IL A TAC A N D4M G 4M G TA B LETS I N D U S T R IA L C H F :M !C A L I M P O R T E R S ,

HARARF-
4351- 00F665 P A C L IT A X E L lO O M G ' - T A X O L IO O lO O M G P E R V IA L IN J fiC T IO N S B R I S T O L -M Y E R S S Q U IB B ( F IT ) L T D .

4352 00F656 P A C L IT A X E L 3 0 M G TAXOL • 30M G PER 5M L I N J E a iO N S B R I S T O E -M Y E R S S Q U IB B ( P T Y ) L T D

• 4355 00G 486 P O L A S E T R O N M E S IL A T E Z A M A N O N ID 1 2 .5 M G P E R 0 .6 2 5 M L I N J E C F IO N S A V B N T IS P H 4 R M A A N T H O N Y F R A N C F .

4358 O 0G 238 M E T R O N ID A Z O L E U S P M E T R IS 0 .5 % W /V IN JE C T IO N S C L A R IS L IF E .S C I E N C E S L T D

4359 .0 1 X 1 2 .1 9 FLU C ON A ZO LE FLUCANOL . 2 M G /M L .I N J E C F IO N S C L A R IS L I F E S C I E N C E S L T D

4360 000240 H Y D R O .K Y E T H Y I . S T A R C H H E S T A R -2 00 P E N T A S T A R C H 6 % W /V S O L U T IO N S C L A R IS L IF E S C I E N C E S L T D

4 ,1 6 5 • 00G 3^ A M O X Y C I L L I N T R IH Y D R .A T E SY M O XY L PO W D ER FO R I2 5 M G /5 M L PO W D ERS FO R . S M P H A R M A C E U T IC A L S

S U S P E N S IO N I2 5 M G /5 M L S U S P E N S IO N
4367 0 0 0 (6 5 I R O N P O L Y M A U IO S E F E V O R IT S Y R U P . 5 0 M G /M L SYRUPS I N D O C O R E M E D IE S L T D

4368 O O G252 T IM O L O L M A L E A T E U S P O C U T I M 0 .2 5 % 0 .2 5 % W /V DROPS. EYE , C I P L A L T D . M U M B A I . I N D IA

4369 00G 253 T IM O L O L M A L E A T E O C U T IM 0 ,5 % E Y E D R O P S 0 .5 % W /V D R O P S ,E Y E - C I P L A L T D . M U M B A I . I N D IA

4374 00G 137 E T O I ’O S ID E E T 0 3 ID •' 1 0 0 M G /5 M L IN JE C T IO N S C I P I- A L T D . M U M B A I . I N D I A

4375 00G 396 C E T I R I Z IN E H Y D R ( X H L O R I D E T R IZ lO M G T A B L E T S .C O A T E D ' IN D O C O R E M E D IE S L T D

4382 -0 0 G 1 6 8 C R O M O L Y N S O D IU M CRO M A LA Q 2 % W /V SPRAYS. N ASA L C I P L A L T D . M U M B A I , I N D IA

4396 00G 215 Q U IN I N E D I H Y D R C X J H L O R I U E K W I N IL 1 2 0 M G /5 M L • IN JE C T IO N S I N T A S P H A R M A C E U T I C A I il L I M IT E D

4399 O O G liO S T A V U D I N E + I . A M I V U D I N E + N E V I R A P IN E S T A L A N E V -J O 4 0 /i5 0 /2 0 0 M G TAB LETS. CO ATED V A R IC H E M P H A R M A C E U T I C A L S ( P V T ) L T D ,

HRE
4413 0 (X )G 43 C T M E T ID I N E A P C IT IN V 200M G T A B L E T S .C O A T E D A J A N T A P H A R M A L I M IT E D '

4415 00G 508 PA R A C ETAM O L F E B R I D O L -5 0 0 500M G S U P P O S I T O R IE S C I P L A L T D , M U M B .A U N D IA

‘ 44*16 • 00G 5O7 PA R A C ETAM O L F E B R ID O L -2 5 0 250M G S U P P O S I T O R IE S C I P L A L T D .M U M B A I .I N D IA „ ' '

4417 00G 506 P^V R A C E TA M O L rE D R ID O L -1 2 5 I2 5 M G .s u p p o s iro R ie s C I P L A L T D . M U M B A I. I N D I A

4428 000555 • S T A V U D IN E S T A V U D IN E 30M G CAPSULES A U R O B IN D O P H A R M A L T D

4429 0 0 0 5 .5 6 S T A V U D IN E ' S T A V U D IN E 40M C - CA PSU LES A U R O B IN D O P H A R M A L T p

4432 O O E873 , F L U R B IP R O F E N TRANSACT 40M G PA TCH ES B O O T S H E A L T H C A R E ( S A ) (P T Y /j L T D

4449 00G 204 C A L C I U M F O L IN . A T E F O R i N J E C T I O N C A L C iU M F O L IN A T “ E B E W E ” .l O M C IN JE C T IO N S M I S S IO N P H A R M A A /S

4451 00G 343 - F R U S E M ID E F R U S H M ID E ■ 40M G TAB LETS I P C A L A B O R A T O R I E S L T D . F N D I4

4458 00F671 A M IK A C IN S U L P H A T E ' . A M IK I N 5 0 0 500M G PER 2M L iN J E C T iO N S . B R I S T O L -M Y E R S S Q U IB B ( P T Y ) L T D

‘U 5 9 B R I S T O L - M Y E R S S e j u iB B ( P T Y ) L T D
00F67O A M IK A C IN S U L P H A T E A M 1 K IN 2 5 0 250M G PER 2M L IN JE C T IO N S
4464 O F IO C K ) L A M IV U D I N E J 4 E V I R A P I N E & S F A V U D 1 N E - rR IV IR O -L N S 4 0 TAB LETS- . R A N B A X Y L A B S L T D .G U R G A O N . I N D I A

4476 - 00G 228 L E F L U N O M ID E I . E I - R A - IO f ' iO M G TAB LETS, CO ATED T O R R E N T P H A R M A C E U T IC A L S IN D IA

4478 O OG 698 E N T E C A V IR M O N O H Y D R A T E B .A R A C L U D E IM G ' TAB LETS. CO ATED B R IS T O L -M Y E R S S Q U IB B (IT Y ) L T D

4479 { )n G 6 9 4 ' E N T E C A V IR M O N O H Y D R A T E BARACLUDE O JO M G T A B L IT IS .C O .A T H ) . B R I S IO L - M Y E R S S Q U I B B ( H -Y ) L T D

4480- - 00G 693 E N T E C A V IR M O N O H Y D R A T E ^B A R A C L U D E 0 i)5 M G /M L S O L U T IO N S B R I S T O L -M Y E R S S Q U IB B ( P T Y ) L T D

4490 000210 D IC L O F E N A C S O D IU M C L O F E N A C -5 0 50M G TABLEFS. CO ATED T A N T U R E IN V E S T M E N T S

4491 O OG 207 • E R Y T H R O M Y C IN S T E A R A T E , ER O TA B 250 250M G • T A B L E T .S , C O A T E D T A N T U R E IN V E S T M E N F S

4492 IX JG 2 0 6 N I F E D I P IN E - N I F H D .S O F T ,1 0 M G CA PSU LES . " T A N T U R E IN V E S T M E N T S .

449h. O OG 537 . .N E V I R A P I N E ' 200M p PH A RM ACA RELTD

A S P E N N E V IR A P IN E . TA B LETS
4497 ■ O OG 535 L A M I V U D IN E + Z i D O V U D i N E A S P E N L A M Z ID I . 5 0 / 3 f) 0 M G TABLEFS. CO ATED P H A R M .A C A R E L T D
4499 0O G5O 4 . Z ID O V U D IN E Z ID O V U D IN E 300M G 'I 'A B L E T S . C O A T E D A U R O B IN D O P H A R M A L T D

4502 00G 44I . I .A M I V U D I N E A N D S T A V U D IN E L A M I V IR - S 4 0 4 0 /1 5 0 M G T A B I.E F S a P L A L T D .M U M B A IJ N D I A

4504 00G 434 Q U I N I .N E S U L P H A T E T A B L E T S 300M G *

Q U IN J L -3 0 1 ) T A B L E T S .C O A T E D A . IA N T A P H A R M A L I M I T E D
4505 OOOOS3 D IC L O F E N A C S O D IU M B IO R A N .5 0 M C . T A B L E T S .C O A T E D R U S A N P H A R M A L IM H E D .
4506 00G 501 N E V IR A P IN E N E V IR A P IN E / • 200M G TAB LETS A U R O B IN D O P H A R M A L T D
4512 000234 C IT A L O P R A M H Y D R O B R O M ID E • F 'E L l Z - 1 0 40M G T A B L i-I S T O R R E N T P H A R M A C E U T IC A U S I N D I A
4538 O O G 56I A T A Z A N A V I R S U L P H .A T E . REY A TA Z . 150M G CA PSU LES ■ B R I S T O L -M Y E R S S Q l T B B ( F F Y ) L T D
4539 ' 000562 A T A Z A N A V IR .S U L P H A T E ' ' • REYAFAZ 200M G ' c a ps u l e s ’ B R I S T O L -M Y E R S S Q U I B B ( P F Y ) L T D
4547 00G 835 A C Y C L O V I R S O M G .- G L O V IR E C R E A M 5 0 M G /G • C A PSU LES R A N B A X Y ( S A ). ( P T Y ) L F D -
4551 00G 472 ' T R M A D O l. 'H Y D R O C H L O R 'i D F . ,
TRAM ADOL 5 0 M G /M L A M PO ULES C L A R IS U F E S C IE N C E S L T D
4552 O O F ^ aa - - T R A M A D O L H Y D R O C H L O R ID E . TRAM AL - 5 0 M G /C A P S U I.E CA PSU LES J O H N .S O N & J O H N S O N PSTLTD'h a RARE
4560 0 1 IG 4 3 I SU LPH AM ETH O X A ZOLE A N D 'S U P R E M B D S 8 0 0 /I6 0 M G , T A D IT -.T S A3ANFA PH.ARMA LIMITED
T R IM E T H O P R IM T A B L E T S
4561 O OG 432 , SU LPH AM ETH OX AZOLEA ND 4 0 0 /8 0 M G
SU PREM ESS TA BLETS A J A N T A P H A R M A L IM I T E D "
T R IM E T O O P R JM T A B L E T S
4598 00F30I A M O X Y C IL L IN I’O W D E R S .E O R
T O R M O X IN , r2 5 M G /M L T O R R E N T P H A R M A C E U F I C A I .S I N D IA

S U S P E N S IO N
4599 ' O O F 391 . C I P R O F L O X A C IN
C IP K O V A 2 5 0 - 2 5 0 M G rr A B L E T TA BLETS .. L U P I N L I M IT E D B O M B A Y
4625 O OG 838 C E F T R I A X O N E S O D IU M F O R I N J E C T I O N U S P
IM M U N O X IG R A M P O W D E R S F O R I N J E C T ia w - V E N U S R E M E D IE S L F D .B H A T O L l K A L A N ,

BADDI
 986 Zim b a b w e a n Go v e r n m e n t Ga 2e t t e , 14t h De c e m b e r , 2012

G e n e r a l N o tic e 5 9 6 o f 2 0 1 2 . Tender number

L A B O U R A C T [ C / M p r a : R 2 S .- W ] N A T .0 5 /2 0 1 2 . P r o v is io n o f s e c u r ity s e r v ic e s to a ll N a tP h a r m
b r a n c h e s a n d h e a d o f f ic e . D o c u m e n ts a r e o b ta in a b le f r o m
A p p lic a tio n f o r R e g is tr a tio n o f a T r a d e U n io n : A m a lg a m a te d th e P r o c u r e m e n t D e p a r t m e n t , N a tP h a r m H e a d O f f ic e , 1 4 ,
’ W o r k e rs U n io n o f Z im b a b w e . L o b e n g u la R o a d , S o u th e rto n , H a r a r e , u p o n p a y m e n t o f a
, n o n - r e fu n d a b le f e e o f U S $ 1 0 ,0 0 . T h e c lo s in g d a te is 1 5 th
I T is h e r e b y n o tif ie d , in te r m s o f s e c tio n 3 3 o f th e L a b o u r A c t J a n u a r y , 2 0 1 3 , a t 1 0 .0 0 a im . '
[ C /w p te r 2 S .- 0 7 ] ,th a ta n a p p lic a tid n h a s b e e n r e c e iv e d f o r th e r e g is tr a ­
t i o n o f th e A m a lg a m a te d W o r k e rs U n io n o f Z im b a b w e to r e p r e s e n t G e n e r a l N o tic e 6 0 0 o f 2 0 1 2 . ’
th e in te r e s ts o f n o n - m a n a g e r ia l e m p lo y e e s in th e E n g in e e r in g , I r o n ,
S te e l, M e ta l a n d A llie d I n d u s tr ie s in Z im b a b w e . L A B O U R A C T [C H A P T E R 2 5 :0 /]

A n y p e r s o n w h o w is h e s - to m a k e r e p re s e n ta tio n s r e la tin g to th e A p p lic a tio n f o r R e g is tr a tio n o f T r a d e U n io n : Z im b a b w e E a rly

. a p p lic a tio n is in v ite d to lo d g e s u c h r e p re s e n ta tio n s w ith th e R e g is tra r C h ild h o o d D e v e lo p m e n t T e a c h e r s a n d A llie d W o r k e rs U n io n
o f L a b o u r , a t C o m p e n s a tio n H o u s e ,a t t h e c o m e r o f F o u r t h S t r e e t a n d
C e n tr a l A v e n u e ^ H a r a r e , o r p o s t th e m to P r iv a te B a g 7 7 0 7 , C a u s e w a y . I T is h e r e b y n o tif ie d , in te r m s o f s e c tio n 3 3 o f th e L a b o u r A c t
[Chapter 28:01], th a t a n a p p lic a tio n h a s b e e n r e c e iv e d f o r th e .
w ith in th ir ty d a y s o f th e p u b lic a tio n o f th is n o tic e M d s ta te w h e th e r
r e g is tr a tio n o f Z im b a b w e E a r ly C h ild h o o d D e v e lo p m e n t T e a c h e r s
h e o r s h e w is h e s to a p p e a r in s u p p o rt o f s u c h r e p r e s e n ta tio n s a t a n y a n d A llie d W o r k e rs U n io n to r e p r e s e n t th e in te r e s ts o f te a c h e r s a n d •
a c c r e d ita tio n p r o c e e d in g s . . th e e n tire s u p p o r tin g s ta f f e m p lo y e d in th e p la y g ro u n d a n d c r e c h e ,
n u r s e r y , d a y m o th e r a n d r u r a l e a r ly c h ild h o o d e d u c a tio n c a r e c e n tr e s .
N .N .S I M A N G O
A n y p e r s o n w h o w is h e s to m a k e r e p re s e n ta tio n s r e la tin g to th e '
: , 1 4 - 1 2 -2 0 1 2 . ; ; f A c tin g R e g is tra r o f L a b o u r ,
a p p lic a tio n is in v ite d to lo d g e s u c h r e p r e s e n ta tio n s W ith th e R e g is tr a r
o f L a b o u r a t C o m p e n s a tio n H o u s e , a t th e c o m e r o f F o u r th S tr e e t a n d
.G e n e r a l N o tic e 5 9 7 o f 2 0 1 2 .
C e n t r a l A v e n u e ; H a r a r e ,o r p o s t t h e m t o P r i v a t e B a g 7 7 0 7 ,C a u s e w a y ,
STATE PRO CU REM EN T BO A RD w ith in 3 0 d a y s o f th e p u b lic a tio n o f th is n o tic e a n d s ta te w h e th e r
h e o r s h e w is h e s to a p p e a r in s u p p o rt O f s u c h r e p r e s e n ta tio n s a t a n y
T f e n d e r s I n v ite d a c c re d ita tio n p r o c e e d in g s .

T E N D E R S m u s t b e e n c l o s e d in s e a le d e n v e lo p e s , e n d o r s e d o n th e o u ts id e w ith t h e N . N . S IM A N G O ,
a d v e rtis e d t e n d e r n u m b e r , d e s c ri p t i o n , c lo s in g d a te a n d m u s t b e p o s te d in tim e t o b e
1 4 -1 2 -2 0 1 2 . ■ A c tin g R e g is tra r o f L a b o u r .
s o r te d in to P o s t O f f ic e B o x N u m b e r C Y 4 0 8 , C a u s e w a y , o r d e liv e r e d b y h a n d t o t h e
P r in c ip a l O f fic e r , S t a t e P r o c u r e m e n t B o a r d , F if th F lo o r , O l d R e s e r v e B a n k B u i ld i n g ,
. S a m o r a M a c h e l A v e n u e , H a r a r e , b e f o r e 1 0 .0 0 a m . o n th e c lo s in g d a te . - . G e n e r a l N o tic e 6 0 1 o f 2 0 1 2 .

C .N Y A N H E T E ,
C U S T O M S A N D E X C IS E A C T [ C H A P T E R 2 i ; 0 2 ]
1 4 -1 2 -2 0 1 2 , P r in c ip a l O f f ic e r , S ta te P r o c u r e m e n t B o a r d .

Tender number A p p o in tm e n t a n d L ic e n s in g o f B o n d e d W a re h o u s e s

M O T H I /T .0 0 1 /1 2 . H a r a r e . S e rv ic e s o f a P r o fe s s io n a l C o n f e re n c e
I T is h e r e b y n o tif ie d t h a t th e C o m m is s io n e r - G e n e r a l o f th e Z im ­
O r g a n iz e r f o r th e 2 0 th S e s s io n o f th e U n ite d N a tio n s W o r ld
b a b w e R e v e n u e A u th o r ity h a s , in te r m s o f s e c tio n 6 8 o f th e C u s to m s
T o u r is m O r g a n iz a tio n ( U N W T O ) G e n e r a l A s s e m b ly , 2 0 1 3 .
a n d E x c is e A c t [Chapter 23:02] , a p p o in te d a s b o n d e d w a r e h o u s e s
M i n i s t r y o f T o u r is m a n d H o s p ita lity I n d u s tr y . T e n d e r
th e b o n d e d w a r e h o u s e s s p e c if ie d in th e S c h e d u le f o r th e w a r e h o u s ­
d o c u m e n ts a n d s p e c if ic a tio n s f o r th e te n d e r a r e o b ta in a b le
in g a n d s e c u r in g o f g o o d s w ith o u t p a y m e n t o f d u ty .
f r o m th e M in is tr y o f T o u r is m a n d H o s p ita lity I n d u s tr y , N in th
F lo o r , T o u ris m H o u s e , 5 5 , S a m o r a M a c h e l A v e n u e ,H a r a r e , G .T . P A S T
u p o n p a y m e n t o f a n o n - r e f u n d a b le f e e o f U S $ 1 0 ,0 0 . T e n d e r C o m m is s io n e r- G e n e r a l o f th e
d o c u m e n ts s h a ll b e s o ld b e tw e e n 1 0 .0 0 a .m . a n d 3 .0 0 p .m . . 1 4 -1 2 -2 0 1 2 . Z im b a b w e R e v e n u e A u th o r ity .
d u r in g w o r k in g d a y s a t ( p la c e ) . C lo s in g d a te f o r s u b m is s io n o f
b id s is 1 5 th J a n u a r y , 2 0 1 3 a t 1 0 .0 0 a .m . B id d e r s a n d m e m b e r s Sc h e d u l e
o f th e p u b lic a r e f r e e to w itn e s s th e o p e n in g o f th e te n d e r
o n th e c lo s in g d a te a n d tim e . B id d in g d o c u m e n ts s h o u ld b e a ppo in t e d b o n d e d w a r e h o u .s e

a c c o m p a n ie d w ith ta x c le a r a n c e c e r tif ic a te , c e r tif ic a te o f

Name and location of warehouse Description of bonded transit shed
in c o r p o r a tio n a n d C R l4 f o r m .
1 . T h e B a tte r y C e n tre . B e in g a w a re h o u s e th a t w ill b e u s e d f o r
G e n e r a l N o tic e 5 9 8 o f 2 0 1 2 . ( P riv a te ) L im ite d , w a re h o u s in g a n d s e c u r in g o f g o o d s
2 6 , M a rsh R o a d , u n d e r b o n d . T h e w a r e h o u s e is a ■
H E A L T H P R O F E S S I O N S A C T [ C H A P T E R 2 7 :T 6 » ]
G le n F o r e s t, r e c ta n g u la r s tm e tu r e b u ilt w ith
E le c tio n o f R a d io lo g is t M e m b e r o f th e M e d ic a l a n d D e n ta l H a ra r e b r i c k a n d m o r ta r a n d u n d e r
P r a c titio n e r s C o u n c il o f Z im b a b w e a s b e s to s r o o f. T h e b o n d e d s e c tio n
c o v e r s a n a r e a m e a s u r in g 5 ,6 m e tre s -
I T is h e r e b y n o tif ie d , in te r m s o f s e c tio n 1 0 o f th e M e d ic a l a n d X 8 5 m e tr e s a n d 3 3 m e tr e s X 4 ,1
D e n ta l P r a c titio n e r s C o u n c il ( E le c tio n o f M e m b e r s o f C o u n c il) m e tre s .
R e g u la tio n s , 2 0 0 2 , p u b lis h e d in S ta tu to ry I n s tr u m e n t 1 6 9 o f 2 0 0 2 ,
th a t D r . W e b s te r K a d z a ts a , b e in g th e o n l y r a d io lo g is t m e iiib e r d u ly . ‘2 . T r a d e P o r t ( P r iv a te ) L im ite d , B e in g a w a r e h o u s e th a t w ill b e , u s e d f o r
. n o n iin a te d , is d u ly e le c te d a s th e R a d io lo g is t M e m b e r o f C o u n c il. o n r S im o n M a z o r o d z e R o a d / w a r e h o u s in g a n d s e c u rin g o f g o o d s
M a n c h e s te r R o a d , g o o d s u n d e r b o n d . T h e w a reh o u se ■
D r .H .M A D Z O R E R A , S o u th e r to n , ■ is a r e c ta n g u la r s tru c tu r e b u ilt w ith
: 1 4 -1 2 -2 0 1 2 . M in is te r o f H e a lth a n d C h ild W e lf a r e . H a ra re b r ic k a n d c o n c r e te a n d u n d e r
c o n c r e te r o o f . T h e b o n d e d s e c tio n
G e n e r a l N o tic e 5 9 9 o f 2 0 1 2 . c o v e r s a n a r e a m e a s u r in g 3 1 5
m e tr e s X 1 2 ,9 m e tr e s .
STATE PRO CUREM EN T BO A RD

T e n d e r s I n v ite d G e n e r a l N o tic e 6 0 2 o f 2 0 1 2 .

t e n d e r s m u s t b e e n c l o s e d i n s e a le d e n v e lo p e s , e n d o r s e d o n th e o u ts id e w ith t h e ' C O M P E T I T IO N A C T [ C H A P T E R T 4 ;2 S ]
a d v e r tis e d t e n d e r n u m b e r , d e s c r i p t i o n , c lo s in g d a te a n d m u s t B e p o s te d in tim e to b e
s o r te d in to P o s t O f fic e B o x N u m b e r C Y 4 0 8 , C a u s e w a y , o r d e liv e re d b y h a n d t o t h e
N o tic e o f I n v e s tig a tio n in to A lle g a tio n s o f R e s tr ic tiv e P r a c tic e s
P r in c ip a l O f f ic e r , S ta te P r o c u re m e n t B o a r d , F i f t h F lo o r , O ld R e s e r v e B a n k B u ild in g ,
~ S a m o r a M a c h e l A v e n u e , H a r a r e , b e f o r e 1 0 .0 0 a J i i . o n t h e c lo s in g d a te .
b y P r iv a te A b a tto irs
s '- ' ' , ■ ' S. - ^

C .N Y A N H E T E , I T is h e r e b y n o tif ie d , in te r m s o f s e c tio n 2 8 ( 2 ) o f th e C o m p e titio n

1 4 -1 2 -2 01 2 . P r in c ip a l O f f ic e r , S ta te P r o c u r e m e n t B o a rd . A c t [Chapter T 4 .-2 S ] ( “ th e A c t” ) , th a t th e C o m p e titio n a n d T a r if f
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2 987

C o m m is s io n is e m b a r k in g o n a n in v e s tig a tio n , in te r m s o f s e c tio n G e n e r a l N o tic e 6 0 5 o f 2 0 1 2 .

2 8 o f th e A c t, in to a lle g a tio n s o f r e s tric tiv e p r a c tic e s b y p r iv a te
a b a tto ir s in th e w h o le s a lin g a n d r e ta ilin g o f b e e f b y o p e n in g th e ir L A B O U R C O U R T A C T [ C / M P r £ l ? 2 S .0 7 ] -
o w n r e ta il o u tle ts a n d s e llin g b e e f d ir e c tly to in d i v id u la s a t th e s a m e
p r ic e th a t th e y c h a r g e to th e b u tc h e r ie s a n d o th e r b u lk b u y e r s . L a b o u r C o u r t C a le n d a r 2 0 1 3
T h e C o m p e titio n a n d T a r iff C o m m is s io n h e r e b y g iv e s n o tic e to
in te r e s te d p e r s o n s o r p a r tie s t o s u b m it w r itte n r e p r e s e n ta tio n s to th e T T is h e r e b y n o tif ie d th a t, th e S e n io r P r e s id e n t , in te r m s o f s e c tio n
C o m m is s io n in r e g a r d to th e a lle g e d m o n o p o ly s itu a tio n b y p r iv a te 9 i o f th e L a b o u r A c t [Chapter 28:01] , a s r e a d w ith r u le 5 ( 2 ) o f th e
a b a tto ir s a t th e C o m m is s io n ’s O f f ic e , a t S e c o n d F lo o r , B lo c k O n e , L a b o u r C o u r t R u le s , 2 0 0 6 , h a s d ir e c te d th a t s ittin g a n d v a c a tio n
■ N o : 1 , K w a m e N k r u r a a h A v e n u e , H a r a re , o r P r iv a te B a g 7 7 7 4 ,
o f th e L a b o u r C o u r t t d u r in g th e y e a r 2 0 1 3 s h a ll b e a s s p e c if ie d in
C a u s e w a y , o r b y e m a il a t c ,o m p c o m m @ n i w e h - C O ./ w w i th i n s e v e n
th e S c h e d u le .
( 7 ) d a y s f r o m th e d a te o f p u b lic a tio n o f th is n o tic e .
A .M U D E F I ,
A ll w r itte n r e p r e s e n ta tio n s to th e C o m m is s io n in r e g a r d to a n y
1 4 -1 2 -2 0 1 2 . A c tin g R e g is tr a r o f L a b o u r C o u r t.
m o n o p o ly s itu a tio n b y p r iv a te a b a tto ir s w ill b e tr e a te d in s tr ic t c o n ­
f id e n c e a n d w ill o n ly b e u s e d f o r th e p u r p o s e s o f th is in v e s tig a tio n . Sc h e d u l e

^ D . S IB A N D A , C O U R T .C A L E N D A R 2 0 1 3
1 4 -1 2 -2 0 1 2 . C h a ir m a n , C o m p e titio n a n d T a r if f C o m m is s io n .
F irs t T e rm 1 4 th J a n u a ry , 2 0 1 3 to 5 th A p r il, 2 0 1 3
E a s te r V a c a tio n 6 th A p r il, 2 0 1 3 to 5 th M a y , 2 0 1 3
G e n e r a l N o tic e 6 0 3 o f 2 0 1 2 . " -
S e co n d T e rm 6 th M a y , 2 0 1 3 to 2 n d A u g u s t, 2 0 1 3
M id - Y e a r V a c a tio n 3 r d A u g u s t, 2 0 1 3 to 1 s t S e p te m b e r, 2 0 1 3
C O M P E T I T I O N A C T [ C t tU T F R 7 4 .-2 S ]
T h ird T e rm 2 n d S e p te m b e r, 2 0 1 3 to 2 9 th N o v e m b e r, 2 0 1 3
C h r is tm a s V a c a tio n 3 0 th N o v e m b e r , 2 0 1 3 to 1 2 th J a n u a ry , 2 0 1 4
N o tic e o f I n v e s tig a tio n in to A lle g a tio n s o f M o n o p o ly S itu a tio n
b y H a r a r e C ity C o u n c il in th e P ro v is io n s o f M u n ic ip a l First Circuit.
E c o n o m ic S e r v ic e s M u ta re 2 8 th J a n u a r y , 2 0 1 3 to 8 th F e b r u a r y , 2 0 1 3
H w an g e 1 8 th F e b ru a r y , 2 0 1 3 to 1 s t M a rc h , 2 0 1 3
I T is h e r e b y n o tifie d , in te r m s o f s e c tio n 2 8 ( 2 ) o f th e C o m p e titio n M a s v in g o 1 1 th M a rc h , 2 0 1 3 ' to 2 2 n d M a rc h , 2 0 1 3
A c t [Chapter jf 4 ;2 S ] ( “ th e A c t” ) , th a t th e C o m p e titio n a n d T a r if f
C o m m is s io n is e m b a r k in g o n a n in v e s tig a tio n , in te r m s o f s e c tio n
Second Circuit
2 8 o f th e A c t, in to a lle g a tio n s o f m o n o p o ly s itu a tio n b y H a r a r e C ity M u ta re 2 0 th M a y , 2 0 1 3 to 3 1 s t M a y , 2 0 1 3
C o u n c il in th e p r o v is io n o f m u n ic ip a l e c o n o m ic s e r v ic e s th r o u g h H w an g e 3 rd Ju n e , 2 0 1 3 to 1 4 th J u n e , 2 0 1 3
e x c e s s iv e p r ic in g , p r ic e d is c r im in a tio n a n d d e liv e r y o f p o o r s e r v ic e s M a s v in g o 1 s t J u ly , 2 0 1 3 to 1 2 th J u ly , 2 0 1 3
n o t c o m m e n s u r a te w ith th e c h a r g e s . .
Third Circuit
T h e C o m p e titio n a n d T a r if f C o m m is s io n h e r e b y g iv e s n o tic e to M u ta re 1 6 th S e p te m b e r , 2 0 1 3 to 2 7 th S e p te m b e r, 2 0 1 3
in te r e s te d p e r s o n s o r p a r tie s to s u b m it w r itte n r e p r e s e n ta tio n s to th e H w an g e 1 4 th O c to b e r, 2 0 1 3 to 2 5 th O c to b e r , 2 0 1 3
C o m m is s io n in r e g a r d to th e a lle g e d m o n o p o ly s itu a tio n b y H a r a r e M a s v in g o 1 1 th N o v e m b e r , 2 0 1 3 to 2 2 n d N o v e m b e r , 2 0 1 3
C ity C o u n c il a t th e C o m m is s io n ’s O f f ic e , a t S e c o n d F lo o r , B lo c k
O n e , N o . 1 , K w a m e N k r u m a h A v e n u e , H a r a r e , o r P r iv a te B a g 7 7 7 4 , G e n e r a l N o ti c e 6 0 6 o f 2 0 1 2 .
C a u s e w a y , o r b y e m a il a t c o m p c o m m @ m w e b .c o .z w w ith in s e v e n
( 7 ) d a y s f r o m th e d a te o f p u b lic a tio n o f th is n o tic e . S U P R E M E C O U R T A C T [ C H A P T E R 7 .T 5 ]
A ll w r itte n r e p r e s e n ta tio n s to th e C o m m is s io n in r e g a r d to a n y H IG H C O U R T A C T [CHAPTER 7 :0 6 ]
m o n o p o ly s itu a tio n b y H a r a r e C ity C o u n c il w ill b e tr e a te d in s tr ic t
c o n f id e n c e a n d w ill o n l y b e u s e d f o r th e p u r p o s e s .o f th is in v e s tig a ­
S u p r e m e a n d H ig h C o u r t C a le n d a r 2 0 1 3
tio n .

D . S IB A N D A , I T is h e r e b y n o tif ie d th a t th e C h ie f J u s tic e , in te r m s o f s e c tio n 2 7

1 4 - 1 2 - 2 0 1 2 .- C h a irm a n , C o m p e titio n a n d T a r if f C o th m is s io n . o f th e S u p r e m e C o u r t A c t [Chapter 7:13] a n d s e c tio n 4 7 o f th e H ig h
C o u r t A c t [Chapter 7 .0 6 ] , h a s d ir e c te d th a t' th e s ittin g a n d v a c a tio n
G e n e r a l N o tic e 6 0 4 o f 2 0 1 2 . o f th e S u p r e m e C o u r t a n d H ig h C o u r t d u r in g th e y e a r 2 0 1 3 s h a ll
b e a s s p e c if ie d in th e S c h e d u le .
C O M P E T I T I O N A C T [ C H A P T E R 7 4 .-2 5 ]
H O N . J U S T IC E R . M A K A R A U J A ,
1 4 -1 2 -2 0 1 2 . A c tin g S e c r e ta r y , J u d ic ia l S e r v ic e s C o m m is s io n .
N o tic e o f I n v e s tig a tio n in to A lle g a tio n s o f M o n o p o ly S itu a tio n
b y B u la w a y o C ity C o u n c il in th e P r o v is io n s o f M u n ic ip a l Sc h e d u l e
E c o n o m ic S e r v ic e s
C O U R T C A LEN D A R 2013

I T is h e r e b y n o tifie d , in te r m s o f s e c tio n 2 8 ( 2 ) O f th e C o m p e titio n SU PR EM E C O U R T C A LEN D A R 2013

A c t [Chapter 14:28] ( “ th e A c t” ) , th a t th e C o m p e titio n a n d T a r if f
F irs t T e rm 1 4 th J a n u a r y , 2 0 1 3 to 5 th A p r il,2 0 l3
C o m m is s io n is e m b a r k in g o n a n in v e s tig a tio n , in te r m s o f s e c tio n 2 8
E a s te r V a c a tio n 6 th A p r il, 2 0 1 3 to 5 th M a y , 2 0 1 3
o f th e A c t, in to a lle g a tio n s o f m o n o p o ly s itu a tio n b y B u la w a y o C ity
S e c o n d T e rm 6 th M a y , 2 0 1 3 to 2 n d A u g u s t, 2 0 1 3
C o u n c il in th e p r o v is io n o f m u n ic ip a l e c o n o m ic s e r v ic e s th r o u g h
M id - Y e a r V a c a tio n 3 r d A u g u s t, 2 0 1 3 to 1 s t S e p te m b e r , 2 0 1 3
th e im p o s itio n , o f e x c e s s iv e c h a r g e s o n w a te r , r a te s a n d le v ie s to
T h ird T e r m 2 n d S e p te m b e r , 2 0 1 3 , to 2 9 th N o v e m b e r , 2 0 1 3
c o n s u m e r s o f th e u tilitie s a n d s e r v ic e s p r o v id e d b y th e c o u n c i l .'
C h r is tm a s V a c a tio n . 3 0 th N o v e m b e r , 2 0 1 3 to 1 2 th J a n u a r y , 2 0 1 4
T h e C o m p e titio n a n d T a r iff C o m m is s io n h e r e b y g iv e s n o tic e
to in te r e s te d p e r s o n s o r p a r tie s to s u b m it w r itte n r e p r e s e n ta tio n s H IG H C O U R T C A L E N D A R 2 0 1 3
to th e C o m m is s io n in r e g a r d to th e a lle g e d m o n o p o ly s itu a tio n b y to 5 th A p r il, 2 0 1 3
F irs t T e rm 1 4 th J a n u a ry , 2 0 1 3
B u la w a y o C ity C o u n c il a t th e C o m m is s io n ’s O f fic e , a t S e c o n d F lo o r ,
E a s te r V a c a tio n ^ 6 th A p r il, 2 0 1 3 to 5 th M a y , 2 0 1 3
B lo c k O n e , N o . 1 , K w a m e N k r u m a h A v e n u e , H a r a r e , o r P r iv a te B a g
S e c o n d T e rm 6 th M a y , 2 0 1 3 to 2 n d A u g u s t, 2 0 1 3
7 7 7 4 , C a u s e w a y , o r b y e m a il a t c o m p c o m m @ m w e b .c o .z w w ith in
" M id - Y e a r V a c a tio n 3 r d A u g u s t, 2 0 1 3 to 1 s t S e p te m b e r , 2 0 1 3
s e v e n ( 7 ) d a y s f r o m th e d a te o f p u b lic a tio n o f th is n o tic e .
T h ird T e r m 2 n d S e p te m b e r , 2 0 1 3 to 2 9 th N o v e m b e r , 2 0 1 3
A ll W r itte n r e p r e s e n ta tio n s to th e C o m m is s io n in r e g a r d to a n y C h r is tm a s V a c a tio n 3 0 th D e c e m b e r , 2 0 1 3 to 1 2 th J a n u a ry , 2 0 1 4
m o n o p o ly s itu a tio n b y B u la w a y o C ity C o u n c il w ill b e tr e a te d in
s tr ic t c o n f id e n c e a n d w ill o n ly b e u s e d f o r th e p u r p o s e s o f th is H IG H C O U R T C IR C U IT S 2 0 1 3
in v e s tig a tio n . First Circuit
G w em 2 8 th J a n u a r y , 2 0 1 3
D . S IB A N D A , M a s v in g o 1 1 th F e b r u a ry , 2 0 1 3
1 4 - 1 2 -2 0 ! ? - ' C h a in iia r ,, C o m p e titio n a n d T a rif f C o m m is s io n . M u ta re ' 2 5 th F e b r u a ry , 2 0 1 3
H w an g e n th M arch , 2 0 1 3
 988 Zim b a b w e a n Go v e r n me n t Ga z e t t e , J[4t h De c e m b e r , 2012

Second Circuit N e v er M a k w e v a (b o m o n 1 5 tH F e b m a ry , 1 9 7 4 ) in h is c a p ac ity a n d

G w e ru 2 0 th M a y , 2 0 1 .3 h e fo rm a lly a n d in p e rp e tu ity a b a n d o n th e n a m e N e v e r M a k w e v a
M a sv in g o 1 0 th J u n e , 2 0 1 3 a n d a d o p ts N e v er C h iiio n g o z a , so th a t, h e n c e fo rth , fo r a ll p u rp o se s
M u ta re 2 4 th J u n e i 2 0 1 3 a n d o c c a sio n s h e sh a ll b e k n o w n Ijy th e n a m e N e v e r G h in o n g o z a .
H w ange 8 th Ju ly , 2 0 1 3 ■
D a te d a t H a rare th is 5 th d a y o f D e c em b e r, 2 0 1 2 r— D a g lu s P u n d u ,
Third Circuit c /o P u n d u & C o m p a n y ,a p p lic a n t’s le g a lp ra ctitio n e rs,S u ite 6 , C e n tre
B lo c k , N o . 1, K w a m e N liu m a h A v e n u e ,-H a ra re . , 370841f
G w e ru .1 6 th S e p te m b e r, 2 0 1 3
M a sv in g o . ■ 7 th O c to b e r, 2 0 1 3
M u ta re 2 8 th O c to b e r, 2 0 1 3 CHANGE OF NAM E
H w an g e 1 1 th N o v e m b er, 2 0 .1 3
T A K E n o tic e th a t, o n th e 7 th d a y o f D e c e m b e r, 2 0 1 2 , M e m o ry
B a ra (b o rn o n 1 4 th A u g u st, 1 9 7 4 ) in h e r c a p a city a s m o th e r a n d
CHANGE OF NAM E
n a tu ra l g u a rd ia n o f Ish e a n e s u B a ra (b o rn o n 2 3 rd M a rc h , 2 0 0 8 ),
a p p e a re d b e fo re m e , V in c e n t M a z h e te se , a le g a l p ra ctitio n e r a n d
.T A K E n o tic e th a t, o n th e 4 th d a y o f D e ce m b e r, 2 0 1 2 , b e fo re m e .
n o ta ry p u b lic , a n d o n h is b e h alf, fo rm a lly a b a n d o n e d th a t n a m e
G ift M tisii a le g a l p ra c titio n e r a n d n o ta ry p u b lic , a p p e a re d F in a l
a n d d id a ssu m e th e n a m e Ja sp e r E m m a n u e l G h im e d z a , so th a t,
, S ib a n d a (b o m o n 1 8 th M a y , 1 9 7 5 ), a n d c h a n g ed h is n a m e to F in a l
h e n c efo rth , h e sh a ll b e k n o w n a s Ja sp e r E m m an u e l G h im ed z a .— •
G u m b e ;. ■
V in c e n t M a z h e te s e , c /o J . M a m b a fa & P a rtn e rs , N in th F lo o r,
D a ted a t H a rare th is 4 th d a y o f D e c e m b e r, 2 0 1 2 .— G ift M tis i, . H u ru d z a H o u se , c o rn er P a rk S tre e t/N e ls o n M a n d e la A v e n u e ,
c /o M u se h d e k w a -M tisi, le g a l p ra c titio n e rs . F o u rth F lo o r, N o rth H a ra re ;. . 3 7 0 8 3 If
W in g , R u n h a re H o u se , c n r F o u ith S tre e t/K w a m e N k ru m a h A v e n u e,
H a rare . 370709f
CHANGE OF NAM E
CHANGE OF NAM E
N O T IC E is h e re b y g iv e n th a t, b y n o ta ria l d e e d e x e c u te d b e fo re
T A K E n o tic e th a t, o n th e 1 2 th d a y o f N o v e m b e r, 2 0 1 2 , b e fo re m e , ■ m e , R o d n e y S a rato g a M a k a u si, a le g a l p ra c titio n e r, a t M a sv in g o ,
F a ra i N y a m a y aro , a le g a l p ra c titio n e r a n d n o ta ry p u b lic , a p p e are d P a n g a n a i C h iw a a p p e are d a n d a b a n d o n e d th e su rn am e C h iw a a n d
E rn e st S v o sv e (b o rn o n 3 rd O c to b e r, 1 9 7 8 ) a n d c h a n g e d h is n a m e a ssu m ed tire n a m e P a n g a n a i M a d a m o m b e G a v a , w h ic h n a m e sh a ll
to E rn e st Je sse F in e sse , so th a t, h e n c efo rth , fo r a ll p u rp o se s a n d b e u se d in a ll re co rd s, d e e d s, d o c u m e n ts a n d tra n sa c tio n s.
o c c asio n s h e sh a ll b e k n o w n b y th e n a m e E rn e st Je sse F in e sse . D a te d a t M a sv in g o th is 5 th d a y o f D e c e m b e r, 2 0 1 2 .— Jo se p h
D a te d a t H a ra re th is 1 2 th d a y o f N o v e m b e r, 2 0 1 2 .— F a ra i M a n d a , 1 8 ,.M u sa sa R o a d , M u fa k o se , H a ra re . 370920f
N y a m a y a ro , e /o F a ra i N y a m a y a ro L a w C h a m b e rs, S u ite 5 3 -5 4 ,
R o b in H o u se , 1 1 , G e o rg e S ilu n d ik a A v e n u e , H a ra re .' 37072If CHANGE OF NAM E

CHANGE OF n a m e T A K E n o tic e th a t, o n th e 2 6 th O c to b e r, 2 0 1 2 , b e fo re m e , F a ra i
, S iy a k u rim a , a le g a l p ra c titio n e r a n d n o ta ry p u b lic , a p p e a re d
N O T IC E is h e re b y g iv e n th a t, b y n o ta ria l d e e d e x e c u te d b e fo re T e n d e k ai T sig a h (b o m o n 1 1 th S e p te m b e r, 1 9 8 3 ), a n d c h a n g e d h is
n a e ,L o ic e R u fu , a le g a l p ra c titio n e r a n d n o ta ry p u b lic , o n th e 2 6 th n a m e to T e n d e k a i N y a k w e n d e , so th a t, h e n c e fo rth , fo r a ll p u rp o se s
d a y o f N o v e m b e r, 2 0 1 2 , p e rso n a lly c a m e a n d a p p e a re d S h e p h e rd a n d o c c a sio n s h e sh a ll b e k n o w n b y th e n a m e T e n d e k a i N y a k w e n d e .
S im b i, w h o c h a n g ed h is n a m e to S h e p h e rd N y e m b a.'
D a te d a t H a ra re th is ' 2 6 th d a y o f O c to b e r, 2 0 1 2 .— F a ra i
D a ted a t H a rare th is 2 6 th d a y o f N o v e m b er, 2 0 1 2 .— L o ic e R u fu , S iy a k u rim a , c /o S a w y e r & M k u sh i, le g a l p ra c titio n ers. E le v en th
c /o M e ssrs D z im b a , Ja rav a z a a n d A sso c ia te s, le g a l p ra ctitio n e rs. F lo o r, S o c ial S e cu rity C e n tre , c o rn er S a m N u jo m a S tre et/Ju liu s
S e c o n d F lo o r, R u n h a re H o u se , c n r. F o u rth S tree t/K v /a m e N k ru m a h N y e re re W a y , H a rare . ■ . 370907f
A v e n u e , H a rare . :3 7 .0 7 2 8 f

CHANGE OF NAM E
' CHANGE OF NAM E

T A K E n o tic e th a t, o n th e 1 2 th d a y o fN o v e ra b e r, 2 0 1 2 ,b e fo re m e , N O T IC E is h e re b y g iv e n th a t, o n th e 6 th o f D e c e m b e r, 2 0 1 2 ,
F a ra i N y a m a y aro , a le g a l p ra ctitio n e r arid n o ta ry p u b lic, a p p e a re d •B rig h t N y a n y iw a (b o m o n 2 8 th Ja n u a ry , 1 9 7 3 ) a p p e a re d b e fo re m e ,
• 'E x ce llen t Jim m .y M p a siri (b o m o n 2 3 rd o f M a y , 19 8 5 ) a n d c h a n g e d N y e v e ro D e sire M u n h a rira , a le g a l p ra c titio n e r a n d n o ta ry p u b lic ,
h is su rn a m e to 'M a n d irn a-Jiri, so th a t, h e n c efo rth , fo r a il p u rp o se s o n h is o w n b e h a lf a n d o n b e h alf o f h is m in o r c h ild ren , n a m e ly :
a n d o c c a sio n s h e sh a ll b e k n o w n b y th e n a m e E x c e lle n t Jim m y M u c h in e rip i N y a n y iw a (b o rn o n 1 2 th Ju n e , 2 0 0 0 ) a n d B ra n d o n -
.1
M a n d im a -Jiri. _• N y a n y iw a (b o rn o n 6 th M a rc h , 2 0 0 8 ) a n d c h a n g ed th e ir n a rh e s to
B rig h t M u n y a n y iw a , B ria n M u c h in erip i M u n y a n y iw a a n d B ra n d o n '
D a te d a t H a ra re th is 1 2 th d a y o f N o v e m b e r, 2 0 1 2 .— F a rai M u n y a n y iw a , re sp e c tiv e ly .
N y a m a y a ro , c /o F a ra i N y a m a y a ro L a w C h a m b e rs, S u ite s 5 3 -5 4 ,
D a te d a t H a rare th is 6 th D e ce m b e r, 2 0 1 2 .— N y e v e ro D e sire
R o b in H o u se , J l, G e o rg e S ilu n d ik a A v e n u e, H a ra re. 257563f
M u n h a rira , c /o L e g a l A id D irec to rate , 1 1 1 , S a m o ra M a c h e l A v e n u e ,
H a ra re; ' 370858T
CHANGE OF NAM E

T A K E n o tic e th a t, o n th e 2 8 th d a y o f N o v e m b e r, 2 0 1 2 , M a v is K a s w a L O S T C E R T IF IC A T E O p -^ R E G IS T R A T IO N
(b o m o n 1 8 th Ja n u a ry , 1 9 8 7 ) a p p e a re d b e fo re m e , G e o rg e L a ita a n d ,
b y n o ta ria l d e e d , sh e d id a b a n d o n th e su rn am e K a sw a a n d a ssu m e th e N O T IC E is h e re b y g iv e n th a t th e u n d e r-m e n tio n e d c e rtific a te o f
(su rn a m e G o ra , th e re b y a u th o risin g a n d re q u e stin g a ll p e o p le to a d d re ss' re g istratio n , issu e d in th e n a m e o f O L ik en F e n o -A llo y s , h a s b e e n
h e r b y th e sa id su rn a m e G o ra .— G eo rg e L aita , c /o L a ita a n d P a rtn e rs, lo st o r m isla id a n d th a t a p p lic atio n v /ill b e m a d e to th e M in in g .
C o m m issio n e r, G w e ru , a t th e e x p ira tio n o f 3 0 d a y s fro m th e d a te
2 1 4 , B irm in g h am R o a d , M a ro n d e ra . 370811f
o f p u b lic a tio n o f th is n o tic e , fo r th e issu e o f a d u p lic a te th e re o f.
CHANGE OF NAM E Registration number Name of block
12457 B M H o rn et C h ro m e 3 3
T A K E n o tic e th a t, o n th e 2 8 th d a y o f N o v e m b er, 2 0 1 2 , G o d fre y •
N d a la (b o rn o n 1 0 th N o v e m b e r, 1 9 8 3 ) a p p e a re d b e fo re m e , G e o rg e D a te d a t G w e ru th is 2 3 rd d a y o f N o v e m b e r, 2 0 1 2 .— O lik e n F e rro -
L a ita a n d , b y rio ta ria l d e e d , h e d id a b a n d o n th e su rn a m e N d a la a n d A llo y s, a p p lic a n t. ■ 370832f
a ssu m e th e su rn a m e Y a sin i, th e reb y a u th o risin g a n d re q u e stin g a ll
p e o p le to a d d ress h im b y th e sa id su rn a m e Y a sin i.— G e o rg e L a ita, L O S T C E R T IF IC A T E O F C O N S O L ID A T E D T H L E
c /o L a ita a n d P a rtn e rs, 2 1 4 , B irm in g h a m R o a d , M a ro n d e ra .
..3 7 0 8 1 2 f N O T IC E is h e re b y g iv e n th a t a p p lic a tio n w ill b e m a d e fo r th e
re p la ce m e n t o f c e rtifica te o f C o n so lid a ted T itle 7 8 9 /7 4 , d a ted 2 6 th
CHANGE OF NAM E ■ M a rc h , 1 9 7 4 , m a d e in fa v o u r o f D a irib o rd Z im b a b w e L im ite d ,
w h e re b y w a s c o n v e y e d c e rta in p ie c e o f la n d situ a te in th e d istric t
T A K E n o tic e th a t, o n th e 5 th d a y o f D e c e m b e r, 2 0 1 2 , b e fo re o f S a lisb u ry c a lle d S ta n d 7 8 8 A G w e io T o w n sh ip , m e a su rin g 2 1 9 7
m e , D a g lu s P u n d u , a le g a l p ra c titio n e r a n d n o ta ry p u b lic , a p p e a re d sq u a re m e tres. . .
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e mb e r , 2012 989

A ll persons having any objections to, or w ishing to m ake any L O S T D E ED O F T R A N S F ER

representations in connexion w ith, the issue of such certified copy,
are hereby required to lodge sam e w ith the R egistrar of D eeds, at N O T IC E is hereby given that w e intend to apply for replacem ent
H arare, w ithin 14 days o f the date o f publication o f this notice.— of D eed of T ransfer00325 0/2009, dated 30th S eptem ber,2009, m ade
W intertons, legal practitioners, H arare. 370719f in favour o f E lisha C hanyoreka K atso in respect of certain piece
L O S T D E ED O F T R A N S FE R o f land in the district of U m tali called Stand 4997 D angam vura
T ow nship of D angam vura, m easuring 320 square m etres.
N O T IC E is hereby given that application is to be m ade for A ll persons claim ing to have any objections to the issue of such
replacem ent ofD eedofT ransfer7695/90,dated 10th O ctober, 1990,
copy, are hereby required to lodge sam e,in w riting, w ith the R egistrar
m ade in favour o f H arriet H illary L utz (born on 22nd A ugust, 1946),
o f D eeds, at M utare, w ithin 14 days after the date o f publication of
w hereby the follow ing property w as conveyed, nam ely certain piece
of land situate in the district o f Salisbury called L ot 3 o f L ot 614 of this notice.
G reendale, m easuring 3 756 square m etres. D ated at M utare this 28th day o f N ovem ber, 2012.— M utungura
A ll persons having any objections to, or w ishing to m ake any & P artners, L egal P ractitioners, F irst F loor, W indsor M sasa H ouse,
representations, in connexion w ith, the issue of such certified copy, M utare. 370717f
are hereby required to lodge the objections, w ith the R egistrar of
D eeds, at H arare, w ithin 14 day s o f the date o f publication of this L O ST D E E D O F T R A N S FE R
notice.— W intertons, legal practitioners, H arare. 257557f
N O T IC E is hereby given that w e intend to apply for a certified
L O S T D E ED O F T R A N SFE R copy o f D eed of T ransfer 10798/2(K )3, m ade in favour of U nitim e
Investm ents (Private) L im ited, w hereby certain piece o f land situate
N O T IC E is hereby given that w e intend to apply for a certified in the district of S alisbury being S tand 626 A dylinn T ow nship of
copy o f D eed o f T ransfer 4731/20 03, dated 25th July, 2003, m ade
L ot 2A B luffhill, m easuring 1 066 square m etres, w as conveyed.
in favour o f M argaret M akota (born 24th Januaiy, 1960), w hereby
certain piece of land situate in the district of U m tali called Stand A ll persons claim ing to have any objections to the issue o f such
5326 D angam vura T ow nship o f D angam vura, m easuring 380 square copy, are hereby required to lodge sam e, in w riting, w ith the R egistrar
m etres, w as conveyed. of D eeds, at H arare, w ithin 14 days from the date of publication of
A ll persons claim ing to have any objections to, or w ishing to m ake this notice.— M uza and N yapadi, F ourth F loor,K uw irirana H ouse,
any representations in connexion w ith, the issue of such copy, are G eorge S ilundika A venue/A ngw a S treet, H arare. 370724f
hereby required to lodge sam e, in w riting, w ith the Deeds R egistry,
at H arare, w ithin 14 days from the date of application of this notice. L O S T D E ED O F T R A N S FE R
D ated at H arare onthis21stday of N o vem ber, 2012.— J M am bara
& Partners, applicant’s legal practitioners. N inth F loor, H urudza N O T ICE is hereby given that w e intend to apply for a certified
H ouse, com er N elson M andela A venue/Park S treet, H arare. copy o f D eed of T ransfer 2485/8 5, dated 7th M ay, 1985, m ade in
257567f
favour o f B ernard A ndrew Z ulu (born on 28th February, 1950),
L O S T D E ED O F T R A N S FE R w hereby certain piece o f land situate in the district of Salisbury
being Stand 11954 Salisbury T ow nship of S tand 11950A Salisbury
N O T IC E is hereby given that w e intend to apply for replacem ent T ow nship, m easuring 2 634 squ are m etres, w as conveyed.
copy of D eed of T ransfer 6244/2 007, dated 2nd O ctober,2007, m ade
A ll persons having any objections to, or w ishing to m ake any
o f D enford R ow land M usiyarira in respect of certain piece of land
in the district o f U m tali called L ot ID D ora, m easuring 85,483 5 representations in connexion w ith, the issue o f such copy, are hereby
hectares. required to lodge sam e, in w riting, w ith the R egistrar of D eeds, at
H arare, w ithin 14 days o f the date o f publication o f this notice.—
A ll persons claim ing to have any objections to the issue of such M tetw a & N yam birai, applicant’s legal practitioners. Fourth Floor,
copy, are hereby required to lodge sam e, in w riting, w ith the D eeds 101 U nion B uilding, 101, K w am e N krum ah A venue, H arare.
R egistry, at M utare, w ithin 14 days o f the date o f publication o f this 370836f
notice.
D ated at M utare on this 28th day of N ovem ber,20 12.— M utungura L O ST D E ED O F T R A N S FE R
■ & P artners, legal practitioners. F irst F loor, W indsor M sasa H ouse,
M utare. 257570f
N O T IC E is hereby given that application w ill be m ade for a
L O S T D E ED O F T R A N S F ER certified copy o f D eed o f T ransfer 4628/9 6, dated 28th June, 1996,
m ade in favour o f Innocent M pofu, w hereby certain piece o f land
N O T IC E is hereby given that w e intend to apply for a certified situate in the district o f S alisbury called S tand 2496 M arlborough
copy of D eed ofT ransfer 6652/20 03, dated 10th Septem ber, 2003, T ow nship o f S tand 2550 M arlborough T ow nship, m easuring 504
held by B ingaguru P rovisions and M anufacturing C om pany (Private) square m etres, w as conveyed.
L im ited in respect o f certain piece of land situate in the district of A ll persons claim ing to have any objections to the issue o f such
U m tali called Stand 3854 U m tali T ow nship of U m tali T ow nship certified copy, are hereby required to lodge sam e, in w riting, w ith
L ands, m easuring 1 715 square m etres. the R egistrar o f D eeds, at H arare, w ithin 14 days o f the date of
A ll persons claim ing to have any objections to, or w ishing to publication of this notice.
m ake representations in connexion w ith, the issue of such copy, D ated at H arare this 30th day of O ctober, 2012.— C higw anda
are hereby required to lodge sam e, in w riting, w ith the R egistrar L egal P ractitioners, applicant’s attorneys. Suite 7, Second Floor,
o f D eeds, at H arare, w ithin 14 days o f the date o f publication of G loster C ourt, 142, S am ora M achel A venue, H arare. 370837f
this notice.— H enning L ock, legal practitioners for the applicant,
W inston H ouse, F irst S treet, M utare. 25757 If L O S T D E ED O F T R A N S FE R

L O ST D E ED O F T R A N S FE R
N O T IC E is hereby given that w e intend to apply for a certified
copy of D eed of T ransfer 1921/2010, dated 11th M ay, 2010, passed
N O T IC E is hereby given that w e inten d to m ake an application
in favour of Innocent M atibiri (bom on 9th O ctober, 1968) in respect
for replacem ent copy of D eed o f T ransfer 294/2007, dated 12th
F ebruary, 2007, m ade in favour of D ouglas M ufunda (born on of an undivided 0,763% share being S hare N o. 35 in certain piece o f
28th A pril, 1995) holding certain piece of land being S tand 433 land in the district of Salisbury called L ot 11 of B luffhill, m easuring
E m akhandeni T ow nship o f S tand 1 E m akhandeni T ow nship situate 6,070 2 hectares.
in the district o f B ulaw ayo, m easuring 194 square m etres, A ll persons having any objections to, o r w ishing to m ake any
representations in connexion w ith, the issue o f such copy, are hereby
A ll persons w ishing to m ake objections or representations against
required to lodge sam e,in w riting, w ith the D eeds R egistries O ffice,
the issue o f such copy, are hereby required to lodge sam e, in w riting,
at H arare, w ithin 14 days of the date o f publication of this notice.
w ith the R egistrar o f D eeds, at B ulaw ayo, w ithin 14 days o f the date
of publication o f this notice.— D ouglas M ufunda, applicant. Stand D ated at H arare this 7 th day o f D ecem ber, 2012.— M essrs K antor
433, E m akhandeni, B ulaw ayo. 297600f and Im raerm an, legal practitioners, H arare. 370838f
 990 Zimb a b w e a n Go v e r n m e n t Ga z e it e , 14t h De c e m b e r , 2012

LOST DEED OF TRANSFER LOST DEED OF TRANSFER

NOTICE is hereby given that we intend to apply for a certified NOTICE is hereby given that we intend to apply for a certified
copy of Deed of Transfer 803/80, dated 18th February, 1980, in copy of Deed of Transfer 4988/2002, dated 30th December, 2002,
favour of William Fambai Marima in terms of which certain piece registered in the name of Yonglin Packaging Bags (Private) Limited
of land situate in the district of Salisbury called Stands 145 and (Certificate of Incorporation No. 6879/2000) whereby certain piece
147 of Stands 7,9,30,112,114,115,116,145,147,149,151,153, of land situate in the district of Salisbury called Stand 897 Ardbennie
T55, 157,159,161,163 Parktown of Subdivision A of Waterfall, Township of Stand 858 Ardbennie Township, measuring 2772 square
measuring 8 327 square metres, was conveyed. metres; and certain piece of land situate in the district of Salisbu^
being Stand 897 Ardbennie Township 13 of Stand 858 Ardbennie
All persons having any objections to, or wishing to make any
Township, measuring 2 772 square metres, were conveyed.
representations in connexion with, the issue of such copy, are
hereby required to lodge same, in writing, with the Deeds Registry, All persons having any objections to, or wishing to make any
representations in connexion with, the issue of such copy, are hereby
at Harare, within 14 days of the date of publication of this notice.—
required to lodge same, in writing, with the Deeds Regisby, at Harare,
Kamusasa & Musendo Legal Practitioners, P.O. Box CY 566, within 14 days of the date of publication of this notice.
Causeway. 370840f
Dated at Harare this 7th day of December, 2012.—Koto and
LOST DEED OF TRANSFER Company Legal Practitioners, First Floor, Kopje House, Suite 4, V
corner Robert Mugabe Road/Kaguvi Street, Harare. 370912f
NOTICE is hereby given that Ralrose Investments (Private) LOST DEED OF TRANSFER
Limited intends to apply for a certified copy of Deed of Transfer
7506/86, dated 4th December, 1986, issued in its favour whereby NOTICE is hereby given that we intend to apply for acertified copy
certain piece of land situate in the district of Salisbury being Stand of Deed of Transfer 4596/80, dated 26th August, 1980, in respect
11391 Salisbury Township of Salisbury Township Lands, measuring of certain piece of land situate in the district of Salisbury called
2 002 square metres, was conveyed. Stand 42 Little Norfolk Township of Lot 60 A Block B Avondale,
measuring 4 149 square metres, made in favour of Nkosana Donald
All persons claiming to have any objections to the issue of
Moyo (bom on 29th August, 1951).
such copy, are hereby required to lodge same, in writing, with
the Registrar of Deeds, at Harare, within 14 days of the date of All persons claiming to have any objections to the issue of such
copy, are hereby required t6 lodge same, in writing, with the Registrar
It
publication of this notice.
of Deeds, at Harare, within 14 days of the date of publication of this
Dated at Harare this 7th day of December, 2012.—Sawyer & notice.
Mkushi,EleventhFloor, Social Security Centre,SamNujomaStreet/
Dated at Harare, this 14th day of December, 2012.—Gambe
- Julius Nyerere Way, P.O. Box 3312, Harare. 370835f
& Partners, legal practitioners, Shanda House, 17, Park Street,
Harare. 370913f
LOST DEED OF TRANSFER
LOST DEED OF TRANSFER
NOTICE is hereby given that we intend to apply for a certified
copy of Deed of Transfer 1101/96, dated 19th December, 1995, NOTICE is hereby given that we intend to apply for a certified
passed in favour of Philemon Tamba and Virginia Tamba, whereby copy of Deed of Transfer 3164/2011, dated 20th July, 2011, made in
certain piece of land situate in the district of Melsetter being Stand 1 favour of Saminyika Two Family Trust, whereby certain 595 square
MelsetterTownship, measuring 4461 square metres, was conveyed. metres of land called Stand 780 Salisbury Township situate in the
district of Salisbury, was conveyed.
All persons having any objections to, or wishing to make any
representations in connexion with, the issue of such copy, are hereby All persons having any objections to, or wishing to make any
required to lodge same, in writing, with the Deeds Registries Office, representations in connexion with, the issue of such certified copy,
at Harare, within 14 days of the date of publication of this notice. are hereby required to lodge same, in writing, with the Deeds
Registry, at Harare, within 14 days of the date of publication of this
Dated at Harare this 7 th day of December, 2012.—Dube, Mani kai
notice.—Honey & Blanckenberg, applicant’s legal practitioners,
& Hwacha, legal practitioners. Sixth Floor, Eastgate Complex, Sam
200, Herbert Chitepo Avenue, Harare. /370914f
Nujoma Street/Robert Mugabe Road, Harare. 370842f
LOST DEED OF TRANSFER
LOST DEED OF TRANSFER
NOTICE is hereby given that we intend to apply for a certified
NOTICE is hereby given that we intend to apply for a certified copy copy of Deed ofTransfer 3701/2011, dated 17th August, 2011, made
of Deed of Transfer 575/2009, dated 29th January, 2009, registered in favour of Mwanezi Goromonzi Tmst, whereby an undivided iM
in the name of Syprian Tapiwa Matipano (bom on 3rd March, 1978) 14,15% share being Share No. 5 in Lot 3 of Willowvale situate in
in respect of certain piece of land situate in the district of Salisbury, the district of Salisbury, measuring 4,047 1 hectares, was conveyed.
measuring 300 square metres called Stand 3354 Ngoni Township. All persons having any objections to, or wishing to make any
All persons claiming to have any objections to, or wishing to make representations in connexion with, the issue of such copy, are hereby
any representations in connexion with, the issue of such copy, are required to lodge same, in writing, with the Deeds Registry, at Harare,
hereby required to lodge same, in writing, with the Deeds Registry, within 14 days of the date of publication of this notice.—Honey &
at Harare, within 14 days of the date of publication of this notice. Blanckenberg, applicant’s legal practitioners, 200, Herbert Chitepo
Dated at Harare this 10th day of December, 2012.—Matipano and Avenue, Harare. 370915f
Matimba, applicant’s legal practitioners. No. 8, Wembley Crescent,
370904f LOST DEED OF TRANSFER
Eastlea, Harare.
NOTICE is hereby given that we intend to apply for a certified
LOST DEED OF TRANSFER
copy of Deed ofTransfer 3788/2011, dated 18th August, 2011, made
in favour of The Sixty Harare Trust, whereby certain 595 square
NOTICE is hereby given that I intend to apply for a certified
metres of land called Stand 86 Salisbury Township situate in the
copy of Deed of Transfer 4835/95, registered on 18th July, 1995,
district of Salisbury, was conveyed.
in favour of Hylton Chaza (born on 24th April, 1958), Moss Chaza
(bom on 10th December, 1964) and Gerald Chaza (bom on 15th All persons having any objections tq, or wishing to make any
December, 1966) over certain piece of land situate in the district of representations in connexion with, the issue of such copy, are hereby
Salisbury being The Remainder of Stand 17 of Prospect, measuring requ ired to lodge same, in writing, with the Deeds Registry, at Harare,
7 795 square metres. within 14 days of the date of publication of this notice.—Honey &
All persons having any objections to, or wishing to make any Blanckenberg, applicant’s legal practitioners,200, Herbert Chitepo
Avenue, Harare. 370917f
representations in connexion with, the issue of such copy, are hereby
required to lodge same, in writing, with the Registrar of Deeds, at
LOST DEED OF TRANSFER
Harare, within 14 days of the date of publication of this notice.—
Nyamushaya, Kasuso & Rubaya, legal practitioners. Third Floor, NOTICE is hereby given that we intend to apply for a certified
UCPF Building, 162, Harare Street, Harare. 370905f copy of Deed of Transfer 3163/2011, dated 20th July, 2011, made
 Zimb a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2 991

in fav o u r o f K in g G eo rg e IV C o u rt T ru st, w h ereb y — n o tice.— N y am u sh ay a, K asu so & R u b ay a, leg al p ractitio n ers,T hird
(1 ) certain 1 7 6 2 sq u are m etres o f lan d called T h e R em ain in g F lo o r,T su n g ay i B u ild in g , 162, H arare S treet, H arare. 3 7 0 8 2 8f
E x ten t o f S u b d iv ision T o f L o t 4 9 B lo ck A o f A v o n d ale situ ate
in th e d istrict o f S alisb u ry; an d LO ST M O R TG A G E B O N D

(2 ) certain 1 7 7 0 sq u are m etres o f lan d called th e R em ain in g N O T IC E is h ereb y g iv en th at w e in ten d to ap p ly fo r a certified

E x ten t o f S u b d iv isio n W o f L o t 4 9 B lo ck A o f A v o n d ale co p y o f M o rtgag e B o n d 7 2 3 5 /2 0 0 2 , reg istered o n th e 2 4 th o f Ju n e,
situ ate in th e d istrict o f S alisb u ry ; an d 2 0 0 2 , m ad e in fav o ur o f Z im b ab w e D ev elo p m ent B an k , in resp ect
(3 ) certain 1 8 5 0 sq u are m etres o f lan d called th e R em ain in g o f certain p iece o f lan d situ ate in th e d istrict o f U m tali called S tan d
E x ten t o f L o t 2 o f L o t 4 9 B lo ck A o f A v o n d ale situ ate in th e 178 P en h alo n ga T o w n sh ip , m easu ring 3 3 1 8 sq u are m etres.
d istrict o f S alisb u ry ; A ll p erso n s h av in g an y o b jectio n s to , o r w ish in g to m ak e an y
w ere co n v ey ed . rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch co p y , are
h ereby req u ired to lo d g e sam e, in w ritin g , w ith th e D eed s R eg istry ,
A ll p erso n s h av in g an y o b jectio n s to , o r w ish in g to m ak e any
at H arare, w ith in 14 d ay s o f th e d ate o f p u b licatio n o f th is n o tice.
rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch co p y , are
h ereb y req u ired to lo d g e sam e, in w ritin g , w ith th e D eed s R eg istry , D ated at H arare th is 7 th d ay o f D ecem b er, 2 0 1 2 .— P u n d u &
at H arare, w ith in 14 d ay s o f the d ate o f p u b licatio n o f th is n o tice.— C o m p any , S u ite 6 , C en tre B lo ck , N o . L K w am e N k ru m ah A v en u e,
H o n ey & B lan ck en b erg , ap p lican t’s leg al p ractitio n ers, 2 0 0 , H erb ert H arare. 370911f
C h itep o A v en u e, H arare. 3 7 0 9 16f
LO ST M O R TG A G E B O N DS
LOST D EED O F TRA NSFER
N O T IC E is h ereb y g iv en th at w e in ten d to ap p ly fo r a certified
N O T IC E is h ereb y g iv en th at an ap p licatio n w ill b e m ad e to th e co p y o f M o rtg ag e B o n d 5 3 2 8 /9 2 , d ated 10th A u g u st, 1 9 9 2 , fo r
R eg istrar o f D eed s, at H arare, fo r a certified co p y o f D eed o f T ran sfer Z W $1 5 0 0 0 0 ,0 0 , an d M o rtgag e B o n d 3 6 9 5 /8 9, d ated 13th A p ril,
0 3 1 3 /9 4, d ated 2 4 th Jan u ary , 1 9 9 4 , m ad e in fav o u r o f R esu rg am 1 9 8 9 , fo r Z W $ 5 0 0 0 0 ,0 0, b o th in fav o u r o f S tan d ard C h artered
(P riv ate) L im ited , w h ereb y certain p iece o f lan d situ ate in th e d istrict M erch an t B an k in resp ect o f certain p iece o f lan d situ ate in th e
o f V icto ria b ein g S tan d 11 A F o rt V icto ria T o w n sh ip , m easurin g o n e d istrict o f S alisb u ry called S tan d 4 2 L ittle N o rfo lk T o w n sh ip o f L o t

.1 th o u san d fo u r h u n d red an d tw en ty -eig h t sq u are m etres (1 4 2 8 m ^),

w as co n v ey ed .
6 0 A B lo ck B A v o n d ale, m easu rin g 4 149 sq u are m etres, m ad e in
th e n am e o f N k o san a D o n ald M o y o (b o m o n 2 9 th A u g u st, 1951).
A ll p erso ns claim in g to h av e an y o b jectio n s to th e issu e o f A ll p erso ns claim in g to h av e an y o b jectio n s to th e issu e o f
su ch co p y , are h ereb y req u ired to lo d g e sam e, in w ritin g , w ith su ch co p ies, are h ereb y req u ired to lo d g e sam e, in w riting , w ith
th e R eg istrar o f D eed s, at H arare, w ith in 14 d ay s o f th e d ate o f th e R eg istrar o f D eed s, at H arare, w ith in 14 d ay s o f th e d ate o f
p u b licatio n o f th is n o tice. p u b licatio n o f th is n o tice.
D ated at H arare th is 7 th d ay o f D ecem b er, 2 0 1 2 .— C h ih am bak w e,
D ated at H arare th is 1 4 th d ay o f D ecem b er, 2 0 1 2 .— G am be
M u tizw a & P artn ers, ap p lican t’s leg al p ractitio n ers,N o . 7 , L aw so n
& P artn ers, leg al p ractitio n ers, S h an d a H o u se, 17, P ark S treet,
A v en u e, M ilto n P ark , H arare. 370918f
H arare. 370839f
LOST D EED O F TRA NSFER A N D M O RTG A G E BO N D
LO ST M O RTG A G E BO ND S
N O T IC E is h ereb y g iv en th at w e in ten d to ap p ly fo r certified
N O T IC E is h ereby g iv en th at w e in ten d to ap p ly fo r certified
co p ies o f D eed o f T ran sfer 5 5 2 1 /8 9 , d ated 2 n d Ju n e, 1989; M o rtg ag e
co p ies o f M o rtg ag e B o n d s 3 6 8 3 /9 5, d ated 2 n d M ay , 1995 an d
B o n d 7 7 7 3 /8 9 , d ated 4 th A u g u st, 1989 an d M o rtgag e B o n d 5 9 3 7 /9 4 ,
6 8 4 6 /9 7 , d ated 3 rd Ju n e, 1 9 9 7 , in th e su m s o f $65 0 0 0 ,0 0 an d $55
d ated 18th Ju ly , 1 9 9 4 , m ad e in fav o u r o f, an d p assed b y L an g to n
0 0 0 ,0 0, resp ectiv ely , p assed b y M ax w ell M u sin d o C h irisa (b o m o n
C h ib in y a (b o m o n 7 th A u g u st, 1 9 4 7 ), w h ereby certain 3 0 0 sq u are
2 8 th D ecem b er, 1939) in fav o ur o f Z im b ab w e B an k in g C o rp o ratio n
m etres o f lan d called S tan d 6 5 9 B u d iriro T o w n sh ip o f W illo w v ale
L im ited o v er certain p iece o f lan d situ ate in th e d istrict o f S alisb u ry
E sta te, situ ate in th e d istric t o f S alisb u ry , w as co n v ey ed an d
called T h e R em ain d er o f L o t 3 o f H atfield E state, m easu rin g 1,542 4
m o rtgag ed in fav o u r o f S tan b ic B an k Z im b ab w e L im ited (fo rm erly
G rin dlay s B an k ), resp ectiv ely . h ectares.
A ll p erso n s h av in g any o b jectio n s to , o r w ish in g to m ak e an y
A ll p erso n s h av in g an y o b jectio n s to , o r w ish in g to m ak e any
rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch certified co p y ,
rep resentatio n s in co n n ex io n w ith, th e issu e o f su ch co p ies, are h ereb y
are h ereby req u ired to lo d g e sam e, in w ritin g , w ith th e D eed s
req u ired to lo d g e sam e, in w ritin g , w ith th e D eed s R eg istry , at H arare,
R eg istry , at H arare, w ith in 14 d ay s o f th e d ate o f p u b licatio n o f th is
w ith in 14 d ay s o f th e d ate o f p u b licatio n o f this n o tice.— H o n ey & n o tice.— G ill, G o d lo n to n & G erran s, ap p lican t’s leg al p ractitio n ers,
B lan ck en b erg , ap p lican t’s leg al p ractitio n ers, T h ro g m o rto n H o u se, B ev erley C o u rt, 100, N elso n M an d ela A v en u e, H arare. 3 7 0 9 0 9 f
5 1 , S am o raM ach el A v en u e, H arare. 37091 O f
C A N C E L L A T IO N O F M O R T G A G E B O N D '
LO ST M O RTG A GE BO N D
N O T IC E is h ereb y g iv en th at w e in ten d to co n sen t to th e
N O T IC E is h ereb y g iv en th at I in ten d to ap p ly fo r a certified co p y c a n c ella tio n o f M o rtg a g e B o n d 5 3 6 6 /2 0 0 2 , fo r th e su m o f
o f M o rtg ag e B o n d 7 0 5 4 /8 9 , reg istered o n 17th Ju ly , 1 9 8 9 , in fav o u r $ 6 8 5 0 0 0 ,0 0 , p assed o n 1 9 th A p ril, 2 0 0 2 , b y M arg aret M g u n i
o f B ev erley B u ild in g S o ciety, o v er certain p iece o f lan d situ ate in (b o m o n 10th A p ril, 1963) o v er an u n d iv id ed 1 ,3 8 2 4 8 1 6 % sh are
th e d istrict o f S alisb u ry called T h e R em ain in g E x ten t o f L o t 9 6 o f b ein g S h are N o . 71 in certain p iece o f lan d situ ate in th e d istrict o f
G reend ale, m easu ring 1 ,9 75 9 h ectares. S alisb u ry called S tan d 1796A S alisb u ry T o w n sh ip , m easu rin g 4 758
A ll p erso n s h av in g an y o b jectio n s to , o r w ish in g to m ak e an y sq u are m etres.
rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch certified co p y , A ll p erso n s h av in g any o b jectio n s to , o r w ish in g to m ak e any
are h ereb y req u ired to lo d g e sam e, in w ritin g , w ith th e R eg istrar o f rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch co p y , are
D eed s, at H arare, w ith in 14 d ay s o f th e d ate o f p u b lication o f th is' h ereb y req u ired to lo d g e sam e, in w ritin g , w ith th e D eed s R eg istries
n o tice.— N y am u sh ay a,K asu so & R u b ay a, leg al p ractitio n ers,T h ird O ffice, at H arare, w ith in 14 d ay s o f th e d ate o f p u b licatio n o f th is
F lo o r, T su n g ay i B u ild in g , 1 6 2 , H arare S treet, H arare. 370829f n o tice.— V .S. N y an g u lu & A sso ciates, leg al p ractitio n ers. E ig h th
F lo o r, H u ru dza H o u se, 1 4 -1 6 , N elso n M an d ela A v en u e, H arare.
LO ST M O RTG A GE BO N D 3 7 0 9 0 6f

N O T IC E is h ereby g iv en th at I in ten d to ap p ly fo r a certified co p y IN T H E H IG H C O U R T O F Z IM B A B W E

o f M o rtg ag e B o n d 4 1 5 6 /8 6 , reg istered o n 2 2 n d Ju ly , 1 9 8 6 , in fav o u r
H eld at H arare.
o f B ev erley B u ild in g S o ciety , o v er certain p iece o f lan d situate in
th e d istrict o f S alisb u ry called T h e R em ain in g E x ten t o f L o t 9 6 o f In th e p etitio n o f C itfo am (P rivate) L im ited , ap p lican t, fo r an o rd er
G reend ale m easu ring 1,975 9 h ectares. o f p ro v isio n al ju d icial m an ag em ent an d fo r th e ap p o in tm en t o f a
p ro v isio n al ju d icial m an ager.
A ll p erso n s h av in g an y o b jectio n s to , o r w ish in g to m ak e an y
rep resen tatio n s in co n n ex io n w ith , th e issu e o f su ch certified co p y , T A K E n o te th at o n th e 14th d ay o f N o v em b er, 2 0 1 2 , an d b efo re
are h ereb y req u ired to lo d g e sam e, in w ritin g , w ith th e R eg istrar o f th e H o n o rab le Ju stice K u d y a in th e H ig h C o u rt at H arare, issu ed an
D eed s, at H arare, w ith in 14 d ay s o f th e d ate o f p u b licatio n o f th is o rd er fo r th e p ro v isio n al ju d icial m an ag em ent o f C itfo am (P rivate)
 992 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

L im ite d a n d S im b a A r m s tr o n g M a n g w e n d e h a s b e e n a p p o in te d 4 . T h a t th e a p p lic a n t ’s d ir e c to r s a n d o th e r p e r s o n s h ith e r to w ith

p r o v is io n a l ju d ic ia l m a n a g e r o f th e c o m p a n y . v e s te d p o w e r s o f m a n a g e m e n t o f a p p lic a n t b e , a n d a r e h e r e b y ,
d iv e s te d o f s u c h p o w e r s .,
A n y in te r e s te d p e r s o n w h o w is h e s to o p p o s e th e c o m p a n y b e in g
p u t u n d e r ju d ic ia l m a n a g e m e n t s h a ll f ile a N o tic e o f O p p o s itio n 5 . T h a t a ll p o w e r s a s d e s c r ib e d in 4 a b o v e b e , a n d a r e h e r e b y ,
w ith th e R e g is tr a r o f th is H ig h C o u r t a t H a r a r e o n o r b e f o r e th e in v e s te d in th e ju d ic ia l m a n a g e r in 3 a b o v e in te r m s o f s e c tio n 3 0 6 ( a )
2 0 th D e c e m b e r , 2 0 1 2 , a n d s h a ll s e r v e a c o p y o f th e n o tic e o n th e to ( m ) o f th e C o m p a n ie s A c t [Chapter 24:03],
, a p p lic a n t’s le g a l p r a c titio n e r s , S h u m b a a n d P a r tn e r s , 5 , P r e m iu m
C lo s e , M t P le a s a n t B u s in e s s P a r k , c /o M a c h e k e c h e a n d P a r tn e r s 6 . T h e c o s ts o f th is a p p lic a tio n s h a ll b e p a id b y th e a p p lic a n t
th r o u g h th e ju d ic ia l m a n a g e r .
B a r d H o u s e G r o u n d F lo o r ,H a r a r e . H e /s h e s h o u ld th e n a p p e a r b e f o r e
th e H ig h C o u r t a t H a r a r e a t th e h e a r in g o f th e m a tte r o n th e 1 6 th
o f J a n u a iy , 2 0 1 3 , to s h o w c a u s e w h y th e c o m p a n y s h o u ld n o t b e IN T E R IM R E L IE F G R A N T E D ,

p la c e d u n d e r f in a l ju d ic ia l m a n a g e m e n t. P e n d in g c o n f ir m a tio n o r d is c h a r g e o f th e P r o v is io n a l O r d e r —
A c o p y o f th is a p p lic a tio n a n d o f th e f u ll o r d e r g r a n te d b y th e ( i) W h ils t th e ju d ic ia l m a n a g e m e n t o r d e r is in f o r c e , a ll a c tio n s ,
C o u r t m a y b e in s p e c te d a t th e o f f ic e o f th e R e g is tr a r o f th e H ig h e x e c u tio n s o f w r its , s u m m o n s a n d o th e r p r o c e e d in g s a g a in s t th e
C o u r t a t H a r a r e a n d a t th e o f f ic e o f th e a p p lic a n t’s le g a l p r a c titio n e r s a p p lic a n t a n d a ll its d ir e c to r s a n d o r g u a r a n to r s o r o th e r le g a l p e r s o n s
as show n above. a n d o r le g a l p e r s o n a w h o h a v e u n d e r w r itte n a p p lic a n t’s d e b to r s s h a ll
D a te d a t H a r a r e o n th is 2 4 th d a y o f O c to b e r , 2 0 1 2 . 257572f b e s ta y e d a n d n o t p r o c e e d e d w ith w ith o u t le a v e o f th is h o n o u r a b le
c o u r t. A n y g o o d s a tta c h e d s h a ll f o r th w ith b e r e le a s e d f r o m s u c h
C a s e H .C . 2 5 0 9 /1 2 a tta c h m e n t.
IN T H E H IG H C O U R T O F Z IM B A B W E
( ii) T h e A s s is ta n t M a s te r s h a ll f o r th w ith a p p o in t a p r o v is io n a l
H e ld a t B u la w a y o . ju d ic ia l m a n a g e r in te r m s o f s e c tio n 3 0 2 ( 1 ) ( b ) ( 1 ) o f th e C o m p a n ie s
A c t [Copter 24:03].
I n th e m a tte r b e tw e e n P a r a m o u n tM o to r s ( P r iv a te ) L im ite d ,a p p lic a n t,
( iii) A ll in te r e s te d p a r tie s m a y a p p e a r b e f o r e th is h o n o u r a b le c o u r t
tr a d in g a s B e lle v u e S e r v ic e S ta tio n f o r a n o r d e r f o r p r o v is io n a l
o n th e 1 7 t h d a y o f J a n u a r y , 2 0 1 3 , a t 1 0 .0 0 a .m . o r s o o n th e r e a f te r a s
ju d ic ia l m a n a g e m e n t a n d th e A s s is ta n t M a s te r o f th e H ig h C o u r t,
th e y m a y b e h e a r d , s h o u ld th e y w is h to o p p o s e th e c o n f ir m a tio n o f
r e s p o n d e n t.
th is P ro v is io n a l O r d e r .
B u la w a y o : M o n d a y , th e 3 r d d a y o f S e p te m b e r , 2 0 1 2 .
S E R V IC E
B e f o r e th e H o n o u r a b le M r J u s tic e C h e d a , A J .
S e r v ic e o f th is P r o v is io n a l O r d e r s h a ll b e e f f e c te d u p o n th e
T O : T h e A s s is ta n tM a s te r o f T h e H ig h C o u r t,o f Z im b a b w e , B u la w a y o . A s s is ta n t M a s te r o f th e H ig h C o u r t a t B u la w a y o b y th e , a p p lic a n t’s
A N D T O : A ll in te r e s te d p e r s o n s . le g a l p r a c titio n e r s o n a c e r tific a te o f s e r v ic e a n d u p o n a n y in te r e s te d
p a r ty b y p u b lic a tio n o n c e in The Chronicle is s u e a n d o n c e in th e
T A K E n o tic e th a t o n th e 3 r d d a y o f S e p te m b e r , 2 0 1 2 , th e H o n o u r a b le G o v e r n m e n t Gazette a s s o o n a s p r a c tic a b le a f te r g r a n tin g o f th is
M r . J u s tic e C h e d a A J s ittin g a t B u la w a y o is s u e d a p r o v is io n a l o r d e r P r o v is io n a l O r d e r .
a s sh o w n h e re u n d e r. B Y T H E JU D G E
T h e a n n e x e d c h a m b e r a p p lic a tio n , a f f id a v it/s a n d d o c u m e n ts w e r e
P a r a m o u n t M o to rs ( P r iv a te ) L im ite d ,
u s e d in s u p p o r t o f th e a p p lic a tio n o f th is p r o v is io n a l o r d e r .
1 0 8 , B a lf o u r R o a d , B u lle v u e , A S S I S T A N T R E G IS T R A R ,
I f y o u in te n d to o p p o s e th e c o n f ir m a tio n o f th e P r o v is io n a l O r d e r , B u la w a y o . 370714f
y o u w ill h a v e to f ile a N o tic e o f O p p o s itio n in F o r m N o . 2 9 B ,
to g e th e r w ith o n e o r m o r e o p p o s in g a f f id a v its , v y ith th e R e g is tr a r o f C a s e H .C . 1 3 4 2 4 /1 2
th e H ig h C o u r t a t B u la w a y o w ith in tw e lv e ( 1 2 ) d a y s a f te r th e d a te
o n w h ic h th is P r o v is io n a l O r d e r w a s s e r v e d u p o n y o u . Y o u w ill a ls o IN T H E H IG H C O U R T O F Z IM B A B W E
h a v e to s e r v e a c o p y o f th is n o tic e o f o p p o s itio n a n d a f f id a v it/s o n
H e ld a t H a r a r e .
th e a p p lic a n t a t th e a d d r e s s f o r s e r v ic e s p e c if ie d in th e a p p lic a tio n .
I n th e m a tte r b e tw e e n C a ir n s H o ld in g L im ite d , 1 s t a p p lic a n t, a n d
I f y o u d o n o t f ile a n o p p o s in g a f f id a v it w ith in th e p e r io d s p e c if ie d
a b o v e , th is m a tte r w ill b e s e t d o w n f o r h e a r in g in th e H ig h C o u r t a t M E C h a r h o n ( P r iv a te ) L im ite d , 2 n d a p p lic a n t, a n d C a ir n s F o o d s
B u la w a y o w ith o u t f u r th e r n o tic e to y o u a n d w ill b e d e a lt w ith a s a n L im ite d , 3 r d a p p lic a n t, f o r a n o r d e r p la c in g th e a p p lic a n ts u n d e r
u n o p p o s e d .a p p lic a tio n f o r c o n f ir m a tio n o f th e P r o v is io n a l O r d e r . p r o v is io n a l ju d ic ia l m a n a g e m e n t a n d f o r th e a p p o in tm e n t o f a
p r o v is io n a l ju d ic ia l m a n a g e r .
I f y o u w is h to h a v e th e P r o v is io n a l O r d e r c h a n g e d o r s e t a s id e
s o o n e r th a n th e r u le s o f th e c o u r t n o r m a lly a llo w a n d c a n s h o w g o o d H a r a r e th e 2 8 th d a y o f N o v e m b e r , 2 0 1 2 .
c a u s e f o r th is , y o u s h o u ld a p p r o a c h th e a p p lic a n t’s le g a l p r a c titio n e r s
B e f o re th e H o n o u r a b le M r . J u s tic e P a te l.
to a g r e e , in c o n s u lta tio n w ith th e R e g is tr a r , o n a s u ita b le h e a r in g d a te .
I f th is c a n n o t b e a g r e e d u p o n o r th e r e is g r e a t u r g e n c y , y o u m a y m a k e M r I . G u m b o f o r th e a p p lic a n ts .
a C h a m b e r a p p lic a tio n , o n n o tic e to th e h e a r in g d a te . I f th is c a n n o t
W H E R E U P O N , a f te r r e a d in g d o c u m e n ts f ile d o f r e c o r d a n d h e a r in g
b e a g r e e d u p o n o r th e r e is g r e a t u r g e n c y , y o u m a y m a k e a c h a m b e r
a p p lic a tio n , o n n o tic e to th e a p p lic a n t, f o r d ir e c tio n s f r o m a ju d g e c o u n s e l,
a s to w h e n th e m a tte r c a n b e a r g u e d .
IT IS O R D E R E D T H A T :
T E R M S O F F IN A L O R D E R S O U G H T 1 . A n y in te re s te d p a r ty s h a ll s h o w c a u s e to th is h o n o u r a b le c o u r t
T h a t y o u s h o w c a u s e to th is h o n o u r a b le c o u r t i f a n y , w h y a f in a l s ittin g a t H a r a r e o n th e 1 6 th o f J a n u a r y , 2 0 1 3 , w h y a n o r d e r s h o u ld
o r d e r s h o u ld n o t b e m a d e in th e f o llo w in g te r m s : n o t b e m a d e in th e f o llo w in g te r r a s :
1 . T h a t a p p lic a n t. P a r a m o u n t M o to rs ( P r iv a te ) L im ite d , b e , a n d 1 .1 T h e a p p lic a n ts C a ir n s H o ld in g L im ite d , M E C h a r h o n
is h e r e b y , p la c e d u n d e r ju d ic ia l m a n a g e m e n t u n til s u c h a tim e a s ( P r iv a te ) L im ite d a n d C a ir n s F o o d s L im ite d b e p la c e d u n d e r
th is o r d e r m a y b e d is c h a r g e d . ju d ic ia l m a n a g e m e n t f o r a n in d e f in ite p e r io d .

2 . W h ils t th e ju d ic ia l m a n a g e m e n t o r d e r is in f o r c e , a ll a c tio n s , 1 .2 T h e c o s ts o f th e s e p r o c e e d in g s b e c o s ts o f ju d ic ia l m a n a g e ­
e x e c u tio n s o f w r its , s u m m o n s a n d o th e r p r o c e e d in g s a g a in s t th e m e n t.
a p p lic a n t a n d a ll its d ir e c to r s a n d o r g u a r a n to r s o r o th e r le g a l p e r s o n s
a n d o r le g a l p e r s o n a w h o h a v e u n d e r w r itte n a p p lic a n t ’s d e b to r s s h a ll 1 .3 S u b je c t to p r o v is io n s o f s e c tio n 2 9 9 o f th e C o m p a n ie s A c t
b e s ta y e d a n d n o t p r o c e e d e d w ith w ith o u t le a v e o f th is h o n o u r a b le [Chapter24:03] ( “ th e A c t” ) , th e M a s te r s h a ll a p p o in t R e g g ie F r a n c is
c o u r t. A n y g o o d s a tta c h e d s h a ll f o r th w ith b e r e le a s e d f r o m s u c h S a r u c h e r a a s ju d ic ia l m a n a g e r o f th e a p p lic a n t c o m p a n ie s w ith th e
a tta c h m e n t. p o w e r s a n d d u tie s s e t o u t in th e A c t.

3 . T h a t M ic h a e l B a ta n d i M p o f u o f M im o s a I n e o m e T a x 1 .4 T h e ju d ic ia l m a n a g e r s h a ll b e e n title d f r o m th e a s s e ts o f th e
C o n s u lta n ts , 2 , M e r s h ip H o u s e , B u la w a y o , b e , a n d is h e r e b y , a p p lic a n t c o m p a n ie s , o f th e p a y m e n ts o f r e m u n e ra tio n a t a r a te to b e
a p p o in te d th e ju d ic ia l m a n a g e r o f a p p lic a n t o n s u c h te r m s a n d d e te r m in e d b y th e M a s te r o f th e H ig h C o u r t a n d to r e im b u r s e m e n ts
c o n d itio n s a s to r e m u n e ra tio n a s m a y b e a p p o v e d b y th e A s s is ta n t o f a ll o u t- o f - p o c k e t e x p e n s e s in c u r r e d b y h im d u r in g th e c o u r s e o f
M a s te r o f th e H ig h C o u r t. h is d u tie s .
 Zimb a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012 993

2. Pending the granting of the order in terms of paragraph 1 Any person having an interest or wishing to make representation
hereof or the discharge of this order: in the m atter may appear at the hearing of the application.— C. Dube,
applicant. 370804f
2.1 The 1st, 2nd and 3rd Applicants are placed under provisional
judicial management.
ERNST & YOUNG
2.2 The M aster is hereby directed to appoint Reggie Francis
AND
Saruchena of Grant Thornton Cam elsa Chartered Accountants as
the provisional judicial manager of the applicants with powers set ERNST & YOUNG SECRETARIAL SERVICES (PRIVATE)
out in the Act. LIM ITED

2.3 All actions and applications and the execution of all writs, Cesssation of Company Statutory Services
summonses and other process against the applicant Companies shall
be stayed and not be proceeded with without leave of this honourable NOTICE is hereby given that Ernst & Young and Ernst &Young
court. Secretarial Services (Private) Limited ceased to provide company
3. This order shall be published in tlie Government Gazette and statutory services on 30th June, 2012. All com panies whose
once in the Newsday paper. com pany statutory records we had possession of wbre notified to
make alternative arrangements and to collect their records prior to
4. Any person intending to support or oppose this application oh that date. Such notifications were in writing and sent to a com pany’s
the return day shall— last known address.
4.1 Give notice to the applicant c/o M essrs Atherstone & Cook W e still hold, in our Harare and M utare offices, the company
Legal Practitioners, Seventh Floor, M ercury House, 24, George statutory records of a large number of companies who have not
Silundika Avenue, Harare (M r Chagonda). responded to our notification and with whom we have lost touch.
Such companies may well have ceased operations, may be defunct
4.2 Serve on the Applicant a copy affidavit which he files with
and the owners thereof may, in many cases, have left Zimbabwe.
the Registrar of the High Court.
Certain of the records still show bur offices as being a com pany’s
BY THE JUDGE. registered office. W e ceased to provide this facility to clients in 2008,
and at that time some companies failed to submit to the Registrar
M essrs Atherstone &. Cook, of Companies a notification of a change in their registered office
legal practitioners. address (form C.R.6). W e accept no responsibility where our address
Seventh Floor, M ercury House, REGISTRAR, is still used without our permission.
24, George Silundika Avenue, Harare. 370923f Statutory records include share registers, minute books, copies of
statutory returns to the Registrar of Companies and of M emorandum
Case J.C. 02/10 and Articles of Association, certificates of incorporation and share
IN THE JUVENILE COURT certificates.
Fo r t h e Pr o v in c e of Ma t a b e l e l a n d So u t h It is our intention to destroy such records upon the expiry of three
Held at Gwanda. m onths from the date of this Notice. Thereafter we will accept no
TAKE notice that an application, in terms of section 9(3) of the liability whatsoever in connection with them.
Guardianship of M inors Act {Chapter 5;0S], for the appointment of Interested parties who have legitim ate title to any records should
FloraNy ati (I.D. No. 28-013863 A28) as the guardian of the following contact either of the under-mentioned persons by no later than 28th
child alleged to have no natural guardian or tutor testamentary: France February, 2013, in order to make arrangements for the collection of
Ncube (born on 24th M arch, 1994) will be made to the Juvenile relevant records. Satisfactory proof of an enquirer’s entitlement to
Court at Gwanda, on 21st day of December, 2012, at 8.00 a.m. or the records may be required.
soon thereafter as the m atter may be heard.
Harare office: M rs F. Khan (fatima .khan @ zw.ey.com)
Further take notice that any person who has an interest in the M utare office: M rs D. Chirewa (dinah.chirewa@ zw.ey.com )
m atter is called upon to appear at the hearing of the application, or
Contact details are:
should lodge objection with the Clerk of Juvenile Court and the
applicantbeforethe21stdayofDecem ber,2012.— Clerkof juvenile Ernst & Young — Harare:
Court. 370715f Physical address: Level 1, Angwa City, Cnr. Julius Nyerere W ay/
Kwam e Nkrumah Avenue.
, J.C. 291/12 Telephone: (263) (04) 750905,750979
IN THE JUVENILE COURT Postal address: P.O. Box 702, Harare.
Fo r t h e Pr o v in c e o f Ma t a b e l e l a n d Ernst & Young — M utare
Held at Bulawayo Physical address: Second Floor, M anica Chambers,
W HEREAS application has been made to the Juvenile Court, 94, Herbert Chitepo Street, M utare
Telephone: (263) (020) 62300
Bulawayo, for the appointm ent of Kevin Siyajaya as guardian of
Postal address; P.O. Box 92, M utare.
M itchelle Siyajaya a m inor person alleged to have no guardian or
tutor testamentary. Dated 14th Decem ber, 2012.-E rnst & Young, Chartered
Accountants (Zimbabwe), Registered Public Auditors. 370834f
Notice is hereby given that the said application will be heard by
the said Court at 8.00 a.m. on the 9th day of January, 2013, at the UQGO'R ACT [CHAPTER 14:12]
Tredgold Building, Bulawayo.
Any person having an interest or wishing to make representation- Application for the Issue of a Part II Liquor Licence
in the m atter may appear at the hearing of the application.— Kevin
NOTICE is hereby given that an application, in terms of section
Siyajaya, applicant. 370716f 53 of the Liquor Act [Chapter 14:12], will be m ade to the Liquor
LicensingBoard,Harare,fortheissueofaNightClubLiquoi:.Licence
J.C. 290/12 in respect of premises situate at Stand 52, Zhom be District Service
IN THE JUVENILE COURT Centre, Kwekwe, trading as Downtown Night Club, for Lazarous
Fo r t h e Pr o v in c e o f Fo r t he Ma t a b e l e l a n d Vhengere.
Held at Bulawayo All persons who have any objections to the application may lodge
their objections, in writing, with the Secretary of the Liquor Licensing
W HEREAS application has been made to the Juvenile Court, Board, Harare, not later than the 28th December, 2012.— Lazarous
Bulawayo, for the appointm ent of Caroline Dube, as guardian of Vhengere, applicant. House 7604/4, M bizo, Kwekwe. 370961f
Khumbulani Dube, Li sa Dube and Albert Dube minor persons alleged
to have no natural guardian or tutor testamentary. LIQUOR ACT [CHAPTER 14:12]
Notice is hereby given that the said application will be heard by
Application for the Issue of a Part II Liquor Licence
the said Court at 8.00 a.m. on the 9th day of January, 2013, at the
Tredgold Building, Bulawayo. NOTICE is hereby given that an application, in terms of section
 994 Zimb a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o d i e L i q u o r B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— T e r e n c e
L i c e n s i n g B o a r d , H a r a r e , f o r th e i s s u e o f a S p e c ia l B o t t l e L i q u o r R o y C ra w fo rd , a p p lic a n t, 1 6 -5 th A v e n u e , W o o d v ille , B u la w a y o .
. L i c e n c e in r e s i ) e c t o f p r e m i s e s s i t u a te a t K a r i m b a F a r m ,M a r o n d e r a , 370803f
t r a d in g a s K a r i m b a B o t t l e S t o r e , f o r P a t r i c i a V e n g e s a y i .
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l i c a t i o n m a y lo d g e L I Q U O R A C T [ C / / A P r £ R i 4 .- i 2 ]
t h e i r o b j e c t i o n s , i n w r i t i n g , w i t h th e S e c r e ta r y o f t h e L i q u o r L i c e n s i n g
B o a r d , H a r a r e , n o t l a t e r t h a n th e 2 8 t h D e c e m b e r , 2 0 1 2 .— P a t r ic i a A p p l ic a t i o n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e
V e n g e s a y i, a p p lic a n t, 1 0 , D u n k irk D riv e , A le x a n d ra P a rk , H a ra re .
317001f N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f
s e c t i o n 5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o
UQUORACT[CHAPTER14:12] th e L iq u o r L ic e n s in g B o a rd , H a ra re , fo r th e is s u e o f a N ig h t C lu b
L iq u o r L ic e n c e in re s p e c t o f p re m ise s s itu a te a t S ta n d 2 7 6 , M a n o ti
A p p lic a tio n f o r th e Is s u e o f a P a rt II L iq u o r L ic e n c e B u s i n e s s C e n t r e ,G o k w e S o u t h , t r a d i n g a s C h a m a k a n d a N i g h tC l u b ,
fo r R ic h a rd H u c h u .
N O T I C E i s h e r e b y g i v e n t h a t a n a p p l i c a t i o n , i n t e r m s o f s e c t io n
5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r A l l p e r s o n s w h o h a v e a n y o b j e c t io n s t o t h e a p p l ic a t io n m a y
L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a B a r L i q u o r L i c e n c e in lo d g e th e ir o b je c tio n s , in w ritin g , w ith th e S e c re ta ry o f th e L iq u o r
re s p e c t o f p re m ise s s itu a te a t S ta n d 4 9 4 . J u ru G ro w th P o in t, J u ru , L i c e n s in g B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .—
t r a d in g a s J u r u L i q u o r B a r , f o r D o n a l d D a n g e r K a t s a n d e . R i c h a r d H u c h u ,a p p l i c a n t,M u y a m b i S c h o o l ,P r i V a t e B a g 1 3 ,M a n o t i,
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o th e a p p l i c a t i o n m a y l o d g e G okw e. 370802f
t h e i r o b j e c t i o n s , i n w r i ti n g , w i th t h e S e c r e ta r y o f t h e L i q u o r L i c e n s i n g
B o a r d , H a r a r e , n o t l a t e r t h a n th e 2 8 t h D e c e m b e r , 2 0 1 2 .— D o n a l d L IQ U O R A C T [CHAPTER 14:12]
D a n g e r K a ts a n d e , a p p lic a n t, 9 , S u n d e rla n d A v e n u e , B e lv e d e re ,
H a rare . 317054f A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e

L IQ U O R A C T [CHAPTER 14:12] N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n

5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r
I
A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a B a r .L i q u o r L i c e n c e i n
re s p e c t o f p re m is e s s itu a te a t 1 7 1 , M a n jo lo B u s in e s s C e n tre , B in g a
N O T I C E i s h e r e b y g i v e n t h a t a n m p l i c a t i o n , i n t e r m s o f s e c t io n R u ra l D is tric t C o u n c il, tra d in g a s B e e m o S p o rts B a r, fo r B ru c e
5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r M aphosa.
L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a R e s t a u r a n t ( S p e c i a l)
L iq u o r L ic e n c e in re s p e c t o f p re m is e s s itu a te a t S ta n d 1 3 J u ru A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y l o d g e
G ro w th P o in t, C h ik w a k a , G o ro m o n z i, tra d in g a s S a k is R e s ta u ra n t t h e ir o b j e c t i o n s ,i n w r i ti n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
& B a r , f o r T e m b a S a u k ir a . B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— B r u c e
M a p h o s a , a p p lic a n t, 2 4 4 , M e d iu m D e n s ity , B in g a . 37080 If
A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
t h e ir o b j e c t i o n s , i n w r i t i n g , w i th t h e S e c r e ta r y o f t h e L i q u o r L i c e n s i n g
B o a r d , H a r a r e , n o t l a t e r t h a n th e 2 8 t h D e c e m b e r , 2 0 1 2 .— T e m b a L I Q U O R A C T [ C H A P T E R 7 4 .- / 2 ]
S a u k i r a , a p p l i c a n t , 4 7 5 9 , G l e n N o r a h “ A " , H a ra r e . 317021f
A p p l i c a t io n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e
L IQ U O R A C T [CHAPTER 14:12]
N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n
A p p lic a tio n f o r th e Is s u e o f a P a rt II L iq u o r L ic e n c e 5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r
L ic e n s in g B o a rd , H a ra re , fo r th e is s u e o f a B a r L iq u o r L ic e n c e in
N O T IC E is h e re b y g iv e n th a t a n m p lic a tio n , in te rm s o f s e c tio n r e s p e c t o f p r e m i s e s s i t u a t e a t 9 5 9 3 , N y a m a u r u ,D a n g a m v u r a , t r a d in g
5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r a s L in k S p o rts B a r, fo r F u n g a i C h ig o g o .
L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a S p e c i a l B o t t le L i q u o r
A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
L ic e n c e m re s p e c t o f p re m ise s s itu a te a t M a n o ti B u s in e s s C e n tre ,
t h e ir o b j e c t i o n s , i n w r i t i n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
G o k w e S o u t h , t r a d i n g a s U p t o w n S p e c ia l B o t t l e S t o r e , f o r H e r y
B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— F u n g a i
A m onM anaba.
C h ig o g o , a p p lic a n t, 1 6 , P lu m e r R o a d , M u ra m b i, M u ta re . 2 5 7 5 7 3 f
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o th e a p p l i c a t i o n m a y l o d g e
t h e ir o b j e c t i o n s , i n w r i t i n g , w i t h th e S e c r e ta r y o f t h e L i q u o r L i c e n s i n g
B o a r d ,H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— H e r y A m o n L I Q U O R A C T [ C H A P T E R 7 4 .- / 2 ]
M a n a h a , a p p l ic a n t. P r i v a t e B a g 2 5 , M a n o t i , G o k w e S o u t h .
A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e
317055f

N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n

L I Q U O R A C T [ C H A P T E R J 4 .- J 2 ]
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r
A p p l ic a t i o n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e L ic e n s in g B o a rd , H a ra re , fo r th e is s u e o f a R e s ta u ra n t L iq u o r
L ic e n c e in re s p e c t o f p re m is e s s itu a te a t S ta n d 5 2 A , B o rro w d a le
N O T IC E is h e re b y g iv e n th a t a n ^ p lic a tio n , in te rm s o f s e c tio n
R o a d , B o r r o w d a l e , t r a d i n g a s T h e C i r c le , f o r T h e C h o c o l a te G a r d e n .
5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i l l b e m a d e t o t h e L i q u o r
L ic e n sin g B o a rd , H a ra re , fo r th e is s u e o f a B a r L iq u o r L ic e n c e A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y
i n r e s p e c t o f p r e m i s e s s i t u a t e a t S t a n d 1 9 6 9 8 , U n i t “ I T ’, S e k e , l o d g e t h e i r o b j e c t i o n s , i n w r i t in g , w i t h t h e S e c r e t a r y o f t h e L i q u o r
C h itu n g w iz a , tra d in g a s B ig G u n s S p o rts B a r, f o r M o re e n C h itu p a . L i c e n s i n g B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .—
A l l p e r s o n s w h o h a v e a n y o b j e c t io n s t o t h e a p p l i c a t i o n m a y l o d g e T h e C h o c o l a te G a r d e n , a p p l ic a n t , S t a n d 5 2 A , B o r r o w d a l e R o a d ,
t h e i r o b j e c t io n s ,i n w r i ti n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g B o rro w d a le , H a ra re . 2 5 7 5 9 If
B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— M o r e e n
C h i t u p a , a p p l i c a n t , 5 5 9 8 , U n i t “ J ” , S e k e , C h i tu n g w i z a , 3 17056f L I Q U O R A C T [ C H A P T E R J 4 .- J 2 ]

L IQ U O R A C T [C H A P T E R /4 ;7 2 ] A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e

A p p l ic a t i o n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e
N O T I C E i s h e r e b y g i v e n t h a t a n a p p l ic a t io n , i n t e r m s o f s e c t i o n
5 3 o f th e L iq u o r A c t [Chapter 14:12 ] , w i l l b e m a d e to th e L iq u o r
N O T IC E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n
L ic e n s in g B o a rd , H a ra re , fo r th e is s u e o f a B o ttle L iq u o r L ic e n c e
5 3 o f t h e L i q u o r A c t [Chapter 7 4 .T 2 ] , w i l l b e m a d e t o t h e L i q u o r
L ic e n s in g B o a r d , H a ra r e , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e in i n r e s p e c t o f p r e m i s e s s i t u a t e a t M a p u v i r e B u s i n e s s C e n t r e , C h i v i,
r e s p e c t o f p r e m is e s s i t u a t e a t 1 6 - 5 t h A v e n u e ,W o o d v i l l e ,B u l a w a y o , t r a d in g a s S i y a w a w a d z a B o t t l e S t o r e , f o r R a c h e l N j e n g e .
tra d in g a s W o o d v ille S u p e rre tte & B o ttle S to re , fo r T e re n c e R o y A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
C ra w fo rd .
t h e ir o b j e c t io n s ,i n w r i t i n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y l o d g e B o a r d , H a r a r e , n o t l a t e r t h a n t h e 2 8 t h D e c e m b e r , 2 0 1 2 .— R a c h e l
t h e i r o b j e c t i o n s , i n w r i ti n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g N je n g e , a p p lic a n t. P riv a te B a g 5 1 3 , C h iv i. 370809f
 H
aa '
Zi m ba b w e a n Go v e r n a i e n t Ga z e t t e , 14t h De c e m be r , 2012 995

1 L IQ U O R A C T [CHAPTER 14:12] L iquor L icensing B oard, H arare, for the issue of a B ottle L iquor
Licence in respect of prem ises situate at D zingire B usiness C entre,
A pplication for the Issue of a Part II Liquor Licence C him anim ani, trading as Edgar C hinheya B ottle Store, for E dgar
C hinheya.
N O T ICE is hereby given that an application, in term s of section
A ll persons w ho have any objections to the application m ay lodge
53 of the L iquor A ct [Chapter 14:12], w ill be m ade to the L iquor
J L icensing B card, H arare, for the issue of a B eerhall L iquor Licence
their objections, in w riting .w ith the Secretary of the Liquor Licensing
B oard, H arare, not later than the 28th D um ber, 2012.— E dgar
I. in respect of prem ises situate at M adziw a M ine B usiness C entre,
C hinheya, applicant, 21, Ferreira Street, C hipinge. 370718f
Sham va, trading as M uunganirw a B eerhall, for B assilia Silikorabola.

% A ll persons w ho have any objections to the application m ay

lodge ttieir objections, in w riting, w ith the Secretary of the Liquor
LIQ U O R A C T [CHAPTER 14:12]
L icensing B oard, H arare, not later than the 28th D ecem ber, 2012.— A pplication for the Issue of a Part II L iquor Licence
B assilia Silikom bola, applicant, M uunganirw a Store, P.O. B ox 85,
Sham va. 370813f N O T IC E is hereby given that an application, in term s of
section 53 of the L iquor A ct [Chapter 14:12], w ill be m ade to
L IQ U O R A C T [CHAPTER 14:12] the L iquor L icensing B oard, H arare, for the issue of a N ight C lub
L iquor Licence in respect of prem ises situate at Stand 14, R utenga,
A pplication for the Issue of a Part II L iquor Licence M asvingo, trading as Z . M an N ight C lub, for Z apata Tem ba Z im ani.
A ll persons w ho have any objections to the application m ay lodge
N O T IC E is hereby given that an application, in term s of section
theirobjections.in w riting, w ith the Secretary of the Liquor Licensing
53 of the L iquor A ct [Chapter 14:12], w ill be m ade to the L iquor
B oard, H arare, not later than the 28th D ecem ber, 2012.— Zapata
L icensing B oard, H arare, for the issue of a B ottle L iquor Licence
Tem ba Z im ani, applicant. Stand 14, R utenga, M asvingo.
in respect of prem ises situate at Stand 5A , M andam abwe R ural
370720f
Service C entre, C hivi, trading as H arinam ukw idza B ottle Store, for
M ercury R am son M anyim o.
LIQ U O R A C T [C //A R re« W .-/2]
A ll persons w ho have any objections to the application m ay lodge
their objections, in w riting, w ith the Secretary of the Liquor Licensing A pplication for the Issue of a Part II L iquor Licence
B oard, H arare, not later than the 28th D ecem ber, 2012.— M ercury
R am son M anyim o,applicant,Stand5A ,M andam abw e R ural Service N O T ICE is hereby given that an application,in term s of section
C entre, C hivi. 370710f 53 of the L iquor A ct [Chapter 14:12], w ill be m ade to the L iquor
L icensing B oard, H arare, for the issue of a B ar L iquor Licence
L IQ UO R A C T [CHAPTER 14:12] in respect of prem ises situate at Stand 73618, N ew Lobengula,
B ulaw ayo, trading as R asesh V IP L ounge, for H onest Sibanda.
A pplication for the Issue of a Part II Liquor Licence
A ll persons w ho have any objections to the application m ay lodge
their objections, in w riting, w ith the Secretary of the LiquorLicensing
N O T ICE is hereby given that an application, in term s of section
B oard, H arare, not later than the 28th D ecem ber, 2012.— H onest
53 of the L iquor A ct [Chapter /4.-i2], w ill be m ade to the L iquor
Sibanda, applicant, 21298, Pum ula South, B ulaw ayo. 37073 If
L icensing B oard, H arare, for the issue of a B ar L iquor Licence in
respect of prem ises situate at L ubangw e B usiness C entre, M atetsi
W ard, trading as D rive In Sports B ar, for A bel Tubili M w anyum eka.
L IQ U O R A C T [CHAPTER 14:12]
A ll persons w ho have any objections to the application m ay lodge A pplication for the Issue of a Part II L iquor Licence
their objections ,inw riting,w iththe Secretaiy' of the L iquor Licensing
B oard,H arare, not later than the 28th D ecem ber,2012.— A bel Tubili N O T ICE is hereby given that an application, in term s of section
M w anyum eka, applicant. N o. 53, M adum abisa V illage, H w ange. 53 of the L iquor A ct [Chapter 14:12], w ill be m ade to the L iquor
370712f L icensing B oard, H arare, for the issue of a B ar L iquor Licence in
respect of prem ises situate at4235,M oodie Street,C hipinge, trading
L IQ U O R A C T [C H A PT ER /4:/2] as M arisha B ar, for G odfrey M abum bo.
A ll persons w ho have any objections to the application m ay lodge
A pplication for the Issue of a Part II L iquor Licence
their objections,in w riting, w ith the Secretary ofthe Liquor Licensing
B oard, H arare, not later than the 28th D ecem ber, 2012.— G odfrey .
N O T IC E is hereby given that an application, in term s of section
M abum bo, applicant, M arisha B ar, P.O . B ox 83, C hipinge.
53 of the L iquor A ct [Chapter /4.T 2], w ill be m ade to the L iquor
370735f
L icensing B oard, H arare, for the issue of aB eerhall L iquor Licence
in respect of prem ises situate at N dabankulu, M atobo, trading as
M aribeha B ar, for M artha M argaret N gw enya.
LIQ U O R A C T [CHAPTER 14:12]
A H persons w ho have any objections to the application m ay lodge A pplication for the Issue of a Part II Liquor Licence
their objections, in w nting, w ith the Secretary of the L iquor Licensing
B oard, H arare, not later than the 28th D ecem ber, 2012.-M artha N O T IC E is hereby given that an application, in term s of section
M argaret N gw enya, applicant, P.O . B ox 38, M aphisa. . 370713f 53 ofthe L iquor A ct [Chapter 74.-i2], w ill be m ade to the L iquor
L icensing B oard, H arare, for the issue of a N ight C lub L iquor
L IQ U OR A C T [CHAPTER 14:12] Licence in respect of prem ises situate at 1468, K am buzum a Section
2, H arare, trading as Takura N ight C lub, for Francis N . M uzeya.
A pplication for the Issue of a Part II L iquor Licence
A ll persons w ho have any objections to the application m ay lodge
theirobjections, in w riting, w ith the Secretary of the L iquorL icensing
N O T ICE is hereby given that an application,in term s of section
B oard, H arare, not later than the 28th D ecem ber, 2012.— Francis
53 ofthe L iquor A ct [Chapter 14:12], will be m ade to the L iquor
L icensing B oard, H arare, for the issue of a B ottle L iquor Licence N . M uzeya, applicant, P.O . B ox.4084, H arare. 370843f
in respect of prem ises situate at 699, S azi R oad, M adubes, Plum tree,
. trading as N dolw ane B ottle Store, for M thokozisi B , N dlovu.
LIQ U O R A C T [CHAPTER 14:12]
M persons w ho have any objections to the application m ay lodge A pplication for the Issue of a Part II L iquor Licence
their objections, in w riting, w ith the Secretary of the L iquor Licensing
B oard,H arare,notlaterthanthe28thD ecem ber,2012.-M thokozisi N O T ICE is hereby given that an application, in term s of section
B . N dlovu, applicant, 699, Sazi R oad, M adubes, Plum tree. 53 ofthe L iquor A ct [Chapter 14:12],w\ll be m ade to the L iquor
370714f L icensing B oard, H arare, for the issue of a B ar L iquor Licence in
respect of prem ises situate at 1468, K am buzum a Section 2, H arare,
L IQ UO R A C T [CHAPTER 14:12] trading as Takura B ar, for Francis N . M uzeya.
A pplication for the Issue of a Part II L iquor Licence A ll persons w ho have any objections to the application m ay lodge
their objections, in w riting, w ith the Secretary of the L iquorLicensing
given that an application, in term s of B oard, H arare, not later than the 28th D ecem ber, 2012.— Francis
section 53 ofthe L iquor A ct [Chapter 74;/2], w ill be m ade to the N . M uzeya, applicant, P.O. B ox 4084, H arare. 370844f
'9 9 6 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

L IQ U O R A C T [CHAPTER 14:12] L iq u o r L ic e n c e in r e s p e c t o f p r e m is e s s itu a te a t 1 5 0 5 ,D z iv a r e s e k w a

T o w n s h ip , t r a d i n g a s T a n g a i N i g h t C l u b , f o r F r a n c i s N . M u z e y a .
A p p lic a tio n f o r th e Is s u e o f a P a rt II L iq u o r L ic e n c e
A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
th e ir o b J e c tio n s ,in w r itin g , w ith th e S e c r e ta ry o f th e L iq u o r L ic e n s in g
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r , 2 0 1 2 .— F ra n c is
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th d L iq u o r
N . M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a r e . 370850f
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e in
r e s p e c t o f p r e m is e s s itu a te a t 1 4 6 8 , K a m b u z u m a S e c tio n 2 , H a r a r e ,
tr a d in g a s T a k u r a B o ttle S to r e , f o r F r a n c is N . M u z e y a . L IQ U O R A C T [CHAPTER 14:12]
A ll p e r s o n s w h o h a v e a n y o b je c tio n s t o th e a p p lic a tio n m a y lo d g e A p p l i c a t io n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e
th e ir o b je c tio n s .in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
B o a r d , H a r a re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— F ra n c is N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n
N . M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a r e . 370845f 5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r
L ic e n s in g B o a r d , H a r a re , f o r th e is s u e o f a B a r L iq u o r L ic e n c e in
L IQ U O R A C T [CHAPTER 14:12] r e s p e c t o f p r e m i s e s s i t u a te a t 1 5 0 5 , D z i v a r e s e k w a T o w n s h i p , t r a d i n g
a s T a n g a i B a r , f o r F r a n c is N . M u z e y a .
A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e
A ll p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n th e ir o b je c tio n s , in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
5 3 o f th e L iq u o r A c t [Chapter 7 4 ; 7 2 ] , w i l l b e m a d e to th e L iq u o r B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r , 2 0 1 2 .— F r a n c is
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a N ig h t C lu b L iq u o r N . M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a re . 370952f
L ic e n c e i n r e s p e c t o f p r e m is e s s itu a te a t 3 8 , C h a m in u k a S tr e e t,
M a b v u k u T o w n s h ip , H a ra re , tra d in g a s M a b v u k u B e e rg a rd e n N ig h t L IQ U O R ACT {CHAPTER 14:12]
C lu b , fo r R o m e o M u z e y a .
A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e
A ll p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
th e ir o b je c tio n s ,in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
B o a r d , H a r a re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— R o m e o 5 3 o f th e L iq u o r A c t [Chapter i 4 . - / 2 ] , w ill b e m a d e to th e L iq u o r
M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a r e . 370846f L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e
in re s p e c t o f p re m is e s s itu a te a t 1 5 0 5 , D z iv a r e s e k w a , tr a d in g a s
L IQ U O R A C T [CHAPTER 14:12] T a n g a i B o ttle S to r e , f o r F r a n c is N . M u z e y a .

A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e A ll p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e

th e ir o b je c tio n s , in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— F ra n c is
5 3 o f th e L iq u o r A c t [Chapter 7 4 ; 7 2 ] , w i l l b e m a d e to th e L iq u o r N . M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a re . 370953f
L ic e n s in g B o a r d , H a r a re , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e
in re s p e c t o f p re m is e s s itu a te a t N y a ru te p o B u s in e s s C e n tre , M u d z i, L IQ U O R A C T [CHAPTER 14:12]
tra d in g a s E . K u g a ra B o ttle S to re , fo r E m m a n u e l K u g a ra .
A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e
A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
th e ir o b je c tio n s ,in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— E m m a n u e l
5 3 o f th e L iq u o r A c t [Chapter i 4 . - / 2 ] , w i l l b e m a d e to th e L iq u o r
K u g a ra , a p p lic a n t, N y a ru te p o B u s in e s s C e n tre , M u d z i. 370847f
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e in
re s p e c t o f p re m is e s s itu a te a t 7 1 1 7 , G le n N o ra h “ B ” , H a ra re , tra d in g
L IQ U O R A C T [CHAPTER 14:12] a s T h e S h a rk s S p o r ts B a r , f o r C h ig u m a d z i T s a r u k a n a i.

A p p lic a tio n f o r t h e I s s u e o f a P a r t I I L iq u o r L ic e n c e A ll p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e

th e ir o b je c tio n s , in w ritin g , w ith th e S e c re ta ry o f th e L iq u o r L ic e n s in g
N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n B o a r d , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— C h ig u m a d z i
5 3 o f th e L iq u o r A c t [ C /to p te r 7 4 .- 7 2 ] , w ill b e m a d e to th e L iq u o r T s a ru k a n a i, a p p lic a n t, 3 9 2 9 , O ld H ig h fie ld , H a ra re . 370903f
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e
in r e s p e c t o f p r e m is e s s itu a te a t 3 8 , C h a m in u k a S tr e e t, M a b v u k u UQ{]ORhCl[CHAPTER14:12]
T o w n s h ip , H a ra re , tra d in g a s M a b v u k u B e e rg a rd e n B a r, fo r R o m e o
M uzeya. A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e

A ll p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e

N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
th e ir o b je c tio n s , in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
B o a r d , H a r a r e , n o t M e r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— R o m e o
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e 't o t h e L i q u o r
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e
M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a r e . 370848f
in re s p e c t o f p re m is e s s itu a te a t S ta n d 1 1 , M u k o d z o n g i B u s in e p
C e n tre , C h iw e s h e , tra d in g a s C h ik u k w a B o ttle S to re , fo r G o d w in
L IQ U O R A C T [CHAPTER 14:12]
M b is w a M u n je ri.
A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
th e ir o b je c tio n s , in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r , 2 0 1 2 .— G o d w in
5 3 o f th e L iq u o r A c t [Chapter 7 4 . - 7 2 ] , w ill b e m a d e to th e L iq u o r M b is w a M u n je ri, a p p lic a n t, M u k o d z o n g i S c h o o l, P riv a te B a g 3 0 4 1 ,
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B o ttle L iq u o r L ic e n c e N z v im b o . 3 7 0 9' 5 4 f*
in r e s p e c t o f p r e m is e s s itu a te a t 3 8 , C h a m in u k a S tr e e t, M a b v u k u
T o w n s h ip , H a ra re , tra d in g a s M a b v u k u B e e rg a rd e n , fo r R o m e o L I Q U O R A C T [ C H A P T E R 7 4 .- /2 ]
M uzeya.

A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e

th e ir o b je c tio n s , in w r itin g , w ith th e S e c re ta r y o f th e L iq u o r L ic e n s in g
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
B o a r d , H a r a re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— R o m e o
M u z e y a , a p p lic a n t, P .O . B o x 4 0 8 4 , H a r a r e . 3 7 0 8 4 9 f.
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e in
r e s p e c t o f p r e m is e s s itu a te a t S ta n d 8 4 0 9 , S t M a r y ’s , C h itu n g w iz a ,
L IQ U O R A C T [CHAPTER 14:12]
tr a d in g a s C h ib h a n g u z a N ig h ts , f o r S y lv e s te r C h ib h a n g u z a .

A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e A H p e r s o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e

th e ir o b je c tio n s , in w r itin g , w ith th e S e c r e ta r y o f th e L iq u o r L ic e n s in g
N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s of B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r , 2 0 1 2 .— S y lv e s te r
s e c tio n 5 3 o f th e L i q u o r A c t [Chapter 14:12], w ill b e m a d e to C h ib h a n g u z a , a p p lic a n t, P .O . B o x 3 6 , R u s v in g o R o a d , Z e n g e z a “ 1 ” ,
th e L iq u o r L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a N ig h t C lu b C h itu n g w iz a . 370919f
 Z iM B A B W A N Go v e r n m e n t G A Z E riE , 14t h De c e mb e r , 2 0 1 2 997

L IQ U O R A C T [CHAPTER 14:12] L IQ U O R A C T [C H A P re R 14:12]

A p p l ic a t io n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e A p p lic a tio n fo r th e Is s u e o f a P a rt II L iq u o r L ic e n c e

N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n

5 3 o f th e L iq u o r A c t [Chapter / 4 . / 2 ] , w i l l b e m a d e to th e L iq u o r 5 3 o f th e L iq u o r A c t [Chapter 7 4 . 7 2 ] , w ill b e m a d e to th e L iq u o r
L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a B a r L i q u o r L ic e n c e i n L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a B o t t l e L i q u o r L ic e n c e
r e s p e c t o f p r e m is e s s i t u a t e a t C h a b w i n o F a r m , M a r o n d e r a , t r a d i n g i n r e s p e c t o f p r e m i s e s s i t u a t e a t L e a s e I S fo . 2 1 6 0 , S t a n d 4 , M u s i l i z w i
a s C h a b w in o B a r, fo r U s h e m a s im b a M a y o w e . R e s e t tl e m e n t, C h i p i n g e , t r a d i n g a s J a b u l a n i B o t t l e S to r e , f o r A n n i e
G i ji m a .
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y
l o d g e t h e i r o b j e c t i o n s , i n w r i t in g , w i t h t h e S e c r e t a r y o f t h e L i q u o r A l l p e r s o n s w h o h a v e a n y o b j e c ti o n s t o t h e a p p l i c a t i o n m a y l o d g e
L ic e n s in g B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— t h e i r o b j e c ti o n s , i n w r it i n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s in g
U s h e m a s im b a M a y o w e , a p p lic a n t, 1 7 , H u x h a ra R o a d , G re e n d a le . B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— A n n ie
370921f G i j im a , a p p l i c a n t , M u s i l i z w i P r i m a r y , P .O B o x 2 8 1 , C h i p i n g e .
370830f
m L IQ U O R A C T [CHAPTER 14:12]
L IQ U O R A C T [CHAPTER 14:12]
A p p l i c a t io n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e
A p p l ic a t i o n f o r T r a n s f e r o f a P a r t I I L i q u o r L ic e n c e
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rm s o f s e c tio n
L i c e n s i n g B o a r d , H a r a r e , f o r t h e i s s u e o f a S p e c i a l B o t tl e L i q u o r 5 8 o f th e L iq u o r A c t [Chapter 14.: 12], w i l l b e m a d e to th e L iq u o r
L i c e n c e i n r e s p e c t o f p r e m is e s s i t u a te a t N y i m o T o w n s h ip , N e u s o , L i c e n s i n g B o a r d , H a r a r e , f o r t r a n s f e r o f t h e B o t tl e L i q u o r L i c e n c e ,
S a n y a t i, t r a d in g a s C h i g a z B o t t l e S t o r e , f o r T o g a r a s e y i C h i g a n g a id z e . in re s p e c t o f p re m is e s s itu a te o n S t a n d 6 3 , T s a m v ir i n g a S tr e e t ,
M u f a k o s e , H a r a r e , f r o m R u f a r o M a r k e t i n g ( P r iv a t e ) L i m i t e d , t r a d i n g
A l l p e r s o n s w h o h a v e a n y o b j e c ti o n s t o t h e a p p l i c a t i o n m a y l o d g e
a s R u k u d z o B o t t l e S t o r e , t o M o l l y I n v e s t m e n t ( P r iv a t e ) L i m i t e d .
t h e i r o b j e c t io n s , i n w r i ti n g , w i th t h e S e c r e t a r y o f t h e L i q u o r L i c e n s in g
B o a r d ,H a r a r e ,n o t la te r th a n th e 2 8 th D e c e m b e r ,2 0 1 2 .— T o g a r a s e y i A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t i o n m a y l o d g e
C h i g a n g a i d z e , a p p l i c a n t , N e u s o , M u s o n a V i l l a g e , S a n y a ti . t h e i r o b j e c t i o n s , i n w r it i n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
370922f B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— M o lly
I n v e s t m e n t ( P r i v a te ) L i m i t e d , a p p l i c a n t , 6 3 , T s a m v ir i n g a S tr e e t ,
L IQ U O R A C T [CHAPTER 14:12] M u fa k o se , H a ra re . 370955f

A p p l ic a t io n f o r t h e I s s u e o f a P a r t I I L i q u o r L i c e n c e L IQ U O R A C T [CHAPTER 14:12]
N O T I C E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n A p p l ic a t i o n f o r T r a n s f e r o f a P a r t I I L i q u o r L i c e n c e
5 3 o f th e L iq u o r A c t [Chapter 14:12],wiW b e m a d e to th e L iq u o r
N O T I C E i s h e r e b y g i v e n t h a t a n a p p l ic a t io n , i n t e r m s o f s e c t i o n
L ic e n s in g B o a rd , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r
in re s p e c t o f p re m is e s s itu a te a t S ta n d 6 6 5 , N y ik a G ro w th P o in t,
L i c e n s i n g B o a r d , H a r a r e , f o r t r a n s f e r o f t h e R e s ta u r a n t ( S p e c i a l )
B i k it a R u r a l D i s t r i c t C o u n c i l, t r a d i n g a s M p a k w a B a r , f o r B i k i t a
L i q u o r L i c e n c e i n r e s p e c t o f p r e m is e s s i t u a t e a t M p a n d a w a n a , G u t u ,
R u ra l D is tric t C o u n c il.
f r o m K . M . M a w e r e , t r a d i n g a s T o p C l a s s R e s t a u r a n t , t o J o .s p h a t
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y l o d g e M u n y o n g a n i. ,
t h e i r o b j e c t i o n s , in w r i t i n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s in g A ll p e r s o n s w h o h a v e a n y o b j e c t io n s t o t h e a p p l i c a t i o n m a y l o d g e
B o a r d , H a r a r e , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— B ik ita t h e i r o b je c t i o n s , i n w r i t i n g , w i t h t h e S e c r e ta r y o f t h e L i q u o r L i c e n s i n g
R u r a l D i s t r i c t C o u n c i l, a p p l i c a n t . P r i v a t e B a g 5 9 4 , N y i k a . B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r , 2 0 1 2 .— J o s p h a t
370957f M u n y o n g a n i , a p p l i c a n t , 1 6 0 3 1 , U n i t “ P ” , S e k e , C h it u n g w i z a .
3170571
L IQ U O R A C T [CHAPTER 14:12]
L IQ U O R A C T [CHAPTER 14:12]
A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e
A p p l ic a t i o n f o r T r a n s f e r o f a P a r t I I L i q u o r L i c e n c e
N O T IC E is h e re b y g iv e n th a t a n a p p lic a tio n , in te rra s o f s e c tio n
N O T I C E i s h e r e b y g i v e n t h a t a n a p p l i c a ti o n , i n t e r m s o f s e c t i o n
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r
5 3 o f t h e L i q u o r A c t [Chapter 14:12], w i ll b e m a d e t o t h e L i q u o r
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e in L i c e n s i n g B o a r d , H a r a r e , f o r t r a n s f e r o f t h e N ig h t C l u b L i q u o r L i c e n c e
re s p e c t o f p re m is e s s itu a te a t 2 k m a lo n g N y ifc a -B ik ita R o a d , B ik ita i n r e s p e c t o f p r e m i s e s s i t u a te a t M p a n d a w a n a , G u t u , f r o m K . M .
R u r a l D i s t r i c t C o u n c i l, t r a d i n g a s P a m b u d z i K r e s t a B a r , f o r B i k i t a M a w e re , tra d in g a s T o p C la ss N ig h t C lu b , to J o s p h a t M u n y o n g a n i.
R u r a l D i s tr i c t C o u n c i l . A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e
A ll p e rs o n s w h o h a v e a n y o b je c tio n s to th e a p p lic a tio n m a y lo d g e t h e i r o b j e c ti o n s , i n w r i ti n g , w i t h t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— J o s p h a t
t h e i r o b j e c t i o n s . i n w r i t i n g , w i th t h e S e c r e t a r y o f t h e L i q u o r L i c e n s i n g
M u n y o n g a n i . a p p l i c a n t , 1 6 0 3 1 , U n i t " P ” , S e k e , C h i t u n g w iz a .
B o a rd , H a r w e , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 .— B ik ita
317058f
R u r a l D i s t r i c t C o u n c i l, a p p l i c a n t . P r i v a t e B a g 5 9 4 , N y i k a .
370956f A D M IN IS T R A T IO N O F E S T A T E

L IQ U O R A C T [CHAPTER 14:12] I n t h e e s t a t e o f t h e l a t e H e n d r i n a M a r c i a H u g o w h o d i e d a t P ie t e r ­
m a r i t z b u r g , S o u t h A f r i c a , o n t h e 2 8 th d a y o f N o v e m b e r , 2 0 0 9 .
A p p lic a tio n f o r th e I s s u e o f a P a r t I I L iq u o r L ic e n c e
N O T IC E is h e re b y g iv e n th a t D ir k M a r tin v a n R y n v e ld in te n d to
N O T IC E is h e r e b y g iv e n th a t a n a p p lic a tio n , in te r m s o f s e c tio n a p p ly to th e M a s te r o f th e H ig h C o u rt o f Z im b a b w e , a t H a ra re , fo r
5 3 o f th e L iq u o r A c t [Chapter 14:12], w i l l b e m a d e to th e L iq u o r th e c o u n te r s ig n a tu r e o f th e g r a n t o f p r o b a te , g r a n te d in h is f a v o u r
L ic e n s in g B o a r d , H a r a r e , f o r th e is s u e o f a B a r L iq u o r L ic e n c e in b y t h e M a s t e r o f H i g h C o u r t , P i e t e r m a r i t z b u r g , R e p u b l ic o f S o u t h
r e s p e c t o f p r e m i s e s s i t u a t e a t S t a n d 4 7 , B i k it a R u r a l S e r v i c e C e n t r e , A f r ic a , o n 2 2 n d J a n u a r y , 2 0 1 0 .
t r a d i n g a s M a z e n e n e B a r , . f o r B i k it a R u r a l D i s t r ic t C o u n c i l . A ll p e r s o n s h a v in g a n y o b je c tio n s to s u c h c o u n te r s ig n a tu r e a n d
A l l p e r s o n s w h o h a v e a n y o b j e c t i o n s t o t h e a p p l ic a t io n m a y l o d g e a n y a s .s e t s o f ; o r c l a i m s a g a i n s t t h e e s t a t e a r e r e q u e s t e d t o p r o v i d e
th e iro b je c tio n s, in w ritin g , w ith th e S e c re ta iy o f th e L iq u o r L ic e n s in g d e t a i l s o f s u c h o b j e c ti o n s , a s s e t s o r c l a i m s t o t h e u n d e r s i g n e d n o t
B o a rd , H a ra re , n o t la te r th a n th e 2 8 th D e c e m b e r, 2 0 1 2 ,- B ik ita la te r th a n th e 1 4 th o f J a n u a r y , 2 0 1 3 .
R u r a l D is tr ic t C o u n c il, a p p lic a n t,P r iv a te B a g 5 9 4 , N y ik a . D a te d a t H a ra re o n th is 4 th d a y o f D e c e m b e r, 2 0 1 2 .— P e tw in
370958f E x e c u to r & T r u s t C o ., a g e n ts f o r th e e x e c u to r . 370729f
 998 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012

IN L A N D W A T E R S S m P P I N G A C T [C flA P T E R 13:06\ 3 .( 1 ) C o p y m u s t a p p e a r o n o n e s id e o n ly o f e a c h s h e e t o f p a p e r.

(2 ) E x c e p t a s is p r o v id e d in s u b s e c tio n (2 ) o f s e c tio n 8 , p a p e r
A p p lic a tio n f o r th e R e n e w a l o f a n O rd in a ry P e rm it to P ro v id e a
m u s t n o t e x c e e d 2 1 0 m illim e tre s in w id th .
S h ip p in g S e rv ic e
(3 ) I f c o p y c o m p ris e s tw o o r m o re s h e e ts o f p a p e r, a ll s h e e ts
N O T IC E is h e re b y g iv e n th a t T o u ris m S e rv ic e s Z im b a b w e , h a s m u s t b e n u m b e re d c o n s e c u tiv e ly , in a ra b ic fig u re s , p re fe ra b ly in th e
m a d e a n a p p lic a tio n to th e In la n d W a te rs S h ip p in g S e rv ic e s B o a rd , to p rig h t-h a n d c o rn e r.
in te rm s o f s e c tio n 3 7 o f th e In la n d W a te rs S h ip p in g A c t [Chapter
13:06], f o r th e re n e w a l o f a n o rd in a ry P e rm it N o . 5 o f 2 0 1 2 , fo r (4 ) W h e re a n y m a tte r is a d d e d a fte r th e c o p y h a s b e e n
a p e rio d o f o n e y e a r to c o n tin u e w ith b o a t h ire s e rv ic e s o n U p p e r p r e p a r e d , a n d s u c h a d d itio n a l m a tte r r e s u lts in o n e o r m o re
Z a m b e z i R iv e r. s h e e ts b e in g in s e rte d b e tw e e n th o s e a lre a d y n u m b e re d , a ll s h e e ts m u s t
b e re n u m b e re d fro m th e re o n w a rd s — n o t,fo r in s ta n c e ? ,7 b , 8 ,e f c e te ra .
A n y o b je c tio n s to th is a p p lic a tio n , m a d e in te rm s o f s e c tio n 4 0 o f
4 . P h o to g ra p h ic c o p y o r c o p y p ro d u c e d o n a d u p lic a tin g m a c h in e
th e In la n d W a te rs S h ip p in g A c t [Chapter 13:06], m u s t b e m a d e in
m a y b e a c c e p te d if it is a b u n d a n tly c le a r.
th e m a n n e r p re s c rib e d in s e c tio n 1 5 6 o f th e I n la n d W a te rs S h ip p in g
R e g u la tio n s ,1 9 7 1 , a n d w ith in 2 8 d a y s a f te r th e d a te o f p u b lic a tio n in 5 . (1 ) S h o u ld a n y c o p y —
th is Gazette, o f th is n o tic e .— T o u ris m S e rv ic e s Z im b a b w e , a p p lic a n t, (a ) e x c e e d 1 0 p a g e s o f d o u b le -s p a c e d ty p in g o n s iz e A 4
V ic to ria F a lls . 37093 If p a p e r; o r

S H E R I F F ’S S A L E (b ) c o n ta in ta b u la ro ro th e rm a tte rw h ic h ln v o lv e s c o m p lic a te d
s e ttin g ; it w ill b e c la s s e d a s “ le n g th y ’ c o p y , a n d w ill b e
In th e m a tte r C B Z B a n k L im ite d , p la in tiff, a n d V e n d b o rg In v e s t­ re q u ire d to b e s u b m itte d n o t le s s th a n 2 1 d a y s b e fo re th e
m e n ts (P riv a te ) L im ite d , d e fe n d a n t. ' d a te o f c lo s in g fo r th e Gazette in w h ic h it is to b e p u b lis h e d .
N O T IC E is h e r e b y g iv e n th a t th e p la n o f d is trib u tio n o f th e (2 ) L e n g th y c o p y m a y b e a c c e p te d a t le s s th a n 2 1 d a y s ’
p u rc h a s e -m o n e y re c e iv e d f r o m th e s id e o f th e u n d e r-m e n tio n e d n o tic e if —
p ro p e rty w h ic h w a s s o ld in p u rs u a n c e o f a n o rd e r o f th e H ig h C o u rt
w ill lie f o r in s p e c tio n a t m y o ffic e a n d a t th e o ffic e o f th e A s s is ta n t (a ) th e w o rk in v o lv e d is o f a s tra ig h t fo rw a rd a n d lio n -
ta b u la r n a tu re ; a n d i
M a s te r, B u la w a y o H ig h C o u rt, fo r a p e rio d o f 1 4 d a y s fro m th e d a te
o f p u b lic a tio n o f th is n o tic e . (b ) th e to ta l v o lu m e o f w o rk o n h a n d f o r th e tim e b e in g
p e rm its its a c c e p ta n c e .
A n y p e rs o n h a v in g a n in te re s t in th e p ro c e e d s o f th e s a le a n d
o b je c tin g to th e s a id p la n o f d is trib u tio n m a y a p p ly to th e H ig h 6 . N o tw ith s ta n d in g a n y th in g to th e c o n tra ry c o n ta in e d in th e s e
C o u rt to h a v e it s e t a s id e o r a m e n d e d , a fte r d u e n o tic e to m e a n d to c o n d itio n s , a n y c o p y —
o th e r p a rtie s in te re s te d , s ta tin g th e g ro u n d s fo r s u c h o b je c tio n .
(a ) w h ic h is o f n a tio n a l im p o r ta n c e , a n d w h ic h is
“ C e rta in p ie c e o f la n d s itu a te in th e d is tric t o f S a lis b u ry b e in g o r ig in a te d a s a m a tte r o f u r g e n t n e c e s s ity , m a y ,
S ta n d l0 2 6 1 S a lis b u ry T o w n s h ip , m e a s u rin g 7 1 4 s q u a re m e tre s .” b y p rio r a rra n g e m e n t, b e a c c e p te d la te fo rth e c u rre n t w e e k ;
I f n o o b je c tio n s a re m a d e to th e p la n w ith in th e tim e s ta te d in th is (b ) m a y , d u e to s h o r ta g e o f s ta f f o r to te c h n ic a l
n o tic e , th e n I s h a ll c o n firm th e p la n . c o n s id e ra tio n s ,b e d e la y e d u n tilc o n d itio n s p e rm itits p ro c e s s in g .
M . M A D EG A , 7 . C o p y m u s t n o t b e s u b m itte d a s p a rt o f a le tte r o r a re q u is itio n .
S h e riff. It m u s t a p p e a r o n a s e p a ra te s h e e t o f p a p e r, o n w h ic h th e re is n o
T h e S h e r if f’s O ffic e , in s tra c tio n o r o th e r e x tra n e o u s m a tte r.
M a p o n d e ra B u ild in g , 8 . (1 ) In c a s e s w h e re n o tic e s h a v e to b e p u b lis h e d in ta b u la r fo rm ,
S a m o ra M a c h e l A v e n u e , c o p y m u s t b e d ra fte d exactly a s it is to a p p e a r. I f p rin te d fo rm s fo r
H a ra re . 370818f . a n y s u c h n o tic e s a re u n a v a ila b le , a d v e rtise rs m u s t p re p a re th e ir
o w n fo rm s . W h ile it is n o t n e c e ss a ry to in c lu d e th e p re a m b le , th e
G O V ERN M EN T G A ZETTE
b o x -h e a d in g s m u s t b e th e re , a n d , w h e re a p p lic a b le , th e n u m b e r o f
th e fo rm ; f o r e x a m p le . “ In s o lv e n c y R e g u la tio n s — F o rm 3 ” .
C o n d itio n s o f A c c e p ta n c e o f C o p y
(2 ) I n th e c a s e o f c o p y f o r ta b u la r n o tic e s , th e p ro v is io n o f
F A IL U R E to c o m p ly w ith a n y o f th e fo llo w in g c o n d itio n s w ill s u b s e c tio n (2 ) o f s e c tio n 3 d o e s n o t a p p ly .
re s u lt in th e re je c tio n o f c o p y , a n d n o re s p o n s ib ility c a n b e a c c e p te d
if s u c h re je c tio n s h o u ld a ffe c t a n y d a te c o n ta in e d in s u c h c o p y o r 9. C o p y fo r a U a d v e rtis e m e n ts , w h e th e r s e n t b y p o s t o r d e liv e re d
a n y re q u ire m e n t o f p u b lic a tio n o n a s p e c ific d a te .
P e r s o n s d r a f tin g any k in d o f n o tic e s a re s tr o n g ly a d v is e d to
b y h a n d , m u s t b e a c c o m p a n ie d b y a re q u is itio n o r a le tte r w h ic h
c le a rly s e ts o u t—
@
f o llo w th e g u id a n c e o f f e re d i n —
(a ) th e n a m e a n d a d d re ss O f th e a d v e rtis e r; a n d
(a ) th e In s tru c tio n s R e la tin g to th e D ra ftin g a n d T y p in g o f
(b ) th e d e b to r’s c o d e n u m b e r, if a n y ; a n d
L e g isla tio n (A tto rn e y -G e n e ra l’s C irc u la r 1 o f 1 9 7 8 ); a n d
(c ) th e re q u ire d d a te o r d a te s o f p u b lic a tio n .
(b ) th e M a n u a l o f S ^ le f o r th e D ra ftin g a n d P re p a ra tio n o f c o p y
p u b lis h e d b y P rin tflo w (P riv a te ) L im ite d ; 1 0 . I f a ty p o g ra p h ic a l e rro r o c c u rs in th e Gazette, it is re c tifie d
w h ic h tw o b o o k le ts a re in te n d e d f o r c o m p le m e n ta ry u s e . a s s o o n a s p o s s ib le b y a c o rre c tin g n o tic e w ith o u t c h a rg e to
In th e s e c o n d itio n s , o th e r th a n w h e re a p a rtic u la r k in d o f c o p y is th e m in is tiy o rd e p a itm e n tc o n c e m e d ,s u b je c tto th e fo llo w in g c o n d itio n s —
s p e c ifie d , “ c o p y ” m e a n s c o p y fo r a ll m a tte r c o n ta in e d in th e Gazette (a ) th a t s u c h e rro r is r e p o r te d to th e e d ito r w ith in th re e m o n th s
its e lf a n d fo r s u b s id ia ry le g is la tio n is s u e d a s s u p p le m e n ts to th e Gazette,
fro m th e d a te o f p u b lic a tio n ; a n d
1 . (1 ) O th e rth a n b y p rio ra ira n g e m e n ts .o n ly o rig in a lty p in g is a c c e p te d . (b ) th a t th e re le v a n t c o p y , u p o n re -e x a m in a tio n , is p ro v e d
(2 ) C a rb o n -c o p ie s a re n o t n o rm a lly a c c e p ta b le , o th e r th a n in c a s e s to b e a b u n d a n tly c le a r; a n d
w h e re th e o r ig in d ty p in g h a s to b e le g a lly re ta in e d , e ls e w h e re , a s , (c ) th a t th e c o rre c tio n o f s u c h e r r o r is le g a lly n e c e s s a ry .
fo r e x a m p le , in th e c a s e o f a p ro c la m a tio n .
(2 ) I f a d r a f tin g e r r o r is n o t d e te c te d b e fo re p u b lic a tio n ,
(3 ) C o m p u te r p r in t- o u ts a re n o t a c c e p te d a u to m a tic a lly , a s th e o rig in a tin g m in is try o r d e p a r tm e n t is re q u ire d to c h a ft its o w n
d is c u s sio n m a y b e n a e s s a iy w ith re g a rd to th e e x ira tim e a n d c o s ts in v o lv e d .
c o rre c tin g n o tic e , ta k e it to th e A tto rn e y -G e n e ra l fo r v e ttin g a n d
2 . (1 ) A ll c o p y m u s t b e c le a r a n d le g ib le , a n d th e re m u s t b e d o u b le p a y f o r s u c h n o tic e to b e p u b lis h e d .
o r o n e a n d a h a lf s p a c in g b e tw e e n th e lin e s .
(3 ) F o r th e re m o v a l o f d o u b t—
(2 ) A n y c o rre c tio n s o r a lte ra tio n s m a d e b y th e o rig in a to r, m u s t
(a ) a ty p o g ra p h ic a l e r r o r is m a d e b y a ty p o g ra p h e r;
b e c le a rly e ffe c te d in b lu e o r b la c k in k , u s in g e d ito ria l m a r k s — n o t
p ro o f-re a d e r ’s m a rk s : (b ) a ty p is t’s e r r o r is c la s s e d a s a d r a f tin g e rro r b y re a s o n o f
th e fa c t th a t th e o ffic e r r e s p o n s ib le f o r d ra ftin g fa ile d to
P r o v id e d th a t a n y c o p y c o n ta in in g e x te n s iv e a lte ra tio n s w ill b e
re je c te d . c h e c k th e ty p is t’s w o r k .
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2 999

G O V ERN M EN T G A ZETTE G O V E R N M E N T P U B L IC A T IO N S O N S A L E
(a s a v a ila b le a t tim e o f o rd e rin g )
A u t h o r iz e d S c a l e o f C h a r g e s , T i m e s o f C l o s in g a n d S u b s c r i p ti o n
R a te a s fro m 1 st J a n u a ry , 2 0 1 2 T H E fo llo w in g p u b lic a tio n s a re o b ta in a b le fro m t h e f o l l o w in g

Charges for statutory instruments P r i n t f l o w p u b l ic a t io n o f f i c e s : t h e P r i n t f l o w P u b l ic a t io n s O f f ic e ,

C e c i l H o u s e , 9 5 , J a s o n M o y o A v e n u e , H a r a r e ( P .O . B o x C Y 3 4 1 ,
T H E c h a r g e f o r p r i n ti n g s t a t u t o r y i n s t r u m e n ts i s U S D 0 , 0 7 p e r C a u s e w a y ) ; o r f r o m t h e P r in t f lo w P u b l i c a t i o n s O f f i c e , N o . 8 ,
A 5 p a g e a n d U S D 0 , 1 4 p e r A 4 p a g e m u l t ip l i e d b y 2 0 0 0 ( b e i n g t h e J o s i a h C h i n a m a n o / M a n c h e s t e r R o a d s ( P .O . B o x 8 5 0 7 ) , B e l m o n t ,
n u m b e r o f c o p ie s p rin te d ). B u l a w a y o ; o r f r o m t h e P r i n t f lo w P u b l ic a t i o n s O f f i c e , N o . 2 , R o b e r t
M u g a b e A v e n u e , M u t a r e ( P r i v a te B a g Q 7 7 3 8 , M u t a t e ) ; o r f r o m t h e
Charges for advertisements including general notices P r in t f l o w P u b l i c a t i o n s O f f i c e , S t a n d N o . 7 1 5 0 B , B r a d b u m S t r e e t ,
T H E a r e a o f a d v e r t is e m e n t m u l t i p li e d b y U S D O ,8 0 . M a s v in g o ( P r iv a te B a g 9 2 9 3 ,M a s v in g o ) ;M S U B a ta n a iC o m p le x ,S e n g a
( P .O . B o x 1 3 9 2 ) , G w e r u .
N o t ic e s w h i c h h a v e t o a p p e a r i n t a b u l a r f o r m a c r o s s t h e f u l l w i d t h o f t h e
p a g e , s u c h a s l o s t i n s u r a n c e p o l i c i e s , d e c e a s e d e s t a te s , i n s o l v e n t e s t a t e s , A F ra m e w o rk fo r E c o n o m ic R e fo rm (1 9 9 1 -9 5 )

c o m p a n y h q u id a tio n s , n o tic e s in te rm s o f th e In s o lv e n c y A c t [Chapter A n In tro d u c tio n to L a w

6:04\, c h a n g e s o f c o m p a n i e s ’ n a m e s et cetera: U S $ 2 0 ,0 0 c a s h p e r e n try . C o m m i s s io n o f I n q u i r y i n t o T a x a ti o n

N o tic e s o f in te n tio n to a lie n a te a b u s in e s s o r th e g o o d w ill o f C u s to m s a n d E x c is e T a riff N o tic e , 2 0 0 7

a b u s in e s s o r a n y g o o d s o r p r o p e r t y f o r m i n g p a r t o f a b u s i n e s s , C u s t o m s C o n t a i n e r i s a ti o n R u l e s
o th e rw is e th a n in th e o rd in a ry c o u r s e o f b u s in e s s s h a ll c o s t C u s to m s V a lu a tio n M a n u a l
U S D 6 0 , 0 0 c a s h f o r t h e t h r e e c o n s e c u ti v e p u b l i c a ti o n s .
F /o m v o lu m e I , p a rt II
E x c e p t in th e c a s e o f a p p ro v e d a c c o u n ts , re m itta n c e s m u s t Flora zambesiaca, v o l u m e U , p a rt I
a c c o m p a n y a l l c o p y o f a d v e r t i s e m e n t s , f a i l in g t h i s , c o p y w i l l b e
Flora zambesiaca, s u p p le m e n t
re m m e d w ith a n a s s e ss m e n t o f c h a rg e s .
G o v ern m e n t Gazette ( s u b s c r i p t i o n r a t e f o r 3 m o n t h s i n c l u d i n g p o s t a l)

Times of closing G o v e rn m e n t Gazette ( i n d i v i d u a l c o p i e s )

T h e Gazette c l o s e s f o r t h e r e c e ip t o f c o p y f o r a l l n o t i c e s t o b e M a n u a l o f R i v e r a n d L a k e m a n s h ip
p u b lis h e d in th e n o rm a l c o lu m n s , a n d fo r s ta tu to ry in s tru m e n ts a t M o d e l B u ild in g B y -la w s , 1 9 7 7
1 1 a . m . o n t h e M o n d a y p r e c e d i n g t h e F r id a y o f p u b l i c a t i o n . N a tio n a l M a n p o w e r S u rv e y , 1 9 8 1 : v o lu m e I
C o p y fo r a ll n o tic e s to b e s e t in ta b u la r fo rm m u s t b e re c e iv e d b y N a ti o n a l M a n p o w e r S u r v e y , 1 9 8 1 : v o l u m e I I
1 1 a . m . o n t h e F r id a y p r e c e d i n g t h e F r i d a y o f p u b l i c a t i o n .
N a ti o n a l M a n p o w e r S u r v e y , 1 9 8 1 : v o l u m e I I I
A ny c o p y w h i c h i s r e c e i v e d a f t e r t h e r e s p e c t iv e c l o s i n g - t i m e s
Patents and Trade Marks Journal ( s u b s c r i p t i o n f o r 3 m o n tiis )
w i l l a u t o m a ti c a ll y b e h e l d o v e r f o r i n s e r t io n i n t h e Gazette o f t h e
Patents and Trade Marks Journal ( i n d i v i d u a l c o p ie s )
f o l lo w i n g w e e k , i n w h i c h c a s e n o r e s p o n s i b i l i t y c a n b e a c c e p te d i f
R h o d e s ia la w re p o rts, 1 9 7 0 , p a rt 1 a n d p a rt 2 , p e r p a rt
t h e p u r p o s e o f t h e n o t i c e i s t h e r e b y n u l l if i e d .
R h o d e s ia la w re p o rts, 1 9 7 1 , p a rt 1 a n d p a rt 2 , p e r p a rt
W h e n p u b lic h o lid a y s o c c u r, th e n o rm a l c lo s in g -tim e s a re v a rie d ,
a n d s u c h v a r i a ti o n s a r e n o t i f i e d i n t h e Gazette i n advance. R h o d e s ia la w re p o rts, 1 9 7 2 , p a rt 2 , p e r p a rt

A l l c o p y m u s t b e a d d r e s s e d t o P r in t f l o w ( P r i v a te ) L im i t e d , a n d R h o d e s ia la w re p o rts, 1 9 7 3 , p a rt 2 , p e r p a rt

e i t h e r p o s t e d t o P .O . B o x C Y 3 4 1 , C a u s e w a y , o r d e l i v e r e d d i r e c t t o t h e R h o d e s ia la w re p o rts , 1 9 7 4 , p a rt 1 a n d p a rt 2 , p e r p a rt
c o m p a n y , in G e o rg e S ilu n d ik a A v e n u e (b e tw e e n S ix th S tre e t a n d E p to n R h o d e s ia n la w re p o rts, 1 9 7 5 , p a r t 2 , p e r p a rt
S tre e t), H a ra re . E n v e lo p e s s h o u ld b e m a rk e d : Gazette copy—urgent. R h o d e s ia n la w re p o rts , 1 9 7 6 , p a rt 1 a n d p a rt 2 , p e r p a rt
R e g u la r a d v e rtis e rs a n d s u b s c rib e rs a re re q u e ste d to a d v is e
R h o d e s ia n l a w r e p o r t e , 1 9 7 7 , p a r t 2 , p e r p a r t
im m e d ia te ly o f a n y c h a n g e o f a d d re s s .
R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 0 (fo u r p a rts ), p e r s e t

Subscription rate R h o d e s ia s u b s id ia ry le g isla tio n , 1 9 7 1 (fiv e p a rts ), p e r p a rt o r, p e r s e t

T h e s u b s c rip tio n ra te fo r th e Gazette f o r th re e m o n th s is U S D 4 0 ,0 0 R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 2 (s e v e n p a rts ), p e r p m t

c a s h p a y a b l e i n a d v a n c e , t o t h e C h i e f & e c u t iv e O f f i c e r , P r i n tf l o w ( P r iv a t e ) R h o d e s i a s u b s i d i a r y l e g i s l a t io n , 1 9 7 3 ( s e v e n p a r t s ) , p e r p M t
L i m it e d , a n d m a y c o m m e n c e w i t h t h e f i r s t i s s u e o f a n y m o n t h .
R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 4 (fiv e p a rts), p e r p a rt

N .M U T U S V A , R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 5 (fiv e p a rts ), p e r p a rt

P u b lic a tio n s O ffic e r. , R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 6 (s ix p a rts), p e r p a rt .

R h o d e s ia s u b s id ia ry le g is la tio n , 1 9 7 7 (fo u r p a rts ), p e r p a rt

G O VERNM EN T G A ZETTE R h o d e s i a s u b s i d i a r y l e g i s l a t io n , 1 9 7 8 ( f o u r p a r t s ) , p e r p a r t

R h o d e s i a s u b s i d i a r y l e g i s l a t io n , 1 9 8 0 ( f i v e p a r t s ) , p e r p a r t
S u b m is s io n o f C o p y fo r G o v e rn m e n t Gazette S t a tu t o r y
R h o d e s i a s u b s i d i a r y l e g i s l a t io n , 1 9 8 1 ( f o u r p a r t s ) , p e r p a r t
In s tru m e n ts a n d N o tic e s
S e c o n d F iv e -Y e a r N a tio n a l D e v e lo p m e n t P la n ; 1 9 9 1 -1 9 9 5
I T is h e re b y n o tifie d , f o r g e n e ra l in fo rm a tio n ,th a t it is n e c e s s a ry to d ra w
S ta tu to ry In s tru m e n ts , 1 9 8 0 (fiv e p a rts), p e r p a rt
a t t e n t i o n t o t h e “ C o n d it i o n s f o r A c c e p t a n c e o f C o p y ” , w h i c h a p p e a r s i n
S ta tu to ry In s tru m e n ts , 1 9 8 1 (fo u r p a rts ), p e r p a rt
e v e i y i s s u e o f t h e Gazette-, a n d p a r t i c u l a r l y t h e n e ^ t o s u b m i t l e n g t h y
c o p y , i n t h e c a s e o f S t a tu t o r y I n s t r u m e n t s , a t l e a s t 2 1 d a y s b e f o r e t h e d a t e S u b s id ia ry L e g isla tio n fro m 1 9 7 0 to 1 9 8 1

o f c lo s in g fo r th e Gazette i n w h ic h th e n o tic e is to b e p u b lis h e d . T r a n s it i o n a l N a t i o n a l D e v e l o p m e n t P l a n , 1 9 8 2 / 8 3 - 1 9 8 4 /8 5 : V o l u m e

T ra n sitio n a l N a tio n a l D e v e lo p m e n t P la n , 1 9 8 2 /8 3 -1 9 8 4 /8 5 : V o lu m e
D u rin g th e p a s t fe w m o n th s o r s o th e re h a v e b e e n m a n y c a s e s
w h e r e urgent c o p y f o r s u b s i d i a r y l e g is l a ti o n , w h i c h r e q u i r e s t h e Z im b a b w e la w re p o rts , fro m 1 9 6 5 u p to 1 9 8 4

s i g n a tu r e o f t h e P r e s id e n t o r a m i n is t e r t o g i v e i t e f f e c t , a n d w h i c h Z im b a b w e la w re p o rts , 1 9 8 3 [P a rt 1 ] (s o ft c o v e r)
i s o f n a t i o n a l - i m p o r t a n c e , h a s b e e n s e n t i n f o r p u b l i c a ti o n i n t h e Z im b a b w e la w re p o rts, 1 9 8 3 [P a rt 2 ] (s o ft c o v e r)
Gazette a f te r c lo s in g - tim e . W h ils t I a c k n o w le d g e th a t it is th e
Z im b a b w e la w re p o rts, 1 9 8 4 (s o ft c o v e r)
d u t y o f P r in t f lo w ( P r i v a t e ) L i m it e d t o g i v e c e r t a i n n o t i c e s s p e c i a l
Z im b a b w e R h o d e s ia s u b s id ia ry le g isla tio n , 1 9 7 9 (fo u r p a rts)
t r e a t m e n t , I a m , h o w e v e r , o f t h e v i e w t h a t a Gazette Extraordinary
h a s t e n d e d t o b e a m u s t r a t h e r t h a n a m a t t e r o f p r i o r it y i n r e s p e c t o f
u n w a rra n te d d e la y s o f urgent c o p y . N E W A C T S : R E V IS E D E D IT IO N S 1 9 9 6

W h ile e v e ry e ffo rt w ill c o n tin u e to b e m a d e to p u b lis h Extraordinaries

o n t h e r e q u i r e d d a t e s , c o p y must b e s u b m i t t e d t i m e o u s l y s o t h a t i t c a n Individual Acts—
b e p r o g r a m m e d i n t o t h e p r i n t in g - w o r k - f lo w a s s o o n a s i t i s a v a i l a b l e .

A c c e s s t o I n f o r m a t i o n a n d P r o t e c t io n o f P r i v a c y A c t {Chapter 10:27]
H . M A T IN G W IN A ,
Gazette E d i to r . A d m in is tra tio n o f E s ta te s A c t t i .'O i ]

P r i n t f l o w ( P r iv a t e ) L i m i t e d , A d m in is tra tiv e C o u r t A c t [Chapter 7:01]

G e o r g e S i lu n d i k a A v e n u e ( b e t w e e n S i x th S t r e e t
A n im a l H e a lth A c t [C /ia /? re r 7 9 ;0 /]
a n d E p to n S tr e e t) , H a r a r e ( P .O . B o x C Y 3 4 1 , C a u s e w a y )
1000 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012

Arbitration Act, 1996 No. 6 of 1996) Mental Health Act, 1996 (No. 15 of 1996)
Audit and Exchequer Act [Chapter 22:03] Mines and Minerals Act [Chapter 27:05]
Banking Act [Chapter 24:01] Missing Persons Act [Chapter 5:14]
Bills of Exchange Act [Chapter 14:02] Money Lending and Rates of Interest Act [Chapter 14:14]
Broadcasting Act [Chapter i2;0i] National Social Security Aiitliority Act [Chapter 77:04]
Broadcasting Services Act [Chapter 2:06] Official Secrets Act [Chapter I! :09]
Building Societies Act [Chapter 24:02] Parks and Wildlife Act [Chapter 20:14]
Capital Gains Tax Act [Chapter 23:01] Patents Act [Chapter 26:03]
Censorship and Entertainments Control Act [Chapter 10:04] Pension and Provident Fund Act [Chapter 24:09]
Children’s Protection and Adoption Ac t [Chapfer 5.-C16] Pneumonoconiosis Act [Chapter 15:08].
Citizenship of Zimbabwe Act [Chapter 4;^)/]' Police Act [Chapter 77:70]
Civil Evidence Act [Chapter 8:01] Precious Stones Trade Act [Chapter 21:06]
Civil Matters (Mutual Assistance) Act [Chapter 8:02] Prescribed Rate of Interest Act [Chapter 8:10]
Civil Protection Act [Chapter/0;0(5] Prescription Act [Chapter 8:11]
Commercial Premises Act (Lease Control) [Chapter 74;04] Presidential Powers (Temporary Measures) Act [Chapter 10:20]
Commissions of Inquiry Act [Chapter/0. 07] Prevention of Corraption Act [Chapter 9:76]
Communal Land Act [Chapter 20.04] Prisons Act [Chapter 7:11]
Companies Act [Chapter 24:03] Private Business Corporation Act [Chapter 24:11]
Competition Act,1996 (No. 17 of 1996). Private Investigators and Security Guards (Control) Act [Chapter 27:10]
Constitution of Zimbabwe Private Voluntary Organizations Act [Chapter }7:05]
Constitution of Zimbabwe Amendment Act (No. 17 of 2005) Privileges, Immunities and Powers of Parliament Act [Chapter 2:08]
Consumer Contracts Act [Chapter 8:03] Protected Places and Areas Act [Chapter 11:12]
Contractual Penalties Act [Chapter 8:04] Public Accountants and Auditors Act [Chapter 27:12]
Control of Goods Act [Chapter 14:05] Public Health Act [Chapter 15:09]
Co-operative Societies Act [Chapter 24:05] Public Order and Security Act [C/zapter 77:77]
. Copper Control Act [Chapter 14:06] Public Service Act [Chapter 16:04]
Copyright and Neighbouring Rights Act [Chapter 26:05] Procurement Act [Chapfer 22:/4]
Criminal Law Amendment Act [Chapter 9:05] Radiocommunication Services Act [Chapter 12:04]
Criminal Law (Codification and Reform) Act [Chapter 9:23] Railways Act [Chapter 13:09]
Criminal Matters Act (Mutual Assistance) [Otapter 9:06] Regional, Town and Country Planning Act [Chapter 29:12]
Farmers Licensing and Levy Act [Chapter 18:10] Reserve Bank of Zimbabwe Act [Chapter 22:10]
Fenci ng Act [Chapter 20:06] Revenue Authority Act [Chap/er 25:7/]
Fertilizers, Farm Feeds and Remedies Act [Chapter 18:12] Road Motor Transportation Act [Chapter 13:10]
Vxn&Ttce Act [Chapter 23:04] Road Traffic Act [Chaprer 75:77]
Firearms Act [Chapter 10:09] Roads Act [Chapter 13:12]
Forest Act [Chapter 19:05] - Rural District Councils Act [Chapter 29:13]
Food and Food Standards Act [Chapter 15:04] Securities Act [Chapter 24:25]
Gold Trade Act [Chap/er 27:05] Serious Offences (Confiscation of Profits) Act [Chapter 9:17]
Guardianship of Minors Act [Chapter 5:08] Shop Licences Act [Chapter 14:17]
Harmful Liquids Act [Chapter 9:10] Small Claims Courts Act [Chapter 7:12]
Health Professions Act [Chapter 27:791 Sports and Recreation Commission Act [Chapter 25:15]
High Court (fonnerly High Court of Zimbabwe) Act (Chapter 7:06] Stamp Duties Act [Chapter 23:09]
Hire-Purchase Act [Chapter 14:09] . State Liabilities Act [Chapter 8:14]
Housing and Building Act [Chapter 22:07] State Service (Disability Benefits) Act [Chapter /6.*05]
Immigration Act [Chapter 4:02] State Service (Pension) Act [Chapter 16:06]
Income Tax Act StockTheftAct [Chaprer9:/5]
Industrial Designs Act [Chapter 26:02] Stock Trespass Act [Chapter 19:14]
Inland,Watere Shipping Act [Chapter 7i.*06] Supreme Court (formerly Supreme Court of Zimbabwe) Act [Chapter 7:13]
Inquests Act [Chapter 7:07] Tobacco Marketing and Levy Act [Chapter 18:20]
Insolvency Act [Chapter 6:04] ' Tourism Act [Chapter 14:20]
Insurance Act [Ompier 24:07] Trade Marks Act [Chapter 26:04]
Interpretation Act [Chapter 1:01] Trade Measures Act [Chapter 14:23]
Justices of the Peace and Commissioners of Oaths Act [Chapter 26:04] Traditional Beer Act [Chapter 14:24]
Labour Relations Act [Chapter 28:01] Traditional Leaders Act [Chapter 29:17]
Labour Relations Amendment Act, 2002 (No. 17 of 2002) . Traditional Medical Practitioners Act [Chapter 27:14]
Labour Relations Amendment Act (No. 7 of 2005) Trapping of Animals (Control) Act [Chapter 20:21]
Land Acquisition Act [Chapter 20:10] Urban Councils Act
Land Survey Act [Chapter 20:72] Vehicle Registration and Licensing Act [Chapter 13:14]
Land Surveyors Act [Chapter 27:06] Veterinary Surgeons Act [Chapter 27:15]
Legal Practitioners Act [Clmpter 27:07] War Veterans Act [Chapter 77:75]
LiquorAct [Chapter J4:i2] War Victims Compensation Act [Chapter 11:16]
Magistrates Court Act [Chapter 7:10] Water Act [Chapter 20:22]
Maintenance Act [Chapter 5:09] Wills Act [Chapter 6:06]
Manpower Planning and Development Act [Chapter 28:02] ZINWAAct
Marriage Act [Chapter 5;i7] Zimbabwe Stock Exchange Act [Chapter 24:18]
Matrimonial Causes Act [Chapter 5:75]

■ f
 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2012 1001

N O T ICE S T O C RE D IT O RS A ND D EBTO RS (pursuant to sections 43 and 66 of the A dm inistration of Estates A ct [C /jap/er(5;07]

Al l persons having claim s against the undei>m entioned estates are required to lodge them in detail w ith the executor or representative concerned w ithin the stated peri­
ods, calculated from the date of publication hereof, and those indebted thereto are required to pay to the executor or representative the am ounts due by them w ithin the sam e
period, failing w hich legal proceedings w ill be taken for the recovery thereof.
M .H.C . 7

N um ber D ate W ithin-

of N am e and description of estate of a N am e and address of executor or representative
estate death period of

A letta Sim angaliso M aronga 7.1.2012 30 days C onstance S. M asilo, 6653, N kulum ane, B ulaw ayo. 370865f
113/2012 A ugustine M aketoTsikisayi 25.1.97 30 days Em ilia Tsikisayi C hingozhoro, 1515— 2nd R oad, 370859f
G len V iew J, H arare.
B .728/2012 Thelm a Joyce Elsley . 20.4.2011 30 days A nderson Executor & Trust (Private) Lim ited, 370860f
P.O. Box A C 45, A scot, B ulaw ayo.
1371/2012 Phillip H atifari Fungura 22.6.2009 30 days A i Z. Fungura, 6403, U nit “J”, C hitungw iza. 37086If
251/2012 V ictoria D zviti . 10.6.99 30 days Evah Jiri, 11371, M unyati Street. Zehgeza 4, 370862f
* C hitungw iza.
296 Jaifos Sezere 13.8.2003 30 days B eauty Sezere, 31627, Entum bane, B ulaw ayo. 370864f
, B .744/20I2 Edw ard Ndlovu 13.7.2002 30 days . Ennie N dlovu, M anabeni Prim ary School, 370866f
Private B ag J2, M balabala.
B .212/2012 E lse M indstnip N ielsen . 24.10.2011 30 days Paul C onnolly, legal practitioner, P.O. B ox 299, 370868f
237, Sopers C rescent, V ictoria Falls.
B Y .561/2012 H erbert Zulu 23.10.99 30 days Everson C hikw anha, 5112, N keta 9, B ulaw ayo, 370869f
B .282/2005 N oah M utakiw a . 6.2.2005 30 days Sithabile M utakiwa, 337, C ow dray Park, B ulaw ayo. 370S67f
06/2012 D ebora K uda B angawayo 19.7.2007 30 days Jennet C hashaya, C apital Foods, P.O. B ox 260, 370814f
R uwa.
R egis M honda . 4.10.2004 30 days R em igio Sim barashe M honda, R ukoba Secondary 3708I6 f
School, P.O , B ox 54, B anket.
H .773/2012 Sam uel M udehw e 21.4.2012 30 days A nnie M . M asvikeni, N o. 463, M ID , C hipinge. 370819f
H .760/2012 Titias M ashaya .. . 22.9.2012 30 days Elizabeth M ashaya, 3232, K uw adzana 3, H arare. 37082 H
1259/2011 Takaendesa K am baram i 31.12.2004 30 days B atsirayi K am baram i, 11, N yazvidzi R oad, 3708221
Zengeza 2, C hitungw iza.
1957/2012 B eauty C him w anda . 31.7.2012 30 days R um bidzai M uroyivva, K 934, K atanga, N orton. 3708231. -
1509/2012 Estella C hekeche 6 .6.2012 30 days Lancelot M arufu C hekeche, 9, C anford A venue, 3708241
C otsw old H ills, M abelreign, Harare.
1509/2012 Estella C hekeche 6 .6.2012 30 days Lancelot M arufu C hekeche, 9, C anford A venue, 370824f
C otew old H ills, M abelreign, Harare.
H .769/2012 Paul Tim othy N yam udeza 12.11.2012 30 days Lilian M uzadzi, 202, Sherwood D rive, A vondale 370895f
W est, H arare.
1925/2012 . K ulsum K assim . 25.3.2011 30 days Y unus K assim , 11, Firsgrove R oad, R idgeview , . 370896f
• H arare.
30/2012 Francis G um burayi M apuranga 16.2.2012 30 days C hoice M uskw e, Stand no. 2371, N ewstands, 3708971
C hinzanga Prim ary School, A rda, M utoko.
B Y .26I/2009 Thom as M hlanga 29.7'2009 30 days Thenjiw e M hlanga, 4387, G w abalanda, B ulaw ayo. 370898f
H arare.
199S/2012 G iltM oyosvii 23.7.2012 30 days Sophia M oyosvil, N yadzonya School, 225, M utoko. 370S99f
B .155/2012 Judah G um po .. . 29.1.2012 30 days M akom borero M am here, 20652, Pum ula South, 370900f
B ulaw ayo.
B .751/2012 V aleria V enter 22 .11.2012 30 days B arbra V enter, Sikom bingo Prim ary School, 3709011
P.O.B ox 9033,G w eru.
985/201 0 Jam es Sam bawam edza 14.5,2010 30 days lEG M usim be& Partners, 96, Prince Edw ard R oad, 370S71f
M ilton Park, H arare. ,
C H .48/2012 Jerem iah Pirikisi 29.8.2012 30 days A lice C hari, N yam uroro Prim ary School, 3708721
P.O .B ox 1001,N em bud2iya,Gokw e.
1574/2012 Em m ah N yathi . 6-.4.2007 30 days N . H ogo, 8591-“N ew Zxjroro, H ighfield, H arare, 370876f
1464/2011 N yasha Zaranyika . 22.1.97 30 days Tsitsi Zaranyika, 5136— 64 C rescent, G len V iew 3, 37087 7f
H arare.
R . 16/2012 Em m anuel M akoni . 7.12.2011 30 days W ashington M akoni, 2231, C him oio A venue, 3708831
Y eovil, M utare.
770/2012 D orothy N yathi 2.6.2008 30 days M isheckM .N yathi,Q 67,M zilikazi Tow nship, . 370887f
B ulaw ayo.
M U R.27/2012 M oab Tavengw a M asendeke 5.8.2003 30 days P. M asendeke, 5538—76 C rescent, G len V iew 3, 370888f
H arare.
1469/2012 D avison M lam bo 18.8.2012 30 days J. M lam bo, 1670, M abvazuv a, R usape. 3708931
■ H .589/2012 B itoJofirisi . 19.7,2010 30 days Taengw a Jeofres, 3357-13th Street, D zivaresekwa 4, 370894f
H arare.
1704/2012 C hirum anzu H erbert M utandw a 15.3.2012 30 days M . M asw era, Private B ag 7766, C ausew ay. 2575391
1423/2012 Jam es G um bodete 24.7.2010 30 days S. G um bodete, 5049, G len N orah B , H arare. 2575431
G .Z vitete . . . 45.2012 30 days Frem us Executor Services (Private) Lim ited, 2575471
P.O . B ox H R 9354, H arare.
1784/2012 G race Franklin . 20 .10.2012 30 days B rian Stew art Fannerey, G ilchrist and C ooksey 2575491
(Private) Lim ited.
1532/2012 N ekairo G unire . 29.8.2012 30 days Enirela G unire, 1201, U nit “A ”, Seke, C hitungw iza. 257565f
660/201 2 V ivian V eve 9.1.2007 30 days Justin V eve, M usikavanhu Prim ary School, 2575681
P.O . B ox 2071, C hipinge.
1483/2012 Pension M unyam a 25.12.2004 30 days H azel Patricia M unyam a, 15562, N ew Zengeza 5, 2575761
R .98/2012 John D avid H ara 23.1.2006 30 days G race H ara, 1288, M abvazuw a, R usape. • 2575501
B .252/2012 Sibongile M afa 23.1.200 8 30 days Phineas M utinhiri, 3, M offat Street, N orthend, 3708781
B ulaw ayo.
1002 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14t h De c e m b e r , 2 0 1 2

M J i.C . 7 (continued)

N um ber D a te W iih in
of N a m e a n d d e s c rip tio n o f e s ta te of a N a m e a n d a d d re s s o f e x e c u to r o r re p re s e n ta tiv e :
e s ta te d e a th p e rio d o f

1 4 3 4 /2 0 1 2 C o n sta n c e M u d z o n g a 4 .8 .2 0 0 9 30 days D a w n M u to k o » 5 , S h e lley L a n e, S tra th a v en , H a rare . 370879f

B Y .7 2 6 /2 0 1 2 D u d e N q in d i .... 1 5 -1 .2 0 0 8 30 days E u n ic e N c u b e , 3 1 6 6 1 , E n tu m b a n e ,B u la w a y o . 370880f
M T .2 4 0 /2 0 1 2 V a in a h M a fu k id z e . 2 9 .1 0 .2 0 0 7 30 days G iv e m o re M u z im b a , P .O . B o x 2 2 4 , C h e ch e c h e , 370882f
C h ip in g e
B .7 4 8 /2 0 1 2 F la c k so n B an d a 2 6 .6 .2 0 0 7 30 days M a g g ie B a n d a , 3 2 2 5 3 , E n m m b a n e , B u la w ay o . 257582f
B Y .7 2 3 /2 0 1 2 C u s to n K a s h o ra 3 0 .1 2 .2 0 0 4 30 days J e s c a K a s h o ra, 5 1 6 8 , G w ab a la n d a, L u v e v e, 257583f
B u la w a y o .
B .2 7 7 /2 0 0 6 E m e ld a F a ra i M v e m v e 1 8 .1 2 .2 0 0 5 30 days V im b is a y i M iria m G a n y a , 5 6 8 2 3 , O ld L o b e n g u la , 257584f
B u la w a y o .
4 8 8 /2 0 1 2 E rn e s t M u ta n d w a C h ifa m b a a ls o k n o w n a s E rn e st 3 .5 .2 0 1 2 30 days G « 3 rg e n a R . M a k w e n a , 8 2 3 0 , N k u lu m a n e , B u la w a y o . 2 5 7 5 8 5 f
M ta n d w a C h ifa m b a .
C
B .1 2 5 /2 0 1 2 L u c y E m e lin e E v a n s . ................................... 2 .2 .2 0 1 2 30 days S te lla M .R a d e m e y e r,7 ,B e llo c R o a d ,M a lin d e la , 257586f
B u la w a y o .
7 4 0 /2 0 1 1 D a i N a th u N a ra n a ls o k n o w n a s D a i G o v in d D a n je e . 1 5 .6 .2 0 0 7 30 days M o h a n la l N a th u N a ra n , P .O . B o x 1 0 , B u la w a y o . 257587f
B Y .7 1 9 /2 0 1 2 M h la m b u y a M a j u d a ........................... ...... . . 2 4 .4 .9 3 30 days M a m g w e D h liw a y o , B lo c k 1 /6 , M {H > p o m a , 257588f
B u la w ay o .
3 8 7 /2 0 1 2 D u li P h in e a s N x u m a lo 5 .4 .2 0 1 2 30 days P a tie n c e N x u m a lo , 4 7 0 8 3 /2 . M p o p o m a F la ts , 257589f
B u la w a y o .
V F .3 0 /2 0 1 2 B ru c e C h ris V a n R o o y e n 5 .5 .2 0 1 2 30 days P a u l C o n n o lly , le g a l p ra c titio n e r, 5 2 3 7 , S o p e r 257590f
C re s c e n t, V ic to ria F a lls .
7 0 6 /2 0 1 2 V iv ian P ro b a P e a rce 8 .1 0 .2 0 1 2 30 days G ^ r g in a M a ta re, F irst F lo o r, Q V B u ild in g , F ife 257598f
S d e e t/9 th A v e n u e , B u la w a y o .
B Y .7 1 4 /2 0 1 2 P e te r M a v o lo n tiy a M n k a n d la 1 1 .8 .8 6 30 days M a rg a re t N c u b e , 1 5 2 , S o ts h a n g a n i F la ts . 257597f
W E .1 3 6 /2 0 1 2 E d w in M a sw a n h is e . 2 3 .3 .2 0 1 2 30 days M a n a sa M a k o m b e , O b ra m T n is t C o m p a n y 257599f
(P riv a te ) L im ite d , N o . 1 , M u ta n g iri B u ild in g ,
M a sv in g o .
1 1 1 2 /2 0 1 2 E d in a C h ito n g o 2 5 .4 .2 0 1 2 30 days P e tw z n E x e c u to r & T ru s t C o m p an y (P riv a te ) L im ite d , 2 5 7 5 6 9 f
T h ird F lo o r, T ra v e l C e n tre , 9 3 , J a s o n M o y o A v e n u e ,
H a ra re .
M T Z 4 7 /2 0 1 2 S a ru d z a i Z a n g iro 8 .6 .2 0 1 2 30 days M a g eb u z a P a id am o y o P a tric k , P .O . B o x 1 6 1 , 2575741
C h ech ech e.
1 3 7 5 /2 0 1 2 E v e risto M u z a 1 6 .il.2 0 1 0 30 days R . M u z a, 1 2 3 5 9 , J o h a n n e s b u rg , N o rto n . 2575621
F ra n cis M u s w ak a 2 2 .1 2 .9 4 30 days S h a ro n V h era , H e rb e rt M u s w a k a , 7 7 3 4 , U n it “ K ” , 2575411
S e k e , C h itu n g w iz a .
H .7 6 1 /2 0 1 2 M a ria K u v e y a 2 4 .6 .2 0 0 2 30 days C h a rle s G o n z o , 7 8 , M u p a n i A v e n u e , M u fa k o s e , 257558f
H a rare .
H .7 5 7 /2 0 1 2 C la ra h H a is o s w i 2 8 .7 .2 0 1 1 30 days A le x a n d e r H a is o s w i, 1 2 2 6 0 , B u d iriro 4 , H ara re . 2575641
W E .2 8 /2 0 1 2 W e llin g to n H a m an d is h e 2 .1 2 .2 0 1 1 30 days M a n a sa M a k o m b e, c /o O b ra m T ru s t C o m p a n y 3707231
(P riv a te ) L im ite d , N o . 1 , M u ta n g iri B u ild in g ,
M a sv in g o .
W E .2 0 3 /2 0 1 2 B en eck H apan y en g w i I I .9 .9 1 30 days M a n a sa M a k o m b e , c /o O b ra m T ru s t C o m p a n y 3707251
(P riv a te ) L im ite d , N o . 1 ,M u ta n g iri B u ild in g ,
M a s v in g o .
2 5 4 /2 0 1 2 W in n ie D h a k a 1 5 .9 .2 0 0 2 30 days N y a ra i M a rce ly n G w a tid zo , 1 5 2 2 4 , N e w Z e n g e z a 4 , 370737f
C h itu n g w iz a .
1 3 9 7 /2 0 1 2 L u c ia h M a h ich a n i 2 6 .i0 .9 6 30 days N y a s h a M a h ich a n i, 1 1 , B a rb e t A v e n u e , N o rth lea , 3707471

G w e ru .
1 6 3 0 /2 0 1 2 M ic h a e l J o h n W h itin g 8 .2 .2 0 0 6 30 days G . M . C ro s la n d , A th e rsto n e & C o o k , P . O . B o x 2 6 2 5 , 3 7 0 7 5 0 f
H a rare .
1 1 9 2 /2 0 1 2 Ire n e H a w k e . . . . 2 2 .5 .2 0 1 2 30 days H a ra re B o a rd o f E x e c u to rs , P .O . B o x 2 0 9 3 , H a rare . 370851f
7 6 5 /2 0 1 2 T a u ris a i P e tro s M a s h o ro k o to 4 .2 .2 0 1 1 30 days S a y ra o re M a s h o ro k o to .C h ig id S c h o o l,P -0 . B o x 9 4 , 370853f
B in d u ra .
2 4 8 /2 0 1 2 . C o n s ta n c e V h in y u . 2 6 .3 .2 0 1 0 30 days M ic h a e l M a n g a , 1 7 , C ly d e S tre et, (3 h e g u tu . 3708541 .
H .7 5 0 /2 0 1 2 L a w re n c e M a s h in g e . 8 .1 1 .2 0 1 2 30 days S a ra h Z a fc a liy a , 1 0 5 9 4 , G le n V ie w 8 ,,H a ra re . 3708551

N O T IC E S O F L IQ U ID A T IO N A N D D I S T R I B U T I O N A C C O U N T S L Y IN G F O R I N S P E C T I O N
(p u rs u a n t to s e ctio n 5 2 o f th e A d m in is tra tio n o f E s ta te s A c t [Chapter 6:01])
No t ic e is h e re b y g iv e n th a t c o p ie s o f liq u id a tio n a n d d is trib u tio n a c c o u n ts in th e u n d e r-m e n tio n e d e s ta te s w ill b e o p e n fo r th e in s p e c tio n o f a ll p e rs o n s in te re s ted th e re in
fo r a p e rio d o f 2 1 d a y s (o r lo n g e r if s ta ted ) fro m th e d a te s s p e c ifie d , o r fro m th e d a te o f p u b lic a tio n h e re o f, w h ic h e v e r m a y b e th e la te r. A c c o u n ts w ill lie fo r in s p e c tio n a t th e
o ffic es s p e c ifie d b e lo w . O b je c tio n s to a n a c c o u n t s h o u ld b e lo d g e d w ith th e M a s te r, H a ra re , o r th e A s sis ta n t M a ste r, B u la w a y o , a s th e c a se m a y b e . S h o u ld n o o b je c tio n s b e
lo d g e d to th e a c co u n t d u rin g th e p e rio d o f in s p e c tio n , A e e x e c u to r c o n c ern e d w ill p ro c e ed to m a k e p a y m e n ts in a c c o rd a n c e th e re w ith .
M .H .C .2 8

N um ber D a te D e sc rip tio n

of N a m e a n d d w e rip tio n o f e s ta te or of O ffic e o f th e
e s ta te p e rio d a c co u n t

6 6 9 /2 0 1 2 P e d z is a i M a p u ra n g a 21 days F irs t a n d F in a l • M a s te r o f th e H ig h C o u rt, H a ra re . 370902f

A c co u n t
4 2 3 /2 0 1 2 Ir^ n M udehw e 21 days F irs t a n d F in a l M a s te r o f th e H ig h C o u rt, H a rare . 370820f
A c co u n t
H .6 2 8 /2 0 1 2 D ic k s o n M a n d ik o n z a 21 days F irst a n d F in a l M a s te r o f th e H ig h C o u rt, H a ra re . 370825f
A cco u n t
 Zim b a b w e a n Go v e r n me n t Ga z e t t e , 14t h De c e m b e r , 2012 1 0 0 3

yiM.C.2% (continued)
N u m b e r D a t e D e s c r i p t i o n

o f N a m e a n d d e s c r i p t i o n o f e s t a t e o r o f O f f i c e o f t h e

e s t a t e p e r i o d a c c o u n t

W E . 1 4 / 2 0 0 9 T o m D h a m b u z a 2 1 d a y s F i r s t a n d F i n a l A d d i t i o n a l A s s i s t a n t M ^ t e r M a s v i n g o . 3 7 0 7 2 6 f

A c c o u n t

1 0 9 7 / 2 0 1 1 G i b s o n C h i n e m b i r i 2 1 d a y s F i r s t a n d F i n a l M ^ t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 3 9 f

A c c o u n t

H . 6 0 7 / 2 0 I 2 M e r c y M a c h i n g u r a 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 0 f

A c c o u n t

M u s i y i w a S a m u e l R w o d z i 2 1 d a y s F i r s t a n d F i n a l , M a g i s t r a t e s , M a r o n d e r a . 3 7 0 7 4 1 f

A c c o u n t

1 0 5 7 / 2 0 1 0 V i c t o r T a p f u m a M u v u t i 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 2 f

A c c o u n t

H . 5 1 4 / 2 0 0 9 S u s a n D h l i w a y o 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 3 f

L i q u i d a t i o n a n d

D i s t r i b u t i o n A c c o u n t

3 8 / 2 0 0 8 B o m w e l l M u d z o n g a . 2 1 d a y s F i r s t a n d F i n a l M a g i s t r a t e s , M u t o k o . 3 7 0 7 4 4 f .

A c c o u n t

4 1 7 / 2 0 0 9 P a r a d z a i M u t e m e r a 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . ^ 3 7 0 7 4 5 f

A c c o u n t

1 0 4 2 / 2 0 1 0 T i m o t h y C h i t u m a n g a 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 6 f

A c c o u n t

7 2 7 / 2 0 1 2 M a s i m b a S a m u r i w o 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 8 f

A c c o u n t

4 4 3 / 2 0 1 2 J u l i e t P a m e l a B o o t h . 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 7 4 9 f

, A c c o u n t

H . 1 6 5 / 2 0 1 2 N a u m e C h i m b i m a 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 8 5 6 f

A c c o u n t

H . 5 5 2 / 2 0 1 2 G o d f r e y C h a k u v i n g a 2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 3 7 0 8 5 7 f

A c c o u n t

B Y . 5 2 3 / 2 0 1 2 D e v a r i s N y o n g o r o 2 1 d a y s F i r s t a n d F i n a l A s s i t a n t M a s t e r o f t h e H i g h C o u r t , 2 5 7 5 9 2 f

A c c o u n t B u l a w a y o .

B Y . 6 2 2 / 2 0 1 2 P r i d e B h e k a . 2 1 d a y s F i r s t a n d F i n a l A s s i t a n t M a s t e r o f t h e H i g h C o u r t , 2 5 7 5 9 3 f

A c c o u n t B u l a w a y o .

B Y . 3 5 3 / 2 0 1 2 H e n r y N t i n i 2 1 d a y s F i r s t a n d F i n a l A s s i t a n t M a s t e r o f t h e H i g h C o u r t , 2 5 7 5 9 4 f

A c c o u n t B u l a w a y o .

B Y . 5 5 4 A / 2 0 1 2 C e p h a s M o y o F i r s t a n d F i n a l A s s i t a n t M a s t e r o f t h e H i g h C o u r t , 2 5 7 5 9 5 f
2 1 d a y s

A c c o u n t B u l a w a y o .

B Y . 4 5 6 / 2 0 1 2 T h u l e T s h a b a n g u . 2 1 d a y s F i r s t a n d F i n a l A s s i t a n t M a s t e r o f t h e H i g h C o u r t , 2 5 7 5 9 6 f

A c c o u n t B u l a w a y o .

8 9 4 / 2 0 1 2 P a t r i c i a E . C o r n i s h F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u i t , H a r a r e . 2 5 7 5 4 2 f
2 1 d a y s

L i q u i d a t i o n a n d

D i s t r i b u t i o n A c c o u n t

K M . 8 3 / 2 0 1 2 E d w a r d C h i h u r u r u 2 5 7 5 5 5 f
2 1 d a y s F i r s t a n d F i n a l M a g i s t r a t e s , K a d o m a .

L i q u i d a t i o n a n d

D i s t r i b u t i o n A c c o u n t

J u d i t h M b e n j e F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 2 5 7 5 5 6 f
2 1 d a y s

A c c o u n t

6 4 4 / 2 0 1 2 K e r e s i a S a b a n h u M a s t e r o f t h e H i g h C o u r t , H a r a r e . 2 5 7 5 5 9 f
2 1 d a y s F i r s t a n d F i n a l

A c c o u n t

9 9 2 / 2 0 0 9 A d o l f N y o m e r a M a s t e r o f t h e H i g h C o u r t , H a r a r e . 2 5 7 5 6 0 f
2 1 d a y s F i r s t a n d F i n a l

A c c o u n t

I 9 8 4 / 2 0 1 1 A v n a l d o E n c a v n a c a o G o u v e i a .
2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e . 2 5 7 5 7 5 f

A c c o u n t

3 9 1 / 2 0 1 2 J u n y a M e k i a l s o k n o w n a s J u n y a D u b e a l s o k n o w n a s J u n y a 2 5 7 5 7 7 f
2 1 d a y s F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e .

J a m e s
A c c o u n t

1 1 6 3 / 2 0 0 7 D a p h n e y I s a b e l l e B r o c k . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M a s t e r o f t h e H i g h C o u r t , H a r a r e . 2 5 7 5 7 8 f
2 1 d a y s F i r s t a n d F i n a l

L i q u i d a t i o n a n d

D i s t r i b u t i o n A c c o u n t

W E 2 1 4 / 2 0 1 1 T i c h a f a r a S h u m b a
F i r s t a n d F i n a l A d d i t i o n a l A s s i s t a n t M a s t e r o f t h e H i g h 2 5 7 5 8 0 f
2 1 d a y s

A c c o u n t C o u r t , M a s v i n g o .

W E . 2 8 8 / 2 0 1 2 R a t i d z o M u f a r a r i ,
F i r s t a n d F i n a l A d d i t i o n a l A s s i s t a n t M a s t e r o f t h e H i g h 2 5 7 5 8 1 f
2 1 d a y s

A c c o u n t C o u r t , M a s v i n g o .

B 3 8 0 / 2 0 1 2
I s h m a e l J e a l o u s M u d a v a n h u 3 7 0 8 8 1 f
F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t . H a r a r e ,
2 1 d a y s

A c c o u n t

B Y . 1 5 1 / 2 0 1 2 S i k u r u p a t a N d h l o v u .
A s s i s t a n t M a s t e r o f t h e H i g h C o u r t , 3 7 0 8 8 4 f
2 1 d a y s F i r s t a n d F i n a l

A c c o u n t C o u r t , B u l a w a y o

P h i l e m o n M d o n g a M u d e
B Y . 6 3 8 / 2 0 1 2
A s s i s t a n t M a s t e r o f t h e H i g h C o u r t , 3 7 0 8 8 5 f
2 1 d a y s F i r s t a n d F i n a l

A c c o u n t , B u l a w a y o .

B Y . 6 2 8 / 2 0 1 2 P h i n i a s N t i n i
A s s i s t a n t M a s t e r o f t h e H i g h C o u r t , 3 7 0 8 8 6 f
2 1 d a y s F i r s t a n d F i n a l

L i q u i d a t i o n a n d B u l a w a y o .

D i s t r i b u t i o n A c c o u n t

2 6 9 / 2 0 1 2 P a u l o u s M a t s v o r o r o . 3 7 0 8 8 9 f
F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e .
2 1 d a y s

A c c o u n t

1 6 2 6 / 2 0 1 2 B e n i z i o S h o n e C o n g o 3 7 0 8 9 0 f
F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e .
2 1 d a y s

L i q u i d a t i o n a n d

D i s t r i b u t i o n A c c o u n t

2 1 8 / 2 0 1 2 S h a d r e c k T a p e r a . 3 7 0 8 9 H
F i r s t a n d F i n a l M a s t e r O f t h e H i g h C o u r t , H a r a r e .
2 1 d a y s

A c c o u n t

1 1 / 2 0 1 0 C l e o p a s M u t a s a . 3 7 0 8 9 2 f
F i r s t a n d F i n a l M a g i s t r a t e s , C h i t u n g w i z a .
2 1 d a y s '

A c c o u n t

1 0 3 2 / 2 0 1 0 H e r b e r t M u r i m i r w a 3 7 0 8 6 3 f
F i r s t a n d F i n a l M a s t e r o f t h e H i g h C o u r t , H a r a r e .
2 1 d a y s

A c c o u n t
1004 Zim b a b w e a n Go v e r n m e n t Ga z e t t e , 14x h De c e m b e r , 2012

E D IC T S : S E L E C T IO N O F E X E C U T O R S , T U T O R S A N D C U R A T O R S D A T IV E
(p u rsu a n t to se c tio n s 2 5 ,7 4 a n d 7 9 o f th e A d m in istr a tio n o f E sta te A c t [Chapter 6:01])
No t ic e is h e r e b y g iv e n th a t th e e sta te o f th e u n d e r -m e n tio n ed d e ce a s e d p e r s o n s , minors o r p e r so n s w h o se w h e r e a b o u ts a r e u n k n o w n , a r e u n r e p r e se n te d a n d th a t th e
n e x t o f k in , c r e d ito r s o r o th e r p e r so n s c o n c er n e d a r e r e q u ir e d to a tte n d o n th e d a te s a n d a t th e tim e s a n d p la c es s p e c ifie d , fo r th e s e le c tio n o f a n 'e x e c u to r , tu to r o r c u r a to r
d a tiv e, a s tlie c a s e m a y b e . M e e tin g s in H a r a r e w ill b e h e ld b e fo r e th e M a ster , in B u la w a y o b e fo r e th e A ssista n t M a ste r ; a n d e ls e w h e r e b e fo re th e D istr ic t A d m in istra to r .

. M .H .C . 2 5

N u m ber T im e o f m e e tin g

of N a m e a n d d e scr ip tio n o f e sta te P la c e o f m e e tin g F o r s e le c tio n o f

e sta te D a te H our

1 9 8 2 /2 0 1 2 N ic h o la s Z u lu , 1 8 .1 .2 0 1 3 lO .C W a .m . H arare E x e c u to r d a tiv e . 370873f

, 1 9 8 7 /2 0 1 2 F e lix M u fu n d a . , 1 8 .1 .2 0 1 3 1 0 .0 0 a ,m . H arare E x e c u to r d a tiv e . 370874f
1 9 9 6 /2 0 1 2 K e te r in a K u n a k a 1 8 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 370875f
7 6 0 /2 0 1 2 M a n a sa M u z o n d o 2 .1 .2 0 1 3 1 0 .0 0 a .m . G w eru E x e c u to r d a tiv e . 370805f
7 6 3 /2 0 1 2 M o r g a n S ith o le 2 .1 .2 0 1 3 1 0 .0 0 a .m . B u la w a y o E x e c u to r d a tiv e . 3 7 0 8 0 6 f
7 5 7 /2 0 1 2 T h o b e k ile M o y o 2 .1 .2 0 1 3 1 0 .Q 0 a .m . B u la w a y o E x e c u to r d a tiv e . 370807f
7 6 5 /2 0 1 2 D e z im o n J e r o m e S ib a n d a . 2 .1 .2 0 1 3 lO .lX ) a .m . B u la w a y o E x e c u to r d a tiv e . 3 7 0 8 0 8 f
200/2012 K e y N d h lo v u . 2 .1 .2 0 1 3 1 0 .0 0 a .m . B u la w a y o E x e c u to r d a tiv e. 3 7 0 8 1 O f
B .7 5 8 /2 0 1 2 P a tr ick N tu li . 2 .1 .2 0 1 3 1 0 .0 0 a .m . V ic to r ia F a lls E x e c u to r d a tiv e . 3 7 0 7 3 0 f
- B .7 3 5 /2 0 1 2 B e th a N c u b e . 2 .1 .2 0 1 3 1 0 .0 0 a .m . B u la w a y o E x e c u to r d a tiv e . 3 7 0 7 3 2 f
B .7 3 7 /2 0 1 2 I m a ta A lr o d N a w a . 2 .1 .2 0 1 3 1 0 .0 0 a .m . B u la w a y o E x e c u to r d a tiv e . 3 7 0 7 3 3 f
B .7 5 9 /2 0 1 2 L ondon K ahw em a 2 .1 .2 0 1 3 1 0 .0 0 a .m . B u la w a y o E x e c u to r d a tiv e . 3 7 0 7 3 4 f
1 9 8 4 /2 0 1 2 A r n o ld M a w o n e k e 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e. 3 7 0 7 3 6 f
1 9 7 7 /2 0 1 2 Ir e en C h im o n y o .1 6 ,1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 3 7 0 7 3 8 f
1 9 7 2 /2 0 1 2 D o u g la s E m b le to n J o h n . 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e. 3 7 0 8 5 2 f
1 5 0 8 /2 0 0 7 N y ik a M u n d iy a . 1 8 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 3 7 0 8 l7 f
1 9 2 2 /2 0 1 2 S im o n M a p fu m o 4 .1 .2 0 1 3 1 0 .(X ) a .m . H^re E x e c u to r d a tiv e . 3 7 0 8 2 6 f
1 9 1 2 /2 0 1 2 A n to n io P h in e a s M id h io v e 4 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 370827f
V
1 9 9 6 /2 0 1 2 J u lie t N c u b e . , ' . 1 1 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 3 8 f
1 9 7 8 /2 0 1 2 S h e r p h er d C h ip id z a . 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 4 0 f
1 9 8 5 /2 0 1 2 J e fita K a sir a y i . 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 4 4 f
1 9 8 3 /2 0 1 2 E sth a M u tsa d y a n g a 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 4 5 f
1 9 8 6 /2 0 1 2 A le x io M a se n d a . 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 4 6 f
1 9 9 1 /2 0 1 2 E m m anu el G eri . 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 6 1 f
1 1 8 0 /2 0 0 9 E llio t T a p fu m a n e y i M a n y ik a 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 6 6 f
1 8 9 6 /2 0 1 2 Shadreck N zounhenda 1 6 .1 .2 0 1 3 1 0 .0 0 a .m . H arare E x e c u to r d a tiv e . 2 5 7 5 7 9 f

C O M P A N IE S A C T [CHAPTER 24:03]

C H A N G E O F C O M P A N IE S ’ N A M E S

No t ic e is h e re b y g iv e n , in te r m s o f s e c tio n 25 of th e C o m p a n ie s A c t [Chapter 24:03], th a t a p p lic a tio n will b e m ade, not less th a n 14 d a y s fr o m th e d a te o f p u b lic a tio n
o f th is n o tic e , to th e C h ie f R e g istr a r o f C o m p a n ie s, fo r h is a p p r o v a l to c h a n g e th e n a m es o f th e u n d e r -m e n tio n e d c o m p a n ie s a s in d ic a te d b e lo w ,

N um ber N am e C h a n g e o f n a m e to A gent

2 3 4 5 8 /2 0 0 8 L itr e to n I n v e s tm e n ts (P r iv a te ) L im ite d H & H M ic r o F in a n c e (P riv a te ) L im ite d C . C liim b u n u 37095If

5 0 1 0 /9 4 E d w a r d s B u r e a u d e C h a n g e (P riv a te ) L im ite d Im a r a F id u cia r y (P riv a te ) L im ite d K P M G , P .O . B o x 6 , H a r a r e . 257548f

6 2 8 0 /9 5 L e E ffe l I n v e s tm e n ts (P r iv a te ) L im ite d D u p w a In v e stm e n ts (P riv a te ) L im ite d W ic k b a r , R O . B o x C Y 1 1 3 3 , 370722f

C a u se w a y .

1 6 8 2 /2 0 1 0 N in tlin g I n v e s tm e n ts (P r iv a te ) L im ite d U n ite d S ta r s H o ld in g s (P riv a te ) L im ite d K P M G , P .O . B o x 6 , H a r ar e . 370727f .,.4

CONTENTS
General Notices General Notices
Number Page Number Page
592. M e d icin e s a n d A llie d S u b sta n c es C o n tr o l A c t [Chapter ]5:03]: 601. C u sto m s a n d E x c i.se A c t [Chapter 23:02]: A p p o in tm e n t a n d L ic e n sin g
A p p r o v a l o f R e g istra tio n o f H u m a n M e d ic in e s . . . . . . . 969 o f B o n d e d W a r e h o u se s ............................................................................... 986
593. M e d ic in e s a n d A llie d S u b sta n c es C o n tr o l A c t [Chapter 15:03]: 602. C o m p e titio n A c t [Chapter 23:02]: N o tic e o f I n v e s tig a tio n in to
■ A p p r o v a l o f R e g istr a tio n o f V e te r in a r y M e d ic in e s ....................... 974 A lle g a tio n s o f R e str ic tiv e P r a c tic e s b y P r iv a te A b a tto ir . . . . . . 986
594. M e d icin e s a n d A llie d S u b sta n c e s C o n tr o l A c t [Chapter 15:03]: 603. C o m p e titio n A c t [Chapter 23:02]: N o tic e o f In v e stig a tio n in to
C a n c ella tio n o f C e r tific a te s o f R e g istr a tio n o f V e te rin a r y M e d ic i n e s . 974 A lle g a tio n s o l M o n o p o ly S itu a tio n b y H a r a r e C ity C o u n c il o n th e
595. M e d ic in e s a n d A llie d S u b sta n c e s C o n tr o l A c t fC /w /7 te r /5 .0 i]: P r o v isio n s o f M u n ic ip a l E c o n o m ic S e r v ice s 987
C a n c e lla tio n o f C e r tific a te s o f R e g istr a tio n o f H u m a n M e d ic in e s . . 976
604. C o m p e titio n A c t [Chapter 23:02]: N o tic e o f In v e stig a tio n in to
596. L a b o u r A c t [C /ia p r c r 2 8 .* (}/]: A p p lic a tio n fo r R e g istr a tio n o f a A lle g a tio n s o f M o n o p o ly S itu a tio n b y B u la w a y o C ity C o u n cil o n th e
T r a d e U n io n : A m a lg a m a te d W o r k er s U n io n o f Z im b a b w e .... 986 P r o v isio n s o f M u n ic ip a l E c o n o m ic S e r v ice s ....................... ..... 987
597. S ta te P r o c u r e m e n t B o a r d : T e n d e r s I n v i te d ....................................... 986
605. L a b o u r A c t [C /t(7 ;? rcT 2 S ;(jy ]: L a fa o u r C o u r tC a le n d a r 2 0 1 3 , . . . 987
■ 598. H e a lth P fo fe s s io n s A c t[C A q p /c /-2 7 ;/0 ]:E le c tio n o fR a d io lo g lstM e m b e r
606. Suprem e C ourt A ct [Chapter 7:14] H ig h C ourt A ct [Clmpter 7.-06]:
o f th e M e d ic a l a n d D e n ta l P r a c titio n e r s C o u n c il o f Z im b a b w e . . . 986
S u p r e m e a n d H ig h C o u r t C a le n d a r 2 0 1 3 ........................................ 987
599. S ta te P r o c u re m e n t B o a r d : T e n d er s I n v i te d ........................................ 986
600. L abour A ct [Chapter 28:01]: A p p lic a tio n fo r R e g istr a tio n o f a Statutory Instrument Issued as a Supplement to this Gazette
T r a d e U n io n : Z im b a b w e E a r ly C h ild h o o d D e v elo p m en t T e a c h er s a n d Number
A llie d W o r k e r s U n io n ............................ ............................ 986
187. B in d u r a (L ic en s in g P r e m ise s) (A m e n d m e n t) B y -la w s, 2 0 1 2 (N o . 1 ).

^r’uted hv the Government Printer, Harare.